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Preface
Abstract
Advances in DNA sequencing revolutionized the field of genomics over the last 5 years. New
sequencing instruments make it possible to rapidly generate large amounts of sequence data
at substantially lower cost. These high-throughput sequencing technologies (e.g. Roche 454
FLX, Life Technology SOLiD, Dover Polonator, Helicos HeliScope and Illumina Genome
Analyzer) make whole genome sequencing and resequencing, transcript sequencing as well as
quantification of gene expression, DNA-protein interactions and DNA methylation feasible
at an unanticipated scale.
In the field of evolutionary genomics, high-throughput sequencing permitted studies of whole
genomes from ancient specimens of different hominin groups. Further, it allowed large-scale
population genetics studies of present-day humans as well as different types of sequence-
based comparative genomics studies in primates. Such comparisons of humans with closely
related apes and hominins are important not only to better understand human origins and
the biological background of what sets humans apart from other organisms, but also for
understanding the molecular basis for diseases and disorders, particularly those that affect
uniquely human traits, such as speech disorders, autism or schizophrenia. However, while
the cost and time required to create comparative data sets have been greatly reduced, the
error profiles and limitations of the new platforms differ significantly from those of previous
approaches. This requires a specific experimental design in order to circumvent these issues,
or to handle them during data analysis.
During the course of my PhD, I analyzed and improved current protocols and algorithms for
next generation sequencing data, taking into account the specific characteristics of these new
sequencing technologies. The presented approaches and algorithms were applied in different
projects and are widely used within the department of Evolutionary Genetics at the Max
Planck Institute of Evolutionary Anthropology. In this thesis, I will present selected analyses
from the whole genome shotgun sequencing of two ancient hominins and the quantification
of gene expression from short-sequence tags in five tissues from three primates.
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Summary
New high-throughput sequencing technologies make it possible to apply sequence-based ap-
proaches in an unanticipated number of fields. In the field of evolutionary genetics, it is
now feasible to apply sequencing-based approaches for a wide range of comparative genomic
studies. For example, high-throughput sequencing can be applied to study the genomes
from ancient specimens of different hominin groups, like Neandertals and Denisovans, and
allow large-scale population genetics studies of present-day humans as well as measuring
quantitative differences in the transcriptomes and DNA-interactome of different apes and
primates.
However, while the cost and time for applying these new technologies was greatly reduced
compared to traditional Sanger sequencing, the error profiles and limitations of the new
instruments differ significantly from those of previous technologies. Further, the types of
errors observed as well as the number and length of sequences vary considerably between
these different new technologies. Therefore, data analysis requires a detailed understanding
of the imperfections in the resulting sequence data and how these pose challenges and cause
biases. I review current sequencing technologies and point out their conceptual limitations.
In this thesis I describe very specific biases and limitations, which go back to the technical
details of how DNA molecules are prepared for sequencing, sequencing templates immobilized
and finally read out.
Current high-throughput technologies have an average error rate of 1/25 to 1/1,000, which is
considerably higher than the 1/10,000 to 1/100,000 observed for high quality Sanger sequence
read outs. The in vitro amplifications which are generally performed prior to sequencing in-
troduce a higher error into the sample before it enters the actual sequencing process. In
addition, currently used random-dispersal protocols for immobilization of sequencing tem-
plates using beads or other solid surfaces cause mixed signal read outs and dependence of
sequencing errors from strength and distance of close-by sequencing reactions.
Most errors on the new instruments originate from signal-to-noise thresholding and signal
detection issues. Further, error rate substantially increases with the position in the sequence
due to reductions in reaction efficiency, molecule damage and phasing, a process in which not
all molecule copies are equally extended in every sequencing step. Shorter read lengths from
these new platforms limit the accurate sequence mapping and assembly of genomes. Only
paired end or mate pair protocols help to overcome some of these limitations by providing
information about relative location and orientation of a pair of reads.
I have analyzed the currently most frequently used high-throughput sequencing platform,
the Illumina Genome Analyzer, in more detail. Based on the problems observed frequently
in runs performed at the Max Planck Institute for Evolutionary Anthropology, I present
simple rules, which shall enable the identification and handling of the most common prob-
lems. I describe the different sources of high variance in run quality, ranging from issues
with the sequencing libraries, to incorrect instrument adjustment and handling. Particles
like chemistry lumps, dust and lint can cause pseudo sequence signals which result in the
analysis of low sequence complexity reads not originating from the actual sequencing library.
While sequence entropy filters efficientily remove these sequence, tagging or indexing allow
a superior method for filtering real library molecules and further reduce the risk of library
contamination.
For sequence reads where part of the adapter sequence is included, the position in the se-
quence read at which the adapter sequence begins has to be identified and the read trimmed
appropriately. Unfortunately, this is not part of the standard Illumina data processing and
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also non-trivial for short adapter fragments, especially given the increasing sequencing error
at the end of reads. If reads are not filtered for known chimeras and trimmed for adapter
sequences, these may interfere with mapping/alignment and thereby impact downstream
analysis. For paired end reads the correct identification of the adapter set-in is eased by
maximizing autocorrelation of the two reads with the outlined read merging process. In ad-
dition to the efficient identification of adapters, merging reduces error rates in the consensus
called sequence part. The algorithm presented has therefore been vital for different ancient
DNA studies at the Max Planck Institute. Various library preparation biases may exist and
impact sequencing results. For this reason, for example PCR duplicates need to be identified
and specifically handled in analysis.
Considering that differences in error profiles are one of the major differences between tech-
nologies, reduction of these errors and precise estimates for the correctness of a specific base
in a sequence are very important for any type of analysis. I present a new approach to base
calling, the conversion of intensity measures into bases, for Illumina sequencing instruments.
The approach presented is unique and currently applies to the full range of different Illumina
sequencing chemistries and platform versions, for which it reduces sequencing error by at
least 10-20%.
On the Illumina platform a strong correlation of adenine and cytosine intensities and of gua-
nine and thymine intensities as well as a dependence of the signal for a specific cycle on the
signal of the cycles before and after (phasing and pre-phasing) complicate base calling. Pre-
vious approaches have either completely modeled the sequencing process or at least corrected
raw intensities prior to the application of statistical learners. Therefore, all these approaches
depend on a good understanding and modeling of the sequencing process. The developed
base calling package, Ibis (Improved base identification system), by-passes this prob-
lem by direct training of one statistical model per sequencing cycle based on raw cluster
intensities of multiple input cycles, directly incorporating the effects of phasing. Thus, Ibis
implements the most general and flexible approach, which is of advantage when considering
the vast improvements of sequencing chemistry and instrument over the last years. Further,
the performance of Ibis on standard hardware is significantly better than for other existing
alternative base callers. Increases in mappable sequences due to reduced base identification
errors as well as improved and calibrated PHRED-like quality scores enable the direct use of
the sequences in other software packages.
I present two applications of Ibis and other principals presented in this thesis. I analyzed
one of the first applications of the Illumina sequencing platform, the NlaIII Digital Gene
Expression (DGE) approach, which infers gene expression levels through short 17nt-tag se-
quencing of the 3’ ends of transcripts. This protocol was used to study brain, heart, kidney,
liver and testis tissues of humans, chimpanzees and rhesus macaques. The biggest analysis
challenge were the short tags which are not unique to specific genomic sites or genes and for
which the uniqueness of tags differs slightly between the three species. Further, annotation
of tags was problematic due to very different annotation quality for the three species. Only
very recent human gene annotation provided the necessary annotation of 3’ untranslated re-
gions and could be projected to the chimpanzee and rhesus macaque genomes, losing about
36% of genes annotated in human but giving similar proportions of tag counts within genes
for all three species.
From comparisons to other studies of the same species and tissues, larger disagreement was
observed than was expected. For example, differences in the percentage differentially ex-
pressed genes or in the symmetry of assignment of changes to evolutionary lineages were
observed. It is likely that all methods have technological (experimental and analysis) bi-
ases. A comparison with the Babbitt et al. study, also using the NlaIII DGE protocol but
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for different brain samples, clearly shows that sampling variation is at least in the range of
biological differences between human and chimpanzee and that analysis variation may even
be as strong as differences of humans and chimpanzees when compared to rhesus macaques.
Future studies will need to control sample environmental effects, sample age, and tissue sam-
pling more thoroughly. Further, improved experimental and analysis protocols are required
which allow to detect and measure subtle effects that could introduce a species bias. Cur-
rently, species specific differences may easily originate from different genome quality, genome
completeness and genome annotation quality.
The second analysis presents whole genome shotgun sequencing data that was generated for
two hominin genomes from ancient DNA, the Neandertal and Denisova genome. Ancient
DNA sequences are generally short in length, damaged, and at low copy-number relative to
co-extracted environmental DNA. For Neandertal and Denisova the challenges from sequenc-
ing ancient DNA, which include adapter sequence at the read ends, chimerical sequences and
other artifacts as well as sequencing error for short molecule lengths, have been addressed
using the described approaches of improved base calling, tag filtering, and short paired end
read merging. In combination with experimental approaches for reducing ancient DNA dam-
age and the consensus from PCR duplicates, the sequencing error associated with ancient
DNA studies could be considerably reduced. The remaining error from sequencing and error
originating from ancient DNA damage in the Denisova molecule read outs is even lower than
for present-day human sequences generated with the same technology.
I show how the ancient DNA sequences can be used to study sites in the human genome
which have changed since the last common ancestor of human and chimpanzee and to identify
features that set fully anatomically modern humans apart from other hominin forms. The
identified positions point to several regions and genes, some of which might be affected by
positive selection in the recent evolutionary history of modern humans. Experimental work
will be required to elucidate the physiological consequences of the identified changes. In
addition, I describe an interesting subset of sites which changed on the human lineage. I
identified tens of thousand of positions where Denisovans and Neandertals disagree in the
ancestral state at sites where the human reference sequence carries the derived allele. These
positions are inconsistent between lines that separated more than half a million years ago
and at least partially, reflect variation at the point of Human-Neandertal-Denisova lineage
separation that segregated differently in the three lineages (incomplete lineage sorting).
It is likely that a large proportion of these sites, which were polymorphic at the time when
human, Neandertal and Denisovan lineage separated, fixed for the derived allele in present-
day humans. Thus, these differently segregating sites might have been reintroduced into
some present-day human populations by admixture with either Neandertals or Denisovans
and can be used to test present-day human individuals whether they show more frequently
the ancestral allele for the Denisova ancestral sites or the ancestral allele for Neandertal
ancestral sites. When analyzing these Neandertal-Denisova discordant sites in twelve present-
day populations, they turned out to be informative for detecting admixture with either of the
ancient population. I could confirm that an African individual shares fewer ancestral alleles
with Neandertal than do all non-African individuals, supporting the admixture signal with
non-Africans described in Green et al. for the Neandertal genome. Further, I could show that
Melanesians, especially the two Papuan individuals, show a signal of Denisovan admixture
not shared with other sampled populations, a result in agreement with the D-statistics for
population pairs presented in Reich et al. for the Denisova genome.
During analysis, I point out differences in sampling of the reads obtained for the Neandertal
and the Denisovan genomes. For example, in human accelerated regions Neandertal and
Denisova data both show that these regions tend to predate the human-Denisova-Neandertal
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split and that differences caused by biased gene conversion tend to be older in time, however
we sampled much more reads covering ancestral sites just in the Denisova data. While this
may point to a simple sampling effect, an excess in the number of Denisova ancestral sites
was observed in the concordance analysis, which can not result from sampling and also does
not originate from a human reference sequence bias (from the Neandertal admixture present
in parts of the reference genome). Currently this excess might either orignate from different
alignment approaches or admixture into the Denisovan individual from some archaic hominin.
Both analyses pointed out that small effects throughout the whole data generation and data
analysis process may introduce sufficiently large biases to complicate drawing biological
conclusions from experimental data. The information and approaches outlined in this thesis,
will however help to either prevent generating such biased data sets or at least reduce the
sequencing instrumentation biases.
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Zusammenfassung
Die Verfu¨gbarkeit neuer Sequenzierinstrumente ermo¨glicht die Anwendung sequenzbasierter
Methoden fu¨r eine Vielzahl biologischer Gebiete. Auf dem Gebiet der evolutiona¨ren Ge-
netik ist es heutzutage mo¨glich sequenzbasierte Methoden fu¨r vergleichende Genomstudien
anzuwenden. Zum Beispiel erlauben diese Hochdurchsatzsequenziermethoden die Analyse
der Genome archa¨ologischer Funde der Gattung Homo, wie beispielsweise von Neander-
talern oder Denisova-Menschen. Des Weiteren ko¨nnen große Populationsstudien heutiger
Menschen durchgefu¨hrt werden sowie quantitative Unterschiede in den Transkriptomen und
DNS-Interaktomen verschiedener Menschenaffen und Affen untersucht werden.
Wa¨hrend die Kosten und der zeitliche Aufwand fu¨r die Generierung von Sequenzierdaten
im Vergleich zur klassischen Sanger-Sequenzierung erheblich gesunken sind, unterscheiden
sich jedoch die Fehlerprofile und Limitierungen der neuen Instrumente erheblich. Die Arten
beobachteter Fehler, die Anzahl bestimmbarer Sequenzen pro Instrumentenlauf sowie die
La¨nge der Sequenzen sind sehr variabel zwischen den verschiedenen Verfahren. Die Analy-
se von Sequenzierdaten setzt daher ein genaues Versta¨ndnis der Unvollkommenheiten jedes
Instruments voraus und wie diese die Analyse verkomplizieren oder sogar systematische
Fehler verursachen ko¨nnen. Ich habe daher Wissen zu allen aktuell verfu¨gbaren Sequenzier-
instrumenten zusammengetragen und die konzeptionellen Schwachpunkte herausgearbeitet.
In dieser Arbeit beschreibe ich spezifische systematische Fehler und Einschra¨nkungen der
verschiedenen Technologien, welche auf technische Details in der Vorbereitung von DNS fu¨r
die Sequenzierung, der Art und Weise wie Moleku¨le fu¨r das Auslesen fixiert werden und der
Methode mit welcher Sequenzen ausgelesen werden, zuru¨ckzufu¨hren sind.
Momentan verfu¨gbare Hochdurchsatzsequenziermethoden besitzen mittlere Lesefehlerraten
von 1/25 bis 1/1’000. Diese sind beachtlich ho¨her als die Raten von 1/10’000 bis 1/100’000 wie
sie fu¨r hochqualitative Sanger-Sequenzen erreicht werden. Die in vitro Vervielfa¨ltigungen von
DNS-Moleku¨len, welche normalerweise vor der Sequenzierung mit den neuen Instrumenten
durchgefu¨hrt werden, verursachen eine ho¨here Anzahl an Sequenzfehlern noch vor dem ei-
gentlichen Auslesen. Des Weiteren ist eine Abha¨ngigkeit der Lesefehlerrate vom Abstand der
ausgelesenen Sequenzen zu beobachten. Dieser Abstand ist durch die Verwendung von experi-
mentellen Protokollen zur zufa¨lligen Verteilung der Sequenzen auf festen Oberfla¨chen (planar
oder in Form von Kugeln) sehr variabel. Die meisten Lesefehler dieser Instrumente werden
jedoch durch Probleme bei der Signaldetektion und der Unterscheidung von Signal und
Hintergrund verursacht. Zusa¨tzlich steigt der Lesefehler beachtlich mit der Position in der
auszulesenden Sequenz. Dies wird durch einen Abfall der Reaktionseffizienz, Bescha¨digung
von Moleku¨len wa¨hrend der Sequenzierung und dem Verlust der Synchronita¨t ausgelesener
Moleku¨lkopien verursacht. Der Verlust von Signalsynchronita¨t beruht darauf, dass aufgrund
unvollsta¨ndiger Effizienz nicht alle Moleku¨lkopien an jedem Reaktionsschritt teilnehmen.
Die u¨berwiegend kurzen Sequenzen, welche mit den neuen Instrumenten bestimmt werden,
begrenzen die Genauigkeit mit der diese bekannten Sequenzen zugeordnet werden ko¨nnen
oder genomische Regionen rekonstruiert werden ko¨nnen. Nur Protokolle welche beide Enden
eines Moleku¨ls bestimmen, entweder in dem die tatsa¨chlichen Enden von Moleku¨len gelesen
oder vorher experimentell weiter auseinander liegende Moleku¨lenden rekombiniert werden,
liefern die notwendige Information u¨ber relativen Abstand und Richtung, welche die fehlende
Information kurzer Sequenzen ausgleichen kann.
Ich habe das derzeit am ha¨ufigsten verwendete Sequenzierinstrument, den Illumina Genome
Analyzer, genauer untersucht und basierend auf den Problemen, welche bei Sequenzierla¨ufen
am Max-Planck-Institut fu¨r evolutiona¨re Anthropologie ha¨ufig beobachtet wurden, einfache
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Regeln aufgestellt die es gestatten sollen diese Fehler zu vermeiden oder in den Sequenzierda-
ten zu korrigieren. In der vorliegenden Arbeit beschreibe ich verschiedene Quellen fu¨r die hohe
Varianz in der Qualita¨t von Sequenzierla¨ufen. Diese umfassen Probleme mit Sequenzierbiblio-
theken, mangelnde Instrumentjustierung und Fehler in der Handhabung. Partikel, wie bei-
spielsweise Klu¨mpchen, Staub und Fusseln in der Sequenzierchemie ko¨nnen Sequenza¨hnliche
Signale hervorrufen und damit zur Analyse von niedrigkomplexen Sequenzen fu¨hren, welche
nicht aus der Bibliothek stammen. Diese Sequenzen ko¨nnen durch Entropie-basierende Filter
entfernt werden, das Filtern mittels Bibliothek-spezifischer Erkennungssequenzen ist jedoch
zu bevorzugen, da hier keine falsch-positiven Sequenzen entfernt werden und zusa¨tzlich die
Gefahr von Kontamination mit anderen Sequenzierbibliotheken reduziert wird.
Fu¨r Sequenzen bei denen ein Teil des Sequenzierbibliothekadapters mitgelesen wird, muss
dieser am Ende der eigentlichen Zielsequenz identifiziert werden und vor der weiteren Pro-
zessierung entfernt werden. Dies ist leider nicht Teil der Standardprozessierung des Illumina-
Instrumentes. Durch die am Sequenzende erho¨hte Lesefehlerrate und ha¨ufig kurze Adap-
terfragmente, ist auch die Erkennung des Adapteres ein nicht-triviales Problem. Wenn Se-
quenzen nicht fu¨r Adapterchima¨ren gefiltert werden oder einsetzende Adaptersequenz nicht
entfernt wird, ko¨nnen Ergebnisse negativ beeinflusst werden. Bei der Sequenzierung von bei-
den Moleku¨lenden kann eine einsetzende Adaptersequenz durch ein beschriebenes Verfahren
zur Maximierung der Autokorrelation einfacher identifiziert werden. Die Berechnung einer
Konsensussequenz in der U¨berlappung beider Endsequenzen reduziert zusa¨tzlich die Lese-
fehlerrate. Daher war dieses Verfahren insbesondere fu¨r die Analyse von DNS-Moleku¨len
aus archa¨ologischen Proben von großer Bedeutung. Verschiedene Pra¨parationsprotokolle fu¨r
Sequenzierbibliotheken existieren und haben erheblichen Einfluss auf die Sequenzierung.
Um beispielsweise systematische Fehler durch die ungleichma¨ßige Vervielfa¨ltigung von DNS-
Moleku¨len zu vermeiden, mu¨ssen solche Kopien identifiziert und speziell gehandhabt werden.
Beru¨cksichtigt man dass verschiedene Fehlerprofile eine der Hauptunterschiede zwischen den
verschiedenen Technologien sind, so ist die Minderung von Lesefehlern sowie die genaue
Abscha¨tzung der Fehlerwahrscheinlichkeit gelesener Basen sehr wichtig fu¨r jegliche Art der
Analyse. In dieser Arbeit stelle ich fu¨r das Illumina-Instrument einen Ansatz fu¨r die Ba-
senbestimmung (die Konvertierung von Maschinenintensita¨tswerten zu Basen) vor. Die vor-
gestellte Methode ist einzigartig unter den bisher verwendeten Ansa¨tzen und kann auf alle
bisher verfu¨gbaren Illumina Instrument- und Sequenzierchemieversionen angewendet werden
und reduziert den Lesefehler um mindestens 10-20%.
Fu¨r diese Instrumente wird eine starke Korrelation der Adenin- und Cytosin-Intensita¨ten so-
wie der Guanin- und Thymin-Intensita¨ten beobachtet. Des Weiteren existiert eine Abha¨ngig-
keit der Intensita¨ten eines bestimmen Instrumentenzyklus von den Intensita¨ten der vorher-
gehenden und nachfolgenden Zyklen. Beide Effekte erschweren die Basenbestimmung. Bisher
verwendete Methoden haben daher entweder den vollsta¨ndigen Sequenzierprozess modelliert
oder die Maschinenintensita¨ten fu¨r diese Effekte teilweise korrigiert bevor ein statistisches
Verfahren zur Basenbestimmung verwendet wurde. Das von mir entwickelte Programm Ibis
(Improved base identification system) umgeht das Problem der Modellierung durch
das Trainieren eines statistischen Klassifikators pro Instrumentenzyklus unter Verwendung
der Intensita¨tswerte mehrerer Zyklen. Daher implementiert Ibis einen sehr allgemeinen An-
satz, was im Bezug auf die Ha¨ufigkeit von Aktualisierungen der Instrument- und Sequen-
zierchemieversionen u¨ber die letzten Jahre von großem Vorteil ist. Zusa¨tzlich ist Ibis im
Vergleich zu anderen Programmen sehr effizient und besitzt keine besonderen Anforderun-
gen an die eingesetzte Rechentechnik. Die geringere Lesefehlerrate und damit ein ho¨herer
Anteil nutzbarer Sequenzen sowie die besseren und kalibrierten Basenfehlerwahrscheinlich-
keiten ermo¨glichen die direkte Verwendung der Ibis-Daten mit anderen Programmen.
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Ich stelle zwei Anwendungen von Ibis sowie der dargelegten Analyseprinzipien vor. Als
erstes analysiere ich eine der ersten Anwendungen fu¨r die Illumina-Sequenzierinstrumente,
das NlaIII Protokoll fu¨r digitale Genexpression (DGE). Dieses Protokoll bestimmt die Ex-
pression von Genen mittels kurzer 17-Nukleotid-langer Erkennungssequenzen der 3’-Enden
von Transkripten. Dieses Protokoll wurde verwendet um die Genexpression in Hirn-, Herz-,
Hoden-, Leber- und Nierengewebe von Menschen, Schimpansen und Rhesusaffen zu messen.
Das gro¨ßte Problem bei der Analyse dieser Daten waren die sehr kurzen Erkennungssequen-
zen, welche nicht einzigartig fu¨r bestimmte genomische Regionen oder Gene sind und fu¨r
welche die Einzigartigkeit auch zwischen den untersuchten Arten leicht variiert. Zusa¨tzlich
stellte sich die Annotation der Erkennungssequenzen als schwierig heraus, da die verfu¨gbare
Genannotation fu¨r die drei Arten von sehr verschiedener Qualita¨t ist. Nur die neusten Ver-
sionen der menschlichen Genannotation beschreiben 3’-untranslatierte Bereiche von Genen
in ausreichend guter Qualita¨t um sie fu¨r die Analyse dieser Daten verwenden zu ko¨nnen. Ich
habe daher die menschliche Genannotation unter Verlust von 36% aller Gene auf die Genome
der beiden anderen Arten projiziert. Nur so konnte ich sicherstellen, dass gleiche Anteile der
bestimmten Erkennungssequenzen in allen drei Arten analysiert werden.
Im Vergleich mit anderen Studien derselben Gewebe und Arten stellte ich gro¨ßere Abweichun-
gen fest. Zum Beispiel zeigten sich Unterschiede im Anteil der unterschiedlich expremierter
Gene in bestimmten Geweben sowie im Anteil der Genexpressionsvera¨nderungen welche ei-
ner bestimmten evolutiona¨ren Linie zugeordnet werden konnten. Es ist daher wahrscheinlich,
dass die verschiedenen experimentellen oder analytischen Methoden systematische Fehler
aufweisen. Der Vergleich mit der Studie von Babbit et al., welche ebenfalls das NlaIII -DGE-
Protokoll in verschiedenen Hirnproben angewendet hat, zeigte sehr klar, dass die Varianz,
welche durch das Beproben von verschiedenen Individuen eingebracht wird, mindestens ge-
nauso groß ist wie die Varianz welche durch biologische Unterschiede zwischen Schimpanse
und Mensch beobachtet wird. Des Weiteren zeigte sich, dass die Varianz aus der Analyse der
Daten mindestens genauso groß sein kann wie die biologischen Unterschiede zwischen Mensch
oder Schimpanse im Vergleich zu Rhesusaffen. Zuku¨nftige Studien mu¨ssen daher versta¨rkt
fu¨r verschiedene Umwelteinflu¨sse, Alter der beprobten Individuen und Art der Gewebebe-
probung kontrollieren. Verbesserte experimentelle Protokolle sowie bessere Analysemethoden
werden beno¨tigt, welche es erlauben systematische Fehler fru¨h zu erkennen und zu messen.
Derzeit ko¨nnen Unterschiede in Genomqualita¨t, Vollsta¨ndigkeit der verfu¨gbaren Genome und
Qualita¨t der verfu¨gbaren Genannotation leicht einen Spezieseffekt verursachen.
Die zweite Analyse stellt Schrotschusssequenzierungsdaten aus archa¨ologischen Proben zwei-
er Hominini vor; das Genom des Neandertalers und des Denisova-Menschen. DNS wie sie
aus archa¨ologischen Funden extrahiert werden kann, ist ha¨ufig stark fragmentiert, chemisch
bescha¨digt und besitzt einen hohen Anteil von DNS aus verschiedenen Umweltquellen. Kurze
DNS-Moleku¨le, welche den Bibliotheksadapter am Ende der ausgelesen Sequenz aufweisen,
Chima¨ren, Artefaktsequenzen, sowie hohe Fehlerraten in Kombination mit den kurzen Se-
quenzen, stellen ein Problem bei der Analyse solcher Daten dar. Das verbesserte Verfahren
zur Basenerkennung, Filtern fu¨r Bibliothekserkennungssequenzen und der Einsatz des Ver-
fahrens zur Rekonstruktion des vollsta¨ndigen Moleku¨ls von Sequenzen beider Moleku¨lenden
konnte viele Probleme in diesen Daten u¨berwinden. Kombiniert mit experimentellen Metho-
den zur Reduktion des chemischen Schadens und der Berechnung von Konsensussequenzen
von Moleku¨lduplikaten konnte der verbleibende Sequenzfehler soweit reduziert werden, dass
er fu¨r das Genom des Denisova-Menschen kleiner ist als fu¨r Sequenzierdaten heutiger Men-
schen welche mit der gleichen Sequenziertechnik bestimmt wurden.
Die Sequenzierdaten des Neandertaler- und Denisova-Genomes ko¨nnen verwendet werden um
Positionen im menschlichen Genom zu identifizieren, welche sich seit dem letzten gemeinsa-
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men Vorfahren von Mensch und Schimpanse gea¨ndert haben. Diese Positionen sind wichtig
um Gene zu identifizieren, welche anatomisch-moderne Menschen von anderen Hominini un-
terscheiden. Die bisher mittels Neandertal- und Denisova-Genom identifizierten Positionen
heben mehrere Gene und genomische Regionen heraus, welche in der ju¨ngeren menschlichen
Evolution von Bedeutung gewesen sein ko¨nnten. Experimentelle Tests werden nun zeigen
mu¨ssen, ob die identifizierten Unterschiede auch funktionelle Bedeutung haben.
Bei der Analyse dieser Positionen beschreibe ich eine interessante Untermenge von meh-
reren zehntausend Positionen, welche im Neandertaler und Denisova-Genom verschiedene
Zusta¨nde haben. Hier zeigt entweder das Neandertaler- oder das Densiova-Genom den in der
menschlichen Referenz vorhandenen neuen Zustand, wa¨hrend das jeweils andere Genom den
urspru¨nglichen Zustand des gemeinsamen Vorfahren mit Schimpansen zeigt. Diese Positionen
sind damit inkonsistent zwischen evolutiona¨ren Linien welche sich vor mehr als einer hal-
ben Million Jahre getrennt haben. Sie repra¨sentieren damit zumindest teilweise Positionen
unvollsta¨ndiger Linienauftrennung welche im gemeinsamen Vorfahren von Mensch, Neander-
taler und Denisova-Mensch noch variabel waren. Es ist wahrscheinlich dass ein großer Teil
dieser Positionen in heute lebenden Menschen fu¨r die neue Sequenzvariante fixiert ist. Der
urspru¨ngliche Zustand fu¨r diese unterschiedlich segregierenden Positionen ko¨nnte aber durch
Vermischung mit Neandertalern und Denisova-Menschen wieder in bestimmte Menschenpo-
pulationen eingebracht worden sein. Daher ko¨nnen diese Positionen, genauer der Anteil mit
der ein heutiger Mensch den urspru¨nglichen Zustand fu¨r solche Positionen mit Neanderta-
ler oder Denisova-Mensch teilt, genutzt werden um eine sta¨rkere Vermischung mit einer der
beiden ausgestorbenen Menschenformen zu detektieren. Durch die Analyse konnte ich die
Ergebnisse von Green et al. besta¨tigen, dass ein untersuchter Afrikaner weniger dieser Pos-
tionen mit Neandertalern teilt als die neun getesteten Nichtafrikaner. Des Weiteren konnte
ich zeigen dass Melanesier, insbesondere zwei Individuen aus Papua-Neuguinea, ein Signal
fu¨r die Vermischung mit Denisova-Menschen zeigen, welches nicht in den anderen Individuen
gefunden werden konnte. Dieses Ergebnis ist in U¨bereinstimmung mit den Ergebnissen der
D-Statistik fu¨r Populationspaare wie sie in Reich et al. vorgestellt wurde.
In der Analyse weise ich auch darauf hin, dass Sequenzen des Neandertal- und Denisova-
Genoms unterschiedlich beprobt werden. Beispielsweise zeigt sich bei der Analyse von Re-
gionen die sich auf der menschlichen Linie besonders stark vera¨ndert haben, dass diese zwar in
beiden Genomen ha¨ufiger den modernen Zustand zeigen als dies im Genommittel der Fall ist
– ein Effekt der wahrscheinlich von Genkonversionsereignissen getrieben wird –, aber in den
Denisova-Daten werden mehr Positionen mit dem urspru¨nglichen Zustand durch Sequenzen
abgedeckt, als dies fu¨r Positionen der Fall ist, die nur in den Neandertaler-Daten abgedeckt
werden. Wa¨hrend dies auf einen Unterschied in den erhaltenen DNS-Moleku¨len hinweisen
ko¨nnte, kann dies nicht den Unterschied abweichender Positionen in Neandertalern oder
Denisova-Menschen erkla¨ren. Auch nach Korrektur eines Effektes der humanen Referenzse-
quenz, welche Neandertal-Vermischung in sich tra¨gt, verbleibt ein U¨berschuss von 18.4% fu¨r
Positionen die den urspru¨nglichen Zustand in Denisova-Menschen aber den neuen Zustand
im Neandertaler-Genom zeigen. Dies ko¨nnte auf Vermischung des Denisova-Menschen mit
einer noch a¨lteren Menschenform oder aber ein Alignierungsartefakt durch die verschiedenen
Algorithmen hinweisen.
Beide pra¨sentierten Analysen haben kleine Effekte in der Datengenerierung und Auswer-
tung aufgezeigt, welche einen hinreichend großen systematischen Fehler verursachen, so dass
nicht ohne weiteres biologische Schlussfolgerungen aus den experimentellen Daten gezogen
werden ko¨nnen. Die Informationen und Methoden welche in dieser Arbeit beschrieben wer-
den, ko¨nnen jedoch dabei helfen diese Effekte in zuku¨nftigen Daten zu vermeiden oder sie in
bestehenden Daten zu reduzieren.
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Chapter 1
Introduction
Over the past five years, advances in DNA sequencing have revolutionized the field of ge-
nomics. It is now possible to generate large amounts of sequence data very rapidly and at
low cost. Using current high-throughput sequencing instruments, the amount of sequencing
data produced by the human genome project [100] in over 13 years can be created within
weeks and for a price of a few tens of thousands of dollars instead of millions of dollars.
These high-throughput sequencing technologies allow the application of sequence-based ap-
proaches in an unanticipated number of fields. Reducing sequencing costs means DNA
sequencing is now available to many more researchers and projects. Common sequencing
applications are wide and varied. They include whole genome sequencing, measuring popula-
tion and species variation, determining transcriptome structure, quantifying gene expression,
determining DNA methylation and unveiling DNA-protein interactions.
In the field of evolutionary genetics, it is now feasible to apply these different sequencing-
based approaches for comparative genomic studies. In primates, and more specifically in
extinct and extant ape populations. The high resolution of sequencing approaches allow
studies of species and population differences that have not been accessible so far due to
the small evolutionary differences studied. Further, these high-throughput sequencing tech-
nologies allow studies of ancient DNA samples with a low fraction of endogeneous DNA,
studies which were too expensive when using traditional sequencing approaches. Compara-
tive genomics studies of humans, hominins and other apes are important in order to better
understand human origins and the biological background of what sets humans apart from
other organisms. They can also provide insights into the basis of diseases or developmental
problems that affect uniquely human traits, such as speech disorders, mental disorders such
as autism and schizophrenia, or metabolic disorders such as obesity.
However, while the cost and time for applying these new technologies have been greatly
reduced compared to traditional sequencing, the error profiles and limitations of the new
platforms differ significantly from those of previous sequencing technologies. Further, the
types of errors observed as well as the number and length of sequences vary considerably
among these different new technologies. Thus, the selection of an appropriate sequencing
platform for particular types of experiments is an important consideration. In addition, data
analysis requires a detailed understanding of the imperfections in the resulting sequence data
and how these pose challenges and cause biases in downstream analysis.
In the following chapters, I will first review the sequencing approaches implemented by
different DNA sequencing instruments and discuss their inherent limitations. Then I will
discuss how experimental steps in the generation of high-throughput sequencing data impact
data quality and generate artifacts that may affect data analysis (chapter 3). In chapter 4,
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I will present an approach for improving the base calling for one of the high-throughput
instruments, the Illumina Genome Analyzer, and show how it allows for a reduction of
error rates and provides more informative base quality scores. In the last two chapters, I will
discuss specific problems as well as selected results from the quantification of gene expression
from short-sequence tags in five tissues from three primates (chapter 5) as well as the analysis
of whole genome shotgun sequencing data of two ancient hominin genomes (chapter 6).
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Chapter 2
DNA sequencing technologies
Ambition is the last refuge of the failure. – Oscar Wilde [96](1205)
The first DNA genome, that of the 5,386-nucleotide, single-stranded bacteriophage φX174
was determined in 1977 [202] using one of the technologies of DNA sequencing invented at
the time [203, 204, 76, 245]. Since then sequencing of whole genomes as well as of individual
genomic regions and genes has become a major focus of modern biology and transformed, if
not founded, the field of modern genetics.
However, in the 1970s and for almost another decade, DNA sequencing was a barely au-
tomated and therefore very tedious process which allowed determining only a few hundred
nucleotides in an experiment. In the late 1980s, semi-automated sequencers with higher
throughput became available [216, 223], still only able to determine a few sequences at a
time. One breakthrough in the early 1990s was the development of capillary array elec-
trophoresis and appropriate detection systems [249, 97, 105, 233, 114]. As recently as 1996,
these developments converged in a commercial single capillary sequencer (ABI Prism 310).
In 1998, the GE Healthcare MegaBACE 1000 and the ABI Prism 3700 DNA Analyzer be-
came the first commercial 96 capillary sequencers, a development which then was termed
high-throughput sequencing.
Only within the last five years, alternative sequencing strategies like pyrosequencing [196,
142], reversible terminator chemistry [231, 16], sequencing-by-ligation [210], virtual termina-
tor chemistry [89] and real-time sequencing [118] were developed or converged into new
instruments. These new instruments require us to completely redefine the term “high-
throughput sequencing”, as they outperform the older Sanger-sequencing technologies by
a factor of 100 to 1,000 in daily throughput and reduce the cost of sequencing one million
nucleotides (1Mb) to 4%-0.1% of that associated with Sanger sequencing. This large differ-
ence in throughput led scientists and companies to introduce new terms like “next generation
sequencing” [149, 8] or “ultra-high-throughput sequencing” [71] for this group of new tech-
nologies. These terms unfortunately leave little scope for the ongoing developments, which
is why I use the terms high-throughput sequencing and Sanger sequencing instead.
In the following, I will describe the concepts of currently available sequencing technologies.
While high-throughput sequencing technologies have been widely reviewed [8, 149, 206, 209]
and possible applications discussed [148, 172, 69, 169, 237, 44], this chapter has a more
technical focus and outlines the inherent limitations that come with each of the technolo-
gies [115].
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2.1 Sanger capillary sequencing
Current Sanger capillary array electrophoresis (CAE) systems, like the widely used Applied
Biosystems 3000 series or the GE Healthcare MegaBACE instrument, are based on the same
general scheme applied in 1977 for the φX174 genome [202, 204]: First, millions of copies
of the sequence to be determined are purified or amplified, depending on the source of the
sequence. Reverse strand synthesis is performed on these copies using a known priming
sequence upstream of the sequence to be determined and a mixture of deoxy-nucleotides
(dNTPs, the standard building blocks of DNA) and dideoxy-nucleotides (ddNTP, modi-
fied nucleotides missing a hydroxyl group at the third carbon atom of the sugar). The
dNTP/ddNTP mixture causes random, non-reversible termination of the extension reaction;
creating from the different copies molecules extended to different lengths. Following denatu-
ration and clean up of free nucleotides, primers and the enzyme, the resulting molecules are
sorted by their molecular weight (corresponding to the point of termination) and the label
attached to the terminating ddNTPs is read out sequentially in the order created by the
sorting step. A schematic representation of this process is available in figure 2.1.
3' ACTGTACTAGTATGCAGTACG ... 5'
5' TGACATG 3'
TGACATGA
TGACATGAT
TGACATGATC
TGACATGATCA
TGACATGATCAT
TGACATGATCATA
TGACATGATCATAC
TGACATGATCATACG
TGACATGATCATACGT
TGACATGATCATACGTC
...
A
T
C
A
T
A
C
G
T
C
1. Amplification
(by cloning)
2. Primer extension in presence 
of blocked and labeled nucleotides
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electrophoreses & 
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Figure 2.1: Schematic representation of the Sanger sequencing process. Input DNA is fragmented
and cloned into bacterial vectors for in vivo amplification. Reverse strand synthesis is performed on
the obtained copies starting from a known priming sequence and using a mixture of deoxy-nucleotides
(dNTPs) and dideoxy-nucleotides (ddNTPs). The dNTP/ddNTP mixture randomly causes the ex-
tension to be non-reversibly terminated; creating differently extended molecules. Subsequently, after
denaturation, clean up of free nucleotides, primers, and the enzyme, the resulting molecules are sorted
using capillary electrophoresis by their molecular weight (corresponding to the point of termination)
and the fluorescent label attached to the terminating ddNTPs is read out sequentially.
Sorting by molecular weight was originally performed using gel electrophoresis but is nowa-
days carried out by capillary electrophoresis [223, 74]. Originally, radioactive or optical labels
were applied in four different terminator reactions (each sorted and read out separately), but
today four different fluorophores, one per nucleotide (A, C, G and T) are used in a single re-
action [216]. Additionally, the advent of more sensitive detection systems and several rounds
of primer extensions (equivalent to a linear amplification) permit smaller amounts of starting
DNA to be used for modern sequencing reactions.
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Unfortunately, there is still little automation for creation of the high copy input DNA with
known priming sites. Typically this is done by cloning, i.e. introducing the target sequence
into a known vector sequence using restriction and ligation procedures and using a bacterial
strain to amplify the target sequence in vivo – thereby exploiting the low amplification error
due to inherent proof-reading and repair mechanisms. However this process is very tedious
and is sometimes hampered by difficulties with cloning specific sequences due to their base
composition, length and interactions with the bacterial host system. Though not yet widely
used, integrated microfluidic devices have been developed which aim to automate the DNA
extraction, in vitro amplification and sequencing on the same chip [58, 22, 197, 144].
Using current Sanger sequencing technology, it is technically possible for up to 384 se-
quences [58, 213] of between 600 and 1,000 nucleotides (nt) in length [211, 92] to be sequenced
in parallel. However, these 384-capillary systems are rare. The more standard 96-capillary
instruments yield a maximum of approximately 6Mb of DNA sequence per day, with costs for
consumables amounting to about $500 per 1Mb. The sequencing error observed for Sanger
sequencing is mainly due to errors in the amplification step (a low rate when done in vivo),
natural variance and contamination in the sample used as well as polymerase slippage at
low complexity sequences like simple repeats (short variable number tandem repeats) and
homopolymers (stretches of the same nucleotide). Further, lower intensities and missing
termination variants tend to lead to sequencing errors accumulating towards the end of long
sequences. In combination with reduced separation by the electrophoresis, base miscalls [64]
and deletions increase with read length. However, the average error rate (the average over all
bases of a sequence) after sequence end trimming is typically very low, with an error every
10,000-100,000 nucleotides [63].
2.2 454/Roche Genome Sequencer
The 454 Genome Sequencer (GS) platform was the first of the new high-throughput sequenc-
ing platforms on the market when released in October 2005. It is based on the pyrosequencing
approach developed by P˚al Nyre´n and Mostafa Ronaghi at the Royal Institute of Technology
Stockholm in 1996 [196]. In contrast to the Sanger technology, pyrosequencing is based on
iteratively complementing single strands and simultaneously reading out the signal emitted
from the nucleotide being incorporated (also called “sequencing by synthesis“ or “sequencing
during extension“). Electrophoresis is therefore no longer required to generate an ordered
read out of the nucleotides, as the read out is done simultaneously with the sequence exten-
sion.
In the pyrosequencing process (figure 2.2 on the next page), one nucleotide at a time is
washed over several copies of the sequence to be determined, causing polymerases to incor-
porate the nucleotide if it is complementary to the template strand. The incorporation stops
if the longest possible stretch of complementary nucleotides has been synthesized by the
polymerase. In the process of incorporation, one pyrophosphate per nucleotide is released
and converted to adenosine triphosphate (ATP) by an ATP sulfurylase. The ATP drives the
light reaction of luciferases present and the emitted light signal is measured. To prevent the
deoxyadenosine triphosphate (dATP) provided in a typical sequencing reaction from being
used directly in the light reaction, deoxy-adenosine-5’-(alpha-thio)-triphosphate (dATPαS),
which is not a substrate of the luciferase, is used for the base incorporation reaction of ade-
nine. Standard deoxyribose nucleotides are used for all other nucleotides. After capturing
the light intensity, the remaining unincorporated nucleotides are washed away and the next
nucleotide is provided.
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GTTCCCTCCCTGTGTCAGAAGTTGCAAGGGAGGGACAGAGTCTTCAACGAGGGGCATTGCACTGAGACACGCAACAGGGGA
Flow gram
PPi
Release of one pyrophosphate 
per nucleotide incorporated
synthesis by ATP sulfurylase
in presence of Adenylyl sulfate
ATP
dGTP
dGTPdGTP
DNA polymerase
ATP driven luciferase light reaction
Sequencing primer
Target sequence
TT  C  AA    C      G    A   GGGG C  ...
2nd flow cycle
A CT G
1st flow cycle
A CT G
3rd flow cycle
A CT G
4th flow cycle
A CT G
Iterative flow of dATPαS, 
dCTP, dGTP, dTTP:
Target sequence
Light intensity 
readout
5'3'
5' 3'
3' 5'
camera 
saturation
Figure 2.2: The pyrosequencing process. One of four nucleotides is washed sequentially over copies of
the sequence to be determined, causing polymerases to incorporate complementary nucleotides. The
incorporation stops if the longest possible stretch of the available nucleotide has been synthesized.
In the process of incorporation, one pyrophosphate per nucleotide is released and converted to ATP
by an ATP sulfurylase. The ATP drives the light reaction of luciferases present and a light signal
proportional (within limits) to the number of nucleotide incorporations can be measured.
In 2005, pyrosequencing technology was parallelized on a picotiter plate1 by 454 Life Sci-
ences (later bought by Roche Diagnostics) to allow high-throughput sequencing [142]. The
sequencing plate has about two million wells – each of them able to accommodate exactly one
28µm diameter bead covered with single stranded copies of the sequence to be determined.
The beads are incubated with a polymerase and single-strand binding proteins and, together
with smaller beads carrying the ATP sulfurylases and luciferases, gravitationally deposited
in the wells. Free nucleotides are then washed over the sequencing plate and the light emit-
ted during the incorporation is captured for all wells in parallel using a high resolution CCD
camera, exploiting the light-transporting features of the plate used.
One of the main prerequisites for applying this array-based pyrosequencing approach is
covering individual beads with multiple copies of the same molecule. This is done by first
creating sequencing libraries in which every individual molecule gets two different adapter
sequences, one at the 5’ end and one at the 3’ end of the molecule. In the case of the
454/Roche sequencing library preparation [142], this is done by sequential ligation of two
pre-synthesized oligos. One of the adapters added is complementary to oligonucleotides on
the sequencing beads and thus allows molecules to be bound to the beads by hybridization.
Low molecule-to-bead ratios and amplification from the hybridized double-stranded sequence
on the beads (kept separate using polymerase chain reaction in an water-in-oil emulsion, i.e
emulsion PCR) makes it possible to grow beads with thousands of bound copies of a single
1a flat plate with millions of wells used as separate reaction chamber
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starting molecule. Using the second adapter, beads covered with molecules can be separated
from empty beads (using capture beads with oligonucleotides complementary to the second
adapter) and are then used in the sequencing reaction as described above.
The average substitution (excluding insertion/deletions) error rate is in the range of 10−3
to 10−4 [142, 184], which is higher than the rates observed for Sanger sequencing but is the
lowest average substitution error rate of the new sequencing technologies discussed here. As
mentioned earlier for Sanger sequencing, in vitro amplifications performed for the sequencing
preparation cause a higher background error rate, that is, the error introduced into the sample
before it enters the sequencing process. In addition, in bead preparation (i.e. emulsion PCR
step) a fraction of the beads end up carrying copies of multiple different sequences. These
“mixed beads” will participate in a high number of incorporations per flow cycle, resulting
in sequencing reads that do not reflect real molecules. Most of these reads are automatically
filtered during the software post-processing of the data. The filtering of mixed beads may
however cause a depletion of real sequences with a high fraction of incorporations per flow
cycle.
A large fraction of the errors observed for this instrument are small insertions or deletions
(InDels), mostly arising from inaccurate calling of homopolymer length, and single base-
pair deletions or insertions caused by signal-to-noise thresholding issues [184]. Most of these
problems can be resolved by higher coverage. For long (> 10nt) homopolymers however, there
often is a consistent length miscall that is not resolvable by coverage [184, 243, 83]. Strong
light signals in one well of the picotiter plate may also result in insertions in sequences in
neighboring wells. If the neighboring well is empty this can generate so-called ghost wells, i.e.
wells for which a signal is recorded even though they contain no sequence template, hence
the intensities measured are completely caused by bleed-over signal from the neighboring
wells. Computational post-processing may correct for these artifacts [82].
As for Sanger sequencing, the error rate increases with the position in the sequence. In
the case of 454 sequencing, this is caused by (1) a reduction in enzyme efficiency or loss
of enzymes which results in a reduction of the signal intensities, (2) some molecules on
the beads no longer being elongated and (3) by an increasing, so-called, phasing effect.
Phasing is observed when a population of DNA molecules amplified from the same starting
molecule (ensemble) is sequenced, and describes the process whereby not all molecules in
the ensemble are extended in every cycle. This causes the molecules in the ensemble to lose
synchrony/phase, and results in an echo of the preceding cycles to be added to the signal as
noise.
The current 454/Roche GS FLX Titanium platform makes it possible to sequence about 1.5
million such beads in a single experiment and to determine sequences of length between 300-
500nt. The length of the reads is determined by the number of flow cycles, i.e. the number of
times all four nucleotides have been washed over the plate, as well as by the base composition
and the order of the bases in the sequence to be determined. Currently, 454/Roche limits
this number to 200 flow cycles, resulting in an expected average read length of about 400nt.
This is largely due to limitations imposed by the efficiency of polymerases and luciferases
which drops over the sequencing run resulting in decreased base qualities. Later in 2011,
454/Roche will release new versions of their sequencing chemistry allowing for sequencing of
about two times longer reads. Currently the platform allows the creation of about 750Mb
of DNA sequence per day at a cost of about 20$/Mb.
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Figure 2.3: Reversible terminator chemistry applied by the Illumina Genome Analyzer. Sequencing
primers are annealed to the adapters of the sequences to be determined. Polymerases are used to ex-
tend the sequencing primers by incorporation of fluorescently labeled and terminated nucleotides. The
incorporation stops immediately after the first nucleotide due to the terminators. The polymerases
and free nucleotides are washed away and the label of the bases incorporated for each sequence is
read with four images taken through different filters (T nucleotide filter is indicated in the figure)
and using two different lasers (red: A, C and green: G, T) to illuminate fluorophores. Subsequently
the fluorophores and terminators are removed and the sequencing continued with the incorporation
of the next base.
2.3 Illumina Genome Analyzer
The reversible terminator technology used by the Illumina Genome Analyzer employs the
sequencing by synthesis concept that is most similar to that used in Sanger sequencing i.e.
the incorporation reaction is stopped after each base, the label of the base incorporated
is read out with fluorescent dyes and the sequencing reaction is then continued with the
incorporation of the next base [16, 231] (see figure 2.3).
Like 454/Roche, the Illumina sequencing protocol requires that the sequences to be de-
termined are converted into a sequencing library, which allows them to be amplified and
immobilized for sequencing [16, 66]. For this purpose two different adapters are added to the
5’ and 3’ ends of all molecules using ligation of so-called forked adapters2 . The library is then
amplified using longer primer sequences which extend and further diversify the adapters, i.e.
add further unique nucleotides at both adapter ends, to create the final sequence needed in
subsequent steps.
This double-stranded library is melted using sodium hydroxide to obtain single stranded
DNAs, which are then pumped at a very low concentration through the channels of a flow
cell. This flow cell has on its surface two populations of immobilized oligonucleotides com-
plementary to the two different single stranded adapter ends of the sequencing library. These
oligonucleotides will hybridize to the single stranded library molecules. By reverse strand
synthesis starting from the hybridized (double-stranded) part, the new strand being created
2Also called Y-Adapters. Duplex of two oligonucleotides with perfect base-pairing at one molecule end,
but non-pairing/unique sequence at the other end.
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is covalently bound to the flow cell. If this new strand bends over and attaches to another
oligonucleotide complementary to the second adapter sequence on the free end of the strand,
it can be used to synthesize a second covalently bound reverse strand. This process of bend-
ing and reverse strand synthesis, called bridge amplification, is repeated several times and
creates what are termed clusters, the accumulation of several thousand copies of the original
sequence in very close proximity to each other on the flow cell [16, 66].
These randomly distributed clusters contain molecules that represent the forward as well
as reverse strands of the original sequences. Before determining the sequence, one of the
strands has to be removed to prevent it from hindering the extension reaction sterically
or by complementary base pairing. Selective strand removal targets base modifications of
the oligonucleotide populations on the flow cell. Following strand removal, each cluster on
the flow cell consists of single stranded, identically oriented copies of the same sequence;
which can be sequenced by hybridizing the sequencing primer onto the adapter sequences
and starting the reversible terminator chemistry.
“Solexa sequencing”, as it was introduced in early 2007, initially allowed for the simultaneous
sequencing of several million very short sequences (at most 26nt) in a single experiment. In
recent years there have been several technical, chemical and software updates. The product,
which is now called the Illumina Genome Analyzer (GA), has increased flow cell cluster
densities (more than 300 million clusters per run), a wider range of the flow cell is imaged,
and sequence reads of up to 125nt can be generated.
A technical update (Paired End Module, PEM) also enabled the sequencing of the reverse
strand of each molecule. This is achieved by chemical melting and washing away the syn-
thesized sequence, repeating a few bridge amplification cycles for reverse strand synthesis
and then selectively removing the starting strand (again using base modifications of the flow
cell oligonucleotide populations), before blocking 3’ ends and annealing another sequenc-
ing primer for the second read (see figure 2.4 on the next page). Using this “paired end
sequencing” approach, approximately twice the amount of data can be generated.
The Illumina library and flow cell preparation includes several in vitro amplification steps
which cause a high background error rate and contribute to the average error rate of about
10−2 to 10−3 [49, 116]. Further, the flow cell preparation creates a fraction of ordinary-
looking clusters which are initiated from more than one individual sequence. These result
in mixed signals and mostly low quality sequences for these clusters. In an effect similar to
the 454 ghost wells, the Illumina image analysis software may identify reagent crystals, dust
and lint particles as clusters and call sequences from these (see section 3.7 on page 55 of
chapter 3).
As is the case for the other platforms, the error rate increases with increasing position in
the determined sequence. This is mainly due to phasing, which increases the background
noise as sequencing progresses. While the ensemble sequencing process for pyrosequencing
creates unidirectional phasing from lagging, non-extended molecules, reversible terminator
sequencing creates bi-directional phasing [61, 116, 106] as some incorporated nucleotides
may also fail to be correctly terminated – allowing the extension of the sequence by another
nucleotide in the same cycle. With increasing cycle numbers, the intensities extracted from
the clusters decline [61, 198, 116]. This may be due to fewer molecules participating in
the extension reaction as a result of non-reversible termination/DNA degradation, due to
dimming effects of the sequencing fluorophores, or due to an increase in background noise
by the accumulation of the sequencing fluorophores in the flow cell.
In early versions of the chemistry, specifically one of the fluorophores (T fluorophore) stuck
to the clusters creating a biased background signal and thereby an overcall of the respective
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Figure 2.4: Synthesis reaction performed for Illumina paired end sequencing. After the end of the
forward read (1), the synthesized sequence of this read is chemically melted using sodium hydroxide,
3’ blocking is removed from all sequences and the flow cell washed (2), molecules bend over and a
few bridge amplification cycles are performed for reverse strand synthesis (3+4) and then selectively
removing the starting strand (5) by targeting base modifications of the flow cell oligonucleotide pop-
ulations. Afterwards, free 3’ ends are blocked and another sequencing primer annealed for sequencing
of the second read (6).
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base [116, 106]. The simultaneous identification of four different nucleotides is also a general
issue. The Genome Analyzer uses four fluorescent dyes to distinguish the four nucleotides A,
C, G and T. Of these, two pairs (A/C and G/T) excited using the same laser, are similar in
their emission spectra and show only limited separation using optical filters. Therefore, the
highest substitution errors observed are between A/C and G/T [49, 116] (see also figure 3.2
on page 39 and figure 4.3 on page 69).
Even though the Illumina Genome Analyzer reads show a higher average error rate and are
considerably shorter than 454/Roche reads, this instrument determines more than 10,000Mb
per day with a price of about 0.50$/Mb. This is more than ten times higher daily throughput
than 454/Roche and for a considerably lower price per megabase.
2.4 Life Technologies SOLiD
The prototype of what was further developed and later sold by Applied Biosystems (ABI)
and later by Life Technologies as the SOLiD sequencing platform, was developed by George
Church’s laboratory at Harvard Medical School and the Howard Hughes Medical Institute
and published in 2005 [210]. With its commercial release in late 2007, SOLiD was the third
new high-throughput system entering a highly competitive market with all three vendors
selling their instruments for around half a million dollars. The Church lab at Harvard Medical
School continued the development of the system and now offers a cheaper (< $200,000) open
source version of the system (called Polonator) in collaboration with Dover System. In the
third quarter of 2008, a biotechnology company from Mountain View, California, named
Complete Genomics started offering a human genome sequencing service. Their technology
is also based on the Church lab sequencing-by-ligation concept, but combines it with a
new strategy of sequencing library construction and sequence immobilization using rolling
circle amplification [52]. Here, I focus on the commercial SOLiD system as this is the most
widespread application of this concept.
The principle behind sequencing-by-ligation is very different from the approaches discussed
thus far. The sequence extension reaction is not carried out by polymerases but rather by
ligases [210] (see figure 2.5 on the next page for a schematic representation of the SOLiD
2-4 platform). In the sequencing-by-ligation process, a sequencing primer is hybridized to
single-stranded copies of the library molecules to be sequenced. A mixture of 8mer probes
carrying four distinct fluorescent labels compete for ligation to the sequencing primer. The
fluorophore encoding, which is based on the two 3’ most nucleotides of the probe, is read.
Three bases including the dye are cleaved from the 5’ end of the probe, leaving a free 5’
phosphate on the extended (by five nucleotides) primer, which is then available for further
ligation. After multiple ligations (typically up to 10 cycles), the synthesized strands are
melted and the ligation product is washed away before a new sequencing primer (shifted by
one-nucleotide) is annealed. Starting from the new sequencing primer the ligation reaction
is repeated.
The same process is followed for three other primers, facilitating the read out of the dinu-
cleotide encoding for each start position in the sequence. Using a specific fluorescent label
encoding, the dye read outs (i.e. colors) can be converted to a sequence [19]. This conversion
from color space to sequence requires a known first base, which is the last base of the library
adapter sequence. Given a reference sequence this encoding system allows for the detection
of machine errors and the application of an error correction to reduce the average error rate.
In the absence of a reference sequence, however, color conversion fails with an error in the
dye read out and causes the sequence downstream of the error to be incorrect.
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Figure 2.5: Life Technologies’s SOLiD sequencing-by-ligation. A sequencing primer is annealed to
single stranded copies of sequences to be determined. Octamer probes are hybridized, ligated to
the sequencing primer and a fluorescent dye at the 5’ end of the ligated 8-mer probes, encoding
the 3’ most two nucleotides of the probe, is read out. Non-extended primers are dephosphorylated.
Three nucleotides of the probe including the dye are cleaved, creating a free 5’ phosphate for further
ligations. After multiple ligations, the synthesized strands are melted and the ligation product is
washed away before a new, by-one-nucleotide-shifted sequencing primer is annealed. Starting from
the new sequencing primer the ligation reaction is repeated. The same is done for three other primers,
allowing the read out of the dinucleotide label for every position in the sequence.
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For parallelization, the sequencing process uses beads covered with multiple copies of the
sequence to be determined. These beads are created in a similar fashion to that described
earlier for the 454/Roche platform. In contrast to the 454/Roche technology, the SOLiD
system does not use a picotiter plate for fixation of the beads in the sequencing process;
instead the 3’ ends of the sequences on the beads are modified in a way that allows them to
be covalently bound onto a glass slide. As for the Illumina system, this creates a random
dispersion of the beads in the sequencing chamber and allows for higher loading densities.
However, random dispersion complicates the identification of bead positions from images,
and results in the possibility that chemical crystals, dust and lint particles can be mis-
identified as clusters. Further, dispersal of the beads results in a wide range of inter-bead
distances which then have differing susceptibility to signals from neighboring beads.
Types and causes of sequence errors are diverse: First, the in vitro amplification steps cause a
higher background error rate than in vivo amplifications using the Sanger cloning approach.
Secondly, beads carrying a mixture of sequences and beads in close proximity to one another
create false reads and low quality bases. Further, signal decline and incomplete dye removal
result in increasing error as the ligation cycles progress [48]. Phasing, as described earlier, is
a minor issue on this platform as sequences not extended in the last cycle are non-reversibly
terminated using phosphatases. Since hybridization is a stochastic process and probes do not
necessarily hybridize adjacent to the (extended) sequencing primer, this causes a considerable
reduction in the number of molecules participating in subsequent ligation reactions, and
therefore substantial signal decline. Given the high efficiency of phosphatases the remaining
phasing effect can be considered very low. However, incomplete cleavage of the dyes may
allow cleavage in the next ligation reaction, which then allows for the extension in the next
but one cycle. This causes a different phasing effect and additional noise from the previous
cycle’s dyes in the dye identification process.
The SOLiD system currently allows sequencing of more than 300 million beads in parallel,
with a typical read length of between 25 and 75nt. At the time of writing, the ABI SOLiD
system is therefore comparable to the Illumina Genome Analyzer system in terms of daily
throughput and price per million nucleotides (≈10,000Mb/day, ≈0.50$/Mb). Average error
rates are dependent on the availability of a reference genome for error correction (10−3-10−4
vs. 10−2-10−3). In the absence of a reference genome, assembly and consensus calling may
be performed based on dye read outs (so called color space sequences) to reduce the errors
before conversion to the nucleotide sequence. If no reference genome is available for error
correction, and no assembly and consensus calling is performed, then the average error rate
is higher than for the Illumina GA.
2.5 Helicos HeliScope
Helicos was the first company to sell a sequencer able to sequence individual molecules instead
of molecule ensembles created by an amplification process. Single-molecule sequencing has
the advantage that it is not affected by biases or errors introduced in a library preparation or
amplification step, and may facilitate sequencing of minimal amounts of input DNA. Using
methods able to detect non-standard nucleotides, it could also allow for the identification of
DNA modifications, commonly lost in the in vitro amplification process.
The HeliScope, as the Helicos sequencer is called, was first sold in March 2008, and at the
end of the first quarter of 2009 only four machines had been installed world-wide. This might
be surprising given the advantages of single molecule sequencing, but probably reflects both
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Figure 2.6: Asynchronous virtual-terminator chemistry performed by the HeliScope. Input DNA is
fragmented, melted and polyadenylated. A fluorescently labeled adenine is added in the last step. This
single stranded DNA is washed over a flow cell with poly-T-oligonucleotides allowing hybridization.
The bound coordinates on the flow cell are determined using the fluorescently labeled adenines.
Having the coordinates identified, the fluorescent label of the 3’ adenines is removed. Polymerases
are washed through with one type of fluorescently labeled nucleotides (A, C, G and T) at a time and
the polymerases extend the reverse strand of the sequences starting from the poly-T-oligonucleotides.
The nucleotide incorporation of the polymerases is slowed down by the fluorescent labeling and allows
for at most one incorporation before the polymerase is washed away. The flow cell is then imaged,
the fluorescent dyes removed and the reaction continued with another nucleotide.
the specific limitations of this platform, the price (about one million dollars), and a relatively
small market that already has invested extensively in new sequencing technologies.
The technology applied by the HeliScope (figure 2.6) could be termed asynchronous virtual-
terminator chemistry [89]: Input DNA is fragmented and melted before a poly-A-tail is
synthesized onto each single stranded molecule using a polyadenylate polymerase. In the
last step of polyadenylation, a fluorescently labeled adenine is added. The library, i.e. the
polyadenylated single stranded DNA, is washed over a flow cell where the poly-A tails bind
to poly-T-oligonucleotides. The bound coordinates on the flow cell are determined using a
fluorescence-based read out of the flow cell. Having these coordinates identified, the fluores-
cent label of the 3’ adenine is removed and the sequencing reaction started.
Polymerases are washed through the flow cell with one type of fluorescently labeled nu-
cleotides (A, C, G and T) at a time and the polymerases extend the reverse strand of the
sequences starting from the poly-T-oligonucleotides. The nucleotide incorporation of the
polymerases is slowed down by the fluorescent labeling and allows for at most one incorpo-
ration before the polymerase is washed away together with the non-incorporated nucleotides
(termed virtual termination; [253, 25]). The flow cell is then imaged again, the fluorescent
dyes are removed and the reaction continued with another nucleotide. By this process not
every molecule is extended in every cycle, which is why it is an asynchronous sequencing
process resulting in sequences of different length (as is the case for the 454/Roche platform).
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Since single molecules are sequenced, the signals being measured are weak (complicating
signal-to-noise thresholding), and there is no possibility that misincorporation errors can be
corrected by an ensemble effect. Due to the fact that molecules are attached to the flow cell by
hybridization only, there is a chance that template molecules can be lost in the wash steps.
In addition, molecules may be irreversibly terminated by the incorporation of incorrectly
synthesized nucleotides. Overall, reads are between 24 to 70nt long (average 32nt) [182] and
thus shorter than for the other platforms. Due to the higher number of sequences determined
in parallel, the total throughput per day (4150Mb/day with ≈0.33$/Mb [182]) is in a similar
range as for the GA and SOLiD systems. The average error rate, which is in the range of a
few percent, is slightly higher than for all other instruments and biased towards insertions
and deletions rather than substitutions.
2.6 Single Molecule Real Time (SMRT)
Another technology for sequencing individual molecules is Pacific Biosciences’s SMRT (Single
Molecule Real Time) sequencing technology [118]. This technology performs the sequencing
reaction on silicon dioxide chips with a 100nm metal film containing thousands of tens-of-
nanometers diameter holes, so called zero-mode waveguides (ZMWs) [57]. Each ZMW is
used as a nano visualization chamber, providing a detection volume of about 20 zeptoliters
(10−21 liters). At this volume, a single molecule can be illuminated while excluding other
labeled nucleotides in the background – saving time and sequencing chemistry by omitting
wash steps.
For SMRT sequencing (figure 2.7 on the next page), a single DNA polymerase is fixed
to the bottom of the surface within the detection volume of each ZMW. Nucleotides with
different fluorescent dyes attached to the phosphate chain are used in concentrations allowing
normal enzyme processivity. As the polymerase incorporates complementary nucleotides, the
nucleotide is held within the detection volume for tens of milliseconds, orders of magnitude
longer than for unspecific diffusion events. This way the fluorescent dye of the incorporated
nucleotide can be identified during normal speed reverse strand synthesis [57]. Further, by
attaching the fluorescent dyes to the phosphate chain of the deoxy-nucleotides the dye is
released with the cleaved pyrophosphate, generating an unmodified complimentary DNA
strand.
In pilot experiments, Pacific Biosciences showed that their technology allows for direct se-
quencing of a few thousand bases before the polymerase is denatured due to optic and
thermal stress from the laser read-out of the dyes. They were also able to show that they
can measure differences in polymerase kinetics to such an extend that modified nucleotides
may be detected [70]. The SMRT technology was intended for release in the fourth quarter
of 2010. Due to this recent release, the amount of information on the actual instrument is
very limited and it is likely that further development is needed to create a robust system
over the next years.
2.7 Upcoming developments
Motivated by the goal of sequencing a genome for $1,000 set by NIH/NHGRI to enable
personalized medicine3, the throughput of all systems described is constantly increasing and
numbers given here are rapidly outdated. In the third quarter of 2010, Illumina started
3http://www.nih.gov/news/pr/aug2007/nhgri-01.htm
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waveguides
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Light detection (CCD camera)
Figure 2.7: Single Molecule Real Time sequencing as implemented by Pacific Biosciences. DNA poly-
merases are fixed to the bottom of zero-mode waveguides (ZMW), a tens-of-nanometers diameter holes
in a 100nm metal film. Each ZMW is used as a nano visualization chamber with a very small detec-
tion volume allowing a single molecule to be illuminated, while excluding other labeled nucleotides
in the background. As the polymerase incorporates complementary nucleotides, the nucleotide with
a fluorescent dye attached to its phosphate chain is held within the detection volume for tens of
milliseconds, orders of magnitude longer than for unspecific diffusion events. The fluorescent dye
attached to the phosphate chain of the deoxy-nucleotides is released into solution when the pyrophos-
phate is cleaved during incorporation, generating an unmodified complimentary DNA strand. [Image
of DNA Polymerase taken from http://www.rcsb.org/pdb/static.do?p=education_discussion/
molecule_of_the_month/pdb3_1.html]
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shipping the HiSeq2000 system, an updated version of the Genome Analyzer instrument
determining sequences of clusters on bottom and top of the flow cell using confocal scanning
rather than total internal reflection optics and capable of processing two flow cells in parallel.
Also 2010, Life Technologies introduced SOLiD4, an update to the SOLiD platform which
among other improvements now allows paired end sequencing.
While on the one end of the spectrum instrument throughput increases, some vendors also
recently started to offer budget versions of their instruments (e.g. Illumina Genome Ana-
lyzer IIe, Illumina MySeq or 454/Roche GS Junior) with lower sequencing capacity. Other
vendors, like the Life Technologies company Ion Torrent, also try to establish their market
in “lower” high-throughput sequencing instruments with benchtop instruments. In the case
of Ion Torrent, the pyrosequencing concept is used with a different detection system for the
incorporation reaction. While the 454/Roche instrument uses the released pyrophosphate
ions in a light reaction and measures the light intensities, the Ion Torrent instrument uses
semiconductor chips to measure the pH change in the solution. Even though the instrument
costs are around one quarter to one third of the price for the big instruments, a similar
infrastructure is required for data processing and analysis, which keeps the financial invest-
ments considerably high. Further, the costs per base are generally higher than for the other
instruments.
At the same time, a completely new generation of sequencers is already on the horizon.
What started with the Helicos and Pacific Biosciences systems – the sequencing of single
molecules without prior library preparation or amplification – will likely become a popular
paradigm. Specifically, three other systems have captured media and scientific attention
well in advance of their actual availability: Oxford Nanopore’s BASE technology [37], IBM’s
proposal of silicon-based nanopores [189] and Life Technologies single molecule sequencing
technology based on quantum dots.
Oxford Nanopore’s BASE technology offers the potential to identify individual nucleotide
modifications (e.g. 5-methyl-cytosine versus cytosine) during the sequencing process [37].
The idea behind this technology is the identification of individual nucleotides using a change
in the membrane potential as the nucleotides pass through a modified α-hemolysin mem-
brane pore with a cyclodextrin sensor [37, 9]. To apply this technology for sequencing, the
pore has to be fused to an exonuclease which degrades single stranded DNA sequences and
releases individual nucleotides into the pore. In addition, the technology needs to be paral-
lelized in array format, before its release as a high-throughput sequencing platform. While
the sensitivity for individual nucleotide modifications seems to be a major advantage, the
destructive fashion of the outlined sequencing process might be considered a hindrance for
applications with precious samples, and does obviously not allow a second read cycle for
error reduction.
In early October 2009, IBM issued a press release [189] describing a method for controlling
the speed of an individual DNA strand passing through a nanopore. For this purpose they
developed a multilayer metal/dielectric nanopore device which utilizes the interaction of
the DNA backbone charges with a modulated electric field to trap and slowly release an
individual DNA molecule. The technology described could theoretically be combined with,
for example, the Nanopore technologies developed at Harvard University [2] or the previously
described BASE [37] technology where it may overcome the destructive approach followed
so far.
At the 11th annual Advances in Genome Biology and Technology (AGBT 2010) meeting in
Marco Island (Florida, USA), Life Technologies presented the first results on their experi-
ments with quantum dots, light-emitting semiconductor nanocrystals of 2-10 nm diameter,
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attached to DNA polymerases (Joseph M. Beechem, personal communication, May 12th
2010). These dots can be laser excited with a specific wavelength and then via Fluorescence
Resonance Energy Transfer (FRET) enable light emission from the fluorescently labeled
nucleotides at a different wave length while the polymerase incorporates them during com-
plementary strand synthesis. These quantum dots do not only provide/transfer the energy
for the fluorescence signal, they also enhance the signal strength. While the actual sequenc-
ing process is similar to the above described SMRT technology from Pacific Biosciences,
except having a free polymerase and a DNA template covalently bound to a flow cell, the
sequencing run can be stalled mid-way to wash off polymerases and nucleotides and replace
them with new ones, thus replacing reagent molecules affected by chemical damage. This
allows a reset of the error process and thus very long reads. When also removing the so-
far synthesized strand, for example by chemical denaturation with sodium hydroxide, the
sequencing reaction can be reset completely – allowing long and low error sequences to be
generated from multiple read outs of the same template molecule.
These new technologies on the horizon, suggest the major future directions in the field of
DNA sequencing: the ability to use individual molecules without any library preparation or
amplification, the identification of nucleotide modifications and the ability to generate longer
sequence reads. These developments are likely to facilitate future research in many fields,
make data analysis easier and further reduce per base sequencing costs.
2.8 General considerations
All current high-throughput technologies have an average error rate that is considerably
higher than the typical 1/10,000 to 1/100,000 observed for high quality Sanger sequences.
Further, the GS FLX Titanium, Genome Analyzer, SOLiD and HeliScope platforms each
have very specific biases and limitations, making it necessary to choose a platform appropri-
ate for a specific project or application (for a summary see figure 2.8 on the following page).
A combination of technologies [153, 188, 47, 34] and experimental protocols [254, 252, 113]
may also be appropriate, and even complementary, for specific projects.
High quality Sanger sequencing is now commonly used to generate low coverage sequencing of
individual positions and regions (e.g. diagnostic genotyping) or the sequencing of virus- and
phage-sized whole genomes. As the Sanger sequence length is longer than most abundant
short repeat classes, it allows the unambiguous assembly of most genomic regions – something
which is generally not possible using the shorter read platforms. However, the technology
is expensive and too slow for sequencing a large number of samples, extended genomic
regions or the many molecules required for quantitative applications (e.g. gene expression
quantification; ChIP-Seq and MeDip-Seq).
For quantitative applications the HeliScope provides the highest throughput in terms of
sequence number and has the advantage of not requiring a multistep library preparation
protocol. On the other hand, the HeliScope provides the lowest resolution in mapping
accuracy for complex genomes due its short read length and error profile. The GA or SOLiD
platforms may thus provide equivalent results for quantitative applications, while providing
fewer but longer reads and requiring a more elaborate library preparation.
While it has not yet been fully analyzed, it is possible (and even likely) that library prepara-
tion protocols could bias the sequence representation in a library [49, 183, 139, 32], making
the replacement of this step an important goal. Further, multi-step library preparation pro-
tocols require higher amounts of input material, limiting their general application. However,
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Figure 2.8: Comparison of high-throughput sequencing technologies available. The table summarizes
throughput, length, quality and costs for the current versions of the mentioned technologies. These
approximate numbers are constantly improving and based on figures available in January 2011. Costs
do not include instrument acquisition and maintenance, further they may be affected by discounts
and scale effects for multiple instruments. Where numbers are very similar, colors ranging from red
(low performance) to green (good performance) indicate a general trend. In the last column, example
applications fitting the throughput and error profiles of each of the platforms are given. Typically,
this does not mean that the technology is limited to these applications, but that it is currently best
suited to such applications.
protocols for library construction from limited sample amounts are available or being devel-
oped for each of the platforms, and publications demonstrate that while vendor protocols
indicate the need for higher sample quantities (microgram range), many users are proceeding
successfully with low input DNA amounts (nanogram to picogram range), as for example
shown for ancient DNA specimens and more specifically with protocols developed in Leipzig
at the Max Planck Institute for Evolutionary Anthropology [195, 26, 27, 143].
Like Sanger sequencing, the GS FLX Titanium provides a read length spanning many of the
short repeat sequences – an important feature for accurate sequence mapping and assembly
of genomes [241]. Despite the insertion/deletion errors, this technology has very low rates
of misidentifying individual bases, making it perfectly suited for the identification of Single
Nucleotide Polymorphisms (SNPs). Also geared to the identification of SNPs, at least for
samples with an existing reference genome, is the SOLiD instrument with its dinucleotide
encoding scheme [19]. Considerably higher coverage is needed in order to perform SNP
calling with similar accuracy using the Illumina GA [88]. Neither the Illumina GA or the
SOLiD sequencing systems are prone to generating high rates of small insertions or deletions,
making them well suited for studying InDel variation.
As mentioned earlier, the drawback of short reads (below about 75nt) obtained from Helicos,
SOLiD or Genome Analyzer instruments is in genome assembly and mapping applications,
where the placement of repeated or very similar sequences cannot be resolved unambiguously.
The correct placement is further complicated by high error rates introducing a requirement
for a minimum sequence distance of an unambiguous placement.
Paired end or mate pair protocols (figure 2.9 on the next page) help to overcome some of
these limitations of short reads [33] by providing information about relative location and
orientation of a pair of reads. Currently a paired end protocol is only commonly applied
on the Genome Analyzer and SOLiD4, while mate pair protocols are available for SOLiD,
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Paired End sequencing Mate Pair sequencing
8-20kb< 1kb
Figure 2.9: In paired end sequencing (left) the actual ends of rather short DNA molecules (<1kb) are
determined, while for mate pair sequencing (right) the ends of long molecules are joined and prepared
in special sequencing libraries. In these mate pair protocols, the ends of long, size-selected molecules
are connected with an internal adapter sequence (i.e. linker, yellow) in a circularization reaction.
The circular molecule is then processed using restriction enzymes or fragmentation. Fragments are
enriched for the linker and outer library adapters are added around the two combined molecule ends.
The internal adapter can then be used as a second priming site for an additional sequencing reaction
in the same orientation or sequencing can be performed from the second adapter, from the reverse
strand.
GS FLX Titanium and Genome Analyzer. In paired end sequencing the actual ends of
rather short DNA molecules (<1kb) are determined, while mate pair sequencing requires the
preparation of special libraries. In these protocols, the ends of longer, size-selected molecules
(e.g. 8kb, 12kb or 20kb) are connected with an internal adapter sequence in a circularization
reaction. The circular molecule is then processed using restriction enzymes or fragmentation
before outer library adapters are added around the two combined molecule ends. The internal
adapter can then be used as a second priming site for an additional sequencing reaction on
the same immobilized molecules. Thus, mate pair sequencing provides distance information
useful for assembly, but does not allow the merging of two overlapping end reads, as by
design the molecule ends will not overlap in sequencing.
Due to the large amounts of sequences that can be generated on these sequencing platforms,
there is interest in sequencing targeted regions (for example a genomic locus, from sequence
capture experiments [77, 94, 26, 30]) in multiple individuals/samples instead of sequencing
one sample to excessive depth. All technologies therefore provide a separation of their
sequencing plate into defined regions or channels. However, at most sixteen or twenty-five
such regions/channels are available (GS FLX Titanium and HeliScope plates), which may
be not sufficient for some applications. Using different library construction protocols most
platforms allow addition of sample-specific barcode (sometimes called “index”) sequences
to the library molecules. These molecules can then be sequenced in the same channel, and
later separated (computationally) based on their barcode sequence [151, 60, 141, 150]. This
facilitates highly parallel sequencing of a large number of samples beyond that possible using
the physical channel separation. Currently such protocols (mostly non-vendor protocols) are
available for the GS FLX Titanium, Genome Analyzer and SOLiD instruments.
Though sequencing prices per gigabase have fallen considerably in recent years, making
projects like the 1,000 Human Genome Variation project [53], 1001 Arabidopsis thaliana
Genomes project [239], whole genomes for 10,000 vertebrate species [91] or the International
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Cancer Genome Consortium [222] possible, high-throughput sequencing still has high acqui-
sition, running and maintenance costs, which are not included in the numbers provided in
figure 2.8 on page 34.
2.9 Summary and conclusions
The discussed technologies make it possible for even single research groups to generate large
amounts of sequence data very rapidly and at substantially lower costs than traditional
Sanger sequencing. While costs have been reduced to less than 4%-0.1% and time has been
shortened by a factor of 100-1,000 based on daily throughput, the error profiles and limita-
tions observed for the new platforms differ significantly from Sanger sequencing and between
approaches. Some vendors recently started to offer budget versions of their instruments
(e.g. Illumina Genome Analyzer IIe, Illumina MySeq or 454/Roche GS Junior) with lower
sequencing capacity. However, financial investments remain considerably high – with costs
per base generally higher than for the standard instrument, and equivalent infrastructure
required. Often the choice of an appropriate sequencing platform is project-specific and
sometimes even combinations can be advantageous. This may open the market further to
companies and sequencing centers providing sequencing-on-demand services.
Over the last years, the whole field observed a shift from the amount of time required
to prepare and run a sequencing experiment to the time required for the analysis of the
generated data [176, 183, 191, 12]. It is likely that also in the future laboratories will need to
invest considerable time, expertise and money in the design of experiments and the analysis
of the vast quantities of data that will be generated. Smaller research groups may still
find the costs of the infrastructure needed for storing, handling and analyzing several tens of
gigabytes of raw sequence data and terabytes of several thousand intermediate files generated
by these instruments each week too high. Even for larger groups and experienced genome
centers this aspect remains an ever-increasing challenge for the ongoing use of these platforms.
Thus especially financial considerations, the number of projects requiring high-throughput
data and the interest of implementing own improvements to the instruments/protocols are
important factors for instrument acquisition.
New technologies like SMRT sequencing by Pacific Biosciences, Quantum-dot sequencing
by Life Technologies or BASE by Oxford Nanopore will allow sequencing long individual
molecules without or with little preparation steps and probably even the identification of
specific nucleotide modifications. Improvements to current instruments are likely to further
increase throughput and reduce cost of reading out DNA molecules. Thus, the goal of a
$1,000 human genome set by NIH/NHGRI for personalized medicine may soon be achieved.
All these developments will hopefully facilitate future research in many fields and simplify
biological data analysis.
The Max Planck Institute for Evolutionary Anthropology decided to have high-throughput
technologies on site, allowing fast access and the development of application-specific protocols
for these platforms. Thus very early on, two 454 FLX instruments were acquired and in
late 2007 a single Illumina Genome Analyzer I instrument was installed at the institute.
Shortly after this first Genome Analyzer I was updated to version II in summer 2008, four
additional Genome Analyzer II instruments were bought. Having seven high-throughput
and two Sanger capillary array sequencers on site provides high flexibility and fast access to
these technologies, but also enabled the development of protocols and algorithms pushing
instrument limits.
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One should never listen. To listen is a sign of indifference to one’s hearers.
– Oscar Wilde [96](1204)
The described advances in DNA sequencing have revolutionized the field of molecular biology
and specifically genomics, making it possible to generate large amounts of sequence data for
answering biological questions very rapidly and at substantially lower costs. This brings a
broader part of the scientific community into the position where a high-throughput project
has to be designed or large sequence data sets have to be analyzed. The new technologies
however come with some limitations and problems. For example, considerable variance in run
quality, specific biases and sensitivities, pseudo-sequences, high error rates as well as adapter
and chimera sequences are observed. These issues require either design of the project in
a way that circumvents them, or at least considers them in data analysis. In this regard,
I analyzed the most commonly1 used high-throughput sequencing platform, the Illumina
Genome Analyzer.
To recapitulate what was described in chapter 2; the Illumina Genome Analyzer is based on
parallel, fluorescence-based readout of millions of immobilized sequences that are iteratively
sequenced using reversible terminator chemistry [16]. A flow diagram with the steps involved
from DNA sample to sequence read outs with quality score, is available in figure 3.1 on the
next page.
Independent of the actual application, Illumina sequencing requires that the molecules to be
determined are converted into special sequencing libraries, allowing molecules to be amplified,
immobilized and primed for sequencing. Up to eight different DNA libraries can be loaded
to the 8-lane flow cell. In each of the lanes, single stranded library molecules hybridize to
complementary oligos which are covalently bound to the flow cell surface. Starting from the
double stranded duplex, the reverse strand of each library molecule is synthesized and the
now covalently bound molecule is then further amplified using bridge amplification. This
generates randomly distributed sequence clusters, each containing more than 1000 copies
1Based on 1430 total instruments, listed world-wide by http://pathogenomics.bham.ac.uk/hts/stats
in February 2011, 63% are Illumina instruments (638 Genome Analyzer, 265 HiSeq), 18% SOLiD, 16% 454
and 2% other.
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Figure 3.1: Illumina sequencing requires that a DNA sample is converted into special sequencing
libraries. This is for example achieved by shearing DNA to a designated size and adding specific
adapter sequences to both ends of the DNA molecules. These adapters allow molecules to be amplified
and immobilized in one or more channels of the 8-channel flow cell. Immobilization and solid-phase
amplification create randomly scattered clusters, consisting of a few thousand copies of the original
molecule in very close proximity to each other. One of the DNA strands is removed to obtain
single stranded, identically oriented copies, 3’ ends of the DNA are blocked and a sequencing primer
hybridized on the adapter sequences. Afterwards, the reversible terminator chemistry is performed.
Here, four differently labeled nucleotides are provided and used for extension of the primers by DNA
polymerases. The polymerase reaction immediately stops after the first base incorporation since
nucleotides used are not only labeled, but also 3’-blocked. After washing away free nucleotides, the
nucleotides incorporated are readout by piece-wise imaging of the flow cell. Then, the terminator
and fluorophore is removed and another incorporation cycle started. The four images are overlaid
(registered) and light intensities extracted for each cluster and cycle using a cluster position template
obtained from the first instrument cycles. Resulting intensity files serve as input for base calling, the
conversion of intensity values into bases and quality scores.
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of the starting molecule. One strand is then selectively removed, free 3’ ends of the DNA
are blocked and a sequencing primer is annealed onto the adapter sequences of the cluster
molecules. Starting from these sequencing primers, the reversible terminator sequencing
reaction is performed.
Fluorophores attached to the incorporated nucleotides are illuminated using a red and a green
laser, and imaged through different filters, yielding four images per tile. The number of tiles
varies; for Genome Analyzer I it is typically 300 tiles per lane, for Genome Analyzer II it is 100
tiles per lane and for Genome Analyzer IIx 120 tiles. For the new HiSeq instruments, which
read the flow cell by confocal scanning rather than image tiling, the flowcell is arbitrarily
divided into 32 tiles for computational purposes – 16 on the upper and 16 on the lower
flowcell layer. After imaging, fluorescent labels and 3’ terminators are removed and the
next incorporation cycle started. Incorporation and imaging cycles are repeated up to a
designated number of cycles, defining the read length for all clusters.
During progression of the sequencing run or when images for all cycles have been collected
(depending on the setup and version), the four images per tile are overlaid (registered) and
light intensities extracted for each cluster and cycle [16]. Briefly, clusters are identified
by overlaying band-pass filtered and transformed/scaled images of the first few cycles. The
resulting cluster position template is then aligned with images of all cycles and the intensities
minus the surrounding background in the four different images extracted. Resulting intensity
files serve as input for base calling, the conversion of intensity values into bases.
C
TGTGCTGCGAGAAGGCTAGAGACAGGCGATT...
ACACGACGCTCTTCCGATCT 
G
TGTGCTGCGAGAAGGCTAGACATAGCGAGGA...
ACACGACGCTCTTCCGATCT 
T
TGTGCTGCGAGAAGGCTAGAACGTTGCAGGAGCATTGCACTAGCCTTC
ACACGACGCTCTTCCGATCT 
A
TGTGCTGCGAGAAGGCTAGATCATGGCTGAA...
ACACGACGCTCTTCCGATCT 
filter T
C
TGTGCTGCGAGAAGGCTAGAGACAGGCGATT...
ACACGACGCTCTTCCGATCT 
G
TGTGCTGCGAGAAGGCTAGACATAGCGAGGA...
ACACGACGCTCTTCCGATCT 
T
TGTGCTGCGAGAAGGCTAGAACGTTGCAGGAGCATTGCACTAGCCTT
ACACGACGCTCTTCCGATCT 
A
TGTGCTGCGAGAAGGCTAGATCATGGCTGAA...
ACACGACGCTCTTCCGATCT 
filter G
C
TGTGCTGCGAGAAGGCTAGAGACAGGCGATT...
ACACGACGCTCTTCCGATCT 
G
TGTGCTGCGAGAAGGCTAGACATAGCGAGGA...
ACACGACGCTCTTCCGATCT 
T
TGTGCTGCGAGAAGGCTAGAACGTTGCAGGAGCATTGCACTAGCCTT
ACACGACGCTCTTCCGATCT 
A
TGTGCTGCGAGAAGGCTAGATCATGGCTGAA...
ACACGACGCTCTTCCGATCT 
filter C
C
TGTGCTGCGAGAAGGCTAGAGACAGGCGATT...
ACACGACGCTCTTCCGATCT 
G
TGTGCTGCGAGAAGGCTAGACATAGCGAGGA...
ACACGACGCTCTTCCGATCT 
T
TGTGCTGCGAGAAGGCTAGAACGTTGCAGGAGCATTGCACTAGCCTT
ACACGACGCTCTTCCGATCT 
A
TGTGCTGCGAGAAGGCTAGATCATGGCTGAA...
ACACGACGCTCTTCCGATCT 
filter A
TGA C
Figure 3.2: The fluorophores attached to the nucleotides are illuminated using a red and a green
laser in a total internal reflection optics system. The four different fluorophores are imaged through
different filters, yielding four images per tile. The A and C read outs as well as the G and T read
outs are correlated (cross-talk) due to similar emission spectra of fluorophores used and their limited
separation by the optical filters.
Chapter 4 discusses base calling on the Illumina platform in depth, here it is only relevant
to note that base calling on this platform is complicated by at least two effects: (1) a strong
correlation of the A and C intensities as well as of the G and T intensities due to similar emis-
sion spectra of fluorophores used and their limited separation by optical filters (figure 3.2),
and (2) dependence of the signal for a specific cycle on the signal of the cycles before and
after, known as phasing and pre-phasing respectively. As described in section 2.3 on page 23,
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phasing and pre-phasing describe the loss of synchrony in the readout of the sequence copies
of a cluster. Phasing is caused by incomplete removal of the 3’ terminators and fluorophores
as well as sequences in the cluster missing an incorporation cycle. Pre-phasing is caused by
the incorporation of nucleotides without effective 3’-blocking. The proportion of sequences
in each cluster which are affected by phasing and pre-phasing increases with cycle number;
hampering correct base identification.
In the last three years there have been several technical updates and instead of the earlier 26
sequencing cycles up to 125 sequencing cycles are currently performed. In addition, flow cell
cluster densities were increased from 5-12 million clusters to about 30-50 million clusters per
lane and layer. Further, a technical update made sequencing of the reverse strand of each
molecule possible. Using this ”paired-end sequencing” approach for determining the reverse
strand, doubles the amount of sequence data generated. The technical update enabling
paired-end sequencing also allows the hybridization of further sequencing primers in one
strand orientation, permitting to sequence, for example, a sample index (i.e. barcode) being
part of the ligated adapter or mate pair library. An index read allows for multiple samples
to be sequenced in one lane (multiplexing) [141, 150], which later can be computationally
separated based on their sample-specific sequence in this separate read.
From this whole process, the Illumina user typically obtains sequences and per base quality
scores. The set of sequences for each lane is typically quality filtered and the user gets a
summary report for judging run quality. Finally the Illumina CASAVA package comes with
additional tools and an interface to the visualization routines in Illumina’s Genome Studio.
Different commercial as well as free programs are available that replace some parts of the
processing such as image analysis (e.g. Swift [242]), base calling (e.g. AltaCyclic [61],
BayesCall [106], Ibis [116], naı¨veBayesCall [107], Rolexa [198]), quality assessment (e.g.
TileQC [50] or FastQC [7]), mapping (e.g. bwa [131], bowtie [126], segemehl [95], SOAP [136])
as well as downstream data analysis and processing (e.g. EULER-USR [33], samtools [132],
SOAPsnp [134], tophat [228], velvet [250]). By now there is a large community of users
and developers for this platform; for example the seqanswers.com website2 is an excellent
resource when starting to explore the variety of programs available for analyzing the data
generated.
3.1 Sequencing libraries, minimum insert size and adapter
artifacts
The most important requirement for a DNA library to be sequenced on the Illumina platform
is the presence of specific outer adapter sequences complementary to the oligonucleotides on
the flow cell used for cluster generation, the so-called ”grafting sequences”. As different
sequencing primers can be used, the rest of the library design is very flexible and various
library preparation protocols with partially distinct adapter sequences are used for specific
applications. Library adapters can be added by single strand ligation (e.g. Illumina small
RNA protocol), double strand blunt-end ligation (e.g. for a multiplex protocol [150]), dou-
ble strand overhang ligation (e.g. A-overhang for Illumina genomic library protocols, and
restriction enzyme overhangs in the Illumina NlaIII DGE protocol), or by extension from
overhanging primers (e.g. multiplex PCR or molecular inversion probes [177, 232]). Each
of these approaches has a different susceptibility to the creation of library adapter dimers,
chimeric sequences and other library artifacts. Each therefore requires a different approach to
2http://seqanswers.com/wiki/SEQanswers
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enrich for only those molecules with correctly added adapters, and to remove short/no insert
molecules and molecules which are too long (>800nt) from the library before sequencing.
Failure to perform this enrichment during library preparation has two potential effects: (1)
these artifact sequences may have a negative impact on the image analysis and base-calling
which are both challenged by an over-representation of one sequence population (see below)
and (2) sequencing of large numbers of such artifacts is uneconomical and lowers the potential
number of informative sequences that can be generated per run. Libraries prepared from
small amounts of input material tend to suffer from a higher fraction of library artifacts
due to the relative abundance of adapter oligonucleotides compared to insert molecules.
Computational post-processing of sequencing data where enrichment is/can not be performed
is possible.
Figure 3.3 on the following page exemplifies for the Illumina NlaIII DGE protocol (a protocol
for digital gene expression tag profiling, see chapter 5 for details) that adapter chimeras might
be created which are of comparable length as the targeted library molecules and thus may not
be removed by selecting a specific library insert-size (e.g. by gel length selection, silica column
purification or Solid Phase Reversible Immobilization (SPRI) purification [46]). In this case,
a program like TagDust [128] can be used with the original adapter and primer oligonucleotide
sequences to identify such artifacts in a library (Figure 3.3B). This program can be either
used to directly remove these sequences or, for a representative lane, its results can be
clustered and the most frequent ones used with other software tools. Figure 3.4 on page 43
shows the results of clustering the most frequent sequences identified by TagDust for an
Illumina Multiplex library. In this case, the sequencing library has been enriched for sequence
similarity to mitochondrial genomes by a hybridization approach prior to sequencing. Again,
different sequence reads resulting from adapter chimeras are observed. However, probably
due to the enrichment and the resulting over-representation of mitochondrial k-mers, one
also sees a large proportion of false positive sequences. This clearly shows that the blind
application of computational filtering approaches has its limits.
Inappropriate size selection during library preparation may complicate analysis due to partial
sequencing of the adaptor at the sequence ends. Thus, when selecting for insert-size, it should
be considered that current experimental methods generally do not provide precise length
cutoffs. The lower cutoff selected should therefore be well-above the desired sequencing
length. For sequence reads where part of the adapter sequence is included, the position
in the sequence read at which the adapter sequence begins has to be identified and the
read trimmed appropriately. Unfortunately, this is not part of the standard Illumina data
processing and also non-trivial for short adapter fragments, especially given the increasing
sequencing error at the end of reads. If reads are not filtered for known chimeras and trimmed
for adapter sequences, these may interfere with mapping/alignment.
In order to test how Illumina’s ELAND mapper [16] as well as the widely used mapping program
BWA [131] are impacted by adapter sequence at the read end, 101-cycle reads of an Illumina
paired end genomic library with 10,000 reads were simulated as follows: ten thousand 350nt
long sequences not containing N characters were extracted from all chromosomes and contigs
of at least 1Mb in the human hg19/GRCh37 assembly. These sequences were then trimmed
for the different molecule lengths and paired end reads created. For sequences below the read
length of 101, the forward and the reverse read adapter sequences were added (forward: AGAT-
CGGAAGAGCGGTTCAGCAGGAATGCCGAGACCGATCTCGTATGCCGTCTTCTGCTTG, reverse: AGATCGGAA-
GAGCGGTTCAGCAGGAATGCCGAGACCGATCTCGTATGCCGTCTTCTGCTTG) and if required extended by
further A bases at the end. On the resulting 3.5 million reads, the error profile extracted
from the control reads of a 2x101 cycle Illumina version 4 sequencing chemistry run was
applied by randomly mutating bases at the observed rate for each position. Considering
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A: Digital gene expression / SAGE experiment
mRNA enrichment with polyT beads
BeadNNN...NNNCATGXXXXXXXXXXXXXXXNNN...NNNAAAAAAAAAAANNN...NNNGTACXXXXXXXXXXXXXXXNNN...NNNTTTTTTTTTTT
NNN...NNNCATGXXXXXXXXXXXXXXXNNN...NNNAAAAAAAAAAA
NNN...NNNGTACXXXXXXXXXXXXXXXNNN...NNNTTTTTTTTTTT Bead
1st Digestion
NNN...NNNCATGXXXXXXXXXXXXXXXNNN...NNNAAAAAAAAAAA
NNN...NNNGTACXXXXXXXXXXXXXXXNNN...NNNTTTTTTTTTTT
NlaIII
Bead
Ligation GEX adapter 1
Bead
...TCTACAGTCCGACATGXXXXXXXXXXXXXXXNNN...NNNAAAAAAAAAAA
...AGATGTCAGGCTGTACXXXXXXXXXXXXXXXNNN...NNNTTTTTTTTTTT
MmeI
recognition site
...CAGAGTTCTACAGTCCGACATGXXXXXXXXXXXXXXXTCGTATGCCGTCTTCTGCTTG
CAAGTCTCAAGATGTCAGGCTGTACXXXXXXXXXXXXXNNAGCATACGGCAGAAGACGAAC
Ligation GEX adapter 2
Bead
2nd Digestion
...TCTACAGTCCGACATGXXXXXXXXXXXXXXXNNN...NNNAAAAAAAAAAA
...AGATGTCAGGCTGTACXXXXXXXXXXXXXXXNNN...NNNTTTTTTTTTTT
cDNA 1st and 2nd strand synthesis
TCGTATGCCGTCTTCTGCTTG
35191                GTATGCCGTCTTCTGCTT
4733           AA-TCGTATGCCGTCTTCT
3109       TCGGAC-TCGTATGCCGTC
2963            G-TCGTATGCCGTCTTCTG
2875 TCGGACTGTAGAATCGTA
2818        ATGGC-TCGTATGCCGTCT
2339        AGGAG-TCGTATGCCGTCT
2307           TC-TCGTATGCCGTCTTCT
2108 TCGGACTGTAGAACTCTT
1936            A-TCGTATGCCGTCTTCTG
1886       AGGAGT-TCGTATGCCGTC
1880              CGTATGCCGTCTTCTGCT
1667              GTATGCCGTCTTCTTCTT
1527           AG-TCGTATGCCGTCTTCT
1509         CCAG-TCGTATGCCGTCTT
1366         GTGA-TCGTATGCCGTCTT
1238          GTG-TCGTATGCCGTCTTC
1209 TCGGACTGTAGA-TCGTAT
TCGGACTGTAGAACTCTGAAC
1907 GTTTCAGGAGTTTATTTT
ACAGGTTCAGAGTTCTACAGTCCGACATG
1268       GCCACCCTCTACAG-CCGA
TCGTATGCCGTCTTCTGCTTG
35191                GTATGCCGTCTTCTGCTT
4733           AA-TCGTATGCCGTCTTCT
3109       TCGGAC-TCGTATGCCGTC
2963            G-TCGTATGCCGTCTTCTG
2875 TCGGACTGTAGAATCGTA
2818        ATGGC-TCGTATGCCGTCT
2339        AGGAG-TCGTATGCCGTCT
2307           TC-TCGTATGCCGTCTTCT
2108 TCGGACTGTAGAACTCTT
1936            A-TCGTATGCCGTCTTCTG
1886       AGGAGT-TCGTATGCCGTC
1880              CGTATGCCGTCTTCTGCT
1667              GTATGCCGTCTTCTTCTT
1527           AG-TCGTATGCCGTCTTCT
1509         CCAG-TCGTATGCCGTCTT
1366         GTGA-TCGTATGCCGTCTT
1238          GTG-TCGTATGCCGTCTTC
1209 TCGGACTGTAGA-TCGTAT
TCGGACTGTAGAACTCTGAAC
1907 GTTTCAGGAGTTTATTTT
ACAGGTTCAGAGTTCTACAGTCCGACATG
1268       GCCACCCTCTACAG-CCGA
B: Most frequent TagDust filtered sequences
mRNA
NlaIII
recognition site Poly-A-Tail
17nt sequence
5' 3'
GEX Adapter 2.1
Matches human NlaIII restriction 
site chr20:+1868416-1868436
GEX Adapter 1.2
GEX Adapter 1.1Sequencing primer site
Figure 3.3: The Illumina NlaIII DGE tag protocol illustrated here, is a protocol for digital gene
expression tag profiling based on Serial Analysis of Gene Expression (SAGE) [234]. The protocol
uses short adapters which allow only single read sequencing and are added by overhang ligation (A).
For this protocol the majority of adapter dimers are removed by a gel excision step after library
preparation. However, the protocol may also create adapter chimeras with a length comparable to
the targeted library molecules. The resulting chimera sequences also show the sequences required for
cluster generation as well as the necessary priming site, causing them to be sequenced together with
the real tags. The program TagDust was used with the original adapter and primer oligonucleotide
sequences to identify such artifacts (B). Shown are the twenty most frequent identified artifacts from
one lane with human tags as well as the oligosequences they might be based on. One of the 20
sequences seems to be a real tag that was incorrectly identified as artifact.
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30 most frequent: 30bp sequences 30 most frequent: 50bp sequences
Genomic R1 Multiplex primer
5’ ACACTCTTTCCCTACACGACGCTCTTCCGATCT-> 5’ GATCGGAAGAGCACACGTCTGAACTCCAGTCAC->
P5 graft      ||||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||||||||               P7 graft
5’ AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT insert AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC index ATCTCGTATGCCGTCTTCTGCTTG
TTACTATGCCGCTGGTGGCTCTAGATGTGAGAAAGGGATGTGCTGCGAGAAGGCTAGA insert TCTAGCCTTCTCGTGTGCAGACTTGAGGTCAGTG index TAGAGCATACGGCAGAAGACGAAC 5’
||||||||||||||||||||||||||||||||||
<-TCTAGCCTTCTCGTGTGCAGACTTGAGGTCAGTG 5’
Multiplex R2
ACACTCTTTCCCTACACGACGCTCTTCCGATCT   GenomicR1
2443 ACACTCTTTCCCTACACGTCTGAACTCCAGTCACACTCGTTATCTCGTAT
1671 ACACTCTTTCCCTACACGTCTGAACTCCAGTCACAGAGACCATCTCGTAT
1426 ACACTCTTTCCCTACACGTCTGAACTCCAGTCACACTGCGCATCTCGTAT
1322 ACACTCTTTCCCTACACGTCTGAACTCCAGTCACAGATTCTATCTCGTAT
1109 ACACTCTTTCCCTACACGTCTGAACTCCAGTCACAGACCTCATCTCGTAT
1098 ACACTCTTTCCCTACACGTCTGAACTCCAGTCACAGATATGATATCGTAT
770 ACACTCTTTCCCTACACGTCTGAACTCCAGTCACAGATATGATCTCGTAT
507 ACACTCTTTCCCTACACGTCTGAACTCCAGTCACAGAGACCATATCGTAT
455 ACACTCTTTCCCTACACGTCTGAACTCCAGTCACAGAGCGTATCTCGTAT
1517       GAGCACACGTCTGAACTCCAGTCACACTCGTTATCTCGTATGCCGTCTTC
845       GAGCACACGTCTGAACTCCAGTCACAGATATGATATCGTATGCCGTCTTC
552       GAGCACACGTCTGAACTCCAGTCACACTGCGCATCTCGTATGCCGTCTTC
1449       GAAGAGCACACGTCTGAACTCCAGTCACACTCGTTATCTCGTATGCCGTC
695       GAAGAGCACACGTCTGAACTCCAGTCACAGATATGATATCGTATGCCGTC
1093              ACACGTCTGAACTCCAGTCACACTCGTTATCTCGTATGCCGTCTTCTGCT
538              ACACGTCTGAACTCCAGTCACACTGCGCATCTCGTATGCCGTCTTCTGCT
471              ACACGTCTGAACTCCAGTCACAGATATGATCTCGTATGCCGTCTTCTGCT
453              ACACGTCTGAACTCCAGTCACAGAGACCATCTCGTATGCCGTCTTCTGCT
767         AGAGCACACGTCTGAACTCCAGTCACACTCGTTATCTCGTATGCCGTCTT
749          GTGCACACGTCTGAACTCCAGTCACACTCGTTATCTCGTATGCCGTCTTC
744           AGCACACGTCTGAACTCCAGTCACACTCGTTATCTCGTATGCCGTCTTCT
Multiplex R2 AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC ATCTCGTATGCCGTCTTCTGCTTG P7graft
796 GGTTCGTTTGTTCAACGATTAAAGTCCTACGTGATCTGAGTTCAGACCGG Mitochondrial sequence
16S ribosomal RNA genes
1974                     GGATTTCTCCGGTCTGAACTCAGATCACGTAGGA CTTTAATCGTTGAACA
918         AGAAACCGACCTGGATTTCTCCGGTCTGAACTCAGATCACGTAGGA CTTT
802 AAATAGATAGAAACCGACCTGGATTTCTCCGGTCTGAACTCAGATCACGT
659                      GATTTCTCCGGTCTGAACTCAGATCACGTAGGA CTTTAATCGTTGAACAA
535      GATAGAAACCGACCTGGATTTCTCCGGTCTGAACTCAGATCACGTAGGA C
516                  CCTGGATTTCTCCGGTCTGAACTCAGATCACGTAGGA CTTTAATCGTTGA
449          GAAACCGACCTGGATTTCTCCGGTCTGAACTCAGATCACGTAGGA CTTTA
441                       ATTTCTCCGGTCTGAACTCAGATCACGTAGGA CTTTAATCGTTGAACAAA
GenomicR1 ACACTCTTTCCCTACACGACGCTCTTCCGATCT
1490             ACACTCTTTCCCTACACGACGCTCTTCCGA
13646             ACACTCTTTCCCTACAC--GTCTGAACTCCAG
1048                CTCTTTCCCTACAC--GTCTGAACTCCAGTCA
1334             ACACTCTTTCCC-ACAC--GTCTGAACTCCAGT
879             ACACTCTTTCCCTACACACGTCTGAACTCC
2859                     GAAGAGCACACGTCTGAACTCCAGTCACAG
2332                     GAAGAGCACACGTCTGAACTCCAGTCACAC
1736                GATCGGAAGAGCACACGTCTGAACTCCAGT
1659                       GAGCACACGTCTGAACTCCAGTCACACTCG
1260                        GAGCACACGTCTGAACTCCAGTCACAGATA
659                  GAGCACACGTCTGAACTCCAGTCACACTGC
1442 AGATCGGAAGAGCACACGTCTGAACTCCAG
846 AGAGCACACGTCTGAACTCCAGTCACACTC
934 AGAGCACACGTCTGAACTCCAGTCACAGAT
1165                         ACACGTCTGAACTCCAGTCACACTCGTTAT
883                         ACACGTCTGAACTCCAGTCACAGATATGAT
816                        GTGCACACGTCTGAACTCCAGTCACACTCG
784                AGCACACGTCTGAACTCCAGTCACACTCGT
AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC Multiplex R2
ATCTCGTATGCCGTCTTCTGCTTG P7graft
5493 CGTATGCCGTCTTCTGCTTGAAAAAAAAAA
819 GGTTCGTTTGTTCAACGATTAAAGTCCTAC      Mitochondrial sequence
749                               GGTCTGAACTCAGATCACGTAGGACT TTAA 
2052                     GGATTTCTCCGGTCTGAACTCAGATCACGT
684                      GATTTCTCCGGTCTGAACTCAGATCACGTA
955         AGAAACCGACCTGGATTTCTCCGGTCTGAA
834 AAATAGATAGAAACCGACCTGGATTTCTCC          16S ribosomal RNA gene
871 GAAAGAAAGAAAGAAAGAAAGAAAGAAAGA
1827  TTTCTTTCTTTCTTTCTTTCTTTCTTTCTT
682  AAAGAAAGAAAGAAAGAAAGAAAGAAAGAA         Simple repeats
694   AAGAAAGAAAGAAAGAAAGAAAGAAAGAAA
671    AGAAAGAAAGAAAGAAAGAAAGAAAGAAAG
Figure 3.4: Adapter dimer variants as well as a population of false positive sequences (italic) identified
by TagDust for an Illumina Multiplex library (top panel). Prior to sequencing, this Illumina Mul-
tiplex library was enriched for the sequence similarity to mitochondrial genomes by a hybridization
approach. TagDust was used with either only the first 30nt (left) or 50nt (right) of the forward
read. The figure shows the 30 most frequently identified artifact sequences. It is likely that high
number of false positive sequences is due to biased k-mer frequencies in the read data after sequence
enrichment.
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that both programs implement very different approaches (seed alignment versus semi-global
alignment of the whole read respectively), the performance of Illumina’s ELAND mapper is
expected to be different from BWA. Since ELAND requires only a fixed seed in the beginning of
the read (typically of 32nt length) adapters starting after this seed region should not affect
ELAND’s mapping.
Indeed, ELAND maps 98% of all simulated reads of at least 30nt insert size (2nt of adapter
sequence being compensated by two mismatches being allowed in the seed), while BWA only
reports 98% successful mappings for reads with an insert size of at least 97nt and not a
single alignment for 30nt insert size (figure 3.5 on the following page). More relevant for
many analyses, however, is the number of mappings reported to be uniquely placed and
whether they are mapped at the correct position in the genome. ELAND reports a uniquely
placed 20nt-insert-size read, but it is placed incorrectly, as are all uniquely placed reads
reported up to an insert size of 67nt. BWA reports the first three uniquely placed fragments
(mapping quality above 20) for an insert size of 83nt (two of them are correctly placed). If
one requires that 98% of the reads are correct placed, ELAND achieves this for insert sizes of
83nt and above (14nt of adapter), while BWA can only compensate with mismatches for 4nt
of adapter sequence (97nt insert size). However, BWA provides a lower total number of false
positive placements due to the inclusion of adapter sequence (8490 vs. 6308). Moreover,
for an insert size of at the least read length, BWA reports 99.999% of uniquely placed reads
(94.2% of all reported alignments) at the correct genomic positions, while ELAND only reports
98.757% of the uniquely placed reads (83.8% of all reported alignments) at the correct genome
coordinates. BWA therefore provides a more accurate mapping of these reads for downstream
analysis.
While length selection and dimer removal are important for the cost-effective sequencing of
a library and downstream data analysis, experimental methods to achieve these generally
consume sample material and may bias molecule representation. It is therefore often only
practical to apply a minimum of these purification steps in order to maintain library quan-
tity and complexity. In such cases, downstream sequence processing prior to data analysis
becomes extremely important.
3.2 Short-insert libraries and paired-end sequencing
While adapter dimers and chimeras from library preparation should be directly removed,
short insert-size molecules (e.g. ancient DNA) result in sequence reads with adapter sequence
at the read end. Here, the adapter start has to be identified and the read trimmed back
to the actual insert length. Unfortunately, this is non-trivial for short adapter pieces and
increasing sequencing error at the end of reads. However, if reads are not trimmed for
adapter sequences, these may interfere with mapping or alignment (as shown before) and
reads are either excluded or placed incorrectly. In both cases downstream data analysis will
be negatively affected.
When libraries containing inserts shorter than the sum of forward and reverse read cycles are
created, these can be sequenced from both ends to obtain higher quality sequence informa-
tion for the overlapping sequence part. For such paired-end reads the correct identification
of the adapter is eased by maximizing autocorrelation of the two reads as well as requiring
identical adapter start positions for both reads. Figure 3.6 on page 46 outlines the ap-
proach implemented for ancient DNA libraries, which has already been applied in different
studies [81, 186, 121, 30, 27, 119]. Briefly, the two reads from a cluster are merged pro-
viding the expected adapter sequences and requiring more than 10nt overlap between the
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Figure 3.5: Untrimmed adapter sequence at the read ends can interfere with alignment or mapping.
On a simulated data set it was tested how ELAND and BWA are affected by inclusion of adapter
sequence in read mapping: (A) ELAND requires only a fixed seed (here 32nt) in the beginning of
the read. Adapters beginning after this seed region may therefore have no effect on the output.
ELAND reports 98% successful mappings for all simulated reads of at least 30nt insert size (2nt of
adapter sequence being compensated by two mismatches allowed in the seed), BWA only reports 98%
successful mappings for reads with an insert size of at least 97nt. (B) Considering only uniquely
placed molecules, ELAND reports the first uniquely placed fragment for 20nt insert size. BWA reports
the first three uniquely placed fragments (mapping quality above 20) for an insert size of 83nt. (C)
All uniquely placed reads reported by ELAND up to an insert length of 67nt are placed incorrectly, as
is one of the three reported by BWA for an insert size of 83nt. When requiring 98% correct placements,
ELAND handles up to 14nt of adapter, while BWA can only compensate with mismatches for 4nt of
adapter sequence. (D) For analysis purposes, BWA shows the better performance due to the lower
number of false positive placements. Moreover, for an insert size of at least the read length (i.e. no
adapters interfering with the alignment), BWA reports 99.999% of uniquely placed reads (94.2% of all
reported alignments) at the designated genomic positions, while ELAND only reports 98.757% of the
uniquely placed reads (83.8% of all reported alignments) at the correct position.
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TATAGACGAGCTACGAGTAACGGCGCGAATGAAGATCGGAAGAGCGGTTCAGCAGGAATGC
TCATTCGCGCCGTTACTCGTAGCTCGTCTATAAGATCGGAAGAGCGTCGTGTAGGGAAAGA
Read 1: (61nt)
Read 2: (61nt)
1. Reverse complement of read 2:
TCTTTCCCTACACGACGCTCTTCCGATCTTATAGACGAGCTACGAGTAACGGCGCGAATGA
TCAGCAGGAATGC
TTCAGCAGGAATGC
GTTCAGCAGGAATGC
...
TATAGACGAGCTACGAGTAACGGCGCGAATGAAGATCGGAAGAGCGGTTCAGCAGGAATGC
TATAGACGAGCTACGAGTAACGGCGCGAATGAAGATCGGAAGAGCGGTTCAGCAGGAATGC
TATAGACGAGCTACGAGTAACGGCGCGAATGAAGATCGGAAGAGCGGTTCAGCAGGAATGC
... TATAGACGAGCTACGAGTAACGGCGCGAATGAAGATCG
TATAGACGAGCTACGAGTAACGGCGCGAATGAAGATC
TATAGACGAGCTACGAGTAACGGCGCGAATGAAGAT
...
Minimum overlap: 11nt; max. reconstructed molecule: 111nt
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2. Step-wise shift of forward read
3. Identify best merging position from identity calculations
Figure 3.6: The identification of the adapter start is eased by searching for overlapping sequence of the
two paired end reads and expecting identical adapter start points for both reads. The figure illustrates
how the forward read is shifted along the reverse complement of the second read for identifying the
original molecule length and thereby the start of the adapters. In every step, the sequence identity in
the overlapping sequence part as well as the identity of the remaining adapter sequences is calculated.
This is the approach applied in several ancient DNA studies [81, 186, 121, 30, 27, 119], except for
two modifications: (1) Instead of the normal sequence identity, a sequence identity corrected for the
observed quality scores was calculated (equation 3.1 and 3.2). (2) A heuristic was implemented by
first searching the variants of decreasing length with adapter sequence present, before checking the
longer variants with no adapter sequence present by increasing length. The search is aborted when
a corrected sequence identity of 0.95 is observed, while otherwise the maximum sequence identity is
searched as described above and read merging performed if a maximum value of least 0.9 corrected
sequence identity, when no adapter is observed, or 0.8 corrected sequence identity, when at least
one of the adapters was observed with 0.9 corrected sequence identity, was obtained. The actual
implementation also required length of more than 10nt for the overlap and rejects inserts shorter
than 5nt as adapter dimers.
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two reads. The overlap is determined by sliding the reverse complement sequence of the
reverse read along the forward read and determining the quality score adjusted sequence
identity (equation 3.1 and 3.2) of forward and reverse read for the different adapter start
positions. Merging is performed if the highest observed sequence identity in the read overlap
was at least 90%. In the overlapping sequence, quality scores are combined (assuming equal
likelihood for non-observed bases, equation 3.3) and the base with the highest base quality
score called. This strategy is more powerful than alignment(-like) approaches used for iden-
tifying adapter starts in single reads, which frequently remove sequence from the read ends
that match the adapter by chance, or which do not identify real adapter sequence due to
the higher sequencing error at the end of reads. Thus, for short insert libraries, paired end
sequencing is preferable.
IDQS(seq1, seq2) =
∑
i
{
1 | seq1i = seq2i
1−min (p(QSseq1,i), p(QSseq2,i)) | else (3.1)
pbase (QS) = 1− 10
QS
−10 (3.2)
pcons(base) =
p1,base · p2,base
{A,C,G,T}∑
n
(p1,n · p2,1)
(3.3)
Read merging performed for short-insert libraries considerably decreases the number of er-
rors and creates sequences reflecting the original outer molecule length (e.g. of interest for
authenticity of ancient DNA samples [119]). Applying the outlined merging approach to the
simulated data set described above, but this time using both paired-end reads, a factor of
5 reduction in the error rate of all merged sequences is observed (average error of 0.24%
reduces to 0.05%; figure 3.7 on the following page). For sequences shorter or equal to the
read length a reduction by a factor of about 21 (0.146% to 0.007%) is observed. One should
however caution the application of merging for long insert libraries, as false positive merging
of simple repeat sequences may cause a wrong reconstruction of such regions. In this simu-
lated data set, on average 0.29% of longer sequences (192-350nt) were incorrectly reported
as merged reads.
If no paired-end data is available and adapter sequence has to be identified from single reads
from a library with insert-size ranging shorter than read length, additional measures may
be required. For example, it might be necessary to require at least 5nt of adapter sequence
to be identified (likelihood from false adapter identification in 5nt random sequence <0.1%)
and to exclude the longer sequences for all downstream analyses, guaranteeing that only
a minimal fraction of erroneous adapter sequences is propagated into alignment and data
analysis. Alternatively, it could be advisable to combine read trimming with the actual
alignment procedure, i.e. offering that the alignment of the 3’ end can be either extended to
the genome or to the adapter. This way, the reference genome provides additional information
for the identification of the adapter set in point. For short adapter pieces the adapter and the
reference may easily result in equally good alignments. In these cases, the alignment should
be terminated and a trimmed alignment reported. Using such an alignment approach and
the information from a reference sequence may introduce a reference bias, an effect that will
be more dominant if alignments scoring equally well for reference and adapter are assigned
to the reference.
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Figure 3.7: Merging of paired end reads efficiently removes adapter sequence for short insert libraries
and increases read accuracy. Shown is the average sequencing error of the two simulated raw reads
(black) in comparison to the sequencing error remaining after read merging for different adapter
start points. The development is shown for two different types of simulated quality scores (red and
green). In red, the quality score is the average error observed for the specific base-type in this cycle
(i.e. all Adenines at this position in the read have the same quality score), while in green an error-
informative quality score was simulated. For this type of quality score a random number between
0 and 10 (uniform sampling) was added to the average quality score of this base when the correct
base was simulated and a random number between 0 and 10 (uniform sampling) was subtracted if a
wrong base was simulated. The average reduction of error (starting from 0.244%) is 1.93x (0.126%)
for the position-dependent quality scores and 4.98x (0.049%) for the error-informative quality scores.
For sequences shorter or equal to read length (5-101nt) a reduction of error (0.146%) by a factor of
1.62x (0.090%) and 20.88x (0.007%) is observed, respectively. Sequences are required to have more
than 10nt overlap for merging and merged sequences below 5nt are discarded as adapter dimers by
the program.
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3.3 Separation of samples from multiplex experiments
With increasing sequencing capacity, multiplex experiments and sample pooling are getting
more and more important for efficient use of the increasing throughput. Especially if individ-
ual loci or only small genomes are studied, sample barcoding is required as the sequencing
regions of current instruments are typically too large for cost efficient sequencing of one
sample per region. Sequencing results from multiplex libraries have to be computationally
separated based on typically 6nt to 8nt index nucleotides that are either part of the actual
sequence reads (index adjacent to insert) or performed as separate technical reads (index
embedded in the adapter sequence).
On the Illumina sequencing platform, multiplex protocols [141, 151] have been established
which include the index sequence embedded into the adapter sequence – separated from the
actual insert (see figure 3.8A). Thus for such a typical Illumina Multiplex library, the index
is determined after the forward read of the insert, in a so-called index read, for which a new
sequencing primer is annealed. This decoupling of actual insert sequence read and index
read, makes it possible to easily leave out the index if it is not required for the experiment,
but it also results in a lower sequencing error as one of the main factors of sequencing error
on the Illumina platform, namely phasing, is reset with the annealing of a new sequencing
primer. In addition, with this approach image analysis and the estimation of base calling
parameters are not affected by the frequently unbalanced base composition of a barcode.
Genomic R1                              Multiplex primer
5’ ACACTCTTTCCCTACACGACGCTCTTCCGATCT->    5’ GATCGGAAGAGCACACGTCTGAACTCCAGTCAC->
P5 grafting         |||||||||||||||||||||||||||||||||   |||||||||||||||||||||||||||||||||             P7 grafting
5’ AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT insert AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC index ATCTCGTATGCCGTCTTCTGCTTG
TTACTATGCCGCTGGTGGCTCTAGATGTGAGAAAGGGATGTGCTGCGAGAAGGCTAGA insert TCTAGCCTTCTCGTGTGCAGACTTGAGGTCAGTG index TAGAGCATACGGCAGAAGACGAAC
||||||||||||||||||||||||||||||||||
<-TCTAGCCTTCTCGTGTGCAGACTTGAGGTCAGTG 5’
Multiplex R2
Genomic R1                              Multiplex primer
5’ ACACTCTTTCCCTACACGACGCTCTTCCGATCT->    5’ GATCGGAAGAGCACACGTCTGAACTCCAGTCAC->
P5 grafting                     |||||||||||||||||||||||||||||||||         |||||||||||||||||||||||||||||||||             P7 grafting
5’ AATGATACGGCGACCACCGAGATCTACAC index2 ACACTCTTTCCCTACACGACGCTCTTCCGATCT insert AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC index ATCTCGTATGCCGTCTTCTGCTTG
TTACTATGCCGCTGGTGGCTCTAGATGTG index2 TGTGAGAAAGGGATGTGCTGCGAGAAGGCTAGA insert TCTAGCCTTCTCGTGTGCAGACTTGAGGTCAGTG index TAGAGCATACGGCAGAAGACGAAC
|||||||||||||||||||||||||||||||||        ||||||||||||||||||||||||||||||||||
<-TGTGAGAAAGGGATGTGCTGCGAGAAGGCTAGA 5’ <-TCTAGCCTTCTCGTGTGCAGACTTGAGGTCAGTG 5’
Multiplex primer 2                           Multiplex R2
A
B
Figure 3.8: (A) Illumina multiplex library with grafting sequences (P5 and P7) for immobilization
and amplification as well as different priming sites for forward (Genomic R1), reverse (Multiplex R2)
and index read (Multiplex primer). The regular index read is performed directly after the forward
read. (B) Modified Illumina multiplex library with an additional second index as well as another
sequencing primer (Multiplex primer 2) for determining this index read after the sequencing of the
template starting from Multiplex R2.
Current demultiplex approaches mostly differ in whether only exact matches from a list
of used/available index sequences are identified and whether quality scores in this part of
the sequencing run are evaluated. Frequently, quality scores are ignored and only perfectly
matching indexes considered. Depending on the application more advanced approaches might
be in place. For long barcodes the sequencing error of current instruments will cause an in-
creasing fraction of sequences to be excluded. Theoretical considerations assuming a uniform
substitution error rate of 0.5% and a 6nt index predict ≈3% erroneous sequence read outs
and ≈5% erroneous read outs for 10nt. Imbalanced usage of barcodes [150] and the non-
uniform distribution of errors across clusters [115, 49] will however cause higher fractions
of erroneous index reads with some clusters showing close to random sequence. Ideally,
complete alignments (considering quality scores in alignment scoring) to the set of indexes
used should be performed. However, due to the large number of sequences that need to
be processed and the computational complexity of an alignment approach, an intermediate
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solution is the application of a quality filter and matching to index variants with very few
substitutions (stored in efficient look-up data structures and hash tables). Applying a filter
to the quality scores in the index read out seems to be of special importance.
The barcodes used for multiplexing are designed to be highly distinguishable [151, 221,
141, 151], i.e. to require several sequence edits before on index read would be converted
into another valid barcode sequence. With typically at least three edits between different
index sequences, they are designed for accurate molecule-to-sample assignments even for
high sequencing error or other errors in the index read (e.g. library amplification or synthesis
errors). Assuming an independent and unbiased average error of at most 0.5% (higher than
the advertised sequencing error on current versions of the Illumina instrument), three edits
would correspond to at most 1.26E-07 misassignments (5 per 40 million sequences ≈5 per
lane) for a 7nt index read. Such designated low misassignment rates may be required for
some applications where conclusions are drawn from individual molecules (e.g. in ancient
DNA or diagnostics from low quality samples), especially if positive controls or samples with
high coverage are sequenced in the same pool.
However, other processes than sequencing, synthesis or amplification errors may also cause
wrong assignments: (1) contamination of barcodes during synthesis or contamination of
barcodes during handling, (2) overwriting of barcodes due to contamination or ”jumping”
in amplification, and (3) incorrect sequence read outs due to mixed intensity read outs (e.g.
in the case of mixed clusters, clusters of close proximity, or any intermediate).
The contamination of barcodes during synthesis can be due to the sequential clean up of the
synthesized indexing primers/adapters on the same HPLC (high purity liquid chromatogra-
phy) column. Even though columns are washed between oligonucleotides, low levels of carry
over are difficult to prevent. Handling contamination and overwriting in amplification steps
results largely from common errors in liquid handling.
Overwriting by ”jumping” however does not require any physical contamination by other
indexing primers; here the overwriting sequences originate from incompletely extended am-
plification products or broken template molecules [166, 152, 163, 124]. Jumping was first
described as a problem in the analysis of heterogeneous genetic material such as RNA viruses,
multi-gene families, or repetitive sequences [152] as well as for damaged ancient DNA [152]
when using polymerase chain reaction. This indicates that low amounts of DNA and the
presence of similar sequences facilitate chimera formation.
The pooled amplification of libraries with different barcodes, especially after an enrichment
process, is similar in several respects. Due to the library preparation protocol all molecules
show common sequence parts. Further, the enrichment causes the inserts of many molecules
to be similar. In addition, from an enrichment process or even from some sample sources
used for library preparation, only little material is obtained (picograms to nanograms of
DNA). Thus the amplification of such libraries can be considered more critical then the
amplification of high quantity and complex libraries. In addition, the Illumina library design
might be especially prone to the effects of jumping. While approaches having the index
adjacent to the insert can only form mislabeled chimera sequences if a sufficiently similar
molecule is encountered during amplification; when the index is separated from the insert by
a common priming site, an incomplete extension within the priming site (figure 3.8 on the
previous page, Multiplex priming site) creates an index primer template that can overwrite
the index of any other library molecules without any mismatches at its 3’ end.
Index misidentification due to incorrect sequence read outs from mixed intensity clusters has
not previously been considered as a source of error. However loading densities on current
instruments are very high (600,000-800,000 cluster per mm2) and clusters are distributed
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randomly on the Illumina flow cells. Thus a considerable proportion of mixed clusters,
i.e. one physical cluster entity originating from two different starting sequences, and very
densely packed clusters exist on every flow cell. Considering the typical results of Illumina’s
default quality filter for signal purity (Pass Filter flag), an upper estimate of such impure
clusters is in the range of 10-15%. For these clusters, the bridge amplification process during
second read synthesis of a paired end sequencing run may also change the ratio of sequence
populations and sequence mismatches at the read priming sites may change the effective
ratio of the sequences during sequencing.
In order to disentangle the effect of all factors that influence the accuracy of assigning
sequence reads to the samples, we3 recently developed a new multiplex protocol with a second
index read at the opposite molecule end (figure 3.8 on page 49) and analyzed the index pairs
obtained under three different experimental conditions. We identified that mixed clusters
contribute most of the false pairs at a rate of about 0.4-0.5% relative to sequences with error
free index read outs. Applying the widely used Illumina Pass Filter flag, removed 11-30% of
these false index pairs, while a filter directly applied on the quality scores of the index reads
removed 92%-94% of the attributed false index pairs (while maintaining similar numbers of
quality filtered sequences). The second strongest effect, PCR jumping was only observed
in one of the experiments, where we pooled a subset of libraries prior to target enrichment,
and hence captured, amplified and sequenced in a multiplex setup. In this specific setup, we
estimated that PCR jumping caused about 0.4% chimerical molecules per correctly paired
molecules after 24 amplification cycles. With rates lower than these two effects, we observed
different levels of index cross-contamination from synthesis and handling (probably partially
also including PCR jumping). We assigned rates of 0.04% false pairs in two experiments. For
the third experiment, where libraries were enriched individually for mitochondrial genomes
– the experiment involving the most sample handling –, we determined a rate of 0.10%.
These results indicate that it is essential to quality filter raw clusters specifically on the
index read(s), to reduce the number of false sample assignments.
3.4 Sample contamination
Another problem is sample contamination during library preparation from other DNA/RNA
sources. Such contamination may be introduced by the experimenter or stem from lab chem-
icals. Hence, contamination from food sources, humans, parasites and bacterial contamina-
tion is frequently observed. Library preparations starting from low amounts of endogenous
DNA and protocols using single strand ligation procedures can be considered most prone for
contamination.
Even though there is no good way of handling contamination except for its avoidance, it has
been suggested before (e.g. [42]) that reads can be filtered by the alignment to the putative
contaminant sequence before data analysis. However, such a filtering may introduce biases
in the data, especially if the evolutionary distance between contaminant and sample is low.
This is a frequent problem in ancient DNA studies of early modern humans, Neandertals or
closely-related primate species. Here the fraction of contamination is deduced from informa-
tive sites (i.e. know sites of fixed differences between species/populations) and a fraction of
contaminant molecules is determined [119, 26, 81, 186]. Once the frequency of contamination
in a sample is known, this information can be incorporated within statistical models during
data analysis. If no informative sites are known, estimates of contamination may be obtained
3together with Matthias Meyer, Susanna Rankin/Sawyer, Svante Pa¨a¨bo and Janet Kelso
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from biallelic or triallelic sites in haploid/diploid sequences. Further, for example Y chro-
mosomal sequences in a female sample as well as heterozygous sites on the X chromosome
can be used to estimate the presence of contaminant DNA in the sample [83, 84, 81, 186].
Cross-contamination of libraries before sequencing may also be a source of contamination,
however this type of cross-contamination can be largely identified and filtered from the final
sequencing data, when sample specific barcodes are used and determined during sequencing
(see section 3.3 on page 49).
3.5 Machine adjustment and run preparation
The correct adjustment of the Genome Analyzer instrument is an important prerequisite for
producing high quality sequencing data. The individual instruments as well as sequencing
kits and flow cells used come with some variance. Therefore, the correct instrument ad-
justment should be frequently checked and preparation of a sequencing run done with much
attention to detail. While liquids and optics of the instrument typically get higher attention,
the correct function of other components such as thermal elements and cooling devices is
equally important for high quality runs.
When loading the chemistry and flow cell, all connectors should be checked for leaks, the
correct priming of the reagents validated and long waiting times evaded. This is to prevent
air bubbles in the pump, tubing and finally flow cell, which could cover parts of the images
(figure 3.9A) or reduce chemistry efficiency, due to smaller effective volumes and incomplete
coverage of the inner flow cell surface. In case several sequencing kits are required (total
read length above 36 cycles), all sequencing kits required for all sequencing reads should be
thoroughly mixed before splitting them by tube volume to not introduce later problems in
base calling due to different fluorophore intensities. Further the incorporation mix should
be filtered and centrifuged before adding the polymerase and filling it in the final tubing.
Thereby chemistry crystal and lint artifacts on the images are reduced. Otherwise, during
illumination such artifacts my result in strong light signals (figure 3.9B) shining over wide
parts of the image and thereby overlaying actual clusters or cause cluster like structures
being mis-identified as clusters in the image analysis process (section 3.7 on page 55).
After performing the first base incorporation, the correct adjustment of the flow cell stage
(flatness), flow cell tilt, the complete illumination of tiles (footprint) and oil application, the
adjustment of the focus laser, the maximum focus range and stage tilt should be checked
with the first cycle report and also manually before final first cycle imaging. Some of the nec-
essary adjustments can be done directly by a skilled lab technician, if a problem is correctly
identified. It is advisable to temporarily store run images (for a few weeks); in case problems
with a run are observed, images still provide the most information for troubleshooting.
Problems with the stage flatness can be identified if on multiple tiles image distortions are
seen, i.e. only part of the image is sharp while the rest is blurry (figure 3.9C). If this effect
is limited to tiles at the flow cell edges, oil covering the flow cell surface could be a more
reasonable explanation. While in the first case the adjustment by an Illumina technician is
required, in the later case, the flow cell has to be removed, cleaned and reinserted into the
instrument (otherwise the oil will be spread by the thermal element over the course of the
run). Commonly, a band of brighter clusters is observed on the right side in the second track
of lane 8 (figure 3.9D). It is probably caused by a reflection of laser light on the right flow
cell edge and seems not problematic for data analysis.
Flow cell tilt is measured automatically with current software versions; if a too high value is
determined, a wrong alignment of the flow cell in the instrument is a likely source. However,
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Figure 3.9: Correct instrument adjustment is an important prerequisite for producing high quality
sequencing data. Preparation and start of a sequencing run has to be done with careful attention to
avoid or identify the following instrumentation artifacts: (A) Air bubbles, caused by leaks, insuffi-
cient priming and long waiting times. Bubbles can obscure parts of the images or reduce chemistry
efficiency. (B) Particles in the sequencing chemistry (e.g. crystals from an unfiltered incorporation
mix) frequently result in image artifacts. (C) Incorrect adjustment of stage flatness and stage tilt can
cause distortions, i.e. parts of the image are sharp while the rest is out of focus. A similar effect limited
to tiles at the flow cell edges, can originate from oil covering the flow cell surface. (D) Reflections in
the instrument can cause variation in cluster brightness, like the commonly observed band of bright
clusters in column 2 of lane 8. (E) If the position of laser excitement is not in sync with imaging
(footprint), a black straight band can be observed at the edges of multiple tiles (partially with comb
like slots). (F) If this effect is limited to tiles at the flow cell edges, oil coverage is insufficient.
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an uneven outer flow cell edge may also cause this problem; in this case, the flow cell tilt has
to be manually set by averaging out the uneven edge. If a black straight band is observed on
one of the four edges of multiple tiles (partially comb like slots can be observed, figure 3.9E)
the position of laser excitement (i.e. footprint) may not be in synchronization with imaging.
In this case the laser spot can be corrected by two adjustable screws. If this effect is limited
to tiles at the flow cell edges, oil coverage below the flow cell is not sufficient and additional
oil has to be applied (figure 3.9F).
Focus calibration reports should be checked for continuous X and Y values. Jumps in these
values are caused by confusion of the focus laser spot with its reflection and, like error
messages of the spot being close to the image edge, these are the result of an incorrect focus
laser adjustment. If the focus laser is not readjusted by an Illumina technician, unfocused
tiles will be obtained. High values for the maximum focus range in the first cycle report (Z-
axis change above 12,000-18,000) might hint at incorrect flow cell alignment causing higher
bending of the flow cell. In this case, Z-values considerably decrease from the middle of the
flow cell towards both ends. However if Z-values decrease or increase monotonically from top
to bottom of the flow cell the stage’s tilt can be adjusted by precision mechanics screws. If
not readjusted, the maximum focus range will be exceeded during sequencing and unfocused
tiles will be the result.
When low intensities are observed in the first cycle report (e.g. due to long handling times
caused by one of the problems described before), the primer hybridization should be repeated.
This step can be performed with a sodium hydroxide wash and hybridization protocol either
in a Cluster Station or cBot (devices used for preparing the Illumina flow cell with the
immobilized clusters; from now on only referred to as Cluster Station), or directly in the
Genome Analyzer instrument, if a PE module is available and identical sequencing primers
are used for all lanes.
3.6 Image analysis
The images for the four fluorophores, for the more than 100 tiles per lane and for each cycle
performed, have to be overlaid (registered) and light intensities extracted for each cluster
and cycle [16]. When all sequences, or a vast majority of the sequences start identically,
the image analysis will consider a higher fraction of the clusters as being grown into each
other and remove them – reducing the overall yield from a sequencing run by 10% to 30%
depending on the loading density and software version (figure 3.10 on the next page). Such
effects are, for example, observed if libraries are made from restriction digested molecules or
if tag/barcode sequences are added on the outer molecule edges and these are determined
in the first read cycles. Starting image analysis (Firecrest module) with a user-defined nr
parameter, thereby setting the number of cycles used for cluster identification, can be used
as a work-a-round. The default value of this parameter depends on the analysis pipeline
version (below v1.3: 1 and not configurable; v1.3 to v1.5: 2, v1.6: 4). However, the design of
project specific primers should be preferred over changing image analysis parameters, as the
data transfer and oﬄine analysis of images causes additional investments of money and time.
Changing this parameter may also increase the fraction of artifacts being identified as clusters
(see sequencing artifacts section). Further, when a majority of sequences are identical in the
first cycles this may cause problems in base calling (see section 3.8 on page 59 and chapter 4
section 4.3 on page 66).
The optimal number of clusters per tile varies depending on the Genome Analyzer version and
the library being sequenced. With the current software version (RTA/OLB v1.8), a complex
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G channel, 1st cycle
G channel, 4th cycle
Lane Sample Conc.[pM] 1
st Cycle 4th Cycle Ratio
1 SL7 1.0 6,941,328 7,238,465 96%
2 SL7 2.0 8,871,763 12,646,584 70%
3 SL6 1.0 7,675,074 8,123,010 94%
5 SL6 1.5 9,061,321 11,200,209 81%
6 SL6 2.0 9,190,638 14,167,561 65%
7 SL8 1.0 6,773,787 6,834,065 99%
8 SL8 2.0 9,003,716 11,369,083 79%
4 PhiX 2.0 11,279,178 11,478,043 98%
Figure 3.10: If all or the vast majority sequences start identical in the first read of a sequencing run,
image analysis will consider a higher fraction of the clusters as being grown into each other and remove
them. This effect is for example observed if libraries are made from restriction digested molecules or
if tag/barcode sequences are added on the outer molecule edges and read in the first read. Changing
parameters for an image oﬄine analysis (Firecrest module) can be used as a work-a-round. The
figure table shows cluster counts as well as a section of the image of the same tile in cycle 1 and 4
for a run from the Neandertal Genome project [81] (080902 BIOLAB29 Run PE51 1) in which the
tag ’GAC’ was read in the beginning of the first read. Cluster counts were obtained from IPAR v1.01
image analysis (done only based on the first cycle of the run) and the results for a version of the
Firecrest v1.9.5 algorithm, in which cluster identification was done in cycle 4.
library, i.e. with sufficiently many different molecules that no base composition biases is
observed when averaged across them, may be loaded with 330,000 to 400,000 clusters per
tile (600,000-800’000 per mm2), while a low complexity library should be loaded in the range
of 250,000 to 330,000 clusters per tile (450,000-600’000 per mm2). Differences between low
and high complexity libraries, are caused by an increased background signal (lower base
qualities) and cluster tracking issues (N bases) if a majority of reads shows the same base in
a cycle and therefore are imaged together. If cluster densities are reduced, the background
signal from close-by clusters is reduced and thus purer intensity values obtained.
To precisely load the correct amount of library DNA for obtaining these designated cluster
counts, a precise quantification by quantitative PCR (qPCR) or high-resolution chip-based
capillary electrophoresis is required [183]. Hence, a stable quantification procedure is also
one of the main prerequisites for performing high-quality sequencing runs.
3.7 Low quality sequences and sequencing artifacts
The random dispersion cluster generation process currently performed for the Genome An-
alyzer platform allows for high loading densities but also complicates the identification of
cluster positions from images. Image analysis and cluster identification algorithms used for
this purpose can incorrectly identify sequencing chemistry crystals, dust and lint particles
as well as other flow cell features as sequence clusters (figure 3.11 on the following page).
The fraction of such artifact clusters is increased for low cluster densities (as the number of
these artifacts does not necessarily increase with cluster density) and for low intensity runs.
Low cluster intensities can have multiple sources: (1) reduced cluster growth during bridge
amplification, (2) wide spread clusters (e.g. due to large library insert sizes), (3) inefficient
sequencing primer hybridization, (4) degraded/bleached fluorophores or bad performance of
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51 TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
5 NTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
4 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG
1 AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
1 AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAATATATAAATTA
1 AAAAAAAAAAAAACAAAAAACAAAAAAAAAACAAACAAAACAACAAATAA
1 AAAAAAAATATTTAATTATTTTTATTTATAATTTTTTTGTTTTTTGTTTT
1 AAACAAACCACACAAACAAAAAAACACAACAAAACAACACCACCACCCAA
1 ATTCTATTTAATACAAATAAAATATCAATTTAAAACTACACTATACATAA
1 CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACA
1 CAAATATATTTATATTTATTTTTTTATTTAATTTTTATATTTTTATTTAT
... 103 non-library sequences from lint in total
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A: Clusters identified from image artifacts
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Figure 3.11: Cluster identification can identify crystals, dust and lint particles as well as other flow
cell features as sequence clusters (A). Indicated are 103 non-library sequences originating from a lint
particle that has been observed in a library that was sequenced with a three base pair tag (’GAC’) in
the beginning of each read. In this case, non-library sequences could therefore be distinguished based
on these first three bases. The fraction of such artifact clusters is increased for low loading density
and low intensity runs. A sequence entropy filter (equation 3.4) is efficient for removing the majority
of these sequences (82.52% for a cutoff of 0.85), but also removes non-artifact sequences (B) – as
indicated in the figure, 0.01% of the human reference genome (GRCh37/hg19).
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Figure 3.12: Sequences resulting from crystals, dust and lint particles as well as other flow cell features
are typically of low complexity (figure 3.11 on the previous page) but only partially of low quality.
Plotted is the quality score frequency distribution (PHRED-scale [63], Ibis base caller [116]) for all
reads matching the ’GAC’ library tag in the beginning of the read (black, n = 557,466,159 bases
from 10,930,709 reads) as well as all sequences not matching the tag sequence and its one base pair
substitutions (red, n = 3,481,668 bases from 68,268 reads). The data was obtained from lane 5 of the
080902 BIOLAB29 Run PE51 1 run from the Neandertal Genome project [81].
polymerase enzymes due to production, storage or handling issues, or (5) increased back-
ground signal. If low intensities are observed for the first time, primer hybridization and
first base incorporation should be repeated to exclude the most frequent sources.
If cluster identification picks up sequencing chemistry crystals, dust and lint particles, the
resulting sequences are typically of low sequence complexity (i.e. consisting of long stretches
of identical bases; figure 3.11 on the previous page) and only partially also of low quality
(figure 3.12). Thus they are not completely removed by signal purity/quality filters. Further,
freely movable versions of these features may also appear in later cycles and overlay the signal
of regular clusters. Depending on their size, these may even cover a larger fraction of a tile
and thereby prohibit the correct read out of many clusters in one or several cycles (figure 3.9
on page 53). In combination with air bubbles (figure 3.9A) caused by leaks or a chemistry
running low, these impermanent features are a frequent source of missing base calls (Ns)
and sequencing error. The number of these fixed and movable artifacts can be reduced by
a clean sequencing set-up and the above described steps. In extreme cases, the exclusion of
complete tiles from analysis should be considered.
Due to the low sequence complexity obtained from the read out of most fixed image features
identified as clusters, these can be removed by a sequence entropy filter (equation 3.4) or
another base composition/base frequency filter. For indexed sequencing libraries [141, 150],
such clusters are efficiently removed by an index sequence filter step. The same applies for
libraries with tag sequences. Filtering for index and tag sequences should be considered supe-
rior, as other filters may also remove non-artifact sequences of low complexity (figure 3.11B).
H(x) = −
∑
i
p(xi) · log2 p(xi) (3.4)
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Further, random cluster dispersal results in a wide range of inter-cluster distances, causing
different susceptibility of clusters to neighboring signals. In the most extreme two clusters
can be completely grown into each other, resulting in the read out of a mixture of signals
from the different sequences. Depending on the ratio of the two sequences and the sequence
similarity, the resulting sequence can be close to random with overall low base quality scores
or be close to one of the original molecules and show low base quality scores/higher error
rate for some positions along the read.
This effect of cluster distance on signal purity causes sequencing errors to be non-randomly
distributed, i.e. the fraction of reads with two errors is not equal to the squared fraction
of reads with one error - but considerably higher (e.g. figures 4.9 on page 79, 4.12 on
page 84, 4.13 on page 85, 4.14 on page 86, 4.15 on page 87 as well as figure 3.13).
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Figure 3.13: Random cluster generation results in a wide range of inter-cluster distances, causing
sequencing error to be non-randomly distributed across clusters. The fraction of reads with two
errors is not equal to the squared fraction of reads with one error. Shown are the observed rates for
reads with 1 to 5 errors for different Illumina Genome Analyzer data sets (solid lines) presented as
test data sets for the Ibis base caller (chapter 4, [116]) and the expected rates when extrapolating
from the fraction of molecules with one error (dashed line).
Hence, there are clusters accumulating error due to their close proximity to another sequence
cluster. These can be identified by a high frequency of low quality bases. Filtering is
commonly done by the default Illumina signal purity filter called “chastity”, or also referred
to as Pass Filter flag. This filter requires that for the first twelve cycles (in later versions
of the analysis pipeline the first 25 cycles and allowing one outlier) corrected intensities for
the bases called are 1.5 times higher than the next highest intensity. However, preferentially
a simple quality-score-based filter should be applied over all reads and not only the first up
to 25 bases of the sequencing run. A quality score filter is by design highly correlated with
signal purity, but also incorporates signal strength.
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3.8 Sequence composition and standard base calling
The Illumina base caller uses a model-based approach for the conversion of intensity values
into bases (for more details see also chapter 4 section 4.3 on page 66). The run-specific
parameters of this model (so-called cross-talk matrix and phasing/pre-phasing values) are
determined form the first few cycles of each read. The cross-talk matrix is typically estimated
from cycle 2, phasing and pre-phasing values from the first 20 cycles. The estimate is easily
confused by a library having an unbalanced base composition in this part of the read. For
an extreme example of a false estimation due to an unbalanced base composition see also
figure 4.1 on page 67. Such problems, are for example, caused by a restriction site or some
tag sequence in either the forward or the reverse read (in case of paired-end sequencing).
The only read type for which this parameter estimation is not used/not done is the index
read. For the index, parameters of the preceding read are applied. Therefore for at least one
lane in each run the base composition has to be balanced and the average constant for each
read over the thousands of clusters per tile, or a separate control lane has to be sequenced
for estimating these base calling parameters.
This control lane library is not limited to only the commonly used φX174 variant; however
the choice should be a higher complexity shot-gun library from an organism with close to 50%
GC content, to account for assumptions in the parameter estimation process [16, 116, 106].
A genomic shot-gun library from most species can be used for this purpose. While mRNA
libraries are sufficiently complex to produce a balanced base composition, prepared from
the standard Illumina-protocol, they show a biased base composition in the first twelve
bases of the reads originating from second strand cDNA synthesis with “not-so-random”
hexamers [87] and cannot be used for base calling parameter estimation.
3.9 Control read spike-in and alternative base callers
In addition to the estimation of base calling parameters, a control lane also provides useful
statistics for sequencing quality. Therefore, spiking-in φX174 control sequences in every
lane is recommended, even though a high complexity shot-gun library lane is available for
parameter estimation and no control lane necessary. Given a known high quality control
library, the obtained per lane statistics for this library can be easily compared, even between
different runs. The choice of φX174 as a quality control is arbitrary; however a spiked-
in sample should have the following features: (1) small genome with no similarity to the
actual library sequenced for later identification/filtering by alignments, (2) a completely
known sequence of the genome of the exact sample for determining error development, (3)
high complexity and balanced base composition to study error patterns. If condition (1) is
fulfilled, the spike-in can be performed without the need of multiplex sequencing for later
separation of the control reads from other library molecules.
A fraction of 1-2% control reads is sufficient for creating quality statistics over all lanes and
for using a reference-based base calling approach like AltaCyclic [61] and Ibis [116] for
increasing the base calling accuracy (see chapter 4). When turning off automatic parameter
estimation for the Illumina base caller and using default values from runs of comparable
sequencing chemistry, this low fraction of control reads in combination with an alternative
base caller allows the omission of the dedicated control lane even for whole runs of libraries
with unbalanced base composition.
Frequently projects use sequence data generated on different sequencing platforms, with
varying versions of the sequencing chemistry and instrument software, or data produced in
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different facilities. This creates a need for assuring data quality and consistency. Quality
score recalibration based on alignments to a reference genome has been identified as one
solution to this problem [53, 147]. Spike-in control reads provide an unbiased source for the
required alignments (see chapter 4 section 4.6 on page 90).
3.10 PCR duplicates in data analysis
Some samples contain very little DNA material (e.g. DNA extracted from ancient speci-
mens), PCR amplification of such sequencing libraries is therefore often unavoidable when
using these samples in sequencing experiments. This may lead to problems in downstream
applications, as non-random amplification from only few starting template molecules may
limit the capacity to identify polymorphisms (or damage [28, 27]) or alter their frequency
in the sample. Figure 3.14 on the following page demonstrates the uneven representation
of PCR duplicates for a deeply sequenced ancient DNA library. Quial et al. [183] described
that such biases may also originate from gel purified modern DNA samples and Mamanova et
al. [141] described them for PCR amplification of modern DNA samples. In the worst case,
the uneven representation can lead to incorrect consensus sequence calls or false estimates
for variant frequencies at polymorphic sites. The best way to deal with this problem is to
identify and remove duplicate sequences that are the result of PCR amplification. However,
in quantitative applications this is frequently not an option as the dynamic range of the mea-
surement exceeds the number of possible different molecules and technical (PCR) duplicates
can therefore not be separated from biological replicas.
Independent molecules are frequently identified based on their outer alignment coordinates
(e.g. [132, 147, 81, 186]); however sequence-based approaches such as clustering [56, 137, 13],
may also be used. When PCR duplicates of the same molecule have been identified (a
PCR cluster), either a representative sequence is chosen or a consensus determined. A
representative sequence should be selected based on the lowest sequencing error probability,
i.e. the highest sum of quality scores. Both the samtools [132] and Genome Analysis Tool
Kit [147] (GATK) packages implement routines for this type of filtering. A consensus sequence,
which may reduce sequencing error considerably (e.g. [27, 81, 186]), should only be calculated
if the identified duplicates are very unlikely to originate from different molecules.
If non-identical sequences originating from different DNA molecules are clustered together,
a consensus approach will average these. This may result in incorrect haplotype calls and
low quality scores for sites where variation is present. For ancient DNA samples with a few
million endogenous molecules, large megabase-sized genomes and random fragment ends, the
assumption of independence is probably valid. Large amounts of endogenous DNA, small
genomes, or protocols that generate non-random fragment ends (such as the use of restriction
enzymes) may, however, conflict with this assumption.
Identifying PCR duplicates in the whole library or the alignable fraction of the data may also
be of interest for determining the complexity of a library, i.e. the total number of different
molecules. The number of unique molecules u and the number of sampled molecules s can
be used to estimate the total number of different sequences M. Assuming sampling with
replacement and thus assuming that the above described biases have a small effect, one can
fit sub-sampled values to equation 3.5 for this purpose.
u ≈ 0 +M ·
(
1− e− sM
)
(3.5)
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Figure 3.14: From in total 44 Illumina Genome Analyer IIx lanes of the Denisova SL3004 library
([186], 2×101+7 cycles, v4 sequencing chemistry), reads aligned with BWA to the human reference
genome (NCBI 36/UCSC hg18) were analyzed for PCR duplicates. The SL3004 library was amplified
with Phusion High-Fidelity DNA Polymerase (Finnzymes) during library preparation. Analyzing
molecules aligning with the same outer coordinates, a mapping quality of at least 30 and a length of
at least 30nt, resulted in an average coverage of 12.9 per PCR duplicate and an empirical coverage
distribution similar to an exponential/power law distribution (left upper panel). This indicates
that many molecules are only observed for deeper sequencing while other molecules are available
at higher frequencies. Analyzing length (left middle panel) and GC content (left lower panel)
patterns as well as the combination (right panel) shows higher PCR duplicate counts for a GC
content between 30% to 70% as well as for shorter molecules compared to longer molecules. This
effect may be due to an amplification bias from the polymerase or the cluster generation process
necessary for Illumina sequencing.
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Figure 3.15: Interaction of the number of unique molecules (u) obtained from PCR duplicate analysis
and the fraction of the library seen (u/M ) when assuming sampling with replacement. Dots show
equal amounts of sampled data (s) being added. The number of unique molecules (u) relates to the
total number of different sequences (M ) and the number of sampled sequences as given in equation 3.5.
If one observes about 85% unique molecules, this indicates that about 28% of the total library (dashed
lines) was sampled.
Such complexity estimates are of interest when determining the fraction of a library that has
been sequenced. The results of such an analysis may indicate that libraries have not been
sequenced deeply and that further sequencing is still efficient, e.g. when 85% of sequence
reads are identified to be unique, only about 28% of the different molecules in a library have
been sequenced (see figure 3.15).
3.11 Summary and conclusions
Library design for the Illumina Genome Analyzer and HiSeq platforms is very flexible due
to custom priming sites and even allows applications-specific library preparation protocols.
Creating libraries without artifacts like adapter dimers, chimeras and contamination from
external DNA/RNA sources as well as a sufficient insert size is, however, a general aim for
every library preparation protocol.
What is not widely known is that, the Illumina software does not handle artifact sequences,
nor does it filter or trim adapters. Thus, some fraction of insert-adapter-chimeras or pure
adapter dimers often ends up in the final data analysis or may introduce a bias when reduced
insert-size reads are excluded during mapping. Explicit identification of starting adapter
sequence and adapter chimeras is hampered by reads showing only a few bases of the adapter
and by higher error rates at the end of reads. For paired end reads the correct identification
of the adapter start is eased by maximizing autocorrelation of the two reads with the outlined
read merging process, which has already been applied in different ancient DNA studies [27,
119, 121, 81, 186]. In addition to the efficient identification of adapter start points, merging
performed for these short insert libraries allows for improved error rate in the called consensus
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sequence part (figure 3.7 on page 48, [27]). Thus, for short insert libraries, paired-end
sequencing is to be preferred over single-read sequencing.
In addition to creating a high-quality sequencing library and quantifying it, the correct
adjustment of the machine, handling, as well as particles in the sequencing chemistry have
a considerable impact on run quality. Reflections, uneven application of oil, air bubbles
and an imperfectly-adjusted machine cause varying data quality. Particles like chemistry
lumps, dust and lint can cause pseudo sequence signals which then result in the analysis
of artifactual reads not originating from DNA molecules in the library sequenced. Tagging
or indexing allows filtering for real library molecules and should be preferred over sequence
complexity-based methods. Sequence complexity-based methods provide high removal rates,
but they may introduce a bias due to the removal of real low complexity sequences.
When an index/tag is placed in the beginning of the read, it may increase effective sequenc-
ing costs due to problems introduced in image data analysis and base calling. Such tags may
reduce the number of clusters identified in image analysis and negatively impact base call-
ing parameter estimation, thereby reducing the total amount of usable sequence. Correctly
performed as separate reads [141, 150], the error profile of the actual reads is not altered
and multiplexing allows for the optimal usage of the increasing sequencing throughput, es-
pecially if subsets of a large genome or several small genomes are studied. When using an
indexed spike-in control library in all lanes of a run, the standard Illumina analysis pipeline
provides useful measures to assess run quality between individual lanes and whole runs. Fur-
ther, these reads allow for quality score calibration and the application of alternative base
callers. Improved base callers should be considered to obtain sequences of increased quality
(chapter 4).
PHRED-like base quality scores [63] should be used for quality-based filtering based on the
complete read and specifically also on the index read(s) of multiplex experiments. Quality
score based filters are equally suited for filtering clusters accumulating error due to their
close proximity to another sequence cluster as the Illumina Pass Filter flag based on the first
run cycles, but may also remove reads affected by freely movable artifacts in later sequencing
cycles.
The most important principles presented, can be summarized as follows: (1) Filter reagents
for undesirable particles and carefully start a run with checking for leaks, oil coverage and
instrument adjustment, (2) Regularly check quality statistics and images for artifacts as well
as the correct adjustment of the instrument, (3) Filter sequence data for library artifacts such
as adapters and chimeras (4) Remove artificial clusters by filtering for sequence complexity,
or if possible, filtering for specific tags/indexes used, (5) Filter low quality reads based
on quality scores of all reads performed, and (6) use alternative base callers to obtain the
maximum yield of high quality sequences from a run. These simple rules laid out here, shall
enable the identification and handling of the most common problems in sequencing runs
encountered on Illumina sequencing instruments.
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Chapter 4
Improving base call quality of the
Genome Analyzer platform
To define is to limit – Oscar Wilde [96](147-148)
As described in chapters 2 and 3, the Illumina Genome Analyzer is based on parallel,
fluorescence-based readout of millions of immobilized sequences that are iteratively sequenced
in a base-wise manner. After sequencing or while the sequencing run proceeds, images are
analyzed and intensities extracted for each sequence cluster (see chapter 3 section 3.6 on
page 54). For this purpose, the four images per tile, showing the cluster fluorophores after
illuminating them with different wavelengths and filtering the emitted light with different
optical filters, are scaled and overlaid (registered). Then the light intensities minus the sur-
rounding background are extracted for each cluster and cycle. Resulting intensity files serve
as input for base calling, the conversion of intensity values into bases. Base calling on the
Illumina platform is complicated by at least two effects:
 A strong correlation of the A and C intensities as well as of the G and T intensities due
to similar emission spectra of fluorophores and a limited separation by optical filters.
 Dependence of the signal for a specific cycle on the signal of the cycles before and after,
known as phasing and pre-phasing respectively (chapter 2 section 2.2 on page 20 and
section 2.3 on page 23). Phasing and pre-phasing describe the loss of synchrony in the
readout of the sequence copies of a cluster. Phasing is caused by incomplete removal
of the 3’ terminators and fluorophores as well as sequences in the cluster missing an
incorporation cycle. Pre-phasing is caused by the incorporation of nucleotides without
effective 3’-blocking. The fraction of molecules in cluster affected by phasing and pre-
phasing increases with the number of cycles, hampering correct base identification as
the run proceeds [61, 198, 116, 106].
Technical improvements in the optical filters and camera of the Genome Analyzer II/IIx,
have helped with distinguishing the A and C as well as G and T fluorophores. Phasing
and pre-phasing were addressed by continuous improvement of the sequencing chemistry
kits that became available over the last three years (currently the fifth chemistry version is
used). Both improvements reduced the overall error rate and allow more sequencing cycles.
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4.1 Improved base calling and quality scoring
During the first year after the release of the Genome Analyzer I platform, two publica-
tions [61, 198] addressed the base calling of the platform; both using statistical learners
trained on sequences called by the standard base caller, Bustard. Erlich et al. [61] published
AltaCyclic – the first machine-learning based approach to base calling for the Genome
Analyzer. Their approach applies Support Vector Machines (SVM) trained for each indi-
vidual cycle. Rolexa [198], a base caller for the statistical software package R [224], applies
Gaussian mixture models, similar to the approach used by Cokus et al. [38] for the analysis
of bisulphite sequencing data. The two base callers differ further in that Rolexa generates
IUPAC ambiguity codes1 for ambiguous base calls, while AltaCyclic produces unambiguous
bases with quality scores.
End of 2008, we2 started developing Ibis (Improved base identification system), an
accurate, fast and easy-to-use base caller for the Illumina sequencing system. We aimed to
significantly reduce the error rate, to provide better quality scores with each base, as well as
to provide a more generalized and computationally lighter approach than the ones presented
before. Our developments converged in the publication and release of Ibis in Genome
Biology end of summer 2009 [116]. Its improvements allow increased output of usable reads
due to reduced error rates and facilitate better quality filtering of the data, sequence read
mapping, de novo assembly and downstream data analysis like SNP calling due to calibrated
PHRED-like [63] quality scores.
With the publication of Ibis in Genome Biology [116], another base caller called BayesCall
was published in Genome Research [106]. Unlike Ibis, AltaCyclic and Rolexa, this base
caller does not use statistical learners, instead a more complex model for the base calling
process is described and model parameters fitted from the sequencing data. The full model
of BayesCall is computationally too expensive and only the, in 2010 published, simplified
model seems useful for a wider application of this approach [107, 129]. As outlined in a recent
base calling review [129], naı¨veBayesCall and Ibis are the only two actively maintained
alternative base callers for the Illumina sequencing platform and both outperform the vendor
base caller about equally well. The latter result was also confirmed by an internal comparison
done right after publication of the two base callers (Wei-Chun Kao personal communication,
September 9th 2009). Ibis is constantly adapted to changes of the Illumina pipeline and
updated versions are available on the project website http://bioinf.eva.mpg.de/ibis.
4.2 Input for base calling (intensity files)
As briefly described above and with more detail in chapter 3 section 3.6 on page 54, the
Genome Analyzer instrument takes four images per tile3 and cycle during a sequencing
run. Depending on the exact instrument and software version, the Firecrest program of
the Genome Analyzer Analysis Pipeline, the IPAR (Integrated Primary Analysis and
Reporting) machine, the OLB (Off-Line Basecaller) or the RTA (Real Time Analysis)
1The Nomenclature Committee of the International Union of Pure and Applied Chemistry (IUPAC) has
assigned one letter codes to express the possibility of different combinations of bases for a specific DNA
sequence position. A table of this assignment is for example available from http://en.wikipedia.org/wiki/
Nucleotide
2together with Udo Stenzel and Janet Kelso
3Actual numbers vary for various technical and practical reasons. Typical are 330 tiles on Genome Ana-
lyzer I, 100 tiles on Genome Analyzer II, 120 on tiles Genome Analyzer IIx and 32 on tiles HiSeq for each
lane of the flowcell.
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software registers the four images, which are slightly scaled and shifted due to the different
optical filters used, and identifies the clusters in the images of each tile. The images of one
tile are then further registered between cycles and the intensity values extracted from the
four images for each of the clusters identified. In addition to the intensity value (measured
as the maximum brightness of the central cluster pixels), also the mean intensity value of
the surrounding pixels (called noise) is determined. The difference of these two values is
stored as the actual intensity value. This results in four floating point numbers per clusters
and cycle. A cluster is identified by the quadruple of lane number, tile number and x-y
coordinates of the cluster in the superimposed reference image.
Depending on the image analysis software (Firecrest, IPAR, RTA or OLB) the created output
files vary, but otherwise provide the same input for the base calling process. The original
Firecrest format (nowadays refered to as legacy format by Illumina) stores this information
as one GZip-compressed tab-separated text file per tile with the first four columns being lane
number, tile number and x-y coordinates and then having one column per cycle. Within
each cycle column the four intensity values are separated by space characters.
For IPAR/OLB output, the cluster coordinates are separately stored in one text file and the
intensity values are stored in another GZip-compressed text file per tile. The latter text
file contains one line per cluster and cycle, i.e. intensity values for one cluster and cycle
are printed as space-separated text in one line and cycles are separated by a comment line
(starting with a # character). RTA also uses the separate file with cluster coordinates, but
stores intensities in a binary format, called Cluster Intensity Format (CIF), with one file
per cycle and tile. This binary format contains a 13 byte header: the characters “CIF”
as the first three bytes, followed by one byte for a version number, one byte for the block
size, two bytes for the cycle number, another two bytes for the number of cycles stored
in the file (currently 1), and 4 bytes for the number of clusters stored in the file. The file
header is followed by four blocks (A,C,G,T), of size block size bytes times number of clusters,
containing the actual intensity float values for one of the four bases.
4.3 Illumina standard base caller
As shown previously by Erlich et al. [61] and Rougemont et al. [198], the intensities of each
two channels of the Illumina instrument are highly correlated due to the similar fluorophores
used for A, C and G, T. In order to separate these channels and normalize their individual
intensities, Illumina’s Bustard base caller transforms the raw intensity values using a so-
called cross-talk matrix estimated from the second imaging cycle (first cycle in earlier software
versions). This estimate is based on the assumption that the four nucleotides are almost
equally frequent at this sequence position in the library being sequenced. If this assumption
is violated, the inaccurate estimates can lead to incorrect base calling.
Figure 4.1 on the next page shows an extreme case example of a wrong estimate. Here
the vast majority of clusters incorporated a cytosine in the cycle where the estimate was
done. This caused the software to scale up intensity of all other bases (diagonal values of
the matrix) and to see a big contribution of the A/C signal to the G/C signal, which should
be close to zero otherwise. To prevent such an incorrect estimation due an unbalanced base
composition of the sequencing library, the cross-talk matrix is commonly estimated using
a control lane in which a variant of φX174 (GC content of 44.7%) is sequenced (see also
section 3.9 on page 59).
Bustard also estimates phasing (the fraction of cluster molecules falling one sequence posi-
tion back in one base incorporation step) and pre-phasing (the fraction of cluster molecules
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A C G T
A 1.31 0.76 7.26 23.49
C 1.00 0.92 5.31 19.85
G 0.02 0.02 1.68 1.08
T 0.03 0.02 0.77 2.09
A C G T
A 1.16 0.52 0.02 0.03
C 0.92 1.09 0.03 0.03
G 0.03 0.06 1.59 0.06
T -0.02 0.01 0.60 0.84
Estimate for sequences 
showing mainly Cs (~99%)
Estimate PhiX control lane
of raw sequences mapped to by PhiX genome
0.50% 84.05%
Figure 4.1: Cross-talk matrix estimates of the Illumina Bustard base caller, here done for cycle 1
(left) and cycle 4 (right) of the same lane and then applied for base calling. The lane contained φX
control reads with a tag sequence (CAG) in the first three cycles of the run. Thus in the first cycle,
most clusters incorporated a cytosine. When applying the obtained cross-talk matrix for base calling,
only 0.5% of sequences aligned to the φX174 reference genome. The matrix on the right was obtained
from the fourth cycle, one cycle after the tag ended, considering actual φX bases. When this matrix
is applied, 84.05% of sequences align. The “correct” matrix also indicates that the separation within
the A/C laser channel is worse than within the G/T laser channel: C signal (0.52) has to be removed
from the A signal, while almost no T signal (0.06) has to be removed from the G signal.
running one cycle ahead in one base incorporation step) as two channel-independent parame-
ters from the increasing correlation of intensities in the first few cycles of the sequencing run.
Using the cross-talk matrix and the two phasing parameters, Bustard first creates corrected
intensity values and then calls the base with the highest corrected intensity for each cluster
and cycle. In the case of equal intensity values or small intensity differences an ’N’ is called.
Further, a trust value, i.e. a base quality score, is assigned to each base call.
The Bustard base calling process described here is based on two additional, implicit assump-
tions: first, that the cross-talk matrix can be considered constant over the run, and second,
that phasing affects all nucleotides in the same way. Erlich et al. [61] have previously shown
that this first assumption is violated. Another argument for this is the commonly observed
decrease in intensities over the course of the run (see figure 4.2 on the next page). This is
likely to be a result of degradation of the fluorophores, the effect of a decreasing number of
sequences being elongated in each cluster when nucleotides for which the termination cannot
be removed are incorporated (as also suggested by Erlich et al. [61]) or cluster molecules being
lost due to degradation events. Further, phasing does not affect all nucleotides equally. With
the chemistries FC-104-100x or FC-204-20xx (sequencing chemistry versions 1 and 2), the
fluorophores used for thymine show a lower removal rate after treatment with TCEP (tris-
(2-carboxyethyl)-phosphine) [16] and accumulate over the sequencing run (T accumulation,
see figure 4.2 on the following page and section 4.4.1 on page 70).
The effects of cross-talk, declining intensities, pre-phasing and phasing, as well as T ac-
cumulation complicate the identification of the correct base, especially in later sequencing
cycles. When mapping raw reads of φX174 RF1 sequenced with 51 cycles, 79.4% map to the
corresponding reference genome allowing up to five mismatches. Only 39.8% map without
any mismatches. Analyzing the different types of mismatches, a non-random distribution
(figure 4.3A on page 69) is observed. Starting around cycle 25, guanine is increasingly con-
fused with thymine (illuminated using the same laser); in later cycles adenine and cytosine
show also a high rate of erroneous thymine calls due to increasing T accumulation. The
error rate of the first base is especially high due to the higher handling time when starting
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Development of intensity values for one tile with 115‘288 clusters in a 51-cycle run
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Figure 4.2: Intensity values for one tile of a φX174 RF1 lane from a 51-cycle Genome Analyzer II
run before and after correction by Bustard. On this tile 115’288 clusters were identified by the image
analysis software Firecrest. Shown are the 95th percentile for the signal intensities in each channel
and cycle. The raw intensities are shown with dashed lines, the intensities after transformation
by Bustard are shown with solid lines. Intensities for A, C, and G decline over the run while the
intensities for T stay nearly constant. Both effects can be explained by degradation of the fluorophores
or non-reversible termination/degradation of sequences over the run as well as the accumulation of
T fluorophores on the synthesized strand. Intensities for the first cycle are lower than in other cycles
due to dimming and bleaching caused by longer handling times before imaging of the first cycle.
Corrected intensities for the last and first cycle do not follow the normal trend, since full phasing
correction cannot be applied.
68
CHAPTER 4. IMPROVING BASE CALL QUALITY OF THE GENOME ANALYZER PLATFORM
0 10 20 30 40 500 10 20 30 40 50
0 .
0 0
0 .
0 1
0 .
0 2
0 .
0 3
Position in read
M
i s
m
a t
c h
 r a
t e
A/C
A/G
A/T
C/A
C/G
C/T
G/A
G/C
G/T
T/A
T/C
T/G
N
A B
Mismatches to PhiX reference sequence by substitution (51nt GAII)
Figure 4.3: Analysis of mismatches seen for Bustard raw reads (A) and Ibis raw reads (B) of a
lane with 11,478,043 φX174 RF1 raw reads sequenced with 51 cycles and mapped with SOAP [135] to
the corresponding reference genome allowing up to five mismatches (including ’N’ characters). For
Bustard 9,110,666 (79.4%) of raw reads can be mapped, for Ibis 9,695,354 (84.5%) of raw reads.
The sequencing error, measured as the mismatch rate, increases with cycle number. For Bustard,
starting around cycle 25, guanine is mistaken as thymine. In later cycles adenine and cytosine are also
mistaken as thymine, due to increasing T accumulation. The error rate of the last base is especially
high due to incomplete phasing correction. The patterns of T accumulation are not observed when
Ibis is used for base calling this lane (B).
the sequencing run (e.g. focusing and first cycle report, see also chapter 3 section 3.5 on
page 52); the last base is especially high due to the inability to correct phasing without a
successive cycle read out.
4.4 Direct application of a statistical learner
When designing a base caller which can cope with the cycle-dependent problems discussed
above, we considered constructing a more complex model of the sequencing chemistry than
available in Bustard – including T accumulation, declining intensities and the specific char-
acteristics of the first and last cycle. All previously available base callers and the BayesCall
program developed in parallel by Kao et al. [106] followed this general approach, although
the complexity of the model and the modeled parameters differs.
However, increasing model complexity has two major disadvantages. First, building a correct
model for the Illumina sequencing platform requires a deep understanding of the causes for
sequencing error and thus a model is likely to be incomplete. Secondly, a sufficiently complex
model will depend on the chemistry or platform version used and has to be adjusted when
either one changes. We instead chose to estimate the sequencing chemistry model as a
parameter directly from the data using statistical learners and a training data set derived
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from the Bustard output. Even though our approach may not provide interpretable model
parameters values, which measure for example the efficiency of specific sequencing chemistry
steps and may thereby inspire further experimental improvements or serve as sequencing
run quality measures, it is the most general and flexible approach, which is of advantage
when considering the vast improvements of sequencing chemistry and instrument over the
last years.
Statistical learners [90], also called machine learning approaches, describe a wide range of
mathematical models and algorithms used to extract patterns and rules from huge data sets.
In general, statistical learning can facilitate a better understanding of the basics underlying
data or can be applied for predicting both qualitative (i.e. discrete labels) and quantitative
descriptors (i.e. values out of a continuous range) from data. In the context of statistical
learning, base calling can be seen as predicting discrete labels, finding the correct nucleotide
label given the intensity values observed for a specific cycle (i.e. a four-class classification
problem).
Previous approaches [61, 198] corrected raw intensities prior to the application of the statis-
tical learner and used only the intensities of one cycle as input. This causes these approaches
to be highly dependent on a correct modeling, or at least very good modeling, of the sequenc-
ing process to obtain the corrected intensities. This problem is bypassed by directly basing
training on the raw cluster intensities. In this case, the statistical learner has to be provided
with the intensities of multiple cycles to incorporate the effects of phasing and pre-phasing.
4.4.1 Simulating phasing, pre-phasing and T accumulation
To identify the correct number of cycles as input for the statistical learner, clusters of a
thousand identical sequences and the fluorophore attachment over several sequencing cycles
were simulated for 10,000 clusters. The 10,000 sequences for these different clusters were cre-
ated randomly using the GC content of φX (44.7%) as a guide. The sequencing model, with
pre-phasing and phasing as described above, can be expressed with the following recurrence:
Basecase :
f0 (0) = 100%, fp 6=0 (0) = 0%, f0 (c 6= 0) = 0%
Recurrence :
fp∈{1,...,l} (c) = fp−1 (c− 1)
+ (fp−2 (c− 1)− fp−1 (c− 1)) · ppre
+ (fp (c− 1)− fp−1 (c− 1)) · p
For phasing and pre-phasing parameters in this model, the values reported by Bustard
(available in the params XML files of the Bustard subfolder of a run) for the last ten runs
done on the MPI Genome Analyzer II sequencers at the time were checked (FC-204-20xx
chemistry, see table 4.1 on the next page). While some runs showed balanced phasing and
pre-phasing values, others showed higher phasing values. I picked the mean of the pre-phasing
values and simulated symmetrical phasing/pre-phasing with a rate of 0.4% per cycle.
It was also of interest whether fluorophore accumulation impacts this model. Thus, I es-
timated fluorophore accumulation from the same 51 cycle run also presented in figures 4.2
and 4.3 above. From one tile with 115,288 clusters, the 5th percentile of raw intensities in
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Table 4.1: Phasing and pre-phasing values determined for ten different Genome Analyzer II runs
(FC-204-20xx chemistry) done at the MPI for Evolutionary Anthropology in late 2008. Values have
been extracted from the params.xml files of the Bustard subfolder of each run.
Run Phasing Pre-phasing
1 0.0072 0.0049
2 0.0053 0.0053
3 0.0039 0.0038
4 0.0039 0.0038
5 0.0044 0.0035
6 0.0043 0.0042
7 0.0062 0.0043
8 0.0070 0.0033
9 0.0048 0.0030
10 0.0052 0.0036
Mean 0.0052 0.0040
Std deviation 0.0012 0.0007
Median 0.0050 0.0038
each of the 51 cycles was extracted. Due to the effects of bleaching and dimming in the first
cycle (as a result of longer handling times), the first cycle was excluded from the analysis.
Afterwards, values for each channel (A, C, G and T) were normalized separately, so that
the 5th percentile raw intensity value of the second cycle is 100 in each of the four channels
(figure 4.4 on the following page).
As phasing and pre-phasing increases, the background noise in each cycle increases. Thus an
exponential increase of the background noise measured with the 5th percentile is expected.
Fitting a logarithmic function (noise = a · log (cycle)+n; inverse of the exponential function)
to the values extracted, a very good fit for A and C was obtained, but G and T seemed
to miss another linear factor: the described T accumulation. I therefore fitted noise =
a · log (cycle) + b · cycle + n, resulting in the fits shown in figure 4.4 on the next page.
With the linear factor the function fits G and T better, for A and C there is no significant
increase with respect to the Akaike information criterion (AIC, [90]). Due to cross-talk the
linear effect observed for G may be completely caused by the accumulation of T fluorophores.
Together with the observation of the base substitution patterns seen for Bustard (figure 4.3A
on page 69), I therefore only model fluorophore accumulation of Ts, with a rate estimated
from the fit as 3.8% per cycle.
For each cycle in the simulation, the number of fluorophores attached to all sequences of the
cluster was determined and the fraction of fluorophores representing the current cycle, the
previous cycle and the next cycle, as well as representing cycles more than one ahead and
more than one behind calculated. Furthermore, the number fluorophores attached due to
T accumulation was calculated. A visual representation of the simulation results is available
in figure 4.5 on page 73, a textual representation is available in table 1 on page 190.
From the simulation results, it turns out that for a read length of 50 cycles 59.5% of the
fluorophores reflect the current cycle, 17.4% are exactly one cycle behind and the same
fraction is one cycle ahead. In a sequencing chemistry with T accumulation, on average
339 T fluorophores stuck to the cluster by cycle 50. In cycle 100, 52.4% of the clusters
are in sync and 19.5% are exactly one cycle behind or one cycle ahead. At this point, on
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5th percentile raw intensities
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y(x) = 19.92·log(x) + 3.80·x + 67.13
10 20 30 40 50
1 0
0
1 5
0
2 0
0
2 5
0
3 0
0
Cycles
5t
h
p e
r c
e n
t i l
e  
r a
w
 i n
t e
n s
i t y
 ( m
i n
i m
u m
 s
e t
 t o
 1
0 0
)
A
C
G
T
Figure 4.4: Development of the 5th percentile of the raw intensities over 50 cycles. Due to the
bleaching/dimming effect of the first cycle, the first of 51 cycles has been excluded. The remaining
values were normalized within each channel (A, C, G and T) separately, so that the 5th percentile raw
intensity of the second cycle is 100. A function consisting of a linear (describing the accumulation of
fluorophores) and a logarithmic part (describing noise increase due to phasing) was fitted. For A and
C the linear part does not significantly increase the quality of the fit (AIC, [90]). The linear effect is
strongest in the T channel and accounts for an increase of 3.8% per cycle; the effect in the G channel
is probably also caused by the T channel - due to the read out with the same laser (cross-talk).
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Phasing effect on signal in each cycle
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Figure 4.5: Development of the fraction of fluorophores representing the current cycle, the previ-
ous and the next cycles, cycles more than one ahead and more than one behind (top), as well as
fluorophores attached due to T accumulation (bottom). The numbers are based on simulations of
10,000 clusters with a thousand identical sequences each. Sequences were created randomly, only
using the GC content of φX174 (44.7%) as reference. A model with pre-phasing (0.4% per cycle),
phasing (0.4% per cycle) and T accumulation (3.8% per cycle) was used and the fluorophore read
outs for 150 sequencing cycles simulated.
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average 1,039 T fluorophores are bound to the 1,000 sequences in each cluster, exceeding the
real incoporation signal. However, even after 150 cycles 85.1% of the fluorophores account
for the previous, the current or the next base to be sequenced (in a sequencing chemistry
without T accumulation). The conclusion from this simulation was that most of the signal
to be captured by a statistical learner is contained in the raw intensities of the previous, the
current and the next cycle.
4.4.2 Using the signal of neighboring bases
I implemented a base caller with Support Vector Machine (SVM) classifiers for each cycle
which have the intensity values of the current cycle and its two neighbors as input. The ex-
ceptions are the first and last cycle, where only one of the neighbors can be included. For the
SVM classifiers of each cycle, a computationally fast implementation of multi-class SVMs [40]
with linear kernels, called SVMmulticlass [230] and available from Thorsten Joachims4 was used.
Support vector machines [39] are a generalization of the very basic principle of separating
two classes by putting the thickest possible board between them, figuratively speaking. In
a mathematical sense, they are a generalization of linear decision boundaries of separating
hyperplanes that are placed in a way to obtain a maximum margin between classes. By max-
imizing the margin, the generalization error of the classifier, i.e. the error from labeling new
examples based on their position relative to the decision boundary, is minimized. Frequently,
real data is sufficiently complex or contains labeling errors, not allowing the separation using
linear decision boundaries/hyperplanes. Therefore, support vector machines exploit that the
input features (i.e. the input variables) may be combined to new features using so-called
kernel functions, which then project the data in a higher dimensional space in which they
may be separated by a hyperplane. Further, SVMs extend the maximum margin principle by
allowing a hyperplane in the final feature space which mislabels some samples of the training
data set, but still maximizes the distance to the nearest correctly separated examples.
By increasing the feature space, complex decision boundaries can be obtained from the
combination of simple kernel functions and simple separating hyperplanes. Figure 4.6 on
the following page provides a visual example for applying some kernel to a two dimensional
data set and obtaining a hyperplane separating the data, which, if projected back to the two
dimensional feature space, corresponds to a higher order decision boundary.
The implementations of support vector machines for two classes do unfortunately not di-
rectly translate to SVMs for multiple class labels. Typically, when requiring a n-class clas-
sifier based on SVMs, n classifiers are trained, each separating the one class from all other
classes (“One-against-all”). Another approach of converting the multi-class problem to a
binary problem is the training of pair-wise classifiers (“one-against-one”), each sub classi-
fier separating two classes of the class set from each other. This pair-wise approach vastly
increases in computational complexity for higher numbers of class labels, even though also
a reduced subset of the data is used with each of the classifiers. Most commonly used are
“one-against-all” SVM classifiers, which are then frequently referred to as multi-class SVMs.
However, actual multi-class SVM implementations, even though with constraints on the
kernel functions, exist as so called structural SVMs [41], which also extend SVMs from
independent and categorical labels to structured objects with relationships defined between
them. To distinguish them from these other approaches, they are sometimes referred to as
“True multi-class”. The SVMmulticlass package by Thorsten Joachims implements this latter
4http://svmlight.joachims.org/svm_multiclass.html
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Figure 4.6: The n input features of a classification problem can be combined using kernel functions
to add additional features to the input space. This extends the RN features space by m dimensions
(Rn+m). The idea is to put the data in a new extended feature space, in which class labels may be
separated by a hyperplane. This way, complex decision boundaries are the result of the combination
of simple kernel functions and simple separating hyperplanes.
type of multi-class SVMs [230]. Figure 4.7 on the next page provides a visual example,
summarizing the three types of multi-class support vector machines.
For training a classifier, a set of examples is required, i.e. multiple examples of up to twelve
intensity values (the input features) and the assigned base (the class label) need to exist for
each cycle of the sequencing process. A putative training data set is created by aligning the
Bustard raw reads with mismatches for a fraction of the tiles to an appropriate reference
sequence (e.g. φX174 RF1) using SOAP v1.11 [135]. Half of this data set is kept as a test data
set and the other half used for training the classifiers (svm multiclass learn) separating
all four nucleotide classes (A, C, G, and T) in each cycle.
The result of the training is verified by using the test data set with the trained models
(svm multiclass classify) and comparing the predicted labels with the ones obtained
from the reference sequence. Evaluating this information, one can also estimate parameters
for calculating a quality score for each called base given the class assignment and the distances
to the classification/decision boundary reported by SVMmulticlass. Based on this measure, I
use the density distributions for the four distances to the decision boundary seen for each
correct class label (16 in total, in an example data set each was observed to follow a normal
distribution based on Shapiro Wilk Normality test [208, 199]). Given the four distances dZ
(Z ∈ {A,C,G, T}) and the parameters determined for the normal distributions estimated
from the actual test data set, the likelihood of the called base being wrong was defined as:
p (¬base) =
∑
Z 6=base p (Z | base)∑
Z∈{A,C,G,T} p (Z | base)
∣∣∣∣∣ p (Z | base) = p (Z ∧ base) · cdf (dZ , µZ , σZ) (4.1)
It was necessary to extend the SVMmulticlass C/C++ package by routines that are able to
handle several classifiers in parallel for the individual cycles, parse Firecrest, IPAR, RTA
and OLB output files, calculate quality scores and create FastQ output files on a per tile basis.
FastQ is currently the most common sequence file format used both in data exchange and as
input for post-sequencing software. This text format is an extension of the FASTA sequence
format, where each sequence in the file is associated with an identifying tag/identifier, and
also with an additional line for quality scores (figure 4.8 on page 77). Unfortunately, there is
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Figure 4.7: Most implementations of multi-class support vector machines are not actually separating
multiple classes in one classifier. Typically, when requiring a n-class classifier based on SVMs, n
binary classifiers are trained, each separating the one class from all other classes (“one-against-all”).
Another approach of converting the multi-class problem to a binary problem is the training of pair-
wise classifiers (“one-against-one”), each sub classifier separating two classes of the class set from each
other. This pair-wise approach vastly increases in computational complexity for higher numbers of
class labels, even though also a reduced subset of data is used with each of the sub classifiers. Actual
multi-class SVM implementations are rare and constraint in the kernel functions used.
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...
@SOLEXA-GA03_0001_PEi_SG:5:1:1033:5267
AGACAGACACAGAGNAAGACCCAGTCCGCCACACAGGCAAACTCACGCAGTACGCGCCG
+SOLEXA-GA03_0001_PEi_SG:5:1:1033:5267
4--'-(/.23/044!51/+//.400/-/1-62/.6021834///62126313/2230+2
...
Figure 4.8: A FastQ file starts with an ’@’ character followed by a unique sequence identifier (plat-
form specific, shown is an Illumina Genome Analyzer read ID providing run ID, lane, tile and X-Y-
coordinates), the next line contains the sequence, then a line starting with a ’+’ character, either
followed again by the complete read identifier or just containing the ’+’, indicates that the next
line contains the quality scores. This example encodes quality scores in the Sanger standard, which
uses ASCII characters from 33-127 to encode base qualities in PHRED-scale between 0 and 94 (e.g. ’4’
(ASCII 52) corresponds to PHRED quality score 19 thus an error likelihood of 1.26%, while ’-’ (ASCII
45) corresponds to PHRED 12 and an error probability of 6.31% (equation 4.2).
no universally accepted rule regarding how quality scores are encoded in this format. Ibis
follows the Sanger standard of encoding PHRED-like quality scores [63] with one character per
quality score and with an offset of 33 (’ !’), as this is a widely accepted encoding:
char(round(−10 · log10 (p (¬base))) + 33) (4.2)
In its first versions, the Illumina software did not use such PHRED-like probabilities (equa-
tion 4.3). Instead, they used a quality score model with negative values (equation 4.4), and
therefore set the zero quality to 64 (’@’). In current software versions, PHRED-like proba-
bilities are used, but still printed with the offset of 64. Other encodings include the actual
quality score numbers separated by space in the quality line (e.g. AltaCyclic base call files).
This encoding is considered to be inefficient and is used rarely today.
QPHRED = −10 · log10 p (¬base) (4.3)
QOldIllumina = 10 · log10
(
p (base)
1− p (base)
)
(4.4)
Applying the outlined approach, i.e. Ibis, to the lane shown in figure 4.3A on page 69
increases the number of perfectly mapped sequences from 39.8% to 60.2% (from 4,564,039 to
6,908,856) and shows an error profile of all mapped sequences (9,695,354 out of 11,478,043)
as depicted in figure 4.3B on page 69 without a noticeable T accumulation effect.
4.5 Comparison to other systems for base calling
Even though the application of statistical learning for the base calling of Illumina sequences
is not novel, Ibis differs significantly in its concept and its performance from earlier proposed
approaches.
AltaCyclic [61] uses a model of phasing/pre-phasing, fluorescent decay and cycle-dependent
cross-talk to correct raw intensities before classification. It then uses SVM classifiers trained
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individually for every cycle on those corrected raw intensities. The AltaCyclic model used
for this correction step does not include base specific phasing parameters and therefore cannot
correct raw intensities for the observed T accumulation effect.
Similarly, the Rolexa package [198] corrects the raw intensities prior to the application of
Gaussian mixture models as classifiers. Deviating from the models of sequencing chem-
istry implemented in AltaCyclic and Bustard, Rolexa models only cross-talk and single-
parameter phasing (pre-phasing is not modeled). In contrast to AltaCyclic, Bustard and
Ibis, Rolexa applies a transformation to the intensities within each tile to correct for local
differences in the illumination of clusters. Further Rolexa uses IUPAC ambiguity codes to
encode uncertainty in base calling, while AltaCyclic, Bustard and Ibis try to call one
correct base and reflect the associated uncertainty in the quality scores.
Even though IUPAC amiguity codes provide information on alternative base calls, the base
quality approach is superior when the sequences are mapped and analyzed with software that
is unable to handle these codes (like most available fast mappers or SNP calling software) and
it provides a higher resolution for the trust in unambiguous calls (the majority of base calls).
Unlike AltaCyclic and Bustard, Ibis does not call an ’N’ character for low quality bases,
as the most likely base can still be informative and as its uncertainty is already captured in
the quality score. For Ibis, ’N’ characters are only returned if all intensity values obtained
from the intensity files are exactly zero for a specific cycle. In this case the image analysis
software failed in recovering the cluster after image registration with the template of cluster
positions.
4.5.1 Performance test on data sets using v1 chemistry
The difference in introducing IUPAC ambiguity codes complicates the direct comparison of
AltaCyclic v0.1.1, Bustard v1.9.5, Ibis 1.0.0 and Rolexa v1.1.6 (with R v2.8.0). Therefore,
Rolexa was configured to call sequences without using ambiguity codes:
1Rolexa . env$HThresholds <− c ( 2 . 0 , 2 . 0 , 2 . 0 ) ;
2Rolexa . env$ IThresholds <− ( log2 ( 4 1 : n r c y c l e s /6) ) ;
3Rolexa . env$ iupac <− c (”A” , ”C” , ”G” , ”T” , ”N” , ”N” ,
”N” , ”N” , ”N” , ”N” , ”N” , ”N” , ”N” , ”N”)
Further, ’N’ characters are specifically considered for a direct comparison. I tested the
performance of the four different base callers first on three data sets using the first sequencing
chemistry version (FC-104-100x):
(A) φX control lane of a 26 cycle Genome Analyzer I run
(B) Human shotgun lane from the same Genome Analyzer I run
(C) φX control lane of a 51 cycle Genome Analyzer II run
For these data sets I mapped all control lane sequences to the φX reference sequence allowing
up to five mismatches but no gaps using SOAP v1.11 [135]. For the lane with human shotgun
sequences, the sequences were mapped to the human reference genome (hg18/NCBI Build
36.1) allowing five mismatches without any gaps, but then restricting the further analysis
to sequences mapping with at most two mismatches to reduce the number of false positive
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Figure 4.9: Fraction of mapped reads and corresponding number of mismatches for the three tested
data sets. On the left the result for the φX control lane of 26 cycle Genome Analyzer I run (A), in
the middle a lane of human shot gun sequence analyzed on the same 26 cycle Genome Analyzer I
run (B) and on the right the φX control lane of a 51 cycle Genome Analyzer II run (C). The raw
sequences of all three data sets were mapped to the corresponding reference genome (hg18/NCBI
Build 36.1 and φX174 RF1) with up to five mismatches but no gaps using SOAP v1.11. For (B),
mappings with more than two mismatches are shown with dashed lines since a high number of false
positive placements is expected when mapping short reads to a large genome sequence.
79
CHAPTER 4. IMPROVING BASE CALL QUALITY OF THE GENOME ANALYZER PLATFORM
placements expected when using a genome with almost three billion bases and short reads.
The fraction of mapped raw reads and corresponding number of mismatches for the three
lanes is shown in figure 4.9 on the previous page.
The number of correct reads when using Ibis compared to Bustard increased about 2.1
fold in (A) (11.3% to 23.4%), 1.8 fold in (B) (21.2% to 37.4%), and 1.5 fold in C (39.8% to
60.2%). When comparing the error profiles of (C) (again figure 4.3 on page 69), one clearly
sees that Ibis was able to correct for the T accumulation pattern present in the v1 chemistry
version. Assuming that all reads belong to the corresponding reference, a (lower) estimate
of the error rate in the run (assuming the remaining reads would be matched when allowing
one more mismatch) can be obtained. For (A) these are 15.2%, 16.4%, 12.3% and 16.0% for
AltaCyclic, Bustard, Ibis and Rolexa respectively. For (B) (assuming to match the rest
with 3 mismatches) these are 7.1%, 7.6%, 5.5%, and 7.4%. In the third data set, the 51 cycle
φX control lane the error rate is much lower (due to the better quality of the run and the
technical improvements of the GAII instrument); the rates for AltaCyclic, Bustard, Ibis
and Rolexa are 3.0%, 4.0%, 2.8% and 4.3% respectively.
The development of the mismatch rates per cycle observed in the mapping for each of the
three data lanes is available in figure 4.11 on page 82. For data set (C), I also compared the
quality scores reported by Bustard, AltaCyclic and Ibis. While Ibis provides PHRED-like
quality scores, Bustard and AltaCyclic use the Illumina-specific encoding of quality scores
with a different offset (64 instead of 33) and a different formula (Illumina Analysis Pipeline 1.0
and earlier versions). Therefore, quality scores from AltaCyclic and Bustard (equation 4.4
on page 77) were converted to PHRED-like quality scores (equation 4.3 on page 77) and
compared in PHRED scale, equation 4.5.
QPHRED = −10 · log
(
1
1 + 10
QOldIllumina
10
)
(4.5)
The results are available in figure 4.10 on the next page. When measuring the deviation from
the optimal line, Bustard has a root mean square deviation (RMSD) of 84.9, AltaCyclic
of 19.3 and Ibis of 0.9. Hence, Ibis provides useful quality scores for further analyses.
4.5.2 Performance on a test data set from v2 chemistry
Here, a comparison of three base callers (AltaCyclic, Bustard and Ibis) is shown on the φX
control lane of a 77 cycle run, which was created using the FC-204-20xx chemistry (v2). This
comparison does not include the Rolexa base caller as Rolexa could not be used succesfully
on these longer reads. Even though this chemistry shows improved phasing values which
allow for a longer read length (this chemistry was officially supported for up to 51 cycles),
it still shows the T accumulation effect of the previously shown v1 sequencing chemistry.
For this 77 cycle run, the base miscalls by substitution are available for each of the base callers
in figure 4.12 on page 84. This figure also includes the performance on a training data set
directly obtained from the Bustard raw sequences without using a reference sequence. In
this case about 3.7 million Bustard reads with at most three ’N’s were used as training
data. This procedure can be considered as the ’last resort’ for using Ibis in cases where
no reference sequence is available for creating a better training data set. A reduction of
the error rate by about 20% compared to Bustard is seen, further about 10% more reads
can be mapped with the same number of mismatches allowed. As expected due to large
T accumulation effect on the last bases of those reads, this is inferior to the results obtained
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Figure 4.10: Comparison of quality scores for the 51 cycle φX control lane data set (C). Quality
scores reported by Bustard, AltaCyclic and Ibis are compared in PHRED scale. For all three base
callers only quality scores reported with 100,000 and more observations were considered. Calculating
the deviation from the optimal line Bustard has a RMSD of 84.9, AltaCyclic of 19.3 and Ibis of
0.9.
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Figure 4.11: The development of error rates was determined by assuming no sample divergence from
the reference (i.e. error rate equals mismatch rate) from alignments of reads called using the four
different base callers (Bustard, Rolexa, AltaCyclic and Ibis) to the reference genomes. (A) Shows
a 26 cycle Genome Analyzer I run (FC-104-100x, v1) of which the φX control lane was analyzed as
well as one lane with human shot gun sequences (B). For a second, a 51 cycle Genome Analyzer II
run (FC-104-100x, v1), only the φX control lane was analyzed (C).
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using a reference (in which error rate reduction is more than 70% and 52% more reads are
mapped). However, even without a reference, base calling using Ibis provides a considerable
improvement compared to the Bustard base caller.
4.5.3 Performance test on current data sets from Genome Analyzer IIx
Even though Ibis was originally developed to handle the T accumulation in sequencing
chemistry (FC-103-300x, v1) and (FC-204-20xx, v2) which have been replaced by new ver-
sions during the last two years, its application is not limited to the reprocessing of data
created with the older chemistries.
In spring 2009, Illumina released a new chemistry version (FC-103-300x, v3) in which the
T accumulation effect could be greatly reduced. This was achieved by replacing the cleavage
reagent and wash buffers used in the previous generation chemistry. In late summer 2009,
Illumina started field tests of a new polymerase used for base incorporation and then released
a new chemistry (FC-104-40xx, v4) including this polymerase in winter 2009. This new poly-
merase reduces the pre-phasing effect and therefore allows for longer reads. In autumn 2010,
Illumina released sequencing chemistry version 5 as the first step of the TruSeq marketing
regime.
To show that the application of Ibis extends to new chemistries, a 76nt cycle run created
with the FC-103-300x chemistry is shown in figure 4.13 on page 85 and a 101 cycle run using
the new polymerase provided by Illumina within the early access program in summer 2009 is
shown in figure 4.14 on page 86. In these figures, the base miscalls by substitution as well as
the fraction of reads mapped for each base caller is presented. These numbers were obtained
by mapping the raw control lane sequences to the φX reference sequence allowing up to five
mismatches but no gaps using SOAP v1.11. Again ’N’s in the sequence were considered as
mismatches to the reference and the five mismatch cutoff reinforced before further analysis.
Error rate estimates are based on reads mapped with Bustard and each of the base callers.
Comparing the results obtained for the Illumina base caller (Bustard), AltaCyclic and Ibis
with the results for training Ibis without a reference, the no-reference approach performed
surprisingly well. It is considerably better than the Bustard results, even though SVM
training being completely based on the Bustard error profile: 6%/16% more reads mapped
and a reduction of the error rate by 28%/24% respectively.
In addition, for these two runs I have shown that it is possible to use mitochondrial reads
from shotgun experiments as an alternative way to create a training data set. In the first
example (76 cycle run), about 50,000 sequences extracted from only one lane and in the
second example (101 cycle run) 1.8 million human mitochondrial sequences extracted from
several lanes of the run were used. In both cases, the results for using the φX control
versus using the mitochondrial reads as input for training are similar and outperform the
no-reference approach: 27% vs. 24.7% reduction of the error rate and 9.8% vs. 9.1% more
reads mapped for the 76 cycle run and 45.6% vs. 45% reduction of the error rate and 49%
vs. 44% more reads mapped for the 101 cycle run.
Figure 4.15 on page 87 shows the error development of one run using the final v4 sequencing
chemistry (instead of v3 chemistry with the early access polymerase shown in figure 4.14
on page 86, v3RDP). The only known difference between v3RDP and v4 chemistry is the
exchange of Tag polymerase by Phusion polymerase in the the first extension reaction of
cluster generation. Again the error rate can be considerably reduced (43.48% reduction) and
the number of mapped reads increased (5.8%) by applying Ibis instead of Bustard v1.6.0
(OLB/RTA v1.6.0).
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Figure 4.12: Mismatches to the reference sequence observed with different base calling strategies
for the φX control lane of a 77 cycle Genome Analyzer II run with T accumulation (v2, FC-204-
20xx chemistry). Plot A shows the results for the standard Illumina base caller (Bustard), plots C
(AltaCyclic) and D (Ibis) show strategies using a reference sequence (φX174); in plot B Bustard
reads have been used directly as input for the Ibis training process, without using a reference
sequence. The reduction of the error rate in B is about 20% compared to Bustard and about 10%
more reads can be mapped with the same number of mismatches allowed. This approach is, as
expected, inferior to the results obtained using a reference (D, in which error rate reduction is more
than 70% and 52% more reads are mapped).
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Figure 4.13: Mismatches to the reference sequence observed with different base calling strategies for
the φX control lane of a 76 cycle Genome Analyzer II run using the current chemistry (FC-103-300x).
Plot A shows the results for the standard Illumina base caller (Bustard). Plots B, C and D show
strategies using a reference sequence (B and C φX174 and D the human mitochondrial reference
sequence). In plot E, Bustard reads have been used directly as input for the Ibis training process,
without using a reference sequence.
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Figure 4.14: Mismatches to the reference sequence observed with different base calling strategies for
the φX control lane of a 101 cycle Genome Analyzer II run using v3 chemistry (FC-103-300x) and
new polymerase (which was later released in v4 sequencing chemistry kits, FC-104-40xx). Plot A
shows the results for the standard Illumina base caller (Bustard). Plots B, C and D show strategies
using a reference sequence (B and C φX174 and D the human mitochondrial reference sequence). In
plot E, Bustard reads have been used directly as input for the Ibis training process, without using
a reference sequence.
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Figure 4.15: Mismatches to the φX reference sequence observed for Bustard and Ibis base calls of the
φX spike-in control reads of a 101 cycle Genome Analyzer IIx run using v4 chemistry (FC-104-40xx).
4.5.4 Required computational resources
To compare the computational resources required for base calling, I measured the time for
training and predicting the 51 cycle φX control lane created with v1 chemistry with each
of the base callers. Base calling this lane using Bustard on an eight core system took 50
minutes (including estimation of cross-talk and phasing parameters) and created the input
needed for all three other base callers. AltaCyclic needs a cluster system to run. Using
about 80 cores of an institute cluster (machines with 4 x 2.6GHz cores, 16Gb RAM) at the
MPG Rechenzentrum in Garchingen, AltaCyclic took about 5.5 hours for the parameter
estimation and 40 minutes for base calling. On an eight core system (8 x 3.0GHz, 32Gb
RAM) these would correspond to at most 61 hours in total (Amdahl’s law [4]). Running
Rolexa on an eight core machine took 17.5 hours. Ibis took 89 minutes for parameter
estimation and 12 minutes for prediction, in total about 1.7 hours. In other words, using
Ibis one has to invest three times more time for base calling, for Rolexa 21 times more time
and for AltaCyclic 73 times more time compared to Bustard.
Memory consumption is difficult to evaluate for the different architectures and approaches,
but for all programs at least 4Gb RAM should be available. This requirement is easily
met by current computer systems used for high-throughput data analysis, since genome
index structures required for alignment often exceed this limit. In terms of disk space,
recalling bases will of course require additional space for storing the new base calls. The
disk space required for storing the model parameters is in the range of mega bytes and
can thus be neglected. However, the actual training and base callling process might require
transformations of the intensity files or Bustard base call data and thus produce intermediate
files of significant size (up to several 100Gb). Therefore, a fast and large temporary file system
is advantageous.
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4.5.5 Dependence on training input data
As is the case for Bustard, AltaCyclic and Rolexa, the results shown before support the
assumption that training on the φX extends well to the prediction of other lanes using the
same estimated models. To further verify this, I did a specific test for overtraining (e.g.
learning base composition of a specific reference) and undertraining on a 51 cycle run using
v2 chemistry.
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Figure 4.16: The plot shows the fraction of raw reads mapped (with up to two mismatches and
without any mismatches) for a 51 cycle run for which several Ibis runs were performed with different
amounts of training data from the φX control (lane 4). The base calling models obtained for the φX
control were applied to recall sequences of the φX lane as well as of a neighboring lane (lane 5) with
rat RNAseq reads. Reads were aligned to the φX174 reference and Rat Baylor 3.4/rn4 chromosome 1
using SOAP v1.11. For rat the fraction mapped was corrected for the length of chromosome 1 relative
to the complete genome assembly (267,910,886 out of 2,571,531,505nt).
I trained several models from the φX in lane 4 using different numbers of tiles (1, 2, 5, 9, 19,
27, 50, 100 of 100 available tiles) for training and predicted with the resulting models the φX
lane as well as a neighboring lane (5) which contained rat (Rattus norvegicus) RNAseq reads.
I then examined the number of sequences mapped to the two different reference genomes
and the number of mismatches observed (see figure 4.16). From this data set, there was
no evidence for overtraining; however undertraining was observed, affecting the prediction
of both lanes. In this test, undertraining resulted in 3-5% fewer perfect reads and only
up to 1% less mappable raw reads than obtained when using at least 1,000,000 sequences
for training (typically about 5-15 tiles of dedicated control lane, depending on the loading
density/instrument version).
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4.5.6 Training without a dedicated control lane
As shown in the sections before, Ibis is not dependent on the inclusion of a control lane. In
the case of resequencing projects or projects where some subset of the sequences generated
come from a previously characterized genome, it is possible to use this sequence data for
obtaining a training dataset for Ibis. I have shown (figures 4.13 on page 85 and 4.14
on page 86) that it is possible to use the mitochondrial sequences generated as part of a
shotgun sequencing experiment for creating such an alternative training set. In the example
presented, the Ibis results are very comparable between the models obtained from the φX
reads and the models from the mitochondrial reads. Further, I have shown that the raw
Bustard output can be used as training data in cases where there is no reference sequence
available (figures 4.12 on page 84, 4.13 on page 85, and 4.14 on page 86). Although the
reduction in error rate is less than obtained when using a reference (especially when the
Bustard base calls are frequently erroneous due to a specific bias like T accumulation),
improved base calls were also obtained in this setup.
In general a control lane, loaded with a DNA sequencing library created from the well-
characterized φX174 strain, is only required by Illumina for runs containing samples with
unbalanced base composition (e.g. smallRNA, RNAseq, ChIP-Seq, sodium-bisulfite treated
DNA). However, if this control lane is available, it does not only allow for correct parameter
estimates of the Bustard base caller, it also allows for between-run quality control and
comparisons. It is thus also of interest when requesting replacement of sequencing run
chemicals and materials from Illumina due to material defects. For Ibis, the control reads
are used for calibrating the quality scores of a run. This all creates an actual benefit in using
the same control library on all runs.
Though a flow cell has eight lanes, only seven lanes can be used for libraries of interest
when having a dedicated control. This increases effective sequencing costs and lowers run
throughput. Further, it is recommended that the control lane be in the middle of the flow cell,
which typically has the highest quality and is rarely affected by run problems (see chapter 3).
Thus the control uses the most favorable region and the quality statistics obtained for the
control and their generalization to all lanes is put into question.
When using a multiplex library preparation protocol [150, 141] for creating an indexed con-
trol DNA library, this library can be spiked at equal concentration into each of the eight
lanes and the control reads identified based on their unique index/barcode sequence. When
spiking 1-2% of such a control library into all lanes (section 3.9 on page 59 in chapter 3),
the resulting about 250,000 to 1 million control reads in each lane allow for lane-specific
quality measurement and provide, with a total of up to 8 million reads, more than sufficient
training data for Ibis (see figure 4.15 on page 87 for a run with spike-in control reads and no
dedicated control lane). This increases usable (i.e non-control) sequence output compared to
a dedicated control lane and provides lane-specific but library-independent quality measure-
ments. Using the same high quality control library for all sequencing runs, per lane statistics
obtained can be easily compared, even between different runs. When applying Ibis, the
quality scores are then also adjusted for each run based on the same control library. Thus
Ibis’s PHRED-like quality scores are comparable between sequencing runs and libraries and
generally do not require further normalization (see also section 4.6 on the next page).
Even for whole runs of libraries with unbalanced base composition a dedicated control lane
can be omitted. In such a case, Bustard model parameters from a run with the same
sequencing chemistry version can be used for obtaining a training data set on which Ibis
base calling can be performed. Even though the application of standard parameters or
parameters of a different sequencing run for Bustard base calling will not result in the best
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possible base calling results, it will be sufficient to obtain a large enough training data set
from spike-in controls. Thus a dedicated control lane can be completely omitted independent
of the base composition of the actual libraries being sequenced, making spike-in φX control
reads valuable for run QC and base calling with quality score calibration while enabling
maximum instrument throughput.
4.6 Downstream quality score recalibration
Having different sequencing platforms, different versions of sequencing chemistry and differ-
ent data production facilities creates a need for assuring data quality consistency. Recently,
quality score recalibration based on alignments has been identified as one solution to this
problem. Currently the most widely applied algorithm is part of the Genome Analysis Tool
Kit5 (GATK) [147] and used for studies of the 1000 Genomes project [53]. However, the qual-
ity score recalibration based on alignments coincides with steps taken for the quality score
calculation in Ibis and generally has to be applied with caution:
1. Quality scores as provided by todays base callers are specific to the platform. On 454
the quality score concept breaks with homopolymers which are only one machine signal
but several bases when converted to sequence space. On SOLiD quality scores have to
incorporate a signal deduced from dinucleotides (i.e two read outs with the chance of
one of them being wrong). Illumina base call qualities are actually inferred for a specific
base, however they are changing with each software update that provides new quality
score tables (determined from runs in Illumina R&D and probably not completely
transferable to other instruments and sites due to between instrument, production and
handling variance). Even though this argues for the rescoring, it also illustrates that
the concept of a quality score for an individual base in a sequence alignment is not a
genuine and general concept.
2. Calibration based on alignments with some divergence to the actual sample is prob-
lematic. Specifically if the divergence of multiple samples to the reference varies and
thus may impact the downstream processing. This might for example cause a biased
correction of quality scores and at the end fewer SNP calls for the samples with higher
reference divergence.
3. If quality scores are used in an inter-species comparison and genome quality or within
species variation varies, then qualities obtained from such a calibration will have a
species bias (i.e will be lower for the species with lower reference genome quality or
higher diversity).
This argues that quality score recalibration based on alignments can only be done if sequence
divergence and population diversity is estimated at the same time. Thus, a recalibration of
quality scores should only be done on a common sequence population with no divergence
(e.g. spiked control reads of all lanes or control reads in a dedicated lane).
The quality scores that Ibis produces are a function of the decision boundary distances ob-
tained when the base intensities are applied to the cycle-specific classifiers (see equation 4.1
in section 4.4.2 on page 74). I model the base quality using a normal approximation of the
distances seen in a dedicated test data set for this cycle (i.e these are reads that have not
been used for model training, but are then used with the models for testing the prediction
5https://www.broad.harvard.edu/gsa/wiki/index.php/Base_quality_score_recalibration
90
CHAPTER 4. IMPROVING BASE CALL QUALITY OF THE GENOME ANALYZER PLATFORM
performance). Thus, Ibis quality scores are normalized in a per run fashion using control
reads. They should not require any further between run normalization. However, qual-
ity scores might not scale perfectly over the whole PHRED score range and a normalization
between different sequencing platforms might still be required.
4.7 Summary and conclusions
Even though Ibis was originally developed to handle the T accumulation in a sequencing
chemistry which has been replaced by several subsequent versions, its application is not
limited to the reprocessing of data created with the older chemistries. I have shown that
Ibis improves the output of sequencing runs from the Genome Analyzer I, which due to their
short read length are barely affected by T accumulation but by a generally lower image and
sequencing quality. I have also shown that it improves base calling accuracy for runs using
recent sequencing chemistries without T accumulation and increased sequencing length. The
reason is the sequencing model independent training process of Ibis, which only relies on
the assumption that the vast majority of the signal needed for base calling is captured by
the intensity values of the previous, the current and the next cycle.
The presented approach is unique in that the causes of sequencing error are not modeled
separately, but captured by incorporating neighboring signals in the statistical learning pro-
cedure. Due to this design, Ibis works on a wide range of different sequencing chemistries
and platform versions. The performance of Ibis on standard hardware is significantly bet-
ter than for other existing base callers [129], enabling it to be run by research laboratories
without access to large computational clusters. The increase in mappable sequences, with-
out ambiguity codes as well as improved and calibrated quality scores enables direct use of
the sequences in other software packages. Thus, there is a considerable benefit in investing
the computational time in Ibis re-base-calling for sequencing runs of all so far available
chemistry versions and Illumina sequencing instruments.
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Chapter 5
Quantification of gene expression
from short-sequence tags
The well-bred contradict other people. The wise contradict themselves.
– Oscar Wilde [96](1205)
The study of gene expression differences at a genome-wide level using microarrays [205]
allowed the characterization of human-chimpanzee phenotypic differences at a scale not pos-
sible before. The analysis of five tissue transcriptomes showed that differences between
humans and chimpanzees relative to variation within species are comparably constant in
brain, liver, kidney, heart, but not in testis, in which an excess of differences between species
relative to within species was found [111]. In most of the investigated tissues the extent of
gene expression divergence between humans and chimpanzees was observed to be propor-
tional to the extent of expression diversity within species. The patterns of transcriptome
differences between humans and chimpanzees in testis and brain were, however, identified as
not being compatible with a neutral model of evolution. In both tissues it was suggested that
positive selective forces have shaped transcriptomic differences. In testis this is supported
by an excess of between species differences relative to the diversity within species. In brain
fewer differentially expressed genes were observed, and these expression changes seem to
have occurred to a larger extent on the human evolutionary lineage than on the chimpanzee
lineage [111, 59, 110].
The technological advances in sequencing described in chapter 2 offer the opportunity to com-
plement and extend this already existing body of knowledge with new insights that come
from the direct sequencing of transcriptomes. The advantage of such sequencing approaches
is that microarrays are static in their design and limited to the analysis of genomic features
known at the time of design, whereas sequence-based gene expression profiling represents
a shotgun approach to identifying the expressed molecules present in a tissue or sample.
Further, the short probes used for hybridization-based technologies are rather sensitive to
polymorphisms in the transcribed region that is probed [15, 45] – a problem that is ampli-
fied in comparative studies in which expression patterns of species with some evolutionary
sequence differences are inferred and compared. In contrast, sequence-based transcriptome
profiling technologies generate sequences from all available molecules and in a separate step
determine the identity of molecules from their sequence and thus facilitate the measure-
ment and comparison of gene expression from species whose genomes show different levels
of genetic divergence.
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Gene expression data from humans, chimpanzees, and a genetic outgroup, such as rhesus
macaques, allows the triangulation of transcriptomic differences between the outgroup, hu-
man and chimpanzee and thus enables differential gene expression to be assigned to the
human lineage or to the chimpanzee lineage. Thus, in order to complement previously gen-
erated tissue transcriptome profiles from primates [59, 111, 112, 218, 10, 23, 240], we1 used
serial analysis of gene expression (SAGE) in conjunction with Illumina Genome Analyzer
sequencing (chapter 2 section 2.3 on page 23) in order to infer gene expression levels. Using
the NlaIII Digital Gene Expression (DGE) approach, we generated tag sequences of 17bp
to study brain, heart, kidney, liver and testis tissues of humans, chimpanzees and rhesus
macaques.
The Illumina NlaIII DGE protocol was one of the first applications of the Illumina sequencing
platform. The first experiments with this protocol were performed at the Max Planck Insti-
tute for Evolutionary Genetics in late 2007. At this point 18 cycle/nucleotide reads were the
common read length of the instrument. The protocol was discontinued by Illumina in spring
2009, after sufficiently long reads and transcriptome/messenger RNA shotgun sequencing
protocols, i.e. RNAseq, had been established for the platform.
5.1 Samples and experimental protocol
Expression data was generated from brain (pre-frontal cortex), heart, kidney, liver, and testis
tissues for each five male humans, five male chimpanzees and five male rhesus macaques.
For the human samples informed consent for use of the tissues for research was obtained in
writing from all donors or their next of kin. All non-human samples were obtained through
opportunistic sampling. These individuals suffered sudden deaths for reasons other than
their participation in this study. For all samples, the cause of death was unrelated to the
tissues used. We note that in human tissues from 25 different individuals were used, while for
the two other primates, tissues largely originate from the same donors (each six chimpanzee
and rhesus macaque individuals were used across the 5 tissues). We may assume largely
unrelated human samples, but chimpanzees and rhesus macaque samples show relatedness
to the half- and full-sibling level. Due to the limited access to samples, we could not restrict
the analysis to individuals of similar age. Human individuals vary between 5 and 88 years
of age, chimpanzees between 6 years and 35 years of age and rhesus macaques between 3
and 9 years of age. Samples are named by a lower case letter h (human), c (chimpanzee)
or r (rhesus macaque), followed by a upper case letter B (brain), H (heart), K (kidney), L
(liver), and T (testis), followed by numbers 1-5 in human and numbers 1-6 for chimpanzee
and rhesus macaque (where numbers are associated with a specific individual).
For the Illumina NlaIII Digital Gene Expression protocol, the original SAGE protocol [234],
where the most 3’ restriction tags from transcripts are ligated, cloned and the concatenated
sequence tags read out using Sanger sequencing, was modified and optimized for sequencing
on the Illumina Genome Analyzer I platform. This DGE protocol relies on the generation
of a library of short (17bp) cDNA tags each corresponding to a sequence located immedi-
ately 3’ of the 3’-most NlaIII restriction site of every transcript in a cell or tissue sample.
Figure 3.3 on page 42 in chapter 3 illustrates the sequencing library preparation protocol.
Briefly, messenger RNA (mRNA) is isolated from total RNA (1-2µg) by binding to magnetic
oligo(dT) beads. The attached mRNA is used as a template for reverse transcription from
the oligo(dT) primers, creating a bead-bound mRNA/cDNA hybrid. Next, in the second
1The project was designed by Esther Lizano Gonza´lez and Thomas Giger. Esther Lizano Gonza´lez also
prepared all sequencing libraries for this project.
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strand cDNA synthesis, the mRNA strand is removed and a replacement strand synthesized
generating a double-stranded cDNA bound to the oligo(dT) bead. Double stranded cDNA
is digested with the restriction enzyme NlaIII and all fragments other than the 3’ fragment
attached to the oligo(dT) beads are washed away. Subsequently an adapter (GEX Adapter
1.2 in figure 3.3 on page 42) is ligated at the site of NlaIII cleavage. This adapter liga-
tion creates the recognition sequence for the restriction enzyme MmeI at the adapter-cDNA
junction. By restriction with the MmeI enzyme, which cuts 21bp downstream from its bind-
ing site, the resulting construct is no longer attached to the oligo(dT) bead and is free in
solution. A second adapter (GEX Adapter 2.1 in figure 3.3 on page 42) is ligated at the
site of MmeI cleavage. Finally, the adapter-ligated cDNA construct is enriched using PCR
and the amplified cDNA construct is gel purified (see also section 3.1 on page 40) prior to
sequencing on an Illumina instrument.
5.2 Sequencing and primary data processing
Libraries for all samples were generated in tissue batches, randomizing species in library
preparation and sequencing. In early 2008, brain and liver samples were sequenced on a
Genome Analyzer I instrument according to the manufacturer’s instructions using in total
seven different flow cells. Sequencing data was analyzed starting from Illumina ’chastity’
filtered FastQ files (see also chapter 3 section 3.7 on page 55). For these files, quality scores
were converted to PHRED-scale [63] and the offset for ASCII encoding changed to Sanger-
style (see chapter 4, specifically equations 4.5 on page 80 and 4.2 on page 77). Heart, kidney
and testes samples were sequenced on Genome Analyzer II instruments according to the
manufacturer’s instructions on ten different flow cells from January 2009 throughout August
2009. Here, the sequencing data was analyzed starting from IPAR 1.01, IPAR 1.3 as well
as SCS 2.4/RTA 1.4 sequence files and intensity files. The raw reads of a dedicated φX174
control lane on each run were aligned to the corresponding φX174 reference sequence to
obtain a training data set for the base caller Ibis (chapter 4 on page 64, [116]), which was
then used to recall bases and quality scores for these Genome Analyzer II runs. Ibis could
not be applied to the earlier Genome Analyzer I runs as intensity files were not archived for
these old runs.
The so-obtained PHRED-scaled FastQ files were adapter and chimera filtered. Even though,
the majority of adapter dimers is removed by the gel excision step, the NlaIII DGE protocol
may also create adapter chimeras with a length comparable to the targeted library molecules
as well as the necessary grafting and priming sites, causing them to be sequenced together
with the real SAGE tags. If not removed, these artifacts can, due to their short read length,
easily be aligned to the reference genome and cause false positive counts. Thus, reads
were filtered for one of the following dimer/chimera sequences that can be created during
library preparation and which are the most frequently identified from a representative lane
using TagDust [128] (see figure 3.3 on page 42): TCGTATGCCGTCTTCTGCTTG, TCGGACTGTAGA-
ACTCTGAAC, CAGGTTCAGAGTTCTACAGTCCGACATG, GTATGCCGTCTTCTGCTT, AATCGTATGCCGTCTT-
CT, TCGGACTCGTATGCCGTC, GTCGTATGCCGTCTTCTG, TCGGACTGTAGAATCGTA, ATGGCTCGTATGCC-
GTCT, AGGAGTCGTATGCCGTCT, TCTCGTATGCCGTCTTCT, TCGGACTGTAGAACTCTT, ATCGTATGCCGT-
CTTCTG, AGGAGTTCGTATGCCGTC, CGTATGCCGTCTTCTGCT, GTATGCCGTCTTCTTCTT, AGTCGTATGC-
CGTCTTCT, CCAGTCGTATGCCGTCTT, GTGATCGTATGCCGTCTT, GTGTCGTATGCCGTCTTC, TCGGACTG-
TAGATCGTAT, GCCACCCTCTACAGCCGA.
Reads were also filtered for the presence of at least 9nt of the adapter sequence (TCGTAT-
GCCGTCTTCTGCTTG) at the read end. Further, the last read base (the first adapter base) of
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A C G T
Figure 5.1: A reflection layer surrounding the actual lanes of version 1 flow cells (mostly used with
Genome Analyzer I instruments), caused the image analysis algorithm to pick up artificial clusters at
the tile edges. Sequences obtained from these artifacts are frequently adenine homopolymers. Upper
picture of flow cell taken by Frank Vinken, MPG.
the remaining 18nt reads was clipped off and reads with more than 1 base below a quality
score of 10 discarded. Subsequently, reads with sequence entropy below 0.85 were removed,
as these might also originate from flow cell artifacts (see chapter 3 section 3.7 on page 55).
Specifically, flow cells used with Genome Analyzer I had a reflection layer surrounding the
actual lanes (figure 5.1), which caused the image analysis to identify a larger proportion of
such artifacts at the outer tile edges. Later flow cell versions are transparent to reduce this
effect.
Figure 5.2 on the next page provides the fraction raw sequences remaining after adapter
chimera and dimer removal for the different tissue batches as well as the fraction of adapter
filtered sequences remaining after quality and complexity filtering. For the kidney and heart
batches some samples showed a large number (up to 40%) of adapter dimers/chimeras.
Data quality also shows considerable variation between batches, supporting the need for the
applied quality filter.
5.3 Tag alignment
The ultra-short sequences obtained from this NlaIII DGE protocol complicate data analy-
sis. Assuming that all sequences remaining after read processing originate from the library
preparation protocol, 21nt long tag sequences (’CATG’ + 17nt) have to be aligned to at least
three gigabase-sized mammalian genomes. Due to sequencing error in these tag sequences
and genomes as well as due to biological variation in the restriction sites, exact matches are
not necessarily expected. However, the number of putative NlaIII restriction sites and the
uniqueness of the resulting tag sequences in the human, chimpanzee and rhesus macaque
genomes also varies (table 5.1 on the following page). Variation in genome quality and
genome completeness are likely to contribute to these differences.
Different processing versions of the data have been considered and partially also tested.
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Figure 5.2: Summary statistics from the raw data processing of the Illumina DGE data by tissue.
Shown are boxplots for the fraction adapter dimers and chimeras removed from the raw reads (left)
as well as the fraction of adapter filtered reads passing the described quality and complexity filters
(right). Libraries for all samples were generated in tissue batches, randomizing species in library
preparation and sequencing. In early 2008, brain and liver samples were sequenced on a Genome
Analyzer I instrument, heart, kidney and testes samples were sequenced on Genome Analyzer II
instruments from January 2009 throughout August 2009.
Table 5.1: The number of NlaIII restriction sites varies for the three primate genomes (human,
chimpanzee, rhesus macaque), as does the fraction of unambiguous tag sequences obtained from
these sites for the three different genomes. It is likely that genome quality and genome completeness
contribute to these differences. Judging from these numbers some proportion of sites with identical
tag sequences occur with high frequency throughout the genome.
’CATG’ sites Tag sequences Unambiguous Ratio
Human 27,561,798 20,418,202 19,348,954 70.20%
Chimp 27,861,673 20,414,200 19,123,594 68.64%
Rhesus 24,847,282 19,485,936 18,753,873 75.48%
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It was, for example, discussed whether sequences should be aligned to a virtual and pre-
annotated tag library or whether sequences should rather be aligned to the complete genome
of each species. For generating a virtual tag library, each reference genome is scanned once
and, for all NlaIII restriction sites, the 21nt sequence corresponding to the MmeI digestion
product extracted. The tag library can be annotated with gene annotation. Sequencing tags
can be aligned with this static virtual library using, for example, a tool that is fast for near-
perfect matches (e.g. PatMan [180]). Illumina followed such an approach in their analysis
pipeline for the DGE protocol, for which they provided pre-compiled virtual tag libraries
for the mouse and human genome and aligned using ELAND. For this five tissues project, I
used a similar approach for the first analyses. However, such a virtual tag library assumes
that there is no sequence variation in the NlaIII restriction sites and that further these sites
were identified without error from the corresponding reference sequence. Considering that
a mammalian genome contains about 30 million NlaIII restriction sites (table 5.1 on the
previous page) and considering typical diversity across human populations (which is lower
than across different chimpanzee populations, [68]) about 0.14% (42,000) of these sites will
differ between any two individuals.
In another approach, the recognition motif of NlaIII (’CATG’) can be attached to begin-
ning of all sequences and the full SAGE tags aligned to the corresponding reference genome.
While this may overcome the variation in the restriction sites between individuals, at least
for tag sequences which are unique and sufficiently informative for one genomic position
when allowing mismatches, it does not overcome the general problem with these short tags
which will for two genomic sites frequently only differ in one substitution. Considering that
sequencing error as low as 1% will generate about one difference in every sixth tag, this
effect is considerably larger than variation in NlaIII sites. There is only one way to coun-
teract this short-tag ambiguity problem: including an assumption that limits the putative
sources/regions for the origin of these tags.
Based on the experimental protocol enriching for 3’ most restriction sites of transcripts,
one such assumption would be that tags may only originate from the last 1,000nt of known
transcripts (assuming rather equal spacing of the restriction sites, complete transcripts and
complete knowledge of all transcripts in the cell). Considering about 79,000 mRNAs anno-
tated in Ensembl v59, this assumption would reduce the search space to less than 3% of the
complete genome. Alternatively, the alignment could also be performed to sets of known full
transcripts, which limits the search space to also about 3% of all genome bases. Further,
aligning to actual transcript sequence has the advantage that tags spanning exons could be
handled correctly and tags extending into a polyadenylation site predicted. However, with
this strategy the vast majority of the genome is not considered during alignment and tags
actually originating from outside annotated transcripts will likely be aligned with few se-
quence differences to known transcripts. This is possibly a concern when considering that
projects like the Encyclopedia of DNA Elements (ENCODE) have shown that essentially
the whole genome is transcribed, even though largely varying in the number of transcribed
molecules [226].
In the final analysis, I extended sequences by including the ’CATG’ restriction motif and
aligned them to the complete genomes (hg19 / GRCh37 excluding additional haplotypes,
pantro2 / CGSC 2.1 and rhemac2 / MGSC Merged 1.0 with the addition of a mitochondrial
genome sequence from Ensembl MMUL 1.54 build) using bowtie 0.12.4 [126]. Bowtie is a
fast short-read aligner which allows substitutions but no insertion/deletions to the reference
genome. This aligner was configured to report up to 100 equally best alignments (with up to
two mismatches) and to discard reads that produce more than 100 alignments (parameters
-a -m 100 --best --strata). Therefore, high frequency tags are excluded from analysis,
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while tags appearing at most 100 times in the genome were reported for each of the genomic
positions. Alignments outside of gene annotation are excluded from quantification.
5.4 Annotation of expressed sequence tags
Typically gene annotation can be obtained from one of the genome browsers or bioinfor-
matics databases maintained by the National Center for Biotechnology Information (NCBI),
the University of California, Santa Cruz (UCSC) or the European Bioinformatics Institute
(EBI)/European Molecular Biology Laboratory (EMBL). These databases differ in which
gene prediction routines are used and how experimental transcript evidence is incorporated.
We used the Ensembl2 database at EBI/EMBL which provides gene annotation for all three
species as well as an assignment of orthologous genes across species [43]. When the first
experiments of this project were analyzed the Ensembl database was in version 50 (released
July 2008). When analyzing one of the human brain samples, the observed tag site distri-
bution along genes and neighboring sequence shown in figure 5.3 on the following page was
obtained.
The figure does not consider actual tag frequency, but simply plots the position of tag sites
observed in this sample and is therefore independent of the actual gene expression values.
As expected for a protocol targeting the most 3’ restriction site in each transcript, the vast
majority of tag sites is observed right before the gene end. However, for some genes, tags fall
right outside the 3’ gene end, indicating incomplete annotation of 3’ untranslated regions
(3’ UTRs) in this Ensembl database version. In addition, a higher frequency of tag sites
is observed at the gene start position, which also extends into sequence upstream of the
actual gene. The presence of these 5’ tags might indicate incomplete mRNA extension. The
extension of this effect into upstream sequence is likely caused by incomplete annotation
of 5’ untranslated regions (5’ UTRs). Further, a mirroring of tag positions within genes is
observed on the antisense strand of genes. Even though antisense transcription has been
described [247, 108, 127], the exact clustering of their 3’ ends with the 3’ ends of the sense
transcripts is unexpected.
When exploring the position of tags on the antisense strand, I find that most of them even
mirror counts for the same NlaIII restriction site on the sense-strand, indicating that they are
likely to originate from a carry-over effect rather than actual antisense transcripts. Carry-
over of the upstream NlaIII digestion fragments on the tube walls and beads will allow
adapter ligation and propagation in the protocol; creating tags that seem to originate from
the opposite strand. More stringent wash protocols after NlaIII digestion might reduce this
effect. Figure 5.4 on page 100 shows for NlaIII restriction sites covered with tag counts on
both strands the Spearman correlation across all samples and compares it to the correlation
when randomizing the assignment of sense to antisense tags.
Carry-over of upstream NlaIII digestion fragments may also cause non-3’-most tags to be
observed from both strands of the cDNA. Further, the incomplete digestion or enzyme hin-
drance at close restriction sites3 may also cause the distribution of the actual count signal
over multiple restriction sites. Figure 5.4 on page 100 shows a clear correlation of counts
for neighboring sites. When analyzing very close NlaIII restriction sites where a second or
even third ’CATG’ is within the 21 bases obtained from MmeI digestion, the spread of tag
counts across the different sites due to hindrance and incomplete digestion can be observed
(figure 5.5 on page 101). The effects of incomplete digestion and steric hindrance can be
2http://www.ensembl.org/
3In the human genome 5.5% of all tag sites contain a second NlaIII restriction site within their sequence.
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Figure 5.4: Boxplot of correlation values across all samples for tag counts orignating from the two
strands of the same NlaIII restriction site (left) or neighboring NlaIII sites on the same strand
(right). For unique NlaIII restriction sites covered with tags on both strands the Spearman corre-
lation of tag counts for the two strands is compared to the Spearman correlation when randomizing
the assignment of sense and antisense tags. For neighboring unique NlaIII sites, observed together in
the same sample, the Spearman correlation of these counts is compared to the Spearman correlation
when randomly reassigning neighboring NlaIII sites.
compensated for by summing over all tags in a gene. However, when summing all tags in
a gene, the carry over effects for upstream NlaIII digestion fragments and incompletely ex-
tended transcripts may cause a gene length bias in gene expression quantification as well
as a noisy gene expression read out due to variance in the extend of carry over between
experiments. Such a length bias is problematic when gene expression values are compared
across genes, but not when the same genes are compared between samples.
Due to the observation of incomplete annotation of 3’ UTRs, we considered extending genes
by a fixed number of bases after their annotated end. However, while further data was
generated and different analysis approaches tested, the Ensembl gene annotation was updated
several times. The updates from Ensembl v50 to Ensembl v59 resulted in about 1.5kb
increase in human median gene length (see table 5.2 on the following page). The annotation
of chimpanzee and rhesus macaque did not change at all between these versions.
The number of tags mapped within 1kb downstream of 13,387 human protein-coding genes
decreased by up to 65.7% between Ensembl v50 and Ensembl v59. The exact number
differed depending on the tissue with a reduction by 36.1% in brain, 47.1% in heart, 65.7%
in kidney, 51.6% in liver and 40.2% in testis observed for the newer annotation. Since
human gene annotation improved, the extension of genes for missing 3’ UTR annotation
was no longer necessary. So I tried applying the species-specific annotation available from
Ensembl v59, limiting to genes with orthologous gene identifiers uniquely assigned between
all three species. Figure 5.6 on page 102 shows the results when averaged over all brain
samples for the three species. Only the recent human genome annotation builds provide
sufficient annotation of UTR sequences. The median gene length of protein-coding genes in
chimpanzee and rhesus macaque is considerably shorter (table 5.2 on the following page).
Thus, gene annotation including UTRs has to be transferred from the human genome to
both other species to prevent an annotation bias.
Gene annotation can be transfered by either aligning the individual gene or transcript
sequences to the other genomes or by transfering gene coordinates using pair-wise whole
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Figure 5.5: For very close NlaIII restriction sites, where a second or third ’CATG’ is within the
21 bases obtained from MmeI digestion, the distribution of transcript counts across multiple tags
due to hindrance and incomplete digestion can be observed. NlaIII is a Type-2 restriction enzyme
with a four base pair recognition motif of which no crystal structure is currently available. However,
EcoRI, also a Type-2 restriction enzyme with a four base recognition motif, covers a full turn of the
DNA double helix (about 10nt). The enzyme image for EcoRI was downloaded from Wikipedia
(http://en.wikipedia.org/) as 1QPS.png, where it was released into public domain by the author.
Table 5.2: Gene length of protein-coding genes in Ensembl v50 and Ensembl v59. Human median
gene length increased by about 1.5kb in the newer version and at least one suspiciously long gene was
removed. The annotation of chimpanzee and rhesus macaque did not change between these versions.
Ensembl v50
Genes Min. 25th Median Mean 75th Max.
Human 21,528 62 6,416 20,040 58,220 55,380 50,940,000
Chimp 19,829 59 6,024 19,970 54,850 55,240 2,341,000
Rhesus 21,905 62 3,014 14,450 45,530 46,090 2,034,000
Ensembl v59
Human 21,727 8 6,999 21,500 59,150 60,390 2,305,000
Chimp 19,829 59 6,024 19,970 54,850 55,240 2,341,000
Rhesus 21,905 62 3,014 14,450 45,530 46,090 2,034,000
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Figure 5.6: Annotation of expressed sequence tags using species-specific Ensembl v59 annotation
(left) and human Ensembl v59 annotation projected to the other two species (right). Chimpanzee
and rhesus macaque annotation largely miss annotation of 3’ UTRs and thus show a larger proportion
of tags falling downstream of actual gene annotation. Thus, a smaller proportion of counts is consid-
ered in genes for those two species. When gene annotation is projected from human to chimpanzee
and rhesus macaque, very similar proportions of tags are assigned to genes in each species.
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Table 5.3: Results from projecting human Ensembl v59 gene annotation to chimpanzee and rhesus
macaque. Counts for transfer RNAs only include the ones encoded in the mitochondrial genome,
cytoplasmic transfer RNAs encoded in the nuclear genome do not have an explicit biotype in Ensembl.
While nuclear genes were projected using UCSC’s liftOver tool, all 37 mitochondrially encoded genes
were projected using a ClustalW mitochondrial genome alignment of the three species.
Ensembl biotype Human Chimp Fraction Chimp & Rhesus Fraction
protein-coding genes 22,099 17,989 81% 14,682 66%
pseudo genes 12,599 10,179 81% 6,858 54%
ribosomal RNAs 537 469 87% 365 68%
transfer RNAs 22 22 100% 22 100%
sn/sno/miRNAs 5,283 4,759 90% 3,804 72%
lincRNAs 1,451 1,257 87% 891 61%
other 9,724 8,345 86% 6,637 68%
total 51,715 43,020 83% 33,259 64%
genome alignments between the reference genomes. Such whole genome alignments are for
example provided by UCSC4 [190], generated using their blastZ and autoMultiZ pipelines5,
or available from Ensembl, using the Enredo-Pecan-Ortheus (EPO) [171, 170] pipeline. I have
used the UCSC whole genome alignments, more precisely the liftOver chain files. These
pre-generated files are available for selected assemblies and can be used with genome coor-
dinates in BED6 format using the UCSC command line tool liftOver. These chain files
are based on whole genome alignments which differentiate between a reference and a target
genome in the generation process, requiring a position of the reference genome to appear at
most once while sequences from the target genome can be used multiple times. Therefore,
liftOver output is non-symmetrical between species.
I used liftOver to project gene start and end coordinates from human to the other two
species and projected coordinates back from chimpanzee and rhesus macaque to validate that
they match the original coordinates of the human genome. Gene start and end coordinates
were projected separately, requiring the projected coordinates to be on the same chromosome
and strand. Further, the new gene length was not permitted to change by more than a factor
of 10, or at most 100kb. The rhesus genome does not include a mitochondrial genome in
the assembly version provided by UCSC. Hence, also the whole genome alignments do not
include it and therefore liftOver fails for mitochondrial genes.
I therefore supplemented the whole genome alignment by aligned mitochondrial genomes of
the three species generated using ClustalW [227], manually ”synchronizing” mitochondrial
genome start positions between human, chimpanzee and rhesus macaque and then transferred
coordinates of 37 mitochondrially encoded genes using this alignment. The liftOver gene
annotation projection step shows different efficiency for different gene classes, especially
when projecting over the evolutionary larger distance to rhesus macaque (table 5.3). When
projecting to chimpanzee 83% of genes are recovered, when projecting to chimpanzee and
rhesus macaque only 64% of genes remain. Applying annotation for the genes which can
be successfully projected, similar proportions of tags are assigned to genes in each species
(figure 5.6 on the preceding page).
4http://hgdownload.cse.ucsc.edu/downloads.html
5part of Kent-tools, http://hgdownload.cse.ucsc.edu/admin/exe/
6http://genome.ucsc.edu/goldenPath/help/hgTracksHelp.html#BED
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5.5 Gene quantification and count normalization
For quantifying gene expression, the bowtie output files from each lane were combined by
individual (as samples hK4, rK4, rK5, rK6, cL1, cL2, hL1, rL2, rL3 and rL4 were pooled from
two lanes) and mapped tags sorted by coordinates. Sites observed fewer than three times
were removed to reduce the effect of adding up erroneous alignments in long transcripts,
and per-site-count files created. Some individuals with similar number of reads in the same
tissue ended up with fewer observed sites. This could indicate that part of the transcriptional
complexity of those samples was lost during library preparation.
I therefore required that no sample had fewer observed sites than 50% of the median value of
observed sites for all samples of the same tissue. This excluded samples hH5, hK2, hK3, cH5,
cK5, and rK5 which did not cluster with samples of the same tissue in a principal component
analysis (PCA) of raw gene counts (figure 5.7). Another sample which did not cluster with
samples from the same tissue is rT2, a sample which did not show any abnormalities in
experimental logs and sequencing statistics. It is the testis sample of an 4.85 years old
rhesus macaque, even though this is only the second youngest rhesus macaque sample the
differences in gene expression may be explained by a late onset of sexual maturity, which
might not be uncommon in rhesus monkeys. Rhesus macaques typically reach puberty after
3-3.5 years of age, but show a wide age range for the birth of their first offspring (3.8-18.8a),
with only 26% of males reproducing before reaching the age of 6 years [17]. Hence, this
sample was excluded from further analyses.
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Figure 5.7: First three principal components obtained from the analysis of normalized gene expression
counts for all 75 individuals across five species and five tissues (prior to variance stabilization using
DESeq). Six outliers excluded due to a low number of covered genomic sites are marked with red crosses
(hH5, hK2, hK3, cH5, cK5, and rK5). rT2 is marked with a yellow cross and was also excluded. This
is a rhesus macaque testis sample which does not cluster with the other testis samples. Even though
it did not show any abnormalities in experimental logs and sequencing statistics, it is possible that
sexual maturity was not reached by this individual.
The per-site-count files for the remaining individuals were overlaid with the reciprocally
projected Ensembl v59 human gene annotation. Within each gene I summed all counts on
the correct strand. For genes overlapping on the same strand, I divided counts between the
two genes after all non-overlapping counts had been considered. The overlapping counts were
split between genes based on either the ratio of the non-overlapping counts (if the overlapping
counts are lower) or evenly split between genes otherwise. Again, genes receiving fewer than
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three counts were discarded.
The outlined approach considers tag sequences appearing in multiple genes, but at most
100 times in the complete genome, for the counts of multiple genes. The proportion of
genes that are quantified by unambiguous counts only, depends on the exact tissue and
species. As little as 12.7% (rhesus macaque kidney) and up to 41.2% (human liver) of genes
are quantified from tags unique to one gene. When requiring at least 50% of the counts
to originate from unambiguous tag sequences, at least 60.4% and at most 69.1% of genes
remain, with the extremes being observed in the previously-mentioned tissues. Table 5.4
on the following page provides a summary for different cutoff values, tissues and all three
species. It is worth noting that these numbers include the removal of about 34% of human
genes due to the annotation projection to rhesus macaque. Species differences observed
for the different cutoffs, indicate that any kind of filters on uniqueness of tag sequences
might introduce (further) species biases. This exemplifies why short-tags and the associated
alignment ambiguity are so problematic for data analysis.
Instead of requiring some proportion of counts to be unambiguous for a gene, one might also
quantify genes only from unambiguous counts – ignoring the proportion of tags excluded and
accepting that occasionally tags quantifying the dominant transcript version are lost. Both
(counting tags multiple times or excluding them from quantification) generate an inaccurate
quantification result. While counting sites multiple times will overestimate gene expression,
removing them will underestimate gene expression (figure 5.8). This alone would not be
problematic for an inter-species study as identifying gene expression changes between species
and tissues does not require a correct ranking of gene expression, however table 5.4 on the
following page indicates that different tag frequencies for the three genomes (see also table 5.1
on page 96) impacts quantification in a species-specific manner. Since already one cutoff,
even though not stringent, has been applied for tag sequences occurring more than 100
times in the genome, additional filters may further put off expression quantification between
species.
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Figure 5.8: Both excluding ambiguous tags, or counting tags multiple times, results in gene quantifi-
cation that is either too low or too high. The presence of ambiguously mapped tag sequences within
transcribed regions means that no correct ranking of gene expression values can be obtained from
this data set.
Table 5.5 and figure 5.9 look at the differences between the two extremes in gene quan-
tification in presence of ambiguous tags: excluding all unambiguous tags or counting them
multiple times (with the restriction that tag sequences more frequent than 100 times in the
genomes were excluded in mapping). Spearman correlation between both estimates is high,
showing that gene ranks are mostly maintained (figure 5.9 on page 107). Results for dif-
ferential expression between human and chimpanzee show some variation (except for testis)
between the two types of analysis (table 5.5 on page 107). However, the relative ordering
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Table 5.4: Fractions of expressed genes remaining for each tissue when requiring different proportions
of the gene expression counts to originate from unambiguous tag sequences (column ’Purity’). Species
and tissue differences can be observed for different cutoff values, e.g. in kidney and liver. The
differences observed indicate that filters on uniqueness of tags might introduce a species and tissue
bias.
Tissue Purity human chimp rhesus
brain
100% 32.9% 34.6% 30.4%
95% 43.9% 44.5% 41.6%
90% 49.7% 50.1% 47.7%
85% 53.7% 53.8% 51.6%
75% 59.3% 59.2% 57.2%
50% 67.9% 68.1% 66.6%
25% 74.2% 74.5% 73.6%
heart
100% 25.7% 22.7% 25.4%
95% 38.2% 37.0% 37.2%
90% 43.2% 42.6% 42.5%
85% 46.9% 46.5% 46.3%
75% 52.5% 52.6% 52.4%
50% 63.4% 64.1% 64.1%
25% 73.0% 74.5% 74.8%
kidney
100% 19.1% 16.0% 12.7%
95% 33.9% 31.6% 28.8%
90% 40.4% 38.5% 35.8%
85% 45.0% 43.2% 40.4%
75% 51.8% 50.2% 47.2%
50% 63.6% 62.8% 60.4%
25% 74.2% 74.5% 73.9%
liver
100% 41.2% 36.1% 35.6%
95% 48.3% 43.4% 43.1%
90% 52.6% 47.9% 47.6%
85% 55.6% 51.2% 50.7%
75% 60.0% 56.1% 55.6%
50% 67.6% 64.2% 64.0%
25% 73.0% 70.7% 70.9%
testis
100% 20.1% 17.6% 20.9%
95% 35.7% 35.0% 37.1%
90% 43.3% 42.9% 44.2%
85% 48.5% 48.2% 48.9%
75% 56.1% 55.6% 55.7%
50% 69.1% 68.7% 68.2%
25% 79.3% 79.7% 78.5%
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of tissues in the number of expressed genes as well as the fraction of differentially expressed
genes is identical.
Table 5.5: The treatment of ambiguous tags affects the number of expressed genes and the fraction
of differentially expressed genes (p-value cutoff of 0.01 after Benjamini-Hochberg FDR correction,
see section 5.6 on page 109 for details). The relative ordering by the number of expressed genes (≈
transcriptional complexity) or by the fraction differentially expressed (≈ gene expression divergence)
is however stable with respect to this difference in data processing.
Counting multiple times Excluding ambiguous counts
Genes Diff.Exp. Tissue Fraction Genes Diff.Exp. Tissue Fraction
10646 1387 brain 13.0% 8765 870 brain 9.9%
8361 224 heart 2.7% 6053 82 heart 1.4%
13401 2040 kidney 15.2% 10661 1256 kidney 11.8%
8285 742 liver 9.0% 6480 349 liver 5.4%
14056 4109 testis 29.2% 11531 3353 testis 29.1%
brain0.93 heart0.88 0.91 liver
testis0.91kidney0.89
Spearman correlation of 
mean gene quantification 
in human counting ambi-
guous tags multiple times 
(x) or excluding them (y)
Figure 5.9: Spearman correlation of gene expression quantifications for human data when ambiguous
tags are excluded (y axis) or counted multiple times (x axis). When excluding ambiguous counts
gene expression values are underestimated, when counted multiple times gene expression values are
overestimated (see also figure 5.8 on page 105). High Spearman rank correlations show that gene
ranks are mostly stable with respect to this difference in data processing.
From the above results, specifically table 5.4 on the preceding page, it seems likely that
excluding ambiguous counts would cause species-specific effects and thus negatively impact
an inter-species study. I therefore restrict further analyses to the “multiple counting” ap-
proach to quantification. From these counts, the 25th and 75th percentiles of gene counts
for all samples belonging to the same tissue (independent of species labels) were adjusted
(scaled using a linear function to the same values) to correct for the different number of
reads for each sample. Between tissues the median of medians, i.e. the median of each of
the 5 tissue groups, was adjusted (i.e. scaled) to the maximum value observed across the five
tissue groups. The estimates for the normalization factors and offset were based on protein-
coding/non-mitochondrial genes only, but then applied for all genes. Protein-coding genes
are the main target of the poly-A capture used in the DGE protocol, and mitochondrial
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Figure 5.10: Number of expressed genes by tissue and Ensembl biotype. Within each tissue, genes
not expressed in all individuals across the three species were excluded. Further, after mapping tag
sequences observed fewer than three times have been excluded. Therefore, expressed genes in one
tissue are supported by reads in each individual. Tissues with the lowest number of expressed genes
are liver and heart; brain, kidney and testis show more expressed genes, with kidney and testis also
having higher proportions of non-coding genes.
genes are expected to show higher variance in their expression due to varying mitochondrial
genome copies per diploid nuclear genome.
As required for packages used in downstream analysis (section 5.6 on the next page), gene
expression counts were converted back to integer values (with the minimum observed count
being set to 1). Further, within each tissue group, genes with missing observations, i.e. genes
not expressed in all individuals, were excluded. Excluding genes not observed in all individu-
als across species, assures that quantification of the gene is not hampered by sequence-specific
effects (e.g. the restriction site falling outside of the gene due to a polymorphism) and indi-
rectly serves as a lower expression value cutoff.
After this last step, the number of expressed genes is defined for each tissue. Figure 5.10
summarizes these numbers and provides the most frequent Ensembl gene biotypes in the
different tissues. Tissues with the lowest number of expressed genes are liver and heart with
8,285 and 8,361 expressed genes, respectively. Brain (10,646), kidney (13,401) and testis
(14,056) have more expressed genes, with kidney and testis also having higher proportions
of non-coding genes. The exact numbers may vary due to the counting of ambiguous tags
multiple times which may inflate numbers.
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5.6 Differentially expressed genes
After applying the described processing steps, we obtain count data for each gene and in-
dividual. For testing whether counts observed in one species are different from counts ob-
served in the other species, one needs to estimate the variation in gene quantification in
each species and ask whether the obtained distributions are largely, i.e. some p-value cutoff,
non-overlapping. We have counts, which relate to tags sampled from a much larger tag
population. From random sampling the tag counts should follow a multinomial distribution,
which can be approximated by a Poisson distribution. Previously tests based on the Poisson
distribution (e.g. [145, 238]) have been used for testing differential expression. However, the
single parameter of a Poisson distribution, its mean which equals its variance, seems to gen-
erate distributions with a variance too small for the variation seen in real data [193, 157]. To
address this so-called overdispersion problem, sequencing count data can be modeled with
negative binomial distributions [194, 5, 192].
Negative binomial distributions have two parameters (mean and variance), which need to
be estimated for each individual gene from the data; data that frequently has too few repli-
cates for a reliable per-gene estimate of these parameters. Therefore, Robinson and Smyth
proposed [194], and also implemented in the bioconductor R [73, 224] package edgeR [192],
the assumption that mean and variance should be related by σ2 = µ+ α · µ2, with α being
constant for the whole experiment. Therefore, effectively only one parameter needs to be
estimated for each gene, allowing application to experiments with small numbers of repli-
cates. DESeq [5], a more recently released bioconductor R package, extends this model to
a variance parameter that is related to the mean expression value of the gene by a smooth
function. Using this assumption, observations for genes with similar expression values can be
pooled for parameter estimation and experimental effects impacting the variance of highly
expressed genes differently than the variance of lowly expressed genes can be modeled.
I used the processed primate gene expression count data with the DESeq7 [5] package to
obtain variance stabilized expression values as well as calling differentially expressed genes
between species pairs for each tissue. Due to the normalization procedure described before,
the internal count normalization of the DESeq package was not used. In order to account
for multiple hypothesis testing when identifying differentially expressed genes, p-values were
Benjamini Hochberg [14] corrected and a false discovery rate adjusted p-value cutoff of
1% applied. Further, as suggested by the DESeq manual, differentially expressed genes with
residuals from the estimated variance function greater or equal to 15 were excluded. Table 5.6
on the next page provides a summary with the fraction of differentially expressed genes
identified in all pair-wise species tests for each tissue. Based on these results, gene expression
between human and chimpanzee changed most in testis, followed by kidney, brain and then
liver. Fewest changes in gene expression are observed in heart. When comparing human
and chimpanzee to rhesus macaque, the order changes slightly, with most changes observed
in testis. More changes are observed in brain than in liver and in kidney, and the fewest
changes are observed in heart.
To assign human-chimpanzee differences in gene expression to a specific lineage, I consid-
ered genes as changed on the human lineage when for this gene a significant expression
change was observed between humans and chimpanzees and between humans and rhesus
macaques, but not between chimpanzees and rhesus macaques. Correspondingly, I defined a
gene to be changed on the chimpanzee lineage, when it showed a significant difference in the
human-chimpanzee comparison and the chimpanzee-rhesus macaque comparison but not in
7http://www-huber.embl.de/users/anders/DESeq/
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Table 5.6: Percentage genes differentially expressed in each tissue, from pair-wise comparisons be-
tween species using the DESeq package and an adjusted p-value cutoff of 1% FDR. This table partially
reprints numbers from table 5.5 on page 107.
Tissue Genes Human vs. Chimp Human vs. Rhesus Chimp vs. Rhesus
brain 10,646 13.0% 34.9% 37.4%
heart 8,361 2.7% 12.1% 13.1%
kidney 13,401 15.2% 30.0% 28.0%
liver 8,285 9.0% 31.6% 28.7%
testis 14,056 29.2% 44.6% 45.3%
the human-rhesus macaque comparison. I assign a gene expression change as outside of the
human-chimpanzee lineage, when the change was observed in the human-rhesus macaque
and the chimp-rhesus macaque comparison but not between humans and chimpanzees. Fur-
ther, I filtered the differentially expressed genes to show the same direction of change in
these comparisons. Figure 5.11 on the following page illustrates this assignment procedure
and presents the results for the different tissues.
Changes were assigned mostly symmetrical between lineages, with liver showing the largest
skew with about 8% more changes being assigned to the human lineage. In kidney about
5% more changes are assigned to the human lineage, in testis about 4% and in heart 3%.
In brain about 2% more changes are assigned to the chimpanzee lineage. For all tissues
and for all changes assigned to either human and chimpanzee, we observe more down then
up-regulation. This is consistent with the idea that random mutations may rather have
negative impact on gene expression (e.g. by weakening a transcription factor binding sites)
than enhancing gene expression. Surprisingly, for genes assigned to the long lineage from
the human-chimpanzee common ancestor to rhesus macaque more up-regulation is seen in
brain and kidney. It is unclear whether this might be a result of positive selection on gene
expression in these tissues or whether it is an artifact of the long lineage to rhesus macaque.
The lineage from the human-chimpanzee common ancestor to rhesus macaque spans more
than 50 million years of divergent evolution [220] and may have allowed multiple expression
changes for the same gene. Such multiple changes will cause an underestimate of gene
expression for larger divergences (saturation effect).
It is of interest that assigning human-chimp differential expression differences was not equally
efficient for the five tissues, i.e. not the same proportion of differentially expressed genes
could be assigned to a lineage by triangulation. The lowest efficiency is observed in testis,
where only 53.2% of changes could be assigned. Kidney and heart showed 59.6% and 64.3%
assignment rates. The highest rates were observed for brain and liver, with 66.3% and
69.1%, respectively. It is striking that the lowest assignment rate is observed for testis, the
tissue with most differentially genes, suggesting some saturation effect when using the rhesus
macaque outgroup.
Since gene expression seems to evolve at different rates between tissues, with testis and kidney
showing the highest rates, one can assess saturation by comparing the rates of differential
expression observed between human and chimpanzee to the rates observed between either of
them and rhesus macaque8. If gene expression differences behave in a clock-like manner with
constant rates, one should obtain a ratio of 6.5Ma/(60Ma − 6.5Ma) [220] for all tissues.
Saturation would cause higher ratios for tissues with higher rates as changes on the long
8Assumes neutral evolution with little or no selection (purifying or positive/functional) in all tissues as
well as constant rates.
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Human
Chimp Rhesus
Triangulation of pair-wise results
* Remove results were 
fold change inconsistent
*
RhesusChimpHuman
up down
brain 1173 1016 1.15
liver 666 731 0.91
heart 301 306 0.98
kidney 1268 812 1.56
testis 1557 1735 0.90
up down
brain 230 248 0.93
liver 72 142 0.51
heart 25 46 0.54
kidney 259 290 0.89
testis 380 624 0.61
up down
brain 137 305 0.45
liver 128 171 0.75
heart 31 42 0.74
kidney 233 433 0.54
testis 431 751 0.57
Figure 5.11: Triangulation of pair-wise expression differences. A genes is considered changed on
the human lineage (green) when for this gene a significant expression change is observed between
humans and chimpanzees and between human and rhesus macaques, but not between chimpanzees
and rhesus macaques. Correspondingly, a gene changed on the chimpanzee lineage (blue) is defined
by a significant difference in the human-chimpanzee comparison and the chimpanzee-rhesus macaque
comparison, but no significant difference in the human-rhesus macaque comparison. Gene expression
changes were assigned as outside of the human-chimpanzee lineage (red), when the change was
observed in the human-rhesus macaque and the chimp-rhesus macaque comparison, but not between
humans and chimpanzees. Further, differentially expressed genes had to show the same direction of
change, i.e. up- or down-regulation, in these comparisons. Decimal numbers next to the number of
up- and down-regulated genes, give the ratio of number of up-regulated by number down-regulated
genes.
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Table 5.7: Checking saturation/clock-like behavior in differentially expressed genes by comparing
the rates of differential expression observed on the human lineage (hsa sp) and chimpanzee lineage
(ptr sp) to the rates observed on the lineage from the common ancestor of human and chimpanzee to
rhesus macaque (shared). Rates of differentially expressed genes in each tissue indicate a saturation
effect which masks changes on the longer lineage to rhesus macaque. Based on these results, only
heart evolves clock-like while kidney and testis suffer from a stronger saturation effect caused by their
higher rates of expression change accumulation.
Tissue Genes hsa sp ptr sp shared hsa spshared
ptr sp
shared Expectation
brain 10,646 4.2% 4.5% 20.6% 20% 22%
12%
=
6.5Ma
60Ma−6.5Ma
heart 8,361 0.9% 0.8% 7.3% 12% 12%
kidney 13,401 5.0% 4.1% 15.5% 32% 26%
liver 8,285 3.6% 2.6% 16.9% 21% 15%
testis 14,056 8.4% 7.1% 23.4% 36% 30%
Table 5.8: Checking saturation/clock-like behavior based on expression distance measured as the
average euclidean distance per expressed gene. Ratios of human-chimp expression distance and either
human-rhesus macaque distance or chimpanzee-rhesus macaque distance are compared to species
sequence divergence [35, 75] ratios or the earlier used species divergence time ratios [220], which are
both similar in value. Average expression distance as defined by Khaitovich et al. [111] includes the
non-significant differences, the actual amount of expression change and the number of genes expressed
in calculation. On this data set the number of expressed genes seems to a have strong effect on this
expression distance, as tissues end up with lower ratio values the more expressed genes are observed.
tissue HC HR CR HC/HR HC/CR Expectation
brain 2.198 ±0.525 3.250 ±0.645 3.502 ±0.424 67.6% 62.8% 21.7% =
2·6.5Ma
60Ma
19.0% =
1.23
6.46
heart 2.341 ±0.820 3.298 ±0.899 3.024 ±0.648 71.0% 77.4%
kidney 2.228 ±0.553 3.899 ±0.793 3.556 ±0.471 57.1% 62.7%
liver 2.441 ±0.524 3.379 ±0.407 3.220 ±0.456 72.2% 75.8%
testis 1.811 ±0.224 4.520 ±1.076 4.127 ±0.957 40.1% 43.9%
branch will be underestimated. Table 5.7 provides the results.
The ratios follow the rates of differentially expressed genes for each tissue, indicating that a
saturation effect is masking changes on the longer lineage. Only in heart, where the fewest
expression changes are observed, do the calculated ratios match the ratio expected from
species divergence time. The same analysis can be done using expression distance measured
as the average euclidean distance per expressed gene [111] instead of the fraction differentially
expressed genes. Table 5.8 provides the results.
Using expression distance between species, one should be able to compare the ratio of hu-
man/chimpanzee distances and human/rhesus macaque or chimp/rhesus macaque to the
ratio of species sequence divergences [35, 75] or the earlier used species divergence times.
However, the expression distance behaves largely different from the fraction of differentially
expressed genes, as it includes the non-significant differences, the actual amount of expres-
sion change and the number of genes expressed in calculation. This measure is therefore
very difficult to interpret in this context. Values are not constant between tissues, indicating
some problems in linearly measuring expression distance to rhesus macaque.
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5.7 Comparison to other data sets
In the last sections, I have discussed how different factors impact the quantification of gene
expression in three species from short tags. Even though several imperfections of the ap-
proach and the data set have been outlined, results also indicated that two important features
like ranking transcriptional complexity of tissues and the fraction of differentially expressed
genes are stable for distinct data analysis approaches. Even though this provides some trust
in the internal consistency of the data set, it does not rule out problems from sampling and
experimental strategy. The only way to assess the data set in this respect is its comparison
to already published data sets including different samples and technologies. In this section,
I will compare our DGE data set of five tissues and three species to:
1. A brain data set of three male human, chimpanzee and rhesus macaque individuals
that was generated using the same NlaIII DGE protocol and published by Babbitt et
al. in Genome Biology and Evolution in 2010 [10].
2. A liver data set of three male and three female human, chimpanzee and rhesus macaque
individuals that uses the non-stranded9 Illumina RNAseq protocol and was published
by Blekhman et al. in Genome Research 2009 [23].
3. An Affymetrix HG-U133+ 2.0 array10 data set of all five tissues each studied in six
human and five chimpanzee individuals and published by Khaitovich et al. in Science
2005 [111].
With these three data sets, we have one data set also using the DGE protocol in different
individuals (1), allowing us to test for the effects of sample selection and and sample process-
ing. One data set (2) using the next generation of gene expression quantification technologies
– RNAseq, which is a “RNA shot-gun sequencing approach” and therefore less affected by se-
quence biases (see section 5.7.2). Unfortunately, different individuals were used in this study,
causing any discrepancies to either originate from technology or sampling. Further, as the
third data set we have the classical approach of measuring gene expression in a genome-wide
manner using hybridization arrays. Since this last data set was also generated at the MPI
for Evolutionary Anthropology, samples used partially overlap with the samples used for the
DGE study. Therefore, fewer samples differences are to be expected in the comparison with
this dataset.
5.7.1 Comparison of brain samples with Babbitt et al.
In 2010, Babbitt et al. [10] published a brain data set of three human, chimpanzee and rhesus
macaque individuals in Genome Biology and Evolution. Their data set was generated using
the same Illumina NlaIII DGE protocol and they also used frontal cortex tissue of male
individuals. Only three individuals have been studied in each species; individuals different
from the ones analyzed in our five tissues DGE study. The authors of this study have analyzed
data slightly differently than described here. Briefly, Babbitt et al. aligned reads using
Maq [133], allowing at most four equally good alignments. Multiple sites within human NCBI
RefSeq annotation (requiring correct strand information) and non-coding RNA annotation
(UCSC’s Genome Browser RNAGene track) were summed. Human RefSeq annotation was
9Non-stranded RNAseq protocols do not provide information on the DNA strand a transcript originates
from, thus they may identify chimeric genes from transcripts overlapping on different strands
103’-amplification-based proprietary in vitro transcription and labeling system; single dye detection
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Table 5.9: Comparison of the two cortex data sets, the data set comprised of three individuals per
species published by Babbitt et al. and the, each five, individuals from the five tissues DGE study.
From the processing presented by Babbitt et al., raw gene counts were used with the DESeq package
as described before. In addition, raw reads of this study were reanalyzed with the outlined analysis
pipeline (section 5.2 on page 94). Differentially expressed genes were assigned to lineages as outlined
in figure 5.11 on page 111.
Genes HC %Diff HR CR hsa sp ptr sp shared H/sh C/sh
Paper 9,961 1,323 13.3% 3,185 3,209 474 320 1,925 24.6% 16.6%
Reanalysis 11,469 1,939 16.9% 3,470 3,553 629 515 1,907 33.0% 27.0%
This study 10,646 1,387 13.0% 3,716 3,978 442 478 2,189 20.2% 21.8%
projected to the other two species using blat [109] alignments. From this processing of the
data, raw counts assigned to RefSeq identifiers were obtained. To compare them with the
five tissues data set, I converted RefSeq identifiers to EnsemblGeneIDs and used their raw
counts with the DESeq package as described before (section 5.5 on page 104).
To identify differences caused from processing, raw reads of their study (Courtney Babbitt,
personal communication, Oct 24 2010) were reanalyzed with the above described analysis
pipeline for our DGE data (section 5.2 on page 94). Table 5.9 provides the number of genes
and the number of differentially expressed genes (including the assignment to lineages) for
both analyses and compares them to the results for the five tissues DGE data set.
Reprocessing from raw reads using our analysis pipeline identified more expressed genes
and resulted in a larger proportion of differentially expressed genes. However, reprocessing
reduced the excess of changes assigned to the human lineage in the Babbitt et al. study from
9.7% to 5.0%. This fraction is however still in conflict with the result from the five tissues
DGE data, where about 2% more changes are assigned to chimpanzee in brain. In table 5.9
it appears that reprocessing caused the data to look more dissimilar between studies. This
is misleading as correlation between the two data sets increased considerably with the new
processing (figure 5.12 on the next page).
Reanalysis of the Babbitt et al. data set increased Spearman correlation between data sets
by about 0.2, indicating a large impact of data processing on gene quantification. Further,
without reanalysis a large proportion of genes with higher counts in our data is observed.
This is probably due to the different treatment of tags mapping to multiple genomic sites and
likely the source of the lower correlation. After reanalysis correlation ranges from 0.79/0.80
in human and chimpanzee to almost 0.87 in rhesus macaque. From sequencing and library
preparation replicates in our data set (not shown), a Spearman correlation of 0.86 was
observed when a library from a second tissue sample of the same individual was prepared
and sequenced. A Spearman correlation of 0.89 and 0.96 was observed when sequencing
the same two sequencing libraries on a different sequencing instrument version. Hence, the
correlation for the rhesus samples is in the range of technical variation observed in our data.
The difference in correlation between human/chimpanzee and rhesus, is likely to originate
from differences in sampling individuals and tissues.
Since the third data set from Khaitovich et al. also includes brain samples for human and
chimpanzee, one can calculate all pair-wise Spearman correlations for human and chimpanzee
mean gene expression between the three data sets. Table 5.10 on the following page gives
the results. The reanalysis does not improve correlation with the Khaitovich et al. array
data set, which are mostly lower as correlations between the data sets generated using the
same technology.
114
CHAPTER 5. QUANTIFICATION OF GENE EXPRESSION FROM SHORT-SEQUENCE TAGS
0.630.59 0.71
0.80 0.87
chimp rhesus
0.79
human
O
u r
 D
G
E
 s
t u
d y
Brain cortex (Babbitt et. al. GBE 2010): raw counts + DESeq
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Figure 5.12: Scatter plots and Spearman correlations of brain cortex expression values from Babbitt
et al. (raw counts presented in the paper (upper panel) and counts after reanalysis from raw reads
(lower panel)) with the brain samples from the five tissues DGE study. Without reanalysis a larger
proportion of genes with higher counts in our data is observed, this is probably due to the different
treatment of tags mapping to multiple genomic sites.
Table 5.10: Pair-wise Spearman correlation of three data sets, the brain samples from the five tis-
sues DGE study, the Babbitt et al. DGE brain samples and the brain samples from the reanalyzed
Khaitovich et al. array data set. For Babbitt et al. brain samples results starting from paper raw
counts and after reanalysis from raw reads are presented.
Human Chimpanzee
Paper Reanalysis Khaitovich Paper Reanalysis Khaitovich
this study 0.59 0.79 0.49 0.63 0.79 0.47
Khaitovich 0.60 0.57 - 0.49 0.49 -
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Using Principal Component Analysis (PCA) one can analyze whether the brain samples
collected by Babbitt et al. cluster with the brain samples in the five tissues DGE data set.
Figure 5.13 shows the first five principal components when using the raw counts provided
with the paper, figure 5.14 on the following page provides the equivalent plots when using
the reanalyzed samples.
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Figure 5.13: Principal Component analysis of the five tissues DGE data set when including the Babbitt
et al. data starting from the raw gene counts presented in the paper. Raw gene expression counts have
been normalized together with the five tissues data and variance stabilized gene expression values,
obtained from DESeq, used as input for PCA. Sample labels are only plotted for brain samples, colors
indicate tissue and symbols species (humans – dots, chimps – triangles, rhesus – crossed squares).
The first two principle components clearly separate tissues, with the second component separating
brain and testis from all the other tissues. The third principle component separates the Babbitt et al.
samples from all other brain samples and only the fourth component separates human/chimpanzee
individuals from rhesus macaque individuals.
When the raw gene expression counts available from the Babbitt et al. publication are nor-
malized and variance stabilized with the five tissues DGE data set prior to PCA, the third
principle component separates the Babbitt et al. samples from all other brain samples and
only the fourth component separates human/chimpanzee individuals from rhesus macaque
individuals. When combining the reanalyzed data with the five tissues DGE data, the third
principle component separates human/chimpanzee individuals from rhesus macaque individ-
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Figure 5.14: Principal Component analysis of the five tissues DGE data set when including the
completely reanalyzed Babbitt et al. data. Variance stabilized gene expression values, obtained
from DESeq, are used as input for PCA. Sample labels are only plotted for brain samples, colors
indicate tissue and symbols the species (humans – dots, chimps – triangles, rhesus – crossed squares).
To ease identification, labels of the Babbitt et al. samples were colored in purple. The first two
principle components clearly separate tissues, with the second component separating testis from all
the other tissues. The third principle component separates human/chimpanzee individuals from
rhesus macaque individuals. The Babbitt et al. samples are separated from the five tissues DGE
samples in the fourth and fifth component.
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uals and only the fourth and fifth component separate the Babbitt et al. samples from the
five tissues DGE samples. The difference of rhesus macaque samples from human and chim-
panzee samples is supposed to be the strongest biological signal after the tissue differences.
This emphasizes how strongly data analysis impacts the results. Figure 5.15 shows the result
of the Principal component analysis when only brain samples are considered.
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Figure 5.15: PCA of five tissues DGE and Babbitt et al. brain data using gene raw counts presented in
the paper (left) or counts after reanalysis from raw reads (right) as input for normalization/variance
stabilization. Labels are provided for all samples. Symbols represent species with dots for humans,
triangles for chimpanzees and crossed squares for rhesus macaques. Without reanalysis samples
from the two studies can be clearly separated using principal component one, after reanalysis the
separation of data sets is not as complete, but still contributing more variance in the data set than
human/chimpanzee differences in brain.
Reducing PCA to only the brain samples shows that even after reanalyzing the data from
raw reads, the two sources of the data can be clearly identified for human and chimpanzee
samples. While two of the three rhesus macaque samples can also be separated after reanal-
ysis, one of the samples can not be separated using the first two principle components. Since
we can rule out processing differences, the remaining signal of sample source must originate
from sampling individuals and tissue as well as subtle differences in experimental processing.
Even though self-evident from the PCA, it is worth noting that the variation introduced
from the two data sets after reanalysis is still considerably larger than the variation from
human-chimpanzee differences in brain.
5.7.2 Comparison of liver samples with Blekhman et al.
Blekhman et al. published the first comparative primate RNAseq data set with non-pooled
individuals in Genome Research 2009 [23]. They generated a liver data set of three male
and three female human, chimpanzee and rhesus macaque individuals which uses the non-
stranded Illumina RNAseq protocol. RNAseq can be described as the equivalent of a genome
shot-gun sequencing approach for the transcriptome. As RNA fragments from the full length
transcript are sequenced, this approach is affected less by sample and library preparation
(e.g. molecule GC biases from PCR amplification and gel excision, see section 3.10 on page 60
of chapter 3 as well as [32, 140]) and analysis biases from ambiguous alignments in specific
parts of the transcript, as the quantification can use the full length of the transcript and
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correct for regions of increased or reduced read coverage. Recent versions of the RNAseq
quantification tool cufflinks11 [229] implement such correction procedures.
Restricting this data set to the male individuals, the data set comprises of 18 Illumina
Genome Analyzer II lanes, two for each individual with on average 6.7 million 36nt reads
per lane (minimum 4.4 million, maximum 8.0 million). Considering the number of reads and
the short length, this data set was probably generated in summer/autumn 2008 shortly after
the release of the Genome Analyzer II update and is therefore of limited sequencing data
quality. As for the Babbitt et al. dataset the authors have provided a table with counts per
gene, but for this study raw reads were also deposited in the Short Read Archive of NCBI.
I have analyzed data starting from both sources.
For the raw gene counts provided, numbers from the two different lanes per individual were
summed, genes with zero counts in one of the individuals were excluded and counts used with
the DESeq package for obtaining variance stabilized data as well as differentially expressed
genes. For the reanalysis of raw reads, reads were mapped with tophat 1.0.13 [228] to
the three reference genomes. Genes were quantified using cufflinks 0.9.1 [229], providing
the projected annotation (as described in section 5.4 on page 98) for exons of the longest
transcript of each gene. Successful projection (same chromosome, strand and maximum
intron size of 300kb) of 75% of exons across the three species was required for a gene to
be included in the annotation. Cufflinks gene quantification was converted to count data
(keeping one decimal of the Fragments Per Kilo base of exon and Million mapped reads
(FPKM) precision), genes with zero counts in one of the individuals were excluded and the
remaining counts used with DESeq for obtaining variance stabilized data as well as differ-
entially expressed genes. Table 5.11 provides number of genes and number of differentially
expressed genes (including the assignment to lineages) for both analyses and compares them
to the results for the liver samples from the five tissues DGE data set.
Table 5.11: Comparison of the two liver data sets, the data set comprised of three male individuals
per species published by Blekhman et al. and the liver subset of the five tissues DGE study. From the
processing presented by Blekhman et al., raw gene counts for the same individual were summed and
used with the DESeq package as described before. In addition, raw reads of this study were reanalyzed
with tophat and cufflinks, gene quantification converted to count data and again used with DESeq.
Differentially expressed genes were assigned to lineages as outlined in figure 5.11 on page 111.
Genes HC %Diff HR CR hsa sp ptr sp shared H/sh C/sh
Reanalysis 12,163 934 7.7% 1,625 1,527 231 249 753 30.7% 33.1%
Paper 8,283 522 6.3% 1,094 834 142 139 426 33.3% 32.6%
This study 8,285 742 9.0% 2616 2,380 299 214 1397 21.4% 15.3%
Reanalysis identified more genes and slightly increased the number of differentially expressed
genes. Otherwise results of the reanalysis are very similar to the results from using the
counts provided with the publication. In comparison with the DGE expression data, fewer
differentially expressed genes are observed and the lineage to rhesus macaque is shortened
in the RNAseq data. Figure 5.16 on the next page provides scatter plots and Spearman
correlations for both analyses.
Spearman correlation increased by more than 0.1 with the reanalysis of the Blekhman et al.
samples using tophat and cufflinks. This points to some problems in the original analysis
of the data set. Since the third data set from Khaitovich et al. also includes liver samples, one
can again calculate pair-wise correlations for human and chimpanzee mean gene expression
11http://cuﬄinks.cbcb.umd.edu/
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Figure 5.16: Scatter plots and Spearman correlation of DGE and Blekhman et al. data using gene
quantifications presented in the paper (upper panel) or quantification results after reanalysis from
raw reads (lower panel).
in the three data sets. Table 5.12 has the results. The reanalysis increased correlation with
the array and the DGE data set, supporting a problem in the original analysis presented by
Blekhman et al. [23]. The correlation with the reanalyzed array data set is always higher than
for the DGE data set. Taking into account that RNAseq sequencing could be considered
the current gold standard in gene expression quantification, the quality of quantifications
obtained from DGE could be questioned. However, since different individuals are studied,
an effect from sample selection can not be excluded.
Table 5.12: Spearman correlation of three different liver data sets, the RNAseq data set from
Blekhman et al. (analyzed from provided gene counts and reanalyzed from raw reads), the liver
samples from the reanalyzed Khaitovich et al. array data set and the liver samples from the DGE
five tissues study.
human chimpanzee
Paper Reanalysis Khaitovich Paper Reanalysis Khaitovich
this study 0.47 0.61 0.45 0.41 0.54 0.41
Khaitovich 0.56 0.70 - 0.57 0.71 -
5.7.3 Comparison of all five tissues with Khaitovich et al.
Khaitovich et al. [111] used Affymetrix HG-U133+ 2.0 arrays to measure gene expression
in the same five tissues for six humans (30 different human individuals across tissues) and
five chimpanzees (12 different individuals across tissues). Gene expression arrays are a well-
established technology (first used in 1995 [205]) and are therefore considered to be reasonably
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well understood in their GC hybridization and labeling biases as well as non-specific cross-
hybridization to the probes [246]. However, as already mentioned in the introduction of
this chapter, hybridization-based technologies are sensitive to polymorphisms in the probed
transcript region [15] – a problem that is amplified in comparative studies in which expres-
sion patterns of species with much higher levels of sequence differences are inferred and
compared on the same array. In such inter-species setups, probes differing in sequence and
frequency in the genomes between species have to be excluded from analysis [45]. This ex-
clusion is typically done by comparing the designed probes to the reference sequences in each
species, assuming no within-species variation as well as complete and error-free genomes. In
combination with serious array design issues due to incomplete and incorrect transcripts in
databases at the time of design [11], arrays are now considered less suitable for inter-species
comparisons, especially since the advent of the new high-throughput sequencing approaches.
The Affymetrix HG-U133+ 2.0 array was designed in 2003. When using recent genome and
annotation builds more than 40% of the >54,000 probe sets can no longer be annotated
to genes, while 6% of the remaining 25-mer probe sets also measure more than one tran-
script [11]. When this data set was analyzed for its publication in 2005, probes were aligned
to the human genome NCBI build 3512 and the first chimpanzee genome build, removing
about 32% of probes (kept 412,301 out of 604,258) from the probe sets that did not match
human or chimpanzee equally good [111]. Between arrays intensities have been normalized
to an equal average intensity measured on the filtered probes. Probe sets were quantified
using the affy bioconductor package and quantile normalization [24]. Gene annotation
was kept as assigned by Affymetrix.
Reanalyzing the orginal data set, I kept 310,073 of the 604,258 probes from all probe sets
after mapping them with bowtie [126] to human genome GRCh13 build 37 (UCSC hg19,
without additional haplotypes) and chimpanzee genome CGSC14 build 2.1 (UCSC pantro2),
where the remaining probes can be aligned without any mismatches and exactly once in both
genomes. The so-identified probes were used with the R probe masking package mask [45] and
the bioconductor EMA package [207]. Probe sets were normalized and quantified tissue-wise
using the GC-RMA [246] background adjustment procedure. After normalization the default
expression cutoff was applied, not removing any of the quantified probe sets. For genes
quantified by multiple probe sets, the median value was considered for the gene. Genes were
tested for differential expression between human and chimpanzee using Welch t-statistics
allowing possibly unequal variances as well as Student’s t-test assuming equal variances in
the two species. Benjamini Hochberg [14] FDR adjusted p-values were used to correct for
multiple testing. Table 5.13 on the next page compares the original analysis results with the
results obtained from the reanalysis using current genome builds and annotation information
for the Affymetrix HG-U133+ 2.0 array.
Comparing the old and the new analysis, ordering of tissues by the percentage of differentially
expressed genes is slightly altered: in the new analysis brain ends up with more changes than
kidney. The order in expression divergences, calculated as the average euclidean expression
distance [111], is almost identical with exception that liver and heart come out with equal
values in the reanalysis but have different values in the original analysis (with non-overlapping
confidence levels, see Supporting Online Material Table S2 of Khaitovich et al. [111]). From
the reanalysis, I could not determine differences in transcription complexity, the previously
reported numbers of expressed genes are however in agreement with the five tissues DGE
expression data set. The fraction of differentially expressed genes (table 5.6 on page 110) as
12this array was designed from experimentally identified transcripts and human NCBI genome build 30
13Genome Reference Consortium for human
14Chimpanzee Sequencing and Analysis Consortium
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Table 5.13: Comparisons of published results with reanalysis results for the Khaitovich et al.
Affymetrix HG-U133+ 2.0 array data set. The original probe intensity files were masked using
current genome builds and updated annotation information for the Affymetrix HG-U133+ 2.0 ar-
ray was applied. Further, an improved background normalization method (GC-RMA [246]) was used.
Genes were tested for differential expression between human and chimpanzee using Welch t-statistics
(columns Diff.exp (W) and %Diff.exp (W)) for possibly unequal variances as well as the Student’s
t-test assuming equal variances in the two species (columns Diff.exp and %Diff.exp). Benjamini
Hochberg [14] (BH) FDR adjusted p-values were calculated to correct for multiple testing and an
adjusted p-value cutoff of 0.01 applied. Expression divergence is calculated as average euclidean
expression distance [111].
Khaitovich et al. 2005, Supporting Online Material Table S2 [111]
Tissue Genes Diff.exp %Diff.exp Divergence
brain 16775 1306 7.8% 0.245
heart 14988 1436 9.6% 0.450
kidney 17865 1605 9.0% 0.405
liver 15046 1060 7.0% 0.586
testis 21731 7036 32.4% 0.538
Reanalysis (masking, GC-RMA, t-test BH FDR 0.01)
Tissue Genes Diff.exp (W) Diff.exp %Diff.exp (W) %Diff.exp Divergence
brain 14138 255 457 1.80% 3.2% 0.085
heart 14138 379 701 2.68% 5.0% 0.162
kidney 14138 218 428 1.54% 3.0% 0.116
liver 14138 67 219 0.47% 1.5% 0.162
testis 14138 3665 4648 25.92% 32.9% 0.186
well as the divergence estimates (table 5.8 on page 112) are not in agreement with the DGE
data set.
While both data sets see most differential expression in testis (with about 30% of expressed
genes between human and chimpanzee), the DGE data set orders the tissues from highest
fraction of differentially expressed genes to lowest as: testis, kidney, brain, liver, heart while
the original array study orders tissues as testis, heart, kidney, brain, liver (placing heart
differently). Since the reanalysis also reorders kidney and brain15 and since the fraction of
differentially expressed genes are very low after FDR correction (except for testis), it might
be argued that the array data set does not have enough power to detect differential expression
in tissues other than testis.
To compare more general patterns between the two data sets, figure 5.17 on the following
page compares gene quantification results from the reanalysis of the array data set with the
quantification in the DGE data set. Spearman rank correlation varies for the five tissues
between 0.47 in heart to 0.51 in testis. In three tissues, namely brain, liver and testis, it
seems that lowly expressed genes do not follow a linear relation between the two data sets.
For those genes, the DGE data set spans a wider value range than the array data. Taking
into account that this effect is not observed in figure 5.16 on page 120 where the DGE data
is compared to RNAseq data in liver, the source of this effect is likely to be found in the
array data set. It is possible that it for example originates from cross-hybridization signal
overlaying the actual signal of lowly expressed genes.
15This reordering is also seen in a reanalysis of the Khaitovich et al. data set by Nowick et al. [161].
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Figure 5.17: Scatter plots and correlations of the human DGE data with Khaitovich et al. array
data reanalyzed from probe intensities. Spearman rank correlation vary between 0.47 and 0.51 for
the different tissues. In brain, liver and testis, lowly expressed genes do not seem to follow a linear
relation in the two data sets. For those genes, the DGE data set spans a wider expression value range
than the array data. This effect is not observed in figure 5.16 on page 120 where the DGE data is
compared to RNAseq data in liver, thus the source of this effect is likely to be found in the array
data set.
5.8 Summary and conclusions
The technological advances in sequencing make it attractive to use a sequencing-based ap-
proach for identifying and quantifying the transcriptome of a cell rather than using arrays
which are limited to the analysis of specific transcripts known at the time of design. Further,
since hybridization-based technologies are rather sensitive to polymorphisms in the probed
region of transcripts, inter-species studies were always challenging with arrays as special
analysis procedures have to be implemented to prevent species biases, e.g. masking probes
with differences in the species under consideration. Even though the described Illumina
Digital Gene Expression protocol overcomes limitations of a static design as well as the hy-
bridization and GC biases observed for array technologies, specific features of this type of
data also complicate analysis.
I could show that incomplete digestion and enzyme hindrance cause dispersion of sequenced
tags across multiple restriction sites and that non-specific carry-over of upstream NlaIII
digestion fragments between experimental steps causes a false signal of antisense transcription
and may also cause additional non-3’-most tag counts on the sense strand. Further, even
though there was no evidence from the analysis of this data set, it is likely that the DGE
protocol has amplification and gel excision biases dependent on the GC content of the short
tags (see section 3.10 on page 60 in chapter 3 as well as two recent studies on the Illumina
smallRNA protocol by Linsen et al. [140] and Caiment et al. [32], a protocol which handles
molecules of comparable length).
What was considered a disadvantage of arrays – their static features with an associated
annotation – turned out to remain a challenge in the DGE protocol. While array probes are
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by-design annotated with some gene (even though sometimes incorrectly), SAGE tags need to
be mapped and annotated across multiple species. This annotation is problematic due to very
different annotation quality for the different species and annotation being inferred for some
species from the annotation of a close reference species (like human), thereby not overcoming
the species-annotation bias seen with arrays. Even human annotations as available in summer
2008 were not appropriate for analysis, since many genes missed the annotation of 3’ UTR
sequences. Recent human gene annotation is considerably more complete and could be
projected to the chimpanzee and rhesus, losing about 36% of genes annotated in human but
giving similar proportions of tag counts within genes for all three species.
The biggest challenge, however, is that the short tag lengths means many tags are not
unique to specific genomic sites or genes. In addition, the uniqueness of tags differs slightly
between the three species. This causes the tags of two and more different genes to be
collapsed into one measurement. As this 3’ tag protocol generates mostly one tag site per
transcript, the original gene expressions values cannot be reconstructed from neighboring
counts. Hence, approaches of counting tags multiple times or removing ambiguous tags
both result in incorrect gene quantifications, i.e. a false ranking of gene expression values.
Considering the Spearman rank correlations between the two types of processing are very
high (0.88-0.93), overall effects may be stable to the problem of ambiguous tags. Further, the
impact on the inter-species analysis is expected to be low, as this ranking bias will be largely
the same in all three species. Variation between species is to be expected from evolution and
loss of NlaIII sites in each genome, which are expected at rates close to species sequence
divergence (1.23% human-chimpanzee nucleotide divergence [35] and 6.46% human-rhesus
macaque nucleotide divergence [75]).
From comparison to other studies of the same species and tissues, larger disagreement is
observed than was expected. It is likely that all methods have technological (experimental
and analysis) biases and that the obtained variance estimates are too low. Sampling the
individuals representing each species (e.g. age, environmental and population differences),
tissue sampling including for example sampling time after death, storage and tissue regions
selection as well as experimental protocols varying between different studies might have a
larger effect than previously expected. The comparison of the Babbitt et al. [10] study
with our results clearly shows that sampling variation is in the same range as biological
differences between human and chimpanzee and that analysis variation may even be as strong
as differences between human/chimpanzee and rhesus macaque. Reanalyzing the Blekhman
et al. [23] also showed issues with the analysis presented in the original publication, since
reanalysis increased Spearman correlation with the DGE five tissues data and the earlier five
tissues array study published by Khaitovich et al. [111] by at least 0.13.
Analyzing agreement between technologies showed disagreement in different measures like
the symmetry of assignment of changes to lineages or the percentage differentially expressed
genes. The extend of disagreement can not easily be explained from false discovery rates of
statistical tests. This can have at least two sources: limits of a multiple testing correction
based on false discovery rate and underestimates of experimental and biological variance.
False discovery rates only measure type I errors, i.e. only false positive results and not false
negative results, thus differences could be due to false negatives. Low variance estimates
might be a problem of the statistics/algorithms used, but could also result from different
sampling of individuals or variation in experimental protocols between experimenters and
labs.
Comparing the two five tissue studies, the strongest and most consistent pattern in the data
sets are the approximately 30% differentially expressed genes between human and chimpanzee
testis. One biological reason for this difference could be the more promiscuous mating behav-
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ior of chimpanzees, which is associated with a high level of sperm competition, which again
might spur an increased sperm production [6, 158, 156]. While the cellular composition of
human testis tubules (the places of meiosis and creation of gametes) seems similar to that of
other primates, the number of interstitial cells may vary between human and chimpanzee.
The study by Mulugeta Achame et al. [156] suggests that per unit of tissue the human testis
may contain around 20% less germ cells than the chimpanzee testis. If this is correct, the dif-
ferential expression observed may be driven by changes in tissue composition between these
species. That expression differences originates from variation in cell-type composition [78]
is an interesting finding in itself and may also be of relevance for other tissues. However,
this does not provide the hoped-for insight into how DNA sequence evolution impacts gene
expression. Further, differences in tissue composition could be studied directly using other
approaches like cell staining and counting. To which extend cell-type differences and differ-
ences in tissue cell-type composition contribute to the phenotypic and functional differences
between species can be addressed by future studies using tissue micro-dissections.
For future studies it will be of interest to minimize all mentioned sources of variation. The
presented result of human-chimpanzee expression differences being smaller than the varia-
tion from sampling and experimental protocols for at least one tissue, challenges current
findings from such inter-species studies. Therefore, experimental and biological variation
need to be considerably reduced in future studies. To achieve this it will be of interest to
stringently control sample environmental effects and age, increase the number of samples,
study specific cell-types rather than tissues and to use improved experimental and analy-
sis protocols. The presented analyses have shown that inter-species studies are also very
sensitive to small differences in data processing. Such differences may easily originate from
different genome quality, genome completeness and genome annotation quality. Measures
have to be established to check for such effects in the analysis.
125
Chapter 6
Analysis of two hominin genomes
from ancient DNA
Humanity takes itself too seriously. It is the world’s original sin. If the cavemen had known
how to laugh, History would have been different. – Oscar Wilde [96](44)
Ancient DNA sequences are generally short in length, damaged [28, 93], and at low copy-
number relative to co-extracted environmental DNA. The high-throughput approaches dis-
cussed in chapter 2 therefore offer a tremendous advantage over traditional sequencing ap-
proaches in that they enable a complete characterization of an ancient DNA extract.
Shotgun sequencing of ancient DNA extracts [154, 81, 186, 185] and sequencing of ancient
DNA libraries that have been enriched for specific loci [120, 119, 121, 26, 30], provide a new
window into preserved genetic material. For example, the first high coverage mitochondrial
genomes [173, 83] made it possible to characterize DNA preservation, contamination and
damage [28, 27, 93] to an extent that had not been achieved previously. As the cost of
sequencing continues to decrease, it has become feasible to analyze entire genomes of ancient
samples [154, 81, 186, 185], including those for which the endogenous DNA makes up only a
very small percentage of the total extracted DNA, e.g. the Neandertal genome [81].
However, the qualities specific to ancient DNA present limitations that require careful con-
sideration in data analysis. For example, sequence data of ancient DNA libraries may include
chimeric sequences, larger proportions of library adapter sequence at the read ends, sequenc-
ing error and artifacts, damage, and alignment ambiguities due to the short read lengths.
Partially, these topics have already been discussed in chapter 3. For ancient DNA, the short
molecule length, DNA damage patterns [27, 28], the low fraction of endogenous DNA as
well as the divergence to the closest modern reference sequence are the dominant sources of
analysis problems [181].
I will discuss specific problems as well as selected results from the analysis of whole genome
shotgun sequencing data of two ancient hominin genomes, the Neandertal [81] and Denisova
genomes [186].
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6.1 Neandertals and Denisovans
Neandertals are the closest evolutionary relatives of present-day humans. They lived in
large parts of Europe and western Asia before they disappeared around 30,000 years ago.
Morphological features typical of Neandertals are described for European fossils dated as old
as 400,000 years. Subsequently, the fossil record also contains more distinctive Neandertal
forms until Neandertals completely disappear. During their later history, Neandertals could
have had contact with anatomically modern humans in the Middle East from at least 80,000
years ago and subsequently in Europe and Asia. [81]
For eastern Asia there is no consensus on which groups were present some 20,000 years ago
and before [186]. Homo floresiensis, a short-statured hominin which likely represents an
early divergence from the lineage leading to present-day humans, lived on the island Flores
in Indonesia until at least 17,000 years ago. In China, it was pointed out that morphological
affinities between Neandertals and the specimen of Maba, or between Homo heidelbergensis
and the Dali skull exist. However, these very same specimens were also classified as early
Homo sapiens by others. [186] DNA evidence indicates that hominins carrying mtDNAs typ-
ical of Neandertals were present as far east as the Altai Mountains in southern Siberia [122].
The distal manual phalanx of a juvenile hominin was excavated at Denisova Cave in the Altai
Mountains of southern Siberia in 2008 [186]. Systematic excavations at this site over the last
25 years suggest that human occupation of this cave started up to 280,000 years ago. The
phalanx was found in layer 11, which is dated to 50,000 to 30,000 years ago. In early 2010,
a DNA capture approach in combination with high-throughput sequencing was used to de-
termine the complete mitochondrial DNA (mtDNA) from this Denisova phalanx [121]. Phy-
logenetic analysis of its sequence, the sequence of multiple Neandertal mtDNA genomes, as
well as present-day human mtDNA genomes, determined that the Denisova mtDNA genome
diverged from the common lineage leading to present-day human and Neandertal mtDNAs
about one million years ago, i.e. about twice as far back in time as the deepest divergence be-
tween present-day human mtDNAs and all currently known Neandertals [121]. Since mtDNA
is inherited as a single unit and only maternally, gene flow, positive selection and chance
events of genetic drift, can have large effects on these measurements. Interpretations of this
single locus may therefore not hold for the whole nuclear genome.
Sequencing the nuclear genome of this phalanx [186], showed that Neandertals and Deniso-
vans both belong to the same, currently unnamed, sister group to all present-day humans
(figure 6.1A). Comparisons of the genomes of Neandertals, Denisovans and apes to the hu-
man genome therefore allow the identification of genomic features specific to fully anatom-
ically modern humans. These ancient genome sequences can provide a catalog of genomic
changes which became fixed, or rose to high frequency in present-day humans after their
separation from these other hominin forms. Identified changes might also point to regions
that were positively selected since modern humans diverged from their last common ancestor
with Neandertals and Denisovans.
Studying the origin of anatomically modern humans, their relationship with other human
forms is a debated question [236, 186]. One model, the replacement model, postulates that
modern humans evolved in a single location in Africa and, from there, spread and replaced all
other existing hominins. The competing model, the multiregional model, claims that modern
humans evolved at different places and from various archaic human groups. In addition, there
is a range of intermediate models that predict an African origin of modern humans but with
some contribution from other hominin groups. A primary question is therefore whether
there was any admixture between anatomically modern humans and archaic hominins, and
to what extent.
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Figure 6.1: (A) Neighbor joining tree based on pairwise autosomal DNA sequence divergences for
five ancient and five present-day hominins. The tree clearly shows that two human populations (e.g.
San and French) are about as closely related as Neandertals and the Denisova individual, suggesting
Neandertals and Denisovans are populations of one extinct Homo subspecies, rather than two separate
subspecies. This, further to be defined Homo subspecies, is a sister clade to all present-day humans.
(B) Variation in genetic divergence over 100kb windows for Denisova, Vindija, and a diverse set of
present-day humans as a fraction of human-chimpanzee divergence. A challenge in detecting signals
of gene flow between Neandertals/Denisovans and present-day human ancestors is that they share
common ancestors within the last 500,000 years, which is no deeper than the nuclear DNA sequence
variation within present-day humans. Figure adapted from Figure 1 and Supplemental Figure 2.4 in
Reich et al. [186].
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The mtDNA genome is the only part of the genome which was examined earlier from multiple
Neandertals and the first Denisova individual. The mtDNA of the sampled Neandertal and
Denisova individuals falls outside of the variation found in present-day humans and therefore
provides no evidence for admixture [81, 121]. This observation does however not rule out that
Neandertals or Denisovans contributed other parts of their genomes to present-day humans
by admixture. The nuclear genome is composed of several ten thousands recombining and
independently evolving DNA segments, which allow for a higher resolution in testing the
genetic relationship between these ancient hominin forms and present-day humans.
Detecting such signals of gene flow between Neandertals/Denisovans and present-day human
ancestors is, however, complicated by the fact that the two groups share common ancestors
within the last 500,000 years [186]. This divergence is not deeper than the nuclear DNA
sequence variation found within present-day humans (figure 6.1B). Thus, even if no gene flow
occurred, these ancient hominins are expected to be more closely related to some present-
day humans than they are to each other in a number of genomic segments [165]. However,
if Neandertals and Denisovans are across multiple genomic regions more closely related to
humans living in some region of the world than compared to others, this indicates that
the ancestors of these present-day humans exchanged parts of their genome with archaic
hominins [81, 186].
6.2 Illumina Sequencing and primary data processing
Even though the Neandertal Genome project started in 2005 on the 454 sequencing plat-
form [82], in 2008 the project changed over to the Illumina sequencing platform in order
to take advantage of the higher throughput in the number of sequences obtained from this
platform. While a single 454 sequencing run yields about one million molecules, the Illumina
Genome Analyzer II instrument as it became available in summer 2008 already allowed the
parallel sequencing of about 100 million sequences. Due to the short molecule length of
ancient DNA, most of the DNA molecules in the Neandertal libraries were accessible with
the shorter reads of this technology due to possibility of sequencing molecules from both
ends. Thus, DNA sequencing of the final data sets used in the Neandertal and Denisova
projects was performed only on the Illumina Genome Analyzer platform [81, 186]. In the
following subsections, I will describe how sequencing data was generated for the two projects
and sequence alignments to the human [235, 125] and chimpanzee reference genomes [35]
obtained.
6.2.1 Neandertal sequence data
To find extracts suitable for sequencing larger parts of the Neandertal genome, 89 different
Neandertal bones from 19 sites were analyzed and in total 201 DNA extracts were made
from between 5 and 560mg of bone. Extracts were converted to 454 sequencing libraries
with a project-specific key (tag) in the beginning of the 454 sequencing read (default ’TCAG’
changed to ’TGAC’). This project-specific key was introduced to discriminate ancient DNA
libraries prepared in a clean room from contamination with other 454 sequencing libraries
(see chapter 3 section 3.4 on page 51). In initial screening, the proportion of human con-
tamination in each extract was tested using a PCR-based approach, later also a targeted
direct sequencing approach using Primer Extension Capture ([26], PEC) was used [119]. As
an additional estimate of the proportion of human contamination and for estimating the
percentage of endogenous Neandertal DNA for each Neandertal extract direct sequencing of
amplified 454 libraries on a single 16th lane of the Roche 454 FLX platform was performed.
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Extracts that were estimated to contain more than 1.5% endogenous Neandertal DNA with
less than 5% human contamination in this endogenous fraction were considered for high-
throughput shotgun sequencing. To increase the fraction of endogenous Neandertal DNA
in these sequencing libraries, restriction enzymes were used to deplete libraries of microbial
DNA. A 454 adapter-ligated library molecule cannot be amplified or sequenced if it is cut
by a restriction enzyme because the two product molecules will carry only a single 454
adapter each. Two different restriction mixes were used for enrichment. All restriction
enzymes used had at least one CG dinucleotide in their recognition sequence – exploiting the
underrepresentation of CG dinucleotides due to cytosine methylation in mammalian genomes
compared to the environmental background [81].
To sequence the 454 Neandertal sequencing libraries on the Illumina GAII platform, they
were converted to Illumina libraries. For this purpose, a PCR primer pair was constructed
that is complementary to the 454 A and B primers on the 3’-ends and has tails carry-
ing the Illumina P5 and P7 grafting sequences [119]. In total, 33 Illumina-converted 454-
sequencing-libraries carrying the project-specific adapters as well as a converted φX control
library carrying the 454 standard adapters were sequenced. Instead of the standard Paired
End sequencing primers, project-specific primers were used for the forward and the reverse
sequencing read, which anneal to the 454 adapter sequences and allow for sequencing the
project-specific key at the beginning of each read. For the φX control library sequenced in
one dedicated lane per run, a sequencing primer covering the 454 standard key was used for
the forward read (allowing for Bustard base calling parameter estimates, chapter 4 section 4.3
on page 66).
In total 33 flow cells were sequenced, 24 with 2×51 cycles (FC-204-20xx sequencing chemistry,
v2) and nine with 2×76 cycles (FC-103-300x sequencing chemistry, v3). Sequencing was
performed at the MPI in Leipzig as well as at Broad institute of Harvard University and
Massachusetts Institute of Technology (MIT) (2×76 cycle runs) in Boston from September
2008 through March 2009.
I analyzed these sequencing runs from raw images using the Illumina Genome Analyzer
Pipeline 1.0 and 1.3.2. To overcome analytical challenges introduced by identical key
sequences at the beginning of the first read (see chapter 3 section 3.6 on page 54), I used
the first five (instead of two) sequencing cycles for cluster identification with the Genome
Analyzer Pipeline 1.3.2. For runs analyzed with the earlier Genome Analyzer Pipe-
line 1.0, I modified the Firecrest algorithm [16] to perform cluster identification in cycle
4 and then extract intensities from the clusters identified starting with cycle 1.
After standard base calling using Bustard with parameter estimation done on the φX con-
trol sequenced in lane 4 of each flow cell, I aligned the φX174 reads to the corresponding
reference sequence for creating a training data set for Ibis (chapter 4). Ibis removed the T
accumulation effect observed for v2 and v3 sequencing chemistry (section 4.3 on page 66 and
following), generated calibrated quality scores and reduced the overall error rate. I filtered
all raw sequences from the new base calling for the three bases of the project-specific key
(’GAC’) and used the algorithm outlined in section 3.2 on page 44 for read merging. Only
successfully merged sequences were considered in downstream analysis. By using project-
specific libraries and a project-specific key, library contamination (section 3.4 on page 51)
is excluded by incompatible sequencing priming sites as well as filtering for the project key
in the sequence reads. The latter filter also efficiently reduces the library and sequencing
artifacts discussed in section 3.1 on page 40 and section 3.7 on page 55. Merging removes
adapter sequence starting at the read ends and further reduces sequencing error.
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6.2.2 Denisova sequence data
The Denisova sequencing data presented in Reich et al. [186] originates from two libraries
(SL3003 and SL3004) sequenced using 2×101 + 7 cycles on two flow cells1 sequenced in
January 2010. For generating these libraries a total of 40mg of bone was removed from
beneath the surface of the Denisova phalanx, DNA was extracted as described by Rohland
et al. [195] and treated with the enzymes Uracil-DNA Glycosylase (UDG) and Escherichia
coli endonuclease VIII (EndoVIII ). The UDG/EndoVIII treatment leads only to a moderate
reduction in the average lengths of the molecules in the library but a several-fold reduction in
nucleotide misincorporation, i.e. ancient DNA damage, due to the removal of uracil residues
from the library [27]. From the extracts, two independent libraries were created with a
modified Illumina multiplex protocol ([150], section 3.3 on page 49). A 7nt-index (’GTCGACT’)
not available outside of the clean room, as well as outer adapter sequences required for
sequencing were then added by a PCR reaction.
Libraries were sequenced according to the manufacturer’s instructions for multiplex exper-
iments on the Genome Analyzer IIx platform (FC-104-400x v4 sequencing chemistry and
PE-203-4001 cluster generation kit v4). The standard protocol was followed except that an
indexed control φX174 library (index ’TTGCCGC’) was spiked into each lane (see section 3.9
on page 59), yielding 2-3% control reads in each lane.
I analyzed the Denisova sequencing data starting from QSeq sequence files and CIF intensity
files generated by the Illumina Genome Analyzer RTA 1.6 software. The Ibis base caller
(chapter 4 on page 64) was trained from the φX174 control reads and then used to call bases
and quality scores. Raw sequences called by Ibis 1.1.1 for the two paired end reads were
subjected to an index read filtering step where the index read was required to match the
index with at most one error [150]. The two reads in each cluster were then merged, including
removal of adapter sequences and dimers as well as requiring more than 10nt overlap between
the two reads (section 3.2 on page 44). Only successfully merged sequences were considered
in downstream analysis.
6.2.3 Identification of endogenous molecules
One of the largest challenges for ancient DNA studies is to distinguish endogenous DNA
sequences from those of environmental contaminants. Here, it is useful to know whether the
potentially contaminating sequences have features distinct from the endogenous DNA. GC
content and length-based filters are typically insufficient to distinguish endogenous from ex-
ogenous, i.e. microbial, fungal and other, DNA. K-mer frequencies, in particular the presence
of longer k-mers, may be more distinctive. Most commonly used are alignment approaches,
in which the sequence reads are aligned to the closest available reference sequence, while
allowing sufficient substitutions and gaps to compensate for evolutionary divergence and
ancient DNA damage.
More generally and independent of the exact approach applied, there are two different ways in
which filters can be applied: (1) negative/subtractive filtering where reads identified by some
criterion are removed from the read set versus (2) positive filtering where only reads identified
by some criterion are kept in the read set. Negative filtering may leave many false sequences
in and remove highly conserved sequences, while positive filtering may miss insertions and
divergent regions as well as include highly similar (e.g. conserved) false sequences.
112 lanes SL3003, 4 lanes SL3004
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Alignment approaches may fail when the reference genome and the actual sample have regions
of high sequence divergence or differ in larger insertions/deletions events. Eventually these
missing alignments may also bias genome-wide estimates like species divergence [181]. For
cases of higher divergence sequences or differences in large insertions/deletions events, overlap
extension from the alignments is required for identification of endogenous molecules. Such an
overlap extension step (e.g. [167]) tries to extend the aligned reads in incompletely covered
regions using non-aligned reads. Ideally, alignment and extension steps must be performed
in an iterative manner, however, there is no guarantee that such a process converges to the
correct sequence.
The same applies to k-mer filters when used instead of alignment approaches. Additional
k-mers identified in all reads passing an initial k-mer filter must be used for an iterative
identification step to reduce problems with regions of high sequence divergence. Alterna-
tively, de Bruijn graph approaches (e.g. [250, 21, 33, 102]) can be used to first build contigs
from overlapping k-mers. These contigs can then be filtered for specific characteristics of
endogenous DNA. Alignments may outperform k-mer/de Bruijn graph approaches in cases
where samples are experimentally enriched for their similarity to specific sequences, as the
enrichment approaches will also enrich for the same k-mers in the environmental/background
DNA molecules.
For the Denisova and Neandertal projects [81, 186], a positive filtering by alignment to the
human and chimpanzee reference genomes was performed. Due to the high fragmentation
and the low coverage obtained in both projects, the direct alignment of sequences (in contrast
to a de novo assembly) is the only feasible approach for the analysis of the ancient DNA
molecules.
For Neandertal, Illumina reads were mapped to the human genome (NCBI 36/hg18) and
chimpanzee genome (CGSC 2.1/pantro2) using a custom mapper called ANFO. This custom
alignment program, written by Udo Stenzel, was developed to take the characteristics of
ancient DNA into account and is available from http://bioinf.eva.mpg.de/anfo. ANFO
builds an index of short words of the target genome, in a fashion similar to the method
described by Morgulis et al. [155]. The query sequences are broken up into their constituent
words for index lookup. Adjacent or near adjacent words are combined into longer matches,
and any match that is considered ”long enough” serves as the seed for a semi-global align-
ment. Every fourth word of length 12nt was indexed and at least 16nt long seeds required,
which gives sensitivity better than megablast [251] and a useful compromise between sen-
sitivity and required computational effort. When building alignments ANFO extends in both
directions from all seeds using a best-first search. This takes advantage of the fact that only
the two best alignments (not every alignment) of each query is needed for calculating map
quality scores (MAPQ). The search terminates when two alignments have been found, or
when all remaining alignments are guaranteed to be less good than the alignment score cut-
off. The score of an alignment is defined as its negative log-likelihood (i.e. better alignments
have lower scores). ANFO mapping quality was defined as the difference in score between the
two best alignments. Following the observation and implementation by Briggs et al.2 [28],
ANFO uses different substitution matrices for DNA thought to be double stranded versus
single stranded and switches between them if doing so affords a better alignment score.
The expected length distribution of single stranded stretches is modeled as geometrically
2The model presented by Briggs et al. describes a considerably higher cytosine deamination rate in single
stranded DNA overhangs as compared to the inner double stranded molecule parts. For single stranded
5’ overhangs of molecules the double strand is repaired by complementary strand synthesis during sequencing
library preparation. The 3’ overhangs of molecules are removed during library preparation. Thus, part of the
determined sequence may either originate from the DNA that was double or single stranded in the original
ancient molecule.
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distributed. To separate hominin sequences from random similarities, the distribution of
alignment scores depending on read length were analyzed. The scores are clearly a mixture
of two distinct distributions, with the distinction becoming much less pronounced for shorter
reads. We3 therefore required a minimum read length of 30nt and a score no worse than
7.5 ·(length−20) to distinguish spurious alignments of bacterial, fungal and non-mammalian
reads from actual hominin sequences.
A total of 2,460,140,110 raw clusters was obtained from 214 lanes with libraries from six
different Neandertal bones (El Sidron 1253, Feldhofer 1, Mezmaiskaya 1, Vindija 33.16,
Vindija 33.25 and Vindija 33.26). The three Vindija bones contributed 85% of the reads, in
about equal shares. From the 2.46 billion raw clusters, 1.35 billion (55%) merged reads were
obtained. This low fraction is not unexpected due the large fraction of low quality reads
observed for these earlier Illumina Genome Analyzer versions. After alignment and duplicate
consensus (all libraries were sequenced with some redundancy of individual molecules and
PCR duplicates identified based on their outer genomic coordinates were consensus-called
incorporating the sequence quality scores, see section 3.10 on page 60, performed by Udo
Stenzel), 86,810,371 (6.4%) unique molecules aligning to hg18 and 87,326,955 (6.5%) unique
molecules aligning to pantro2 were reported. These 87 million molecules correspond to about
4.2Gb (roughly 1.5x) of Neandertal sequence.
For Denisova, 447,964,927 index filtered merged reads (originating from 562,650,846 raw
reads, 80%) were aligned with BWA [131] to the human genome (NCBI 36/hg18) and chim-
panzee genome (CGSC 2.1/pantro2) using default parameters. ANFO alignments got consid-
erably more time-consuming, probably due to the higher length of the Denisova molecules.
Further, ancient DNA damage was greatly reduced by enzymatic treatment in these reads,
permitting the use of BWA. The BWA alignments were converted to SAM/BAM format [132] with
BWA’s samse command and subsequently analyzed for PCR duplicates. Both libraries were
sequenced with low redundancy of individual molecules and the few PCR duplicates were
consensus-called (see also section 3.10 on page 60, performed by Udo Stenzel). For the two
libraries, this resulted in a total of 111,466,516 (24.9%) unique sequences that were mapped
to the human genome, altogether resulting in 6.6Gb of sequence. After we restricted to the
82,227,320 (18.4%) sequences with a PHRED-scaled mapping quality of at least 30, this re-
sulted in a total of 5.2Gb (roughly 1.9x) of filtered sequence data. The number of sequences
unambiguously mapped to the chimpanzee genome with a mapping quality of at least 30 is
72,304,848, which is 87.9% of that for the human genome.
6.2.4 Present-day human low-coverage data
To put divergence measures of the Neandertal and Denisova genomes into perspective with
regard to present-day humans as well as to test whether Neandertals and Denisovans are
on average across many independent regions of the genome more closely related to present-
day humans in certain parts of the world, we4 sequenced individual genomes from multiple
human populations for the Neandertal and Denisova genome projects.
For the Neandertal Genome project [81], we sequenced one San from Southern Africa, one
Yoruba from West Africa, one Papua New Guinean, one Han Chinese, and one French
from Western Europe. For the Denisova Genome project [186], we sequenced another seven
present-day humans, a Mbuti genome from Africa, a Sardinian genome from Europe, a Mon-
golian genome from Central Asia, a Cambodian genome from South-East Asia, an additional
3The Neandertal Genome Analysis Consortium, specifically Udo Stenzel
4Neandertal and Denisova Genome Consortia
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Papuan genome from Melanesia, a Bougainville islander genome from Melanesia, and a Kari-
tiana genome from South America. The geographical distribution of all modern and ancient
DNA samples studied in these two projects is shown in figure 6.2.
Figure 6.2: Geographic distribution of samples studied in the Denisova [186] and Neandertal
Genome [81] projects. Individuals from different human populations were obtained from the Human
Genome Diversity Panel (HGDP) by the Centre d’Etude du Polymorphisme Humain (CEPH): HGDP-
00491 (Bougainville Melanesian), HGDP00711 (Cambodian), HGDP00521 (French), HGDP00778
(Han Chinese), HGDP00998 (Karitiana Native American), HGDP00456 (Mbuti), HGDP01224 (Mon-
golian), HDGP01029 (San), HGDP00665 (Sardinian), HGDP00542 (Papuan), HGDP00551 (Papuan)
and HGDP00927 (Yoruba). Figure kindly provided by Knut Finstermeier.
Low-coverage data of 5 humans presented in Green et al.
In Green et al. [81], we presented whole genome shot-gun data from five Human Genome
Diversity Panel (HGDP) individuals, for whom cultured lymphoblastoid cell lines are pro-
vided by the Centre d’Etude du Polymorphisme Humain (CEPH). One microgram of DNA
was obtained for each of the individuals. DNA was sheared, Multiplex Illumina sequencing
libraries constructed [150], and length excision performed (300bp using 2%-agarose gel). Il-
lumina sequencing of these five libraries was performed on the Genome Analyzer II platform
with 2×76 cycles on each one flow cell (FC-103-300x v3 sequencing chemistry) from May to
June 2009. Due to low cluster densities for the run of the French individual (HGDP00521),
another four lanes were sequenced from this library on an additional sequencing run (same
chemistry and protocols).
I analyzed the runs starting from intensity files (CIF format) using the Illumina Genome
Analyzer Pipeline 1.4.0. Base calling parameter estimation for the Illumina base caller
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Bustard was done on the φX174 control sample in sequenced in lane 4 of each run. The
φX174 reads were used to obtain a training data set for Ibis (chapter 4). Raw sequences
called from Ibis for the two paired end reads of each sequencing cluster were aligned separately
with BWA [131] to the human (NCBI 36/hg18) and chimpanzee (CGSC 2.1/pantro2) genome
with default parameters. Using BWA’s sampe command the alignments for two reads were
combined and converted to SAM/BAM format. In this step, missing paired alignments were
searched within a window of 800nt around one aligned read (BWA sampe parameter -a 800).
Subsequently, the BAM output files of all lanes from the same library were merged and the
resulting files filtered by removing read pairs for which either the forward or reverse read
failed one of the following criteria:
 Missing the “properly paired” bit in the BAM file.
 Mapping quality of at least 30.
 “Duplicated molecules”, i.e. read pairs for which another, higher or equal quality,
read pair had boundaries that map to the same outer coordinates (samtools rmdup
command, see also PCR duplicate section 3.10 on page 60).
 Sequence entropy of at least 1.0 (see also equation 3.4 of sequencing artifact section 3.7
on page 55).
We obtained 101-161 million raw sequence clusters for the different samples, of which 87.6%-
90.6% of reads could be aligned to the human reference genome and 81.6%-86.0% to the
chimpanzee genome. When applying the described filters, these numbers reduced to 73.9%-
76.2% and 65.3%-68.2%, respectively. This corresponds to on average 16Gb and 13Gb of
sequence data aligned to the human and chimpanzee reference genomes.
Low-coverage data of 7 humans presented in Reich et al.
In Reich et al. [186], we presented another seven individuals which we again selected from the
CEPH-HGDP panel. Also for these samples, Illumina multiplex sequencing libraries were
prepared from the sheared DNA (200-400bp) according to the protocol described in Meyer
and Kircher [150]. Further, for each sample (except HGDP00998 which was used without
size selection due to the low amount of DNA obtained after library preparation) a narrow
band around 300bp was excised from a 2% agarose gel after adapter ligation to obtain inserts
of optimal size for sequencing.
Each of the Illumina multiplex libraries was sequenced in one lane using 2×101 + 7 cycles
on one flow cell according to the manufacturer’s instructions for multiplex sequencing on
the Genome Analyzer IIx platform (FC-104-400x v4 sequencing chemistry and PE-203-4001
cluster generation kit v4) in March 2010. Instead of having a dedicated control lane, as done
for the earlier samples, an indexed control φX174 library was spiked into each lane, yielding
2-3% control reads. I analyzed the sequencing run starting from QSeq sequence files and CIF
intensity files from the Illumina Genome Analyzer RTA 1.6 software. Ibis was trained on
the Bustard control reads aligned to the φX174 reference sequence and used to call bases
and quality scores from intensity files. The raw paired-end reads were merged (including
adapter removal, section 3.2 on page 44). The index reads used for the sequencing runs were
not further evaluated for downstream analysis, they were used only to validate the correct
assignment of samples to lanes.
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The paired-end read merging resulted in two sets of reads for each sample: regular paired-end
reads and merged reads. The paired-end reads were aligned using BWA [131] to the human
(NCBI 36/hg18) and chimpanzee (CGSC 2.1/pantro2) genomes using default parameters.
Using BWA’s sampe command, the alignments of the first and second read were combined
and converted to SAM/BAM format. In this step, missing paired alignments were searched
within a window of 500nt around one aligned read. Merged reads were aligned separately to
these genomes, again using BWA with default parameters. Using BWA’s samse command, these
alignments were also converted to SAM/BAM format and combined with the BAM output files
for paired-end using samtools [132]. Alignments to hg18 and pantro2 were filtered using the
criteria for the five higher coverage humans, with the following modifications:
 Instead of removing reads missing the “properly paired” flag, non-mapped merged
reads and paired-end reads missing one of the alignments were removed.
 “Duplicated” reads with the same outer coordinates (chapter 3 and section 3.10 on
page 60) lower or equal sum of quality scores were removed using a custom script
handling both paired end and merged reads.
We obtained 30.6-39.7 million raw sequences for these seven samples, of which 76.83%-82.12%
of reads aligned to the human reference genome and 68.25%-73.52% also passed the described
filters. For the chimpanzee, 68.74%-73.99% of reads aligned and 59.26%-63.26% remained
after filters. This corresponds to on average 4.4Gb and 3.8Gb of sequence data aligned to
the human and chimpanzee reference genomes.
6.3 Identification of changes on the human lineage
Studying sites in the human genome which changed since the last common ancestor of human,
chimpanzee and bonobo allow to define the genetic background of what sets humans apart
from other primates. Further, the comparison of the human genome to the genomes of
Neandertals and the Denisova individual allows to identify the subset of genomic sites which
set fully anatomically modern humans apart from other hominin forms. These might point
to uniquely human traits and physiological changes that allowed humans to become the
dominant species on this planet.
Positions that have changed on the hominin lineage since separation from apes and more dis-
tantly related primates can be identified from multi-species whole genome alignments. Such
multi-species whole genome alignments can be created from pair-wise alignments available
from the UCSC Genome browser5 using autoMultiZ from the UCSC Kent-tools6. Whole
genome alignments differentiate between a reference and a target genome. While each po-
sition of the reference genome appears at most once in the alignment, sequences from the
target genome can be used multiple times. This causes whole genome alignments to be non-
symmetrical. I therefore generated and used two multi-species whole genome alignments,
one based on hg18 as reference and the other based on pantro2 as reference.
These alignments I screened for differences between the human and chimpanzee, and assigned
the lineage on which the change occurred based on two out-groups (the orangutan and rhesus
macaque). I extracted 15,216,383 single nucleotide changes (SNCs) and 1,364,433 insertion
or deletion differences from the human-based alignment that were inferred to happen on
5http://hgdownload.cse.ucsc.edu/downloads.html
6http://hgdownload.cse.ucsc.edu/admin/exe/
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the human lineage, and 15,523,445 SNCs and 1,507,910 InDels from the chimpanzee-based
alignment that were inferred to happen on the human lineage. Only positions identified in
both human-based and chimpanzee-based alignments, where no gaps were present within a
5nt-window of the event, and where both out-groups agree with the chimpanzee base, were
retained. In the case of InDels, I required that the InDel length does not vary between
species and that the InDel sequence is not marked as a repeat (based on UCSC lower case
genome soft masking). This generates a set of 10,535,445 SNCs and 479,863 InDels inferred
to have occurred on the human lineage.
6.3.1 Identification of positions with Neandertal sequence coverage
As described above, Neandertal merged reads from Vindija 33.16, Vindija 33.25 and Vindija
33.26 were aligned to the human (hg18) and chimpanzee genomes (pantro2) using ANFO. To
further reduce the effects of sequencing error, we used the alignments of Neandertal reads to
the human and chimpanzee reference genomes to construct human-based and chimpanzee-
based consensus “minicontigs”. To generate these consensus sequences, we selected uniquely
placed, overlapping alignments (ANFO MAPQ ≥ 90) and merged these into a single multi-
sequence alignment using the common aligned genome sequence. At each position in the
resulting alignment, for each observed base, and for each possible original base, we calculated
the likelihood of the observation, estimated the likely length of single stranded overhangs,
and considered the potential for ancient DNA damage using the Briggs-Johnson model [28].
If most observations in a given position showed a gap, the consensus became a gap, otherwise
the base with the highest quality score (calculated by dividing each likelihood by the total
likelihood, equation 3.3 on page 47) was used as the consensus. At the current coverage of
the Neandertal sequence (≈1.5x), heterozygous sites will appear as low quality bases with
the second base having a similar likelihood to the consensus base.
We extracted the Neandertal sequence for the identified human-lineage-specific changes from
minicontig alignments to both the human and the chimpanzee genomes. To ensure high
quality and consistency between the human chimpanzee alignments, I filtered the data:
1. The Neandertal sequence at the same position in both human and chimpanzee-based
alignments was required to be identical and to have a PHRED base quality score > 30.
2. All positions that fall within 5 nucleotides of the ends of minicontigs were excluded to
minimize alignment errors and substitutions due to the nucleotide misincorporations,
which are frequent close to the ends of ancient DNA molecules.
3. Positions that fall within 5 nucleotides of insertions or deletions (i.e. gaps) in the
minicontig alignments were excluded.
Using this filtered dataset, Neandertal sequence data covers 3,202,190 of the 10,535,445
substitutions and 69,029 of 479,863 InDels inferred to have occurred on the human lineage,
respectively. Figure 6.3 on the next page summarizes these numbers for different parts of
genes.
6.3.2 Identification of positions with Denisova sequence coverage
Like for the Vindija Neandertal reads, we used the alignments of the Denisova phalanx reads
to the human and chimpanzee reference genomes to construct human-based and chimpanzee-
based consensus sequences from multiple reads of the same Denisova molecule, and joined
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Figure 6.3: Single nucleotide changes (SNC) and insertion/deletion changes (InDels) on the human
lineage inferred from whole genome alignments and their state obtained from the minicontigs created
from all Vi33.16, Vi33.25 and Vi33.26 reads.
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overlapping fragments to construct “minicontigs”. In this process, overlapping alignments
were merged along the common reference to create a single multi-sequence alignment. For
each column of the alignment, the number of gaps was counted, and if half the reads or more
showed a gap, a gap (resulting in a deletion or no insertion, as appropriate) was called. If
fewer than half the reads showed a gap, the most likely diallele (IUPAC ambiguity codes)
per column was calculated as outlined in Reich et al. Supplementary Information 4 [186].
We used the resulting minicontigs to extract the Denisova sequence homologous to the
human-lineage-specific changes from both the human and the chimpanzee minicontig align-
ments and the filtered the data as outlined for the Neandertal before. Using this filtered
dataset, we have Denisova sequence coverage for 4,267,431 of the 10,535,445 substitutions
and 105,372 of the 479,863 InDels inferred to have occurred on the human lineage.
6.3.3 Annotation of genomic features
We annotated all SNC and InDel events using the Ensembl v54 annotation for hg18 and
Ensembl v55 for pantro2 (in cases where no human annotation was available). Further, a set
of 16,762 human CCDS genes (Consensus Coding Sequence project of EBI, NCBI, WTSI,
and UCSC), each representing the longest annotated coding sequence for the respective
gene, was used for downstream analyses of protein-coding genes. If not otherwise indicated
by specific citations, functional information for genes was obtained from GeneCards ([200],
http://www.genecards.org/).
Due to the low coverage of the Neandertal and Denisova genomes, mostly one allele is
sampled from the ancient genomes. We therefore may miss polymorphic derived alleles
and consider the Neandertal and Denisova genome ancestral for these positions, thereby
incorrectly assigning the arrival of the derived alleles to the human lineage after its separation
from Neandertal and Denisova.
6.4 Changes in protein-coding sequences analyzed from Ne-
andertal data
From the Neandertal data, we identified 19,780 SNCs in the coding regions of the human
CCDS set. Six of these occur in two overlapping transcripts, while one occurs in three
overlapping transcripts. These positions result in 11,337 synonymous substitutions and
8,451 non-synonymous substitutions. Non-synonymous amino acid substitutions that rose
to nearly 100% frequency (are fixed) in present-day humans since the separation of humans
from Neandertals and Denisovans might be of special interest as they may represent targets
of recent selection in humans.
Recently, other group members of the department of Evolutionary Genetics identified in a
separate study, a number of amino acid substitutions in signal peptides of secreted proteins
where most or all present-day humans differ from the El Sidron 1253 Neandertal individual.
Signal peptides direct the import of proteins into the endoplasmic reticulum, an extensive
membrane network important for the transport of synthesized proteins as well as facilitation
of protein folding. In the absence of other trafficking signals, membrane proteins carrying
signal peptides are transported to the cell surface, while the signal peptide is cleaved off after
the successful insertion of the polypeptide into the membrane of the endoplasmic reticulum.
Gralle et al. [79] analyzed both the ancestral and the derived forms of these protein domains
with respect to their efficiency in mediating transport of proteins to the cell surface. This
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study could not identify any significant functional differences, suggesting that also most
non-synonymous changes in other protein domains may be functionally neutral.
Even though the very positions studied by Gralle et al. [79] are included in the set of identified
human SNCs, we did not obtain reliable Neandertal state information from the genome shot-
gun data of the three Vindija individuals. In the 19,780 SNCs falling in coding sequences in
the present genome analysis, we find 175 changes in signal peptides, 106 are non-synonymous.
For 91 of these positions Neandertal shows the derived state, and for 15 sites Neandertal
shows the ancestral state. All the latter changes are known to be polymorphic in modern
humans (dbSNP 130, [212]) and are therefore possibly functionally equivalent and may not
have been relevant in modern human evolution.
6.4.1 Amino acid substitutions
We excluded all non-synonymous substitutions where current humans are known to vary,
and identified 78 fixed, i.e. not known to be variable in present-day humans with respect to
dbSNP 130, non-synonymous amino substitutions from a total of 2,910 positions where the
Neandertal carries the ancestral (chimpanzee-like) allele (table 2 on page 194). We identify
five genes affected by two substitutions that either change amino acids or introduce a stop
codon, and that have become fixed among humans since the divergence from Neandertals:
 DCHS1 (CCDS7771), which encodes fibroblast cadherin-1, a calcium-dependent cell-
cell adhesion molecule that may be involved in wound healing.
 RPTN (CCDS41397), which encodes repetin, an epidermal matrix protein that is ex-
pressed in the epidermis and particularly strongly in eccrine sweat glands, the inner
sheaths of hair roots and the filiform papilli of the tongue.
 SPAG17 (CCDS899) sperm-associated antigen-17 that is thought to be important
for the structural integrity of the central apparatus of the sperm axoneme, which is
important for flagellar movement.
 TTF1 (CCDS6948), a terminator of ribosomal gene transcription and regulator of
RNA polymerase I transcription.
 SOLH (CCDS10410), which encodes a protein of unknown function.
It is striking that two of these genes are expressed primarily in the skin. This may suggest
that modern humans and Neandertals differed with respect to skin morphology and physi-
ology. Besides the number of changes in each gene, the potential physico-chemical impact
of exchanging an amino acid in a protein is relevant for prioritizing these 78 positions. We
have categorized the amino acid replacements into classes of chemical similarity (table 2
on page 194) using Grantham scores [80]. Based on the classification proposed by Li [138]
scores from 0-50 are considered conservative, 51-100 are moderately conservative, 101-150
moderately radical and >151 are considered radical.
On this basis, only one of the substitutions in the five genes with multiple SNCs is considered
radical, resulting in the change of codon 431 in sperm associated antigen 17 from the ancestral
aspartic acid to the derived tyrosine. A further four of the complete list of 78 nucleotide
substitutions result in radical amino acid changes, 7 in moderately radical changes, 33 in
moderately conservative, 32 in conservative changes and a single one affects a stop-codon
(table 2 on page 194). The genes showing radical amino acid substitutions are involved in
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reproduction, hormone response, olfaction, and immunity – groups which have been shown
in human-chimpanzee genome comparisons to have undergone positive selection [36]:
 GREB1 (CCDS42655, gene regulated in breast cancer 1 ), an estrogen-responsive gene
which is an early response gene in the estrogen receptor-regulated pathway. The amino
acid substitution in GREB1 occurs in a serine-rich region of the protein.
 OR1K1 (CCDS35132, olfactory receptor, family 1, subfamily K, member 1 ), an ol-
factory receptor, has an exchange of arginine to cysteine in one of the extracellular
domains of the protein.
 NLRX1 (CCDS8416, nucleotide-binding oligomerization domain, leucine rich repeat
containing X1 ) acts as a modulator of the innate immune response elicited from the
mitochondria in response to viral challenge. Expression of NLRX1 results in inhibition
of the RLH and MAVS -mediated interferon-beta promoter activity and in the disrup-
tion of virus-induced RLH -MAVS interactions. The amino acid substitution is in the
NACHT domain of the protein which is thought to interact with MAV in order to
bring about the innate viral response.
 NSUN3 (CCDS2927, NOL1/NOP2/Sun domain family 3 ) is a protein of unknown
function which seems to have S-adenosyl-L-methionine-dependent methyl-transferase
activity.
6.4.2 Stop/Start codon substitutions
We identified only one gene (RPTN, CCDS41397) in which a fixed, non-synonymous substi-
tution introduces a stop codon in the human protein which is not seen in Neandertal. We
examined the Neandertal minicontigs in the region surrounding the position of the human
stop codon and identified only one stop codon – 108 amino acids downstream of the position
at which the human stop codon is observed. The earlier mentioned human RPTN protein is
thus shortened by 108 amino acids – from 892 amino acids in Neandertal to 784 amino acid
residues in humans. A second gene (KIAA1751, CCDS3097) carries a stop codon showing a
non-synonymous change which is known to be polymorphic in modern humans.
We identified no fixed, non-synonymous changes in start codons where Neandertal shows
the ancestral allele. Just one non-synonymous change which is not fixed in modern humans
was identified in melastatin-1 (TRPM1 ). Functional variants of the TRPM1 (CCDS10024)
that use alternative start positions have been described in human tissues and may be able
to compensate for the loss of the specific transcript variant [162]. TRPM1 encodes an ion
channel with the function of maintaining normal melanocyte pigmentation.
6.4.3 Indels in coding sequence
We identified 36 insertion/deletion events within coding sequences. In four cases the Nean-
dertal is ancestral, and in all of these cases are modern humans known to be polymorphic
for the position.
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6.5 Changes in protein-coding sequences analyzed from Deni-
sova data
From the Denisova data, 35,523 SNCs, were identified in the coding regions of the human
CCDS set. Thus, about 1.8 times more SNCs were covered in the Denisova data than
in the Neandertal data. Of these 21,354 were synonymous substitutions and 14,169 non-
synonymous substitutions. In the Neandertal data a slightly higher proportion (43% vs.
40%) of non-synonymous substitutions was obtained, indicating non-random sampling in at
least one of the data sets.
6.5.1 Amino acid substitutions
Again excluding all non-synonymous substitutions where current humans are known to vary
(dbSNP v131), we identified 129 fixed, non-synonymous amino substitutions from a total of
2,176 positions in 119 genes where the Denisova individual carries the ancestral (chimpanzee-
like) allele (table 3 on page 197). We identify 10 genes affected by two amino acid substitu-
tions that are consistent with being fixed in present-day humans since divergence from the
common ancestors of Denisovans:
 AN30A (CCDS7193), Ankyrin repeat domain-containing protein 30A
 HPS5 (CCDS7836), Hermansky-Pudlak syndrome 5 protein
 ITB4 (CCDS11727), Integrin beta-4 precursor
 PIGZ (CCDS3324), GPI mannosyltransferase 4
 RGS14 (CCDS43405), Regulator of G-protein signaling 14
 RP1L1 (CCDS43708), Retinitis pigmentosa 1-like 1 protein
 SPTA1 (CCDS41423), Spectrin alpha chain, erythrocyte
 SSH2 (CCDS11253), Protein phosphatase Slingshot homolog 2
 TTF1 (CCDS6948), Transcription termination factor 1
 ZN333 (CCDS12316), Zinc finger protein 333
Interestingly, two of these genes are associated with skin diseases (HPS5 and ITB4 ), which
is similar to the high representation of genes associated with skin morphology and physiology
in the Neandertal-based catalog presented in the section above (page 140). Using Grantham
scores to categorize the 129 amino acid replacements into classes of chemical similarity [80,
138], we classified 54 sites as conservative (scores of 0-50), 65 as moderately conservative
(scores of 51-100), 8 as moderately radical (scores of 101-150), and 1 as radical (score of
>151) (table 3 on page 197). The only gene with an amino acid substitution that is classified
as radical is OR1K1 (olfactory receptor, family 1, subfamily K, member 1, CCDS35132), an
olfactory receptor with a replacement of arginine by cysteine in one of the extracellular
domains. This change was also identified in the Neandertal data described above.
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6.5.2 Stop/Start codon substitutions
We identified one fixed non-synonymous change in a stop codon. In OLM2B (Olfacto-
medin-like protein 2B precursor, CCDS1236) the loss of a stop-codon at amino acid 470, a
change that is observed in all present-day humans, is required for the protein to contain the
olfactomedin-like domain (amino acids 493-750). In Denisova, the ancestral stop-codon is
present and the protein therefore does not include this domain.
We did not identify fixed, non-synonymous changes in start codons where the Denisova
individual carries the ancestral allele. However, at one gene, Riboflavin kinase (RIFK,
CCDS35044), Denisova carries an ancestral start codon (dbSNP 131 rs2490582) that is lost
in about 98% of present-day humans. In addition, there are two genes where some (but
not all) present-day humans have gained a start codon relative to Denisova. This includes
the melastatin-1 gene (TRPM1, CCDS10024; dbSNP 131 rs4779816 derived allele frequency
88%) and zinc finger protein 211 (ZNF211, CCDS12957; dbSNP 131 rs9749449 derived allele
frequency 77%). The difference in TRPM1 was also observed for Neandertal (see section 6.4.2
on page 141). ZNF211, is an as-yet uncharacterized zinc finger protein probably involved in
transcriptional regulation.
6.5.3 Insertions and deletions in coding sequence
We identified 69 insertion/deletion events within coding sequences. In 15 cases the Denisova
state is ancestral, and for 14 of these, present-day humans are not known to vary in dbSNP
131 (table 6.1 on the following page). Twelve of these 14 InDels are 3 bases long. Of these,
6 delete exactly one amino acid and the other 6 affect two amino acids while maintaining
the reading frame.
In HADHB/ECHB (CCDS1722, hydroxyacyl-CoA dehydrogenase / 3-ketoacyl-CoA thio-
lase / enoyl-CoA hydratase, β subunit), the β subunit of an enzyme essential for the
metabolism of long-chain fatty acids, the first amino acid, which is part of the mitochondrial
transit peptide region of the protein, is removed. Since the mitochondrial transit peptide is
responsible for the transport of the protein from the cytoplasm to the mitochondrion, it is
possible that this change affects the cellular localization or the efficiency of the localization
of this protein. Mutations in this gene are associated with hypoglycaemia, hypotonia and
lethargy [164].
An entire codon is deleted from RTTN (CCDS42443, rotatin), a protein required for the
early developmental processes of left-right specification and axial rotation and which may
play a role in notochord development [65]. Examples of other three-base deletions are in
AHNK (CCDS31584, Desmoyokin), a protein involved in neuroblast differentiation, in EME1
(CCDS11565, essential meiotic endonuclease 1 homolog 1 ), involved in DNA replication and
repair, SNG1 (CCDS13989, synaptogyrin 1 ) involved in short and long-term regulation of
neuronal synaptic plasticity, and the spermatogenesis-associated protein SPT21 (CCDS172,
spermatogenesis associated 21 ). Interestingly, several genes in which present-day humans
appear to have undergone deletions while Denisova carries the ancestral state are involved
in neuronal development and function, spermatogenesis and metabolism.
Particularly striking are single base deletion within coding sequence, as these destroy read-
ing frame. One such InDel that we detected is in one of the final codons of the membrane
protein ADAM8 (CCDS31319, a disintegrin and metalloproteinase domain 8 ). This InDel
is predicted to lead to a change of frame in the cytoplasmic portion of the protein, 6 amino
acids from the derived C-terminus. Disintegrin and metalloprotease proteins are involved
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Table 6.1: Table of 15 insertion/deletion changes in coding sequences where Denisova has the ances-
tral, chimpanzee-like, state. For type ’del’ (deletion) the sequence reported in column ’Seq.’ was lost
on the human lineage. For type ’ins’ (insertion), the reported sequence was gained on the human
lineage.
Human (hg18) Database identifier
Type Seq. Chr Start End CCDS ID SwissProt Exon
del CTT 1 16599892 16599892 172 SPT21 9
del ACT 2 26330629 26330629 1722 ECHB 1
del GAG 6 151715809 151715809 5229 AKA12 3
del GAC 8 101275635 101275635 34930 SPAG1 9
del C 10 134926669 134926669 31319 ADAM8 23
del CTC 11 62060131 62060131 31584 AHNK 1
del AGC 17 45807977 45807977 11565 EME1 1
del CTC 18 66014830 66014830 42443 RTTN 7
del ATC 19 14913983 14913983 12320 OR7C2 1
del CAG 19 55573634 55573634 42593 NR1H2 4
del ACT 19 58146287 58146287 33096 Z816A 3
del CAA 22 38107768 38107768 13989 SNG1 4
ins AGC 2 79990299 79990302 42703 CTNA2 6
ins GCG 2 95210767 95210770 42712 ZNF2 4
ins G 17 21087327 21087328 42286 GTL3B 3
in a variety of biological processes involving cell-cell and cell-matrix interactions, including
fertilization, muscle development, and neurogenesis. ADAM8 has also been linked to in-
flammation and remodelling of the extracellular matrix (including cancers and respiratory
diseases) [117]. A single base pair insertion in chromosome 17 open reading frame 103 (also
known as gene trap locus F3b – GTL3B, CCDS42286), a protein of unknown function, also
results in a change in reading frame.
6.6 Changes in non-protein-coding sequences
In the following, I will discuss changes in the non-coding parts, the so-called untranslated re-
gions (UTRs), of protein-coding human transcripts, microRNAs which are one class of short
non-coding RNAs and associated with post-transcriptional regulation [219, 104], as well as
Human Accelerated Regions (HARs) which are defined as regions of the genome conserved
throughout vertebrate evolution, but which have changed radically since humans and chim-
panzees split from their common ancestor [20, 31, 174, 175, 178]. There are different other
transcribed and non-transcribed regions of the genome which are of functional relevance, the
three features presented are just a small and probably even a non-representative subset.
6.6.1 5’ UTR substitutions and insertion/deletions
Neandertal data
We have reliable Neandertal sequence data for 2,616 of the 12,045 substitutions changes
in 5’ untranslated regions of human transcripts. Of these, 42 affect positions where the
ancestral allele is observed in Neandertals, and humans are fixed derived (dbSNP 130).
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Two genes show multiple changes. TMEM105 (CCDS11781, transmembrane protein 105 ),
a transmembrane protein with no known function, has three changes in the 5’ UTR, and
SLC25A2 (CCDS4258, solute carrier family 25 member 2 ), which is thought to have a role
in metabolism as a mitochondrial transport protein, has two such changes. Neandertal state
information was also obtained for 71 of 810 InDels in 5’ UTRs; three of them show the
ancestral state retained in Neandertals (ARHGEF11 – Rho guanine nucleotide exchange
factor (GEF) 11 /CCDS1163, ZNF564 – zinc finger protein 564 /CCDS42505, RIBC2 –
RIB43A domain with coiled-coils 2 /CCDS14066) while present-day humans are fixed derived.
Denisova data
We have Denisova sequence data for 5,654 of the 12,045 substitutions in 5’ untranslated
regions occurring on the human lineage. Of these, there are 66 positions in 64 genes where
the ancestral allele is observed, and present-day humans are consistent with being fixed for
the derived allele.
Two genes each carry two changes in the 5’ UTR: ETS2 (CCDS13659, human erythroblastosis
virus oncogene homolog 29 ), a transcription factor that is involved in stem cell development,
apoptosis and tumorigenesis, and FNBP4 (CCDS41644, formin binding protein 4 ) a gene
with roles in a cell adhesion and G-protein coupled receptor signaling. Denisova state in-
formation was also obtained for 198 of 810 InDels in 5’ UTRs. For 24 of these (each in a
different gene) the Denisova individual retains the ancestral state while present-day humans
are fixed for the derived allele (dbSNP 131).
6.6.2 3’ UTR substitutions and insertion/deletions
Neandertal data
We have reliable Neandertal sequence data for 18,909 of 55,883 substitutions in 3’ UTRs.
Among these, there are 190 positions where Neandertal shows the ancestral state and modern
humans are fixed derived (dbSNP 130).
Twelve genes show multiple substitutions, with one gene having four substitutions (CCDC117
– coiled-coil domain containing 117, CCDS13846) and three genes having three substitutions
each (ATP9A – ATPase, class II, type 9A/CCDS33489, LMNB2 – lamin B2 /CCDS12090,
RCOR1 – REST corepressor 1 /CCDS9974). We also identify 784 of 5,972 InDels in 3’ UTRs,
33 of which show the ancestral state in Neandertals while modern humans are fixed derived.
Each of the 33 InDels is found in a different gene.
Denisova data
We have Denisova data for 26,113 of 55,883 SNCs in 3’ UTRs. Among these, there are
283 positions (in 234 genes) where the Denisova individual shows the ancestral state and
present-day humans are consistent with being fixed for the derived allele (dbSNP 131).
We also find 37 genes with multiple substitutions, with one gene having 4 substitutions
(PRDM10 – PR domain containing 10, CCDS8485), 10 genes with 3 substitutions, and 26
genes with 2 substitutions. The protein encoded by PRDM10 is a transcription factor that
is implicated in somite and craniofacial formation during embryonic development [168] and
that may be involved in the development of the central nervous system as well as in the
pathogenesis of gangliosidosis (GM2, neuronal storage disease) [215].
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We also have Denisova data for 1,271 of 5,972 InDels in 3’ UTRs, 109 of which show the
ancestral state in Denisova while present-day humans are fixed for the derived allele. These
InDels are located in 108 different genes. Two InDels are present in the 3’ UTR of MPP5
(MAGUK p55 subfamily member 5, CCDS9779), a protein that may play a role in tight
junction biogenesis and in the establishment of cell polarity in epithelial cells.
6.6.3 microRNAs
MicroRNAs (miRNA) are small non-coding RNAs that regulate gene expression by mRNA
cleavage or repression of mRNA translation. MiRNAs have been shown to have important
role in mammalian brain and embryonic development [219, 104]. In 1,685 miRNAs anno-
tated in Ensembl 54 (including 670 miRBase-derived miRNAs [85]), I identified 357 single
nucleotide changes and 17 insertion/deletion events from the whole genome alignments which
occurred on the human lineage.
Neandertal data
We have Neandertal sequence data for 103 of the 357 single nucleotide changes. In 88
cases the Neandertal carries the derived allele. The remaining 15 alleles are ancestral. In
only one case, ENSG00000221170 (hsa-mir-1304 ), is the Neandertal state ancestral and the
human state fixed derived (dbSNP 130). For hsa-mir-1304, the substitution occurs in the
seed region of the mature miRNA (see figure 6.4 on the next page), suggesting that it is
likely to have altered target specificity in present-day humans relative to Neandertals and
the outgroups [130]. Folding is unlikely to be changed since base pairing is unaffected by the
substitution.
Reliable Neandertal sequence data is also available for two of the 17 insertion/deletion events
in miRNAs. In ENSG00000211530 (AL354933.8 ) the Neandertal has the derived allele, while
in ENSG00000212045 (AC109351.3 ) the allele is ancestral while modern humans are fixed
derived. AC109351.3 has a large loop that is one base shorter in Neandertal than in human
(figure 6.4 on the following page). This change is not expected to alter folding near the
mature miRNA or to change target specificity of the putative miRNA.
Denisova data
We have Denisova sequence for 143 of the 357 single nucleotide differences, and Denisova
shows the derived state of the human reference sequence (hg18) at 125 of these sites. Out
of the remaining 18 sites, 17 are polymorphic in present-day humans, while one change in
miRNA hsa-mir-564 is fixed in present-day humans for the derived allele (dbSNP 131). The
substitution, however, is unlikely to affect microRNA function as it is located in a small
bulge outside of the mature sequence. This substitution does however slightly change the
estimated minimum free energy of hsa-mir-564, indicating that the derived version is slightly
more stable (figure 6.5 on page 148).
Denisova sequence is also available for 5 of the 17 insertion/deletion events in miRNAs that
occurred on the human lineage. In one case, hsa-mir-1260, Denisova carries the ancestral
allele while present-day humans are apparently fixed for an insertion of adenine. This inser-
tion is outside of the mature sequence in an inferred loop structure and is thus not likely to
affect function (figure 6.6 on page 148).
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Figure 6.4: RNAfold (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi, [86]) output for the
two microRNAs showing the ancestral state in Neandertal while being fixed derived in modern humans
with respect to dbSNP 130. For hsa-mir-1304 (A) the ancestral cytosine is observed in Neandertal
while modern humans are fixed derived for thymine (uracil in the microRNA transcript). The change
is located in the seed of the mature microRNA, thus it likely alters target specificity of the derived
version present in modern humans. In AC109351.3 (B), Neandertal shows an ancestral adenine as
an additional base in the big bulge. This change is not likely to effect folding and function of this
putative microRNA.
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Figure 6.5: RNAfold (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi, [86]) output for the
human microRNA hsa-mir-564 showing the ancestral state in Denisova while being fixed derived
in modern humans with respect to dbSNP 131. The free energy of the thermodynamic ensem-
ble is −54.43kcal/mol for the ancestral version, and slightly better for the derived version with
−55.32kcal/mol. The minimum free energy structure (MFE) has a frequency of 22.05% and 31.33%
in the ensemble for Denisova and human, respectively.
Denisova (ancestral)
Human (derived)
Ensemble free energy: -22.15 kcal/mol
Ensemble free energy: -21.54 kcal/mol
hsa-miR-1260
Base-pair probability
0 1
Figure 6.6: RNAfold (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi, [86]) output for the
human microRNA hsa-mir-1260 showing the ancestral state in Denisova (i.e. missing a human derived
adenine insertion) while being fixed in modern humans with respect to dbSNP 131. The free energy
of the thermodynamic ensemble is −22.15kcal/mol for the ancestral version, and slightly worse for
the derived version with −21.54kcal/mol.
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6.6.4 Human Accelerated Regions
Human Accelerated Regions (HARs) are defined as regions of the genome conserved through-
out vertebrate evolution, but which have changed radically since humans and chimpanzees
split from their common ancestor. Whether the acceleration is functionally relevant and thus
driven by positive selection or whether it is a byproduct of biased gene conversion is a matter
of intense debate [72, 179, 55, 54, 160]. Biased gene conversion may happen during recombi-
nation of two chromosomes/DNA molecules when two new double stranded DNA molecules
with partially false-paired nucleobases (heteroduplexes) are created [3]. These false-paired
bases are identified by cellular repair mechanisms, which preferentially repair C-A mispairings
to C-G and G-T misparings to G-C [18]. Even though molecular and biochemical processes
are not yet completely understood [217, 101], this “biased” conversion/repair is argued to
be a result of the deamination of methylated cytosines in vertebrate genomes [29, 1], which
if deaminated, a C5me-G pairing results in a T-G mispairing. Should human accelerated
regions largely be the reminiscence of recombination hotspots, i.e. frequent sites of homolo-
gous recombination of parental chromosomes, then biased gene conversion may have driven
a larger number of changes in these regions.
In order to determine whether the acceleration took place before or after the human-Denis-
ova-Neandertal split, we7 examined a total set of 2,613 Human Accelerated Regions identified
in five different studies [20, 31, 174, 175, 178].
Neandertal data
We are restricted in our coverage of the HAR regions due to the filtering of the whole-genome
alignments (see section 6.3.1 on page 137) and by the Neandertal coverage within each HAR
region. We identified a total of 8,949 single nucleotide changes and 213 InDels on the human
lineage in these HARs. Neandertal sequence was available for 3,259 sites (3,226 substitutions
and 33 InDels).
If we calculate the percentage of positions showing the derived state (2,977; 91.35% [90.32%,
92.28%] – 95% Wilson two-sided confidence interval for a proportion including continuity
correction [244, 159]), we observe that this is significantly higher than for the genome-
wide set (87.86% [87.82%, 87.90%]) of all derived substitutions (2,813,802) and all derived
deletions (60,248). When we count the percentage of positions in which Neandertal shows
the derived state only at the positions which may be the sites of biased gene conversion (A/T
in chimpanzee to G/C in human, 62% of the positions under consideration), we find that
this effect is even more extreme. In these substitutions, we find 1,971 derived out of 2,038
(96.84% [97.49%, 96.03%]). However, such sites show also genome wide a higher frequency
of derived alleles (1,714,366 out of 1,796,587 = 95.42% [95.39%,95.45%]). The incidence of
changes from ancestral G/C to a derived A/T in human is 519 derived out of 683 (76.0%
derived [72.57%, 79.11%]) compared to the genome-wide average of 658,717 out of 895,453
(73.56% [73.47%,73.65%]).
The fact that the vast majority of A/T to G/C changes in human accelerated regions are
shared between Neandertal and human suggests that positions affected by biased gene con-
version probably predate the human/Neandertal split considerably. This could be interpreted
as evidence for a relocation of recombination hotspots to previously highly conserved sites,
prior to the human-Neandertal split. This relocation of recombination hotspots might date
back to the speciation of all human forms from their last common ancestor with chimpanzees
7work in collaboration with Herna´n Burbano and Janet Kelso
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and bonobos, or the fusion of two ape chromosomes to form human chromosome 2 [248, 99].
The fusion of two chromosomes is likely to affect sites of recombination [146] and there is
evidence that the fusion occurred in the common ancestor of humans and Neandertals as
recently as 740,000 years ago and no more than about 3 million years ago [51]. The number
of sites are to small to test for a larger effect on chromosome 2, however it is encouraging
that chromosome 2 has the third highest number of annotated HARs per megabase and the
highest number of total HARs.
Even though the majority of sites in HARs are observed to be derived in the Neandertal
individual, there is still a considerable number of ancestral states observed (269 SNCs and
9 InDels). There are 51 positions (in 45 HARs) where Neandertal is ancestral and humans
are derived and not known to vary (dbSNP 130). These represent recent changes that likely
occurred since the human-Neandertal split.
Denisova data
The above results from the Neandertal genome analysis indicate that the acceleration of
HARs predates the Neandertal-human split. Denisova sequence is available for 3,494 changes
(3,445 substitutions and 49 InDels). Of these, 3,128 are derived in Denisova (89.52% [88.45%,
90.51%]), which is significantly higher than for the complete set (86.64% [86.61%, 86.67%])
of all derived substitutions (3,696,534) and all derived InDels (91,985). Thus, we continue
to find that Denisova carries the derived allele more often in HARs than elsewhere in the
genome. We note that confidence levels for the HARs overlap with the earlier reported
Neandertal values, while being non-overlapping and smaller in Denisova for genome-wide
sites. This indicates a generally larger fraction of ancestral states in Denisova compared to
Neandertal, while showing equally frequent derived states in HARs.
Testing for effects of biased gene conversion, we again restricted our analysis to SNCs with
A/T in chimpanzee and G/C in human (50% of covered SNCs in HARs). We find that
1,554 out of 1,719 (90.4% [88.89%,91.73%]) changes in HARs have the derived state in
Denisova, which is also significantly higher than for the 1,532,287 out of 1,750,152 (87.55%
[87.5%,87.6%] sites genome-wide that have the derived state in Denisova. Checking the
opposite pattern (derived A/T and ancestral G/C), we obtain 1,044 out of 1,188 (87.88%
[85.86%,89.65%]) for HARs, a fraction in agreement with the genome-wide average of all
SNCs, and 1,620,005 out of 1,875,789 (86.36% [86.31%,86.41%]) a number lower than the
genome-wide average of all sites.
For Denisova, we identify 104 positions (98 SNPs and 6 InDels) where the Denisova individual
is ancestral while present-day humans are consistent with being fixed for the derived allele
(dbSNP 131). These represent recent changes that probably occurred since the Denisova-
modern human split and merit further study.
Taken together, these results support that changes in HARs tend to predate the human-
Denisova-Neandertal split and that differences caused by biased gene conversion tend to be
older in time. Nevertheless, the results for Denisova are different from the results in the
Vindija Neandertals in that more ancestral sites are covered in the Denisova genome. From
these numbers, it is unclear whether the high frequency of derived states observed in the
Vindija is an artifact of sample processing (lab protocols and computational analysis) or
whether they are due to real differences of the two ancient genomes. In total there are
3,722 HAR SNC sites with information on ancestral/derived states for both Neandertals and
Denisovan. In 96% of the cases the observed states agree, of 153 discordant single nucleotide
changes, Denisova is derived in 91 (59%) cases. In the sites covered in only one data set,
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Denisova shows 9.6 times more derived than ancestral sites and the Vindija Neandertals 12.5
times more derived sites. Therefore, it is likely an ancient molecule sampling bias causes the
difference between data sets.
6.7 Neandertal-Denisova concordance
Of the 10,535,445 SNCs inferred to have occurred on the lineage leading to the human
reference genome (hg18), 4,267,431 (40.51%) positions are covered in the Denisova data
while 3,202,190 (30.39%) are covered in Neandertal. The expected overlap from random
sampling is 12.31% (40.51% · 30.39%), and thus the actual overlap of 15.61% is higher than
expected. We hypothesize this may be due to higher coverage of GC-rich sequences in both
data sets. The overlap of InDels of 6.05% is also higher than expected from random sampling
(3.16%).
The Neandertal and the Denisova specimens carry the same assigned state at SNCs in 87.91%
of the ancestral positions (Neandertal = Ancestral (A) | Denisova = A) and 97.69% of
the derived positions (Neandertal = Derived (D) | Denisova = D). Similarly for InDels,
p (Neandertal = A | Denisova = A) = 87.64% and p (Neandertal = D | Denisova = D) =
98.60%. Table 6.2 provides individual counts.
Table 6.2: Concordance between Denisova and Neandertal for single nucleotide changes (SNCs) and
insertion/deletion changes (InDels) assigned to the human lineage. A = ancestral, D = derived, M
= missing, N = neither chimpanzee nor human state, P = polymorphic in Denisova. Disagreements
are highlighted.
Single nucleotide changes Insertion/deletion changes
Count Denisova Neandertal Count Denisova Neandertal
190836 A A 2532 A A
32785 A D 365 A D
339171 A M 9937 A M
227 A N 12 A N
26245 D A 357 D A
1389396 D D 25642 D D
2279365 D M 65957 D M
1528 D N 29 D N
164555 M A 5409 M A
1389996 M D 34218 M D
3204 M N 382 M N
534 N A 4 N A
818 N D 23 N D
1517 N M 458 N M
12 N N 56 N N
58 P A
807 P D
2943 P M
1189 P N
Positions where the Neandertal and Denisova data disagree on the ancestral state may be
of special interest (32,785 + 365 Denisova = A & Neandertal = D; 26,245 + 357 Denisova
= D & Neandertal = A). These sites show a derived state in the human reference sequence,
as well as the derived state in either Denisova or Neandertal but not in both. Considering
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that Neandertals and Denisovans form a common clade, these positions could for example
be due to variation present at the time when the lineages of modern humans, Neandertals
and Denisovans separated.
On positions where Neandertals show the derived allele, Neandertals are more closely related
to modern humans and for positions which show the derived allele in Denisova, Denisovans
are more closely related to modern humans. Since Denisovans and Neandertals are genome-
wide more closely related with each other than they are to modern humans, i.e. they form a
common clade, this effect is described as incomplete lineage sorting. Incomplete lineage sort-
ing is not unexpected, especially as it also exists between for example humans, chimpanzees
and gorillas [201], which are not as closely related. For Neandertals, Denisovans and humans
these sites are interesting in the respect that the ancestral allele observed in Neandertals or
Denisova might have been reintroduced into some present-day human populations by admix-
ture with individuals from either Neandertal or Denisovan populations. By comparing the
ratio of frequencies with which a present-day human shares the ancestral state for these sites
with either Neandertal or Denisova one may therefore detect whether this individual carries
a larger admixture signal for either of the two ancient hominins (section 6.8).
Of the 59,030 single nucleotide differences where Neandertal and Denisova disagree, 61 over-
lap with the coding regions of 63 Ensembl annotated genes (49 of which belong to described
the CCDS longest transcript set) and result in a non-synonymous change in the amino acid
sequence. Three genes have two such sites:
1. RPTN (repetin, CCDS41397), an matrix protein that is expressed in the epidermis
and particularly strongly in eccrine sweat glands, the inner sheaths of hair roots and
the filiform papilli of the tongue [98]. Repetin was described as one of five genes with
two amino acid altering substitutions that have become fixed among humans since
the divergence from Neandertals. The same positions are present in the derived state,
however, in the Denisova specimen.
2. RGS14 (regulator of G-protein signaling 14, CCDS43405), an integrator of G protein
and MAPKinase (Ras/Raf ) signaling [214], carries two non-synonymous substitutions
that are fixed in present-day humans, ancestral in the Denisova individual, and derived
in the Neandertals.
3. ZN333 (zinc finger protein 333, CCDS12316) carries two non-synonymous substitu-
tions that are fixed in present-day humans, ancestral in Denisova, and derived in the
Neandertals. ZN333 is the only known gene containing two KRAB domains, which
function in transcriptional repression [103]. In addition to the two coding positions
there are several other positions located in the introns, which are also ancestral in the
Denisova individual and derived in the Neandertals.
6.8 Allele sharing of humans at sites of Neandertal-Denisova
discordance
In the previous section, tens of thousand of positions where Denisovans and Neandertals
disagree at sites where the human reference sequence (hg18) carries the derived allele were
identified. These positions are inconsistent between lines that separated more than half a
million years ago (Reich et al. [186] Supplemental Information Table S6.2). Therefore, these
sites might, at least partially, reflect variation at the point of Human-Neandertal-Denisova
lineage separation that segregated/drifted differently in the three lineages.
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For these sites it is clear that at least some human (the reference sequence in which they were
identified) shows the derived allele, while Neandertal and Denisova show either the human
(derived) or the chimpanzee (ancestral) state. Requiring that the ancient DNA sequences
agree with the human or the chimpanzee reference reduces the chance that we are looking at a
sequencing error at these sites. This is especially relevant for sites of ancient DNA damage,
which tend to generate derived alleles rather than ancestral, as substitution changes are
frequently due to transitions (A→G, G→A, C→T, T→C) of which G→A and C→T are also
caused by ancient DNA damage.
Further, it is likely that a large proportion of sites which were polymorphic at the time when
human, Neandertal and Denisovan lineages separated, fixed the derived allele in present-day
in humans8 due to drift and population bottlenecks. Thus, these differently segregating
sites might have been reintroduced into some present-day human populations by admixture
with either Neandertals or Denisovans. Hence, they can be used to test present-day human
individuals whether they more frequently show the ancestral allele for the Denisova ances-
tral sites or the ancestral allele for Neandertal ancestral sites. A difference would indicate
admixture contributing this excess of ancestral alleles to these populations.
Instead of using such ancestral positions, it might be more intuitive to identify positions
which show a derived state in either Denisova or Neandertals, which is not observed in the
human reference genome, the chimpanzee reference or the other ancient genome, and to test
present-day human individuals for sharing these derived alleles. However, this would enrich
for positions of sequencing error which are much more frequent in the Neandertal data (see
table 6.4 on page 155).
6.8.1 Overrepresentation of Denisova ancestral alleles
A striking observation is that for these sites, Denisova is ancestral more often than Neander-
tal. I will first discuss the fact that there are more cases where Denisova has the ancestral and
Neandertal the derived allele at sites where the human reference sequence shows a human-
lineage derived allele than there are cases where Neandertal has the ancestral and Denisova
the derived allele (32,785 vs. 26,245 SNCs and 365 vs. 357 InDels; table 6.2 on page 151).
The difference in counts could have the following explanations:
1. A higher sequencing or alignment error for the Denisova sequence. Since most genomic
sites are derived, i.e. match the reference sequence, errors will cause alignments of
higher divergence and more ancestral sites.
2. An earlier split time of Denisova from the other lineages (that is, Denisova is an out-
group to both present-day humans and Neandertals) and the higher number of ancestral
sites goes back to its deeper divergence from the human lineage.
3. Admixture into the Denisova individual from some archaic hominin (as supported by
the mitochondrial data [121]) contributing these ancestral sites.
4. The human reference sequence being closer to Neandertals than to Denisovans because
of a Neandertal-related contribution of genetic material to non-Africans, as described
in Green et al. [81]. This could restore ancestral sites in the human reference and
thereby reduce the number of Neandertal-specific ancestral sites.
8Assuming neutral evolution and constant population size, i.e. no bottlenecks and no population expansion,
the average number of generations for losing an ancestral allele at p = 1
3
frequency is −4·Ne·p·ln p
(1−p) = 2.197 ·
Ne [62]. Assuming Ne between 3,100-7,500 [225] and considering a generation time of 28.6a [67] for ancient
humans, an ancestral allele is lost after on average 195,000-471,000 years by drift.
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5. The Neandertal genome being closer to the human reference at some positions because
of Eurasians contributing genetic material into Neandertals, i.e. introducing modern
human derived sites in Neandertal for which Denisova is ancestral.
Explanation (1), higher sequencing or alignment error in Denisova, is unlikely to explain the
data, since such processes would alter substitution frequencies (as sequencing and alignment
errors cause substitutions which do not follow substitution rates of biological processes), and
yet the signal is consistent across all classes for the two genomes as shown in table 6.3.
Table 6.3: Substitution frequencies for single nucleotide changes on the human lineage where Nean-
dertal and Denisova disagree on their state. DA columns show the substitution frequencies for sites
where Denisova carries the ancestral allele and Neandertal the derived. NA columns show the sub-
stitution frequencies for sites where Neandertal carries the ancestral allele and Denisova the derived
allele.
DA Derived Ancestral Fraction NA Derived Ancestral Fraction
588 A C 1.80% 461 C A 1.80%
2119 A G 6.50% 1795 G A 6.80%
411 A T 1.30% 342 T A 1.30%
1800 C A 5.50% 1521 A C 5.80%
2050 C G 6.30% 1572 G C 6.00%
8082 C T 24.70% 6472 T C 24.70%
7916 G A 24.10% 6230 A G 23.70%
2110 G C 6.40% 1672 C G 6.40%
1813 G T 5.50% 1426 T G 5.40%
737 T A 2.20% 584 A T 2.20%
4060 T C 12.40% 3354 C T 12.80%
1099 T G 3.40% 816 G T 3.10%
32785 All sites 26245 All sites
10608 Transversions only 8394 Transversions only
Further, the processing of the Denisova sample (section 6.2.2 on page 131) includes several
steps that reduce its error compared to Neandertal (e.g. UDG/EndoVIII treatment, v4
sequencing chemistry and longer read overlaps in the read merging process). In fact, the
sequencing error rate estimates obtained in Reich et al. [186], indicate that the error rate in
the Denisova data set is 37 times lower than in the Neandertal data set. The alignment error
is difficult to assess, especially as two different aligners have been used for the data sets.
Considering the very low sequence error rate of the Denisova sample and its estimated
divergence of 12% of the lineage from present-day humans to the human-chimpanzee common
ancestor, divergence adds 0.074% (1.23% human-chimpanzee SNP differences [35] · 0.5 ·12%)
differences to the sequencing error. This leaves Denisova with fewer substitution differences
in the alignment than the present-day human samples (table 6.4 on the following page) due
to their higher sequencing error rate. However, as all these numbers are actually obtained
from our alignments, estimates are conditioned on the alignments and might also be biased.
InDel error rates are much lower on the Illumina sequencing platform (chapter 2 section 2.3
on page 23) and also happen at a lower evolutionary rate. If there was a higher sequence
or alignment error in the Denisova sample, one might expect the count difference on InDels
to be informative for validating the difference in numbers of ancestral sites. While there is
an excess of 25% of ancestral Denisova SNC sites, only 2% more InDels are observed for
the Denisova individual. However, gap penalties are different between ANFO and BWA, with
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Table 6.4: Sequencing error rates inferred for present-day humans and ancient DNA data sets obtained
from the autosomes, at positions of one-to-one human and chimpanzee orthology whose common
ancestor sequence is supported by at least one outgroup sequence (Reich et al. [186] Supplementary
Information 2, Table 2.4).
Data set All sites Transversions
Denisova 0.041% 0.013%
Neandertal (Vindija) 1.547% 0.094%
∅ 5 humans 0.287% 0.176%
∅ 7 humans 0.189% 0.122%
BWA having higher penalties and thus putatively excluding gapped alignments from analysis.
On the other hand the Denisova reads are longer and may thus allow for more gapped
reads. In total 52.6% more insertion/deletion sites are covered for Denisova data compared
to the Neandertal data, while 33.3% more SNCs are covered in Denisova compared to the
Neandertal data. Putting numbers into perspective, the Denisova data comprises about 24%
more aligned bases than the Neandertal data set. A minor alignment effect can therefore
not be completely rejected. From these numbers, it is also likely that InDels might be more
strongly affected by an alignment effect due to the different scoring. Considering the low
number of InDel events observed, it is therefore reasonable to exclude them from analysis.
Explanation (2), that Denisovans are an outgroup to both present-day humans and Nean-
dertals, is also unlikely to explain the data, since, as shown by other analyses in Reich et al.
and also clear in figure 6.1 on page 128, Neandertals and Denisovans are sister groups on a
genome-wide scale.
Explanations (3), (4) and (5), which involve ancient admixture events, could easily contribute
to the higher number of Denisova ancestral sites. Archaic admixture into the Denisova
individual (3) would be an explanation for the high divergence time of its mitochondrial
genome (see section 6.1 on page 127 and [121]) and would also contribute to the number of
sites where the human reference is derived but Denisova ancestral. Due to the Neandertal
contribution of genetic material to non-Africans (4) as described in Green et al. [81], the non-
African proportion of the composite human reference sequence will be closer to Neandertals
than to Denisovans. This effect will decrease the number of sites derived in the reference
but ancestral in Neandertal, while not affecting the number of derived sites in the reference
that are ancestral in Denisova (thus also causing a relative increase of sites ancestral in
Denisova). The same is true for modern human admixture into the Neandertal sequence
(5), which introduces modern human derived sites into Neandertal and thereby increases the
number of sites where only Denisova is ancestral.
While the archaic admixture (3), which might be assumed to predate a putative admixture
event with modern humans, alters the Denisova genome and therefore adds Denisova ances-
tral sites, it does not impact the frequency with which a present-day individual may match
this Denisova ancestral state due to archaic admixture on the Denisovan lineage. If archaic
admixture was introduced to the Denisova genome after a putative admixture event with
modern humans, the additional ancestral Denisova sites from this late archaic admixture
cannot be found in present-day humans and the ancestral allele sharing with Denisova would
always be lower for Denisova than the ancestral allele sharing with Neandertals. This could
be tested if a human population without any admixture from Neandertals and Denisovans
was available.
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The Neandertal admixture into the human reference sequence (4) will affect the frequency
of matching the Neandertal ancestral state, as specifically those sites of variation at the
point of Neandertal-Denisova lineage separation contributed by Neandertals to present-day
humans will be depleted in the above identified positions. Denisova ancestral sites observed
due to modern human derived sites in the Neandertal sequence (5) may only influence the
frequency with which a present-day individual matches the Denisova ancestral state if these
derived sites of the human reference are private to some human populations. Due to (4) and
(5), I will specifically analyze the impact of the human reference sequence.
6.8.2 Testing twelve present-day human individuals
To learn more about the relationships of a diverse group of present-day humans to these two
ancient hominins, one can extract the genotype of an individual P of known ancestry for
the identified Denisova or Neandertal ancestral positions, i.e. determine whether the indi-
vidual P from some population matches the ancestral or the derived state. Determining the
genotype is equivalent to generating a virtual 6-way alignment P-hg18-Denisova-Neandertal-
Chimpanzee-Outgroups. Since our catalog ascertained sites where hg18 has a derived allele
(D) specific to the human lineage and Denisova and Neandertal are discordant for the de-
rived (D) and ancestral (A) allele, we only analyze sites with the base patterns ?DADAA
and ?DDAAA, using the terminology shown in figure 6.7 on the following page.
To quantify the rate at which Neandertal or Denisova share ancestral alleles with a present-
day human P at these sites, I compute two rates: the fraction of P carrying the ancestral
allele at sites where the Neandertal genome is ancestral, NA = ADDAAA/(DDDAAA +
ADDAAA) and the same fraction for sites where the Denisova genome is ancestral, DA =
ADADAA/(DDADAA + ADADAA). These statistics allow testing whether individual P
matches ancestral alleles in Neandertal or Denisova more often, controlling for the fact that
ancestral alleles occur with different numbers for these two ancient hominins. Further, the
ratio NA/DA corrects for different population histories of each individual, as well as any
processing effects such as differences in error rate which may cause the individual to share
the derived state with the human reference sequence more or less frequently. Therefore, the
ratio provides a value comparable between different present-day humans.
I obtained each P from the low-coverage sequencing data of 5 present-day humans published
with Green et al. [81] (Han, French, Papuan, San and Yoruba; section 6.2.4 on page 134)
and 7 additional individuals sequenced for Reich et al. [186] (Cambodian, Native Kari-
tiana, Mbuti, Bougainville Melanesian, Mongolian, Papuan and Sardinian; section 6.2.4
on page 135). From the reads aligned for each of these individuals to the human (hg18)
and chimpanzee (pantro2) reference sequences, I extracted the genotype at the identified
Neandertal-Denisova discordant positions from both alignments. At sites with multiple read
coverage, I used the base from the read with the highest sum of quality scores, and required
the base obtained from the human and chimpanzee alignments to agree. Taking the read of
the highest sum of quality scores is motivated by the sampling from possibly heterozygous
regions. Calculating a consensus or considering the alignment with the higher alignment
score would bias against variable sites, or introduce a bias towards the reference sequence
(see also earlier considerations on handling PCR duplicates in chapter 3 section 3.10 on
page 60).
Variance estimates are obtained by a Block Jackknife approach (100 blocks) [123, 187].
Briefly, I sorted all sites by physical position, i.e. genome coordinates, divided them into
100 blocks by their coordinate (each with an equal number of sites and a block size larger
than the extent of linkage disequilibrium of sites), and calculated the statistics for all 100
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Figure 6.7: Genealogies consistent with Neandertal-Denisova discordant site classes and the calcu-
lation of ancestral allele sharing of an individual P with the Denisova (DA) or Neandertal genomes
(NA). These two statistics allow testing whether P matches ancestral alleles in Neandertal or Denisova
more often, controlling for the different number of ancestral alleles identified from the two ancient
hominins. The ratio NA/DA provides a measure on how much closer P is to Neandertals as compared
to the Denisova individual at these sites. By taking the ratio of NA and DA, population demographic
and sample specific effects cancel and a value comparable between different individuals P is obtained.
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Figure 6.8: The ratio of NA/DA (error bars give ±1 standard deviation) for sites obtained from
the catalog of changes shows a distinct relationship of present-day Africans and non-Africans to
archaic hominins. Without a reference bias, NA/DA should be consistent with zero when equal or
no admixture is detected in an individual.
different selections of 99 blocks (i.e. leaving one out). I then took the variance observed
over the 100 samples, multiplied it by 100, and determined the square root (for obtaining a
standard deviation).
Figure 6.8 shows NA/DA for each sample with ±1 standard deviation. Ignoring exact values,
all European and most Eurasians samples show a stronger allele sharing with Neandertals,
while the Papuan individuals show a stronger allele sharing with the Denisova individual.
The three African individuals are intermediate. Considering actual values, Africans have
a negative point estimate for NA/DA, suggesting more sharing of Denisova ancestral sites.
Based on the results of the analyses of the Neandertal genome in Green et al. [81], one
might have expected the African samples to be equally closely related to Neandertals and
Denisovans (that is, the NA/DA ratio should be consistent with zero). The difference from
zero could be due to an African admixture involving relatives of Denisovans, or the analysis
being affected by a bias of the human reference which is comprised of non-African segments,
which are closer to Neandertal and result in a reduction of introgressed NA sites.
6.8.3 Generating an African catalog
To minimize any effect of the Eurasian ancestry in hg18 on this analysis, which might cause
the shift towards negative NA/DA values in figure 6.8 (see arguments (4) and (5) in sec-
tion 6.8.1 on page 153), I generated a new catalog of positions that changed on the human
lineage in which I replaced the human reference base of the whole genome alignments by
bases that I required to agree in the Mbuti and San individuals and which I extracted from
human and chimpanzee short read alignments as described above. Thus, I sampled the read
with the highest sum of base quality scores and considered only positions where the base
obtained in the chimpanzee alignment disagrees with the base obtained from the human
alignments.
This results in a catalog of sites where the two African individuals consistently show the
derived allele. I obtained 5,711,830 single nucleotide changes on the human lineage (com-
pared to 10,535,445 for the hg18-based catalog). There are 15,173 DA sites where Denisova
is ancestral and Neandertal derived and 12,819 NA sites where Denisova is derived and Ne-
andertal ancestral. The difference in counts is less than that obtained using hg18 (24.9%
excess of DA sites versus 18.4% excess in the African-genome-based catalog), suggesting
that some of the earlier observed asymmetry may be due to the inclusion of non-African
segments of the human reference sequence, which from Green et al. [81], we know are more
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Table 6.5: NA and DA counts from sites ascertained using the San and Mbuti individuals. These two
must not show any ancestral states, as derived positions were identified for those two individuals.
Sample Region NA,A NA,D DA,A DA,D
HGDP01029 San Africa 0 12819 0 15173
HGDP00456 Mbuti Africa 0 12819 0 15173
HGDP00927 Yoruba Africa 1494 3981 1744 4659
HGDP00665 Sardinian Europe 1222 2763 1303 3407
HGDP00521 French Europe 1596 3797 1682 4613
HGDP00998 NatAmerican Asia 894 2092 920 2528
HGDP00778 Han Asia 1555 3871 1666 4674
HGDP01224 Mongolian Asia 1210 2857 1302 3420
HGDP00711 Cambodian Asia 1291 3074 1382 3779
HGDP00491 Bougainville Melanesia 1294 2951 1404 3544
HGDP00542 Papuan1 Melanesia 1518 3843 1770 4509
HGDP00551 Papuan2 Melanesia 1264 2838 1481 3364
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Figure 6.9: The ratio of NA/DA (error bars give ±1 standard deviation) for sites obtained from the
African catalog of changes again shows a distinct relationship of present day Africans and non-Africans
to archaic hominins.
closely related to Neandertal. Table 6.5 provides counts observed for these sites in the twelve
present-day human samples. By design San and Mbuti can not show any ancestral states for
these positions and define the number of Denisova and Neandertal ancestral sites.
Figure 6.9 shows the result for the NA/DA analysis using this “African” catalog of positions.
With sites ascertained from the two deepest-divergence human populations, the value for
the remaining African individual, the Yoruba HGDP00927, is centered around zero. This
indicates that the earlier observed negative shift was a result of the Neandertal introgressed
sites in the human reference sequence or non-African admixture in the Neandertal genome
rather than a result of an affinity to the Denisova genome. Further, this indicates that no
significant proportion of archaic admixture after a putative admixture event with modern
humans is present in the Denisova genome (which would cause a positive shift in NA/DA,
see argument (3) in section 6.8.1 on page 153).
The majority of non-Africans being more closely related to Neandertals than to Denisovans
(NA/DA > 0) is distinctly observed (Sardinian HGDP00665 Z=2.5 standard deviations,
French HGDP00521 Z=3.2, Native Karitiana HGDP00998 Z=2.9, Han HGDP00778 Z=2.7,
Mongolian HGDP01224 Z=2.2, Cambodian HGDP00711 Z=2.8). However, the two indi-
viduals from Papua New Guinea (Papuan1 HGDP00542 Z=0.1 and Papuan2 HGDP00551
Z=0.2) are, like the one remaining African sample (Yoruba HGDP00927 Z=0.1), consistent
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Table 6.6: NA and DA statistics from sites ascertained using the San and Mbuti individuals. Since
San and Mbuti represent the deepest divergences in human populations, all populations are about
equally distant from this artificial reference and the actual NA and DA values are similar between
individuals. NA and DA values are however still affected by sample specific effects like sequencing
error.
Sample Region NA sd DA sd NA/DA sd
HGDP01029 San Africa - - - - - -
HGDP00456 Mbuti Africa - - - - - -
HGDP00927 Yoruba Africa 27.29% 1.09% 27.24% 0.92% 0.05% 0.90%
HGDP00665 Sardinian Europe 30.66% 1.13% 27.66% 1.03% 3.00% 1.14%
HGDP00521 French Europe 29.59% 1.23% 26.72% 0.99% 2.87% 0.91%
HGDP00998 NatAmerican Asia 29.94% 1.29% 26.68% 1.13% 3.26% 1.18%
HGDP00778 Han Asia 28.66% 1.04% 26.28% 0.90% 2.38% 0.85%
HGDP01224 Mongolian Asia 29.75% 1.11% 27.57% 0.92% 2.18% 1.02%
HGDP00711 Cambodian Asia 29.58% 1.07% 26.78% 1.07% 2.80% 1.13%
HGDP00491 Bougainville Melanesia 30.48% 1.14% 28.38% 1.07% 2.11% 1.21%
HGDP00542 Papuan1 Melanesia 28.32% 1.22% 28.19% 0.94% 0.13% 1.12%
HGDP00551 Papuan2 Melanesia 30.81% 1.22% 30.57% 1.08% 0.25% 1.13%
with either compensating admixture proportions with both the Neandertal and Denisova
lineages, or no admixture at all. The individual from Bougainville Island is also not different
from NA/DA = 0 when considering a typical Z-score cutoff of two (HGDP00491 Z = 1.7),
but intermediate between the two individuals from Papua New Guinea and other EurAsians.
Taking into account that Neandertal admixture was observed for Papuan1 (HGDP00542)
and described by Green et al. [81], NA/DA being not significantly different from zero for all
three Melanesians is likely to reflect a second gene flow event from relatives of Denisovans into
the ancestors of Melanesians, which balances out the effect of gene flow into the ancestors of
all non-Africans from the perspective of this analysis.
Since I have used two of the deepest divergence human populations to identify the positions
analyzed in the NA/DA ratio, all populations are about equally distant from this artificial
reference and the NA and DA values are similar between individuals (table 6.6). Considering
actual NA and DA values, which are still affected by sample specific effects like sequencing
error, it is clear that the Yoruban individual (HGDP00927) has the lowest NA value and a
very similar DA value. Thus, he shows neither Neandertal nor Denisova admixture, while all
non-Africans show increased NA values, and Melanesian individuals in addition also increased
DA values.
One may quantify the fraction of NA and DA sites that carry the Neandertal admixture signal
for non-Africans and the Denisovan admixture signal for Melanesians, by fixing one of the
parameters, i.e. NA or DA, and thereby scaling the other to be comparable between different
individuals. Enforcing identical NA values for all non-African individuals, the DA values of
Papuan1 and Papuan2 are 9.7% (±3.7%) and 9.3% (±3.9%) increased compared to the non-
African samples. Enforcing identical DA values for all individuals excluding Melanesians, the
Neandertal admixture signal on NA not present in the Yoruban individual can be quantified
with 9.1% (±3.6%). This indicates similar fractions of NA and DA sites which could serve as
admixture markers. Considering the ascertainment scheme of these sites from human lineage
derived positions, they are however unlikely to represent a genome-wide average and thus
these fractions do not measure the actual genome-wide admixture proportions.
Although error bars are fairly large using this method, the African individual shares fewer
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ancestral alleles with Neandertal than do all non-African populations, supporting the signal of
Green et al. [81]. Further, Melanesians, especially the two Papuan individuals, show a signal
of Denisovan admixture not shared with other sampled populations, a result in agreement
with the D-statistics for population pairs presented in Reich et al. [186]. This supports the
idea that a larger proportion of the Neandertal-Denisovan discordant sites go back to sites
that reflect variation at the point of Human-Neandertal-Denisova lineage separation, which
then segregated differently in these lineages.
6.9 Summary and conclusions
Due to the short nature of ancient DNA molecules as well as their low copy-number rela-
tive to co-extracted environmental DNA, high-throughput approaches provide a tremendous
advantage over traditional sequencing approaches in that they enable a complete character-
ization of an ancient DNA extract. As the cost of sequencing decreased, it became feasible
to analyze entire genomes from ancient samples, like the genomes of Neandertals [81] and
the Denisova phalanx [186] discussed in this chapter. The high-throughout data generated
from ancient DNA libraries includes adapter sequence at the read ends, chimeric sequences,
sequencing errors and artifacts, and alignment ambiguities due to the short read lengths and
damage. For the Neandertal and Denisova genomes these challenges have been addressed
largely using the approaches outlined in chapter 3. In combination with experimental ap-
proaches, the sequencing error associated with ancient DNA studies could be considerably
reduced during the course of this project. For example, sequencing and ancient DNA damage
errors remaining in the Denisova genome sequences are 4.6 times lower than for present-day
human sequences analyzed with the same instrument and sequencing chemistry version.
The comparison of the human genome to the genomes of Neandertals and the Denisova
individual allows the identification of features that set fully anatomically modern humans
apart from other hominin forms. In particular, these ancient genome sequences provide
a catalog of changes that have become fixed, or have risen to high frequency, in present-
day humans and point to regions and genes affected by positive selection in the recent
evolutionary history of modern humans. Further, these genomes allow the investigation
of whether Neandertals or Denisovans contributed parts of their genomes to present-day
humans by admixture.
Even though it is likely that most of the identified positions are functionally neutral, we
believe that each of the rather small number of changes in functional regions of the human
genome that have become fixed in humans since the divergence from the common ancestor
with the Denisova and Neandertal individuals are of sufficient interest to warrant functional
investigations. Once the Neandertal and Denisova genomes are sequenced to higher coverage,
the number of these candidate positions will approximately double, e.g. the non-synonymous
fixed derived amino acid changes that happened after the human lineage separated from
Neandertals and Denisovans will increase to around 200 positions. Continuing studies of
human genome diversity, for example the 1,000 Genome project [53], will further narrow
down the number of putatively relevant sites and experimental work will be required to
elucidate the physiological consequences of the remaining changes.
Analyzing the concordance of Neandertals and the Denisova individual with respect to ge-
nomic sites that have changed on the human lineage identified a considerable number of sites
which show a derived state in the human reference sequence, as well as the derived state in
either Denisova or Neandertal but not in both. These may, at least partially, reflect standing
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variation at the time of the separation of the modern human and the Neandertal/Denisova
ancestors which segregated differently in these lineages.
It is of interest that there are more sites where Denisova has the ancestral allele than where
Neandertal does at sites where they are discordant. This observation does not appear to
be an artifact of differential error between the Denisova and Neandertal samples, since the
patterns are consistent across substitution classes, however I could show a bias from the
ancestry of the composite human reference sequence. Even when eliminating the reference
bias by ascertainment of positions from two high divergence African genomes, an excess of
18.4% remained. This excess might either originate from alignment and sampling artifacts,
or actually originate from admixture into the Denisova individual from some archaic hominin.
Even though supported by the high divergence time of the Denisovan mitochondrial genome
from present-day humans [121], this mitochondrial sequence may also be explained by genetic
drift and a sufficiently large ancient population size [186]. Thus results are inconclusive at
this point.
When analyzing the Neandertal-Denisova discordant sites in present-day populations, they
were informative for detecting admixture with either of the ancient populations. I could
confirm that an African individual (Yoruba HGDP00927) shares fewer ancestral alleles with
Neandertal than do all non-African populations, supporting the signal described in Green
et al. [81]. Further, I could show that Melanesians, especially the two Papuan individu-
als HGDP00542 and HGDP00551, show a signal of Denisovan admixture not shared with
other sampled populations, a result in agreement with the D-statistics for population pairs
presented in Reich et al. [186].
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Discussion and conclusions
In this thesis, I reviewed the sequencing concepts implemented by different high-throughput
sequencing instruments and discussed their inherent limitations. I described how specific ex-
perimental steps in the generation of high-throughput sequencing data impact data quality
and generate artifacts that may challenge data analysis. I introduced filters and algorithms
which I have implemented at the Max Planck Institute for Evolutionary Anthropology to
handle different sequencing artifacts and I have outlined approaches that can be used to
reduce them in data generation. Further, I presented a machine learning approach for im-
proving the base calling of the Illumina sequencing platform which I have implemented in
the program Ibis. I explained how Ibis allows for a reduction of error rates and more
informative base quality scores, independent of the actual Illumina sequencing instrument
version and chemistry.
In the last two chapters, I discussed specific problems and selected results from the quantifi-
cation of gene expression from short-sequence tags in five tissues from human, chimpanzee
and rhesus macaque as well as the analysis of whole genome shotgun sequencing data of two
ancient hominin genomes, the Neandertal and the Denisovan genome.
DNA sequencing and technologies
Only within the last five years, the development of alternative sequencing strategies like
pyrosequencing, reversible terminator chemistry, sequencing-by-ligation, virtual terminator
chemistry and single molecule real-time sequencing converged into new sequencing instru-
ments. These new high-throughput sequencing instruments have a daily throughput which
is a factor of 100 to 1,000 higher, and reduced the cost of sequencing one million nucleotides
to 4%-0.1% of that of Sanger sequencing. In chapter 2, I have described the concepts of
all currently available sequencing instruments. I have shown that each of these platforms
has very specific biases and limitations, which go back to the technical details of how DNA
molecules are prepared for sequencing, sequencing templates immobilized and finally how
these are read out.
Current high-throughput technologies, and specifically the three most widely used: Roche
454 FLX, Life Technologies SOLiD and Illumina Genome Analyzer instruments, have an
average error rate that is considerably higher than the typical 1/10,000 to 1/100,000 observed
for high quality Sanger sequence reads. The sequencing error observed for Sanger sequencing
is mainly due to errors in the amplification step, natural variance and contamination in the
sample used as well as polymerase slippage at low complexity sequences like simple repeats
and homopolymers.
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A large fraction of the errors observed for the Roche 454 technology are small insertions or
deletions, mostly arising from inaccurate calling of homopolymer length, and single base-pair
deletions or insertions caused by signal-to-noise thresholding issues. Error rate increases with
the position in the sequence. This is due to reduction in reaction efficiency, molecule damage
and phasing, a process whereby not all molecule copies are extended in every sequencing step.
Phasing causes the molecules in the ensemble to lose synchrony/phase, and results in an echo
of the preceding cycles as signal noise.
While the ensemble sequencing process for 454 pyrosequencing creates unidirectional phasing,
reversible terminator sequencing as applied for the Illumina instruments creates bidirectional
phasing, as incorporated nucleotides may fail effective termination – allowing immediate ex-
tension by another nucleotide. Further, the Genome Analyzer uses four fluorescent dyes to
distinguish the four nucleotides of which two pairs (A/C and G/T) are more difficult to
separate. Phasing, as described before, is mostly not an issue for the SOLiD platform, as
sequences not extended are non-reversibly terminated. Since hybridization is a stochastic
process and probes do not necessarily hybridize adjacent to the primer, this termination
causes a considerable reduction in the number of molecules participating in subsequent lig-
ation reactions, and therefore a substantial signal decline and error increase. Incomplete
cleavage of dyes may allow cleavage after the next ligation, which then allows for the exten-
sion in the next but one cycle – a different kind of phasing.
Generally, the in vitro amplifications performed prior to sequencing for these three tech-
nologies, cause a higher error to be introduced into the sample before it enters the actual
sequencing process. In addition, currently used random-dispersal protocols for immobiliza-
tion of sequencing templates using beads or other solid surfaces cause mixed signal read outs
and dependence of sequencing errors on the strength and distance from close-by sequencing
reactions.
High quality Sanger sequencing is still commonly used to generate low coverage sequenc-
ing of individual positions, regions or very small genomes. Since Sanger sequence length
(700-1,000bp) is longer than most abundant short repeat classes, it allows the unambiguous
assembly of most genomic regions. However, Sanger technology is too expensive and too slow
for sequencing a large number of samples, extended genomic regions or the many molecules
required for quantitative applications. The 454 GS FLX Titanium provides a read length
(400-500bp) still spanning many short repeat sequences – an important feature for accurate
sequence mapping and assembly of genomes. Paired end or mate pair protocols help to over-
come some of the limitations of short reads by providing information about relative location
and orientation of a pair of reads.
Despite the insertion/deletion errors, the 454 technology has very low rates of misidentifying
individual bases (1/1,000 - 1/10,000), making it suited for the identification of single nu-
cleotide polymorphisms. Also geared to the identification of SNPs, at least for samples with
an existing reference genome, is the SOLiD platform. Higher coverage is needed in order to
perform SNP calling with similar accuracy using the Illumina Genome Analyzer. Neither
the Illumina Genome Analyzer nor the SOLiD sequencing systems are prone to generating
high rates of insertions or deletions, making them well suited for studying InDel variation.
Over the last years, the field of genetics experienced a shift from the amount of time required
to prepare and run a sequencing experiment to the time required for the analysis of the
generated data. It is likely that also in the future, laboratories will need to invest considerably
more time, expertise and money in the design of experiments and the analysis of the vast
quantities of data than in generating sequences. Smaller research groups may still not be
able to afford the infrastructure needed for storing, handling and analyzing several tens of
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gigabytes of pure sequence data from these sequencing platforms. Even for larger groups
and experienced genome centers this aspect remains an ever-increasing challenge.
New technologies like SMRT sequencing by Pacific Biosciences, Quantum-dot sequencing
by Life Technologies or BASE by Oxford Nanopore will allow sequencing long individual
molecules without or with little preparation steps and probably even the identification of
specific nucleotide modifications. Improvements to current instruments are likely to further
increase throughput and reduce cost of determining DNA sequences. Thus, the goal of a
$1,000 human genome set by NIH/NHGRI for personalized medicine may soon be achieved.
All these developments will hopefully facilitate future research in many fields and hopefully
also simplify biological data analysis, to put these technologies into more hands.
Computational challenges from sequencing data production
The described advances in DNA sequencing already now bring a broader part of the scien-
tific community in situations where a high-throughput project has to be designed or large
sequence data sets have to be analyzed. The new technologies however come with some
limitations and problems like for example considerable variance in run quality, specific bi-
ases and sensitivities, pseudo-sequences, high error rates as well as adapter and chimera
sequences. These issues require to either design the project in a way to circumvent them or
to consider them in data analysis before answering the actual biological question. In this
regard, I analyzed the currently most frequently used high-throughput sequencing platform,
the Illumina Genome Analyzer, in chapter 3.
The different Illumina sequencing instruments provide a high flexibility for creating func-
tional sequencing libraries, as the only requirement, specific outer grafting sequences, can be
added using various experimental approaches. This makes library design very flexible and al-
lows application-specific protocols. Most preparation protocols require different DNA/RNA
ligation, PCR amplification, purification and length selection steps. These can cause non-
random sampling of the original molecules, which may limit the capacity to identify sequence
variants or alter molecule frequency and quantification. Having different library preparation
protocols requires that all of them are optimized for even sampling, a minimum of artifacts
like adapter dimers, chimeras and contamination from other DNA/RNA sources as well as
a sufficient insert size.
Illumina software does not handle artifact sequences nor does it filter or trim adapters. This
is the reason why insert-adapter-chimeras or pure adapter dimers often end up in final data
analysis. When adapter sequence starting at the read end is not identified for short-insert size
libraries, this introduces a bias as reads are either excluded during mapping or reported with
wrong alignment coordinates. When explicitly done for a sequencing run, the identification
of starting adapter sequence and adapter chimeras is hampered by reads showing only a few
bases of the adapter and by higher error rates at the end of a read. For paired end reads the
correct identification of the adapter start position is eased by maximizing autocorrelation of
the two reads with the outlined read merging process. Hence, for short insert libraries, paired
end sequencing is to be preferred over single read sequencing. In addition to the efficient
identification of adapters, merging reduces error rates in the consensus called sequence part.
The presented algorithm has therefore been vital for ancient DNA studies at the Max Planck
Institute.
In addition to creating a high-quality sequencing library and quantifying it, the correct
adjustment of the machine, handling, as well as particles in the sequencing chemistry do
have an impact on run quality. Reflections, uneven application of oil, air bubbles and a not
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perfectly-adjusted machine cause varying data quality and increased error rates. Particles
like chemistry lumps, dust and lint can cause pseudo sequence signals which then result
in the analysis of low sequence complexity reads which do not originate from the library
sequenced. Tagging or indexing allows to filter for real library molecules and should be
preferred over sequence-complexity-based methods. Even though filter based on sequence
entropy provides high removal rates, it may introduce a bias due to the removal of real
low complexity sequences. Further, filtering sequence tags or indexes is advantageous as it
may also exclude contamination of sequencing lanes with molecules originating from other
sequencing libraries and samples.
When an index/tag is placed in the beginning of the read, it can increase sequencing costs
due to problems introduced in image data analysis and base calling. Correctly performed
as separate reads, the error profile of the actual reads is not altered and multiplexing allows
for the optimal usage of the increasing sequencing throughput, especially if subsets of a
large genome or several small genomes are studied. When using an indexed spike-in control
library in all lanes of a run, measures of run quality can be obtained and compared between
individual lanes and whole runs. Further, these reads allow for quality score calibration and
the application of alternative base callers. PHRED-like base quality scores should be used for
quality-based filtering based on the complete read and specifically also on the index read
outs of multiplex experiment. Quality-score-based filters remove clusters accumulating error
due to their close proximity to another sequence cluster, but also remove reads affected by
freely movable artifacts in specific sequencing cycles.
Improving base call quality of the Genome Analyzer platform
The Illumina Genome Analyzer is based on parallel, fluorescence-based readout of millions of
immobilized sequences that are iteratively sequenced in a base-wise manner. After sequencing
or while the sequencing run proceeds, images are analyzed and intensities extracted for
each sequence cluster and all cycles of the run. The measured light intensities minus the
surrounding background are extracted and resulting intensity values serve as input for base
calling, the conversion of intensity values into bases. Base calling on the Illumina platform
is complicated by at least two effects. First, a strong correlation of the adenine and cytosine
intensities as well as of the guanine and thymine intensities due to similar emission spectra of
fluorophores and a limited separation by optical filters. Second, a dependence of the signal
for a specific cycle on the signal of the cycles before and after, known as phasing and pre-
phasing, respectively. The fraction of molecules in a cluster affected by this loss of synchrony
in the readout of the sequence copies increases with the number of cycles, hampering correct
base identification.
Already during the first year after the release of the Illumina platform, statistical learners
trained on sequences called by the standard base caller were suggested for improving the base
calling of the platform. In chapter 4, I presented Ibis (Improved base identification
system), a more accurate, fast and easy-to-use base caller for all Illumina sequencing instru-
ments.
Previous approaches corrected raw intensities prior to the application of statistical learners
and used only the intensities of one cycle as input. This causes these approaches, and other
model-based approaches, to depend on a good understanding and modeling of the sequencing
process for obtaining corrected intensities. Ibis by-passes this problem by direct training
of one statistical model per sequencing cycle based on raw cluster intensities of multiple
input cycles, directly incorporating the effects of phasing and pre-phasing. Even though
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this approach may not provide interpretable model parameters, Ibis implements the most
general and flexible approach. This is of advantage when considering the vast improvements
of sequencing chemistry and instrument over the last years.
Ibis was originally developed to handle the T accumulation, in a sequencing chemistry which
has been replaced by several subsequent versions, and still its application is not limited
to the reprocessing of data created with the older chemistries. I have shown that Ibis
improves the output of sequencing runs from the Genome Analyzer I, which due to their
short read length are barely affected by T accumulation, but by a generally lower image
and sequencing quality. Further, I have shown that it improves base calling accuracy for
runs using recent sequencing chemistries without T accumulation and increased sequencing
length. The reason is the sequencing model independent training process of Ibis, which
only relies on the assumption that the vast majority of the signal needed for base calling is
captured by the intensity values of the previous, the current and the next cycle.
The presented approach is unique and currently applies to the full range of different sequenc-
ing chemistries and platform versions, where it reduces sequencing error by at least 10-20%.
The performance of Ibis on standard hardware is significantly better than for other exist-
ing alternative base callers, enabling it to be run by research laboratories without access to
large computational clusters. The increase in mappable sequences as well as improved and
calibrated PHRED-like quality scores enable the direct use of the sequences in other software
packages. Thus, there is a considerable benefit in investing the computational time in Ibis
re-base-calling for sequencing runs.
Quantification of gene expression from short-sequence tags
Comparative genomics studies of humans, hominins and other apes are important in order to
better understand human origins and the biological background of what sets humans apart
from other primates. They may also provide insights for the basis of diseases or developmen-
tal problems that affect uniquely human traits, such as speech disorders, mental disorders
like autism and schizophrenia or metabolic disorders like obesity. The first studies of gene
expression differences using microarrays allowed the characterization of human-chimpanzee
gene expression at a genome-wide scale, which was not possible before. The analysis of five
tissue transcriptomes showed that while gene expression may mostly evolve neutrally in the
two species, positive selective forces may shape brain and testis transcriptomes.
The technological advances in sequencing allowed to complement these original studies with
new insights from direct sequencing of transcriptomes. While microarrays are static in
their design and limited to the analysis of genomic features known at the time of design,
sequence-based gene expression profiling represents a more direct approach for identifying
the expressed molecules. Further, hybridization-based technologies are rather sensitive to
polymorphisms in the transcribed region that is probed – a problem that is amplified in
comparative studies in which expression patterns of species with some sequence differences
are inferred and compared. The Illumina NlaIII Digital Gene Expression (DGE) approach
was used to study brain, heart, kidney, liver and testis tissues of humans, chimpanzees and
rhesus macaques. This NlaIII DGE protocol was one of the first applications of the Illumina
sequencing platform and is based on the Serial Analysis of Gene Expression (SAGE) which
infers gene expression levels through short (here 17nt) tag sequencing from the 3’ end of
transcripts.
The tag data was generated in tissue batches over a period of one and a half years. Se-
quencing reads were processed following the principles outlined in chapter 3. Reads were
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filtered for dimer/chimera sequences and for the presence of adapter sequence at the read
end. Further, reads were filtered based on PHRED quality scores and sequence entropy. Low
complexity sequences were of increased frequency for older Genome Analyzer runs, due to a
reflection layer surrounding the actual lanes of version 1 flow cells. For the kidney and heart
batches, samples showed up to 40% of adapter dimers/chimeras. Data quality also showed
considerable variation between batches, supporting the need of the applied quality filters.
Even though the Illumina Digital Gene Expression protocol could overcome limitations of
a static microarray design, I could show that specific features of this type of data also
complicate analysis. Incomplete digestion and enzyme hindrance cause the dispersion of
transcript counts across multiple restriction sites. Unspecific carry-over of upstream NlaIII
digestion fragments between experimental steps causes a false signal of antisense transcription
and may also cause additional, i.e. non-3’-most, tag counts on the sense strand. Further,
the free annotation of genomic features, which was considered an advantage of a sequencing
approach, turned out to remain a challenge. Annotation of tags was problematic due to
ambiguities from their short length and due to very different annotation quality for the
different species. Only very recent human gene annotation provided the necessary 3’ UTR
annotation and could be projected to the chimpanzee and rhesus, losing about 36% of genes
annotated in human but giving similar proportions of tag counts within genes for all three
species.
The biggest challenge, however, was that many tags are not unique to specific genomic
sites or genes, and that the uniqueness of tags differs slightly between the three species.
This causes the tags of two and more different genes to be collapsed into one measurement.
Different approaches of counting tags multiple times or removing ambiguous tags do all
result in wrong gene quantifications, i.e. a false ranking of gene expression values. The effect
seems not very strong as rank correlations around 0.9 are observed between two extreme
approaches. Further, the impact on the inter-species analysis is expected to be low, as this
ranking problem will be largely the same in all three species. Variation between species is
only expected from evolution and loss of NlaIII sites in each genome, with rates expected to
be close to average species sequence divergence.
From comparisons to other studies of the same species and tissues, larger disagreement was
observed than expected. Differences in the symmetry of assignment of changes to lineages
or the percentage differentially expressed genes were observed. The extend of disagreement
could not easily be explained with the false discovery rates of the applied statistical tests. It
is likely that all methods have technological (experimental and analysis) biases, and that the
obtained variance estimates are too low. Specifically, the comparison with the Babbitt et al.
study (which uses the same NlaIII DGE protocol for different brain samples), clearly showed
that sampling variation is larger than variance from biological differences between human
and chimpanzee and that analysis variation may even be as strong as differences between
human/chimpanzee and rhesus macaque.
Comparing the previous microarray and the new DGE five tissue study, the strongest and
most consistent pattern in the data sets are the about 30% differentially expressed genes
between human and chimpanzee testis. Other studies have however suggested that human
testes may contain around 20% less germ cells per volume than chimpanzee testes. If this
proves to be correct, the differential expression effect may be largely driven from changes
in tissue composition. Even though it is completely valid that expression differences origi-
nate from variation in cell-type composition, expression differences from changes in cell-type
composition conflict with the goal of understanding how DNA sequence evolution impacts
gene expression in fully developed tissue.
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The presented result of human-chimpanzee expression differences being smaller than the vari-
ation from sampling and experimental protocols for at least one tissue, challenges current
findings from these inter-species studies. For future studies it will be of interest to minimize
all sources of variation. To achieve this, it will be necessary to stringently control sample en-
vironmental effects and sample age, increase the number of samples, study specific cell-types
rather than tissues and to use improved experimental and analysis protocols. The analyses
presented clearly showed that inter-species studies are very sensitive to small differences in
data processing. Such differences may easily originate from different genome quality, genome
completeness and genome annotation quality. Measures have to be established to check for
such effects in the analysis.
Analysis of two hominin genomes from ancient DNA
Since ancient DNA sequences are generally short in length, damaged, and at low copy-number
relative to co-extracted environmental DNA, high-throughput sequencing approaches offer
a tremendous advantage over traditional Sanger sequencing in that they enable a complete
characterization of an ancient DNA extract. As the cost of sequencing continues to decrease,
it has become feasible to analyze entire genomes of ancient samples, including those for which
the endogenous DNA makes up only a very small percentage of the total extracted DNA. The
Max Planck Institute for Evolutionary Anthropology has used high-throughput sequencing
for whole genome shotgun sequencing of two extinct hominin genomes, the Neandertal and
Denisova genome. Chapter 6 described the processing of the ancient DNA as well as present-
day human Illumina sequencing data which I have performed for both projects.
The high-throughout data obtained from ancient DNA libraries includes reads with adapter
sequence at the ends, chimerical sequences and other artifacts, sequencing error as well as
alignment ambiguities due to the short read lengths and DNA damage. For Neandertal and
Denisova these different challenges have been addressed using the approaches outlined in
chapter 3 and 4 (e.g. improved base calling, tag filtering, and read merging). In combination
with experimental approaches, the sequencing error associated with ancient DNA studies
could be considerably reduced. For example, the remaining error from sequencing and ancient
DNA damage in the Denisova molecule read outs are 4.6x lower than for present-day human
sequences analyzed with the same instrument and sequencing chemistry version.
I exemplified how the sequence data can be used to study sites in the human genome which
have changed since the last common ancestor of human, chimpanzee and bonobo. The
comparison of the human genome to the genomes of Neandertals and the Denisova individual
allows to identify features that set fully anatomically modern humans apart from other
hominin forms. In particular, I generated a catalog of changes that have become fixed or
have risen to high frequency in present-day humans since the divergence from these other
human forms. The identified positions point to several regions and genes, some of which
might be affected by positive selection in the recent evolutionary history of modern humans.
Once the Neandertal and Denisova genomes are sequenced to higher coverage, the number
of these candidate positions will approximately double as currently some regions are not
sufficiently covered to determine the exact state of these two ancient hominins for all positions
which changed on the human lineage. Continuing studies of human genome diversity like for
example the 1,000 Genome project, will help to reduce the number of putatively relevant sites.
However, most importantly, experimental work will be required to elucidate the physiological
consequences of the identified changes.
In addition, I described an interesting subset of sites which changed on the human lineage.
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These sites were identified from analyzing the concordance of Neandertals and the Denisova
individual. This subset is seen in the ancestral state in Neandertals or the Denisova individual
but not in both. Considering that Neandertals and Denisovans form a common clade, these
positions at least partially represent variation present at the time when the lineages of modern
humans, Neandertals and Denisovans separated. Since positions where differently fixed in
these three lineages, allele sharing patterns were generated that do not follow the genome-
wide phylogeny of the three species. Hence, these sites can be described as incomplete lineage
sorting. Thus, the ancestral states might have been reintroduced into some present-day
human populations by admixture with either Neandertals or Denisovans. Therefore, these
sites can be used to test present-day human individuals whether they show more frequently
the ancestral allele for the Denisova ancestral sites or the ancestral allele for Neandertal
ancestral sites.
I pointed out that an excess in the number of Denisova ancestral sites exists in the catalog
of changes, even when removing a bias from the human reference genome due to Neandertal
admixture in its non-African parts. This excess might originate from admixture into the
Denisova individual from some other archaic hominin, however biases from alignment can
not be ruled out and results are inconclusive at this point. When analyzing the Neandertal-
Denisova discordant sites in twelve present-day populations, they turned out to be infor-
mative for detecting admixture with either of the ancient population. I could confirm that
an African individual shares fewer ancestral alleles with Neandertal than do all non-African
individuals, supporting the admixture signal with non-Africans described in Green et al. for
the Neandertal genome. Further, I could show that Melanesians, especially the two Papuan
individuals, show a signal of Denisovan admixture not shared with other sampled popula-
tions, a result in agreement with the D-statistics for population pairs presented in Reich et
al. for the Denisova genome.
Outlook
The field of high-throughput sequencing data analysis emerged in 2005, when the 454 Genome
Sequencer became available. It is obvious that such a young field has a lot of potential for
further improvements and even major changes. We will most likely see several improvements
to instruments and library preparation protocols over the next few years. These will hopefully
reduce amplification, ligation and purification biases, or at least lower the DNA/RNA input
requirements or the number of experimental steps, to reduce their effects. In this respect
more transparency from vendors will be required as thorough studies of biases should not
need to be done independently by all groups applying these protocols.
Further, more experimental controls will be developed. What is already standard at the
Max Planck Institute for Evolutionary Anthropology, the sequencing of a spike-in control
library with every sample, will likely be more widely applied. Additional controls for library
preparation and specific steps of sequencing preparation will become available and make
library quality a more transparent measure. The goal will be to better understand biases
and to actually measure and detect them. Without any measure of the actual biases, one
might be lucky to detect them (as the case for the presented studies) but may not be able
to correct the data appropriately.
These developments will hopefully contribute to a better planning of experiments, including
the controls for small effects and the comparability of conditions. Once data is generated,
it is frequently very difficult to identify these problems and too expensive to repeat part
of the experiment. Specifically in the context of comparative studies, downstream analysis
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needs to be outlined before data generation and sources of species bias tested. As long as
genome quality, completeness and annotation vary between species, there will always be this
danger. If these problems are resolved, a concern remains about different levels of species
diversity, and how one reference sequence can represent this diversity. In the analysis of
Neandertal and Denisova, the population history of some genomic regions of the human
reference influenced the results. Either a population history-free genome, i.e. the “average
human genome”, has to be generated or all types of analyses have to be checked that they
do not depend on such small signals. Another approach might be the idea of genome graphs
incorporating all known sequence variation and appropriate algorithms to work on these.
The outlined adapter and chimera handling needs to be integrated into sequencing analysis
pipelines and possibly also the vendor pipelines. Alternative base callers and quality score
calibration from control reads should be a standard step in sequencing analysis pipelines.
Further, improved aligners and analysis software is required which fully uses quality scores
and provides sensitive measures on mapping accuracy and mapping likelihood. More gener-
ally, likelihood and error propagation in data analysis needs be to strengthened, otherwise
reported significance measures will not be correct.
For Ibis, future developments may include the reimplementation using free SVM packages,
instead of a package which is only free for non-commercial use. This should then allow
the integration into the standard Illumina analysis pipeline. Using one-against-all multi-
class approaches may also allow more direct measures of base quality scores. It might be
of interest to report up to four base quality scores instead of one base. Currently, however,
effectively no downstream software exists that would handle such data.
Quantification of gene expression by tag profiling or microarrays are likely to be replaced by
RNAseq approaches. RNAseq is the equivalent of a genome shot-gun sequencing approach
for the transcriptome and determines RNA fragments from the full length transcripts. It
is therefore less affected by sample and library preparation biases (e.g. molecule GC biases
from PCR amplification and gel excision) or analysis biases due to ambiguous alignments.
Quantification can use the full length of the transcript and correct for regions of increased
or reduced read coverage, as is already implemented in recent RNAseq quantification tools.
In addition, RNAseq provides both quantification and information on different splice forms
as well as variation in transcription start and polyadenylation sites. This information may
enable de novo transcriptome annotation, e.g. for poorly annotated primate genomes. Differ-
ences in genome quality and completeness between different primate genomes will however
still complicate comparative analyses. While some studies currently aim for low-coverage
sequencing of many different individuals and species, improvements to the genome quality
of non-reference and model species will require bigger investments of money and time.
Improvements in sequencing technologies will most likely include considerable increases in
read length. While this development is of advantage for many application using recent
DNA and RNA sources, the field of ancient DNA will probably not profit much from these
improvements due to the generally short ancient molecule lengths. Here approaches with high
parallelization and sensitivity to base modifications will be of interest. If DNA damage could
be directly identified during read out, the original base can be inferred during data analysis
and experimental steps prior to sequencing reduced. While currently the treatment of ancient
DNA for deaminated cytosines provides great reduction in sequence error, it also reduces
molecule length and causes some molecules to be lost in the additional experimental steps.
More efficient extraction and preparation methods in combination with highly parallelized
sequencing could permit access to the small proportion of longer molecules and hopefully
allow for high coverage and high quality genomes from ancient DNA samples.
171
Bibliography
[1] M. Abu and T.R. Waters. The main role of human thymine-DNA glycosylase is re-
moval of thymine produced by deamination of 5-methylcytosine and not removal of
ethenocytosine. Journal of Biological Chemistry, 278(10):8739, 2003.
[2] F. Albertorio, M. E. Hughes, J. A. Golovchenko, and D. Branton. Base dependent
DNA-carbon nanotube interactions: activation enthalpies and assembly-disassembly
control. Nanotechnology, 20(39):395101, 2009.
[3] B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter. Molecular
Biology of the Cell. 4th edition. Garland Science, New York, USA, 2002.
[4] Gene Amdahl. Validity of the Single Processor Approach to Achieving Large-Scale
Computing Capabilities. AFIPS Conference Proceedings, 30:483–485, 1967.
[5] S. Anders and W. Huber. Differential expression analysis for sequence count data.
Genome Biology, 11(10):R106, 2010.
[6] M.J. Anderson, S.J. Chapman, E.N. Videan, E. Evans, J. Fritz, T.S. Stoinski, A.F.
Dixson, and P. Gagneux. Functional evidence for differences in sperm competition in
humans and chimpanzees. American journal of physical anthropology, 134(2):274–280,
2007.
[7] S. Andrews. FastQC: A quality control tool for high throughput sequence data. http:
//www.bioinformatics.bbsrc.ac.uk/projects/fastqc/, 2010.
[8] W. J. Ansorge. Next-generation DNA sequencing techniques. Nature Biotechnology,
25(4):195–203, 2009.
[9] Y. Astier, O. Braha, and H. Bayley. Toward single molecule DNA sequencing: direct
identification of ribonucleoside and deoxyribonucleoside 5’-monophosphates by using
an engineered protein nanopore equipped with a molecular adapter. J Am Chem Soc,
128(5):1705–10, 2006.
[10] C.C. Babbitt, O. Fedrigo, A.D. Pfefferle, A.P. Boyle, J.E. Horvath, T.S. Furey, and
G.A. Wray. Both noncoding and protein-coding RNAs contribute to gene expression
evolution in the primate brain. Genome Biology and Evolution, 2(0):67, 2010.
[11] B. Ballester, N. Johnson, G. Proctor, and P. Flicek. Consistent annotation of gene
expression arrays. BMC genomics, 11(1):294, 2010.
[12] J. Batley and D. Edwards. Genome sequence data: management, storage, and visual-
ization. Biotechniques, 46(5):333–4, 336, 2009.
[13] N. Beifang, F. Limin, S. Shulei, and L. Weizhong. Artificial and natural duplicates in
pyrosequencing reads of metagenomic data. BMC Bioinformatics, 11.
172
BIBLIOGRAPHY
[14] Y. Benjamini and Y. Hochberg. Controlling the false discovery rate: a practical and
powerful approach to multiple testing. Journal of the Royal Statistical Society. Series
B (Methodological), 57(1):289–300, 1995.
[15] D. Benovoy, T. Kwan, and J. Majewski. Effect of polymorphisms within probe-
target sequences on olignonucleotide microarray experiments. Nucleic Acids Research,
36(13):4417, 2008.
[16] D. R. Bentley, S. Balasubramanian, H. P. Swerdlow, G. P. Smith, J. Milton, C. G.
Brown, K. P. Hall, D. J. Evers, C. L. Barnes, H. R. Bignell, J. M. Boutell, J. Bryant,
R. J. Carter, R. Keira Cheetham, A. J. Cox, D. J. Ellis, et al. Accurate whole human
genome sequencing using reversible terminator chemistry. Nature, 456(7218):53–9,
2008.
[17] F.B. Bercovitch, A. Widdig, A. Trefilov, M.J. Kessler, J.D. Berard, J. Schmidtke,
P. Nu¨rnberg, and M. Krawczak. A longitudinal study of age-specific reproductive
output and body condition among male rhesus macaques, Macaca mulatta. Naturwis-
senschaften, 90(7):309–312, 2003.
[18] C.A. Bill, W.A. Duran, N.R. Miselis, and J.A. Nickoloff. Efficient repair of all types
of single-base mismatches in recombination intermediates in Chinese hamster ovary
cells: competition between long-patch and GT glycosylase-mediated repair of GT mis-
matches. Genetics, 149(4):1935, 1998.
[19] Applied Biosystems. A Theoretical Understanding of 2 Base Color Codes and Its
Application to Annotation, Error Detection, and Error Correction, 2008.
[20] C.P. Bird, B.E. Stranger, M. Liu, D.J. Thomas, C.E. Ingle, C. Beazley, W. Miller,
M.E. Hurles, and E.T. Dermitzakis. Fast-evolving noncoding sequences in the human
genome. Genome Biology, 8(6):R118, 2007.
[21] I. Birol, S.D. Jackman, C.B. Nielsen, J.Q. Qian, R. Varhol, G. Stazyk, R.D. Morin,
Y. Zhao, M. Hirst, J.E. Schein, et al. De novo transcriptome assembly with ABySS.
Bioinformatics, 25(21):2872, 2009.
[22] R. G. Blazej, P. Kumaresan, and R. A. Mathies. Microfabricated bioprocessor for inte-
grated nanoliter-scale Sanger DNA sequencing. Proceedings of the National Academy
of Sciences USA, 103(19):7240–5, 2006.
[23] R. Blekhman, J.C. Marioni, P. Zumbo, M. Stephens, and Y. Gilad. Sex-specific and
lineage-specific alternative splicing in primates. Genome Research, 20(2):180, 2010.
[24] B.M. Bolstad, R.A. Irizarry, M. Astrand, and T.P. Speed. A comparison of normaliza-
tion methods for high density oligonucleotide array data based on variance and bias.
Bioinformatics, 19(2):185, 2003.
[25] J. Bowers, J. Mitchell, E. Beer, P. R. Buzby, M. Causey, J. W. Efcavitch, M. Jarosz,
E. Krzymanska-Olejnik, L. Kung, D. Lipson, G. M. Lowman, S. Marappan, P. McIner-
ney, A. Platt, A. Roy, S. M. Siddiqi, K. Steinmann, and J. F. Thompson. Virtual ter-
minator nucleotides for next-generation DNA sequencing. Nature Methods, 6(8):593–5,
2009.
[26] A. W. Briggs, J. M. Good, R. E. Green, J. Krause, T. Maricic, U. Stenzel, C. Lalueza-
Fox, P. Rudan, D. Brajkovic, Z. Kucan, I. Gusic, R. Schmitz, V. B. Doronichev, L. V.
Golovanova, M. de la Rasilla, J. Fortea, A. Rosas, and S. Pa¨a¨bo. Targeted retrieval
and analysis of five Neandertal mtDNA genomes. Science, 325(5938):318–21, 2009.
173
BIBLIOGRAPHY
[27] A. W. Briggs, U. Stenzel, M. Meyer, J. Krause, M. Kircher, and S. Pa¨a¨bo. Removal
of deaminated cytosines and detection of in vivo methylation in ancient DNA. Nucleic
Acids Research, 2009.
[28] A.W. Briggs, U. Stenzel, P.L.F. Johnson, R.E. Green, J. Kelso, K. Pru¨fer, M. Meyer,
J. Krause, M.T. Ronan, M. Lachmann, et al. Patterns of damage in genomic DNA
sequences from a Neandertal. Proceedings of the National Academy of Sciences USA,
104(37):14616, 2007.
[29] T.C. Brown and J. Jiricny. A specific mismatch repair event protects mammalian cells
from loss of 5-methylcytosine. Cell, 50(6):945–950, 1987.
[30] H. A. Burbano, E. Hodges, R. E. Green, A. W. Briggs, J. Krause, M. Meyer, J. M.
Good, T. Maricic, P. L. Johnson, Z. Xuan, M. Rooks, A. Bhattacharjee, L. Brizuela,
F. W. Albert, M. de la Rasilla, J. Fortea, A. Rosas, M. Lachmann, G. J. Hannon, and
S. Pa¨a¨bo. Targeted investigation of the Neandertal genome by array-based sequence
capture. Science, 328(5979):723–5, 2010.
[31] E.C. Bush and B.T. Lahn. A genome-wide screen for noncoding elements important
in primate evolution. BMC Evolutionary Biology, 8(1):17, 2008.
[32] F. Caiment, C. Charlier, T. Hadfield, N. Cockett, M. Georges, and D. Baurain. As-
sessing the effect of the CLPG mutation on the microRNA catalog of skeletal muscle
using high-throughput sequencing. Genome Research, 20(12):1651, 2010.
[33] M.J. Chaisson, D. Brinza, and P.A. Pevzner. De novo fragment assembly with short
mate-paired reads: Does the read length matter? Genome Research, 19(2):336, 2009.
[34] W. Chen, R. Ullmann, C. Langnick, C. Menzel, Z. Wotschofsky, H. Hu, A. Doring,
Y. Hu, H. Kang, A. Tzschach, M. Hoeltzenbein, H. Neitzel, S. Markus, E. Wieders-
berg, G. Kistner, C. M. van Ravenswaaij-Arts, T. Kleefstra, V. M. Kalscheuer, and
H. H. Ropers. Breakpoint analysis of balanced chromosome rearrangements by next-
generation paired-end sequencing. European Journal of Human Genetics, 2009.
[35] Chimpanzee Sequencing and Analysis Consortium. Initial sequence of the chimpanzee
genome and comparison with the human genome. Nature, 437(7055):69, 2005.
[36] A.G. Clark, S. Glanowski, R. Nielsen, P.D. Thomas, A. Kejariwal, M.A. Todd, D.M.
Tanenbaum, D. Civello, F. Lu, B. Murphy, et al. Inferring nonneutral evolution from
human-chimp-mouse orthologous gene trios. Science, 302(5652):1960, 2003.
[37] J. Clarke, H. C. Wu, L. Jayasinghe, A. Patel, S. Reid, and H. Bayley. Continuous base
identification for single-molecule nanopore DNA sequencing. Nature Nanotechnolgy,
4(4):265–70, 2009.
[38] S. J. Cokus, S. Feng, X. Zhang, Z. Chen, B. Merriman, C. D. Haudenschild, S. Pradhan,
S. F. Nelson, M. Pellegrini, and S. E. Jacobsen. Shotgun bisulphite sequencing of the
Arabidopsis genome reveals DNA methylation patterning. Nature, 452(7184):215–9,
2008.
[39] C. Cortes and V. Vapnik. Support-vector networks. Machine learning, 20(3):273–297,
1995.
[40] K. Crammer and Y. Singer. On the algorithmic implementation of multiclass kernel-
based vector machines. Journal of Machine Learning Research, 2(2):265–292, 2002.
174
BIBLIOGRAPHY
[41] K. Crammer and Y. Singer. On the algorithmic implementation of multiclass kernel-
based vector machines. The Journal of Machine Learning Research, 2:265–292, 2002.
[42] C. J. Creighton, J. G. Reid, and P. H. Gunaratne. Expression profiling of micrornas
by deep sequencing. Briefings in Bioinformatics, 10(5):490–7, 2009.
[43] V. Curwen, E. Eyras, T.D. Andrews, L. Clarke, E. Mongin, S.M.J. Searle, and
M. Clamp. The Ensembl automatic gene annotation system. Genome Research,
14(5):942, 2004.
[44] A. V. Dalca and M. Brudno. Genome variation discovery with high-throughput se-
quencing data. Briefings in Bioinformatics, 11(1):3–14, 2010.
[45] M. Dannemann, A. Lorenc, I. Hellmann, P. Khaitovich, and M. Lachmann. The effects
of probe binding affinity differences on gene expression measurements and how to deal
with them. Bioinformatics, 25(21):2772, 2009.
[46] M. M. DeAngelis, D. G. Wang, and T. L. Hawkins. Solid-phase reversible immobiliza-
tion for the isolation of pcr products. Nucleic Acids Research, 23(22):4742–3, 1995.
[47] S. Diguistini, N. Y. Liao, D. Platt, G. Robertson, M. Seidel, S. K. Chan, T. R. Docking,
I. Birol, R. A. Holt, M. Hirst, E. Mardis, M. A. Marra, R. C. Hamelin, J. Bohlmann,
C. Breuil, and S. J. Jones. De novo genome sequence assembly of a filamentous fungus
using Sanger, 454 and Illumina sequence data. Genome Biology, 10(9):R94, 2009.
[48] Eileen T Dimalanta, Lei Zhang, Cynthia L Hendrickson, Tanya D Sokolsky, Adam E
Sannicandro, Jonathan M Manning, Stephen F McLaughlin, Haoning Fu, Clarence C
Lee, Alan P Blanchard, Gina L Costa, and Kevin J McKernan. Increased Read Length
on the SOLiD Sequencing Platform, 2009.
[49] J. C. Dohm, C. Lottaz, T. Borodina, and H. Himmelbauer. Substantial biases in ultra-
short read data sets from high-throughput DNA sequencing. Nucleic Acids Research,
36(16):e105, 2008.
[50] P.C. Dolan and D.R. Denver. TileQC: a system for tile-based quality control of Solexa
data. BMC Bioinformatics, 9(1):250, 2008.
[51] T.R. Dreszer, G.D. Wall, D. Haussler, and K.S. Pollard. Biased clustered substitutions
in the human genome: the footprints of male-driven biased gene conversion. Genome
research, 17(10):1420, 2007.
[52] R. Drmanac, A. B. Sparks, M. J. Callow, A. L. Halpern, N. L. Burns, B. G. Kermani,
P. Carnevali, I. Nazarenko, G. B. Nilsen, G. Yeung, et al. Science, 327(5961):78–81,
2010.
[53] R.M. Durbin, D.L. Altshuler, G.R. Abecasis, D.R. Bentley, A. Chakravarti, A.G. Clark,
F.S. Collins, F.M. De La Vega, P. Donnelly, M. Egholm, et al. A map of human genome
variation from population-scale sequencing. Nature, 467(7319):1061–1073, 2010.
[54] L. Duret and N. Galtier. Biased gene conversion and the evolution of mammalian
genomic landscapes. Annual review of genomics and human genetics, 10:285–311,
2009.
[55] L. Duret and N. Galtier. Comment on Human-specific gain of function in a develop-
mental enhancer. Science, 323(5915):714c, 2009.
175
BIBLIOGRAPHY
[56] R.C. Edgar. Search and clustering orders of magnitude faster than BLAST. Bioinfor-
matics, 26(19):2460, 2010.
[57] J. Eid, A. Fehr, J. Gray, K. Luong, J. Lyle, G. Otto, P. Peluso, D. Rank, P. Baybayan,
B. Bettman, A. Bibillo, K. Bjornson, B. Chaudhuri, F. Christians, R. Cicero, et al.
Real-time DNA sequencing from single polymerase molecules. Science, 323(5910):133–
8, 2009.
[58] C. A. Emrich, H. Tian, I. L. Medintz, and R. A. Mathies. Microfabricated 384-lane
capillary array electrophoresis bioanalyzer for ultrahigh-throughput genetic analysis.
Analytical Chemistry, 74(19):5076–83, 2002.
[59] W. Enard, P. Khaitovich, J. Klose, S. Zollner, F. Heissig, P. Giavalisco, K. Nieselt-
Struwe, E. Muchmore, A. Varki, R. Ravid, et al. Intra-and interspecific variation in
primate gene expression patterns. Science, 296(5566):340, 2002.
[60] Y. Erlich, K. Chang, A. Gordon, R. Ronen, O. Navon, M. Rooks, and G. J. Han-
non. DNA Sudoku–harnessing high-throughput sequencing for multiplexed specimen
analysis. Genome Research, 19(7):1243–53, 2009.
[61] Y. Erlich, P. P. Mitra, M. delaBastide, W. R. McCombie, and G. J. Hannon. Alta-
Cyclic: a self-optimizing base caller for next-generation sequencing. Nature Methods,
5(8):679–82, 2008.
[62] W.J. Ewens. Mathematical population genetics: theoretical introduction. Springer
Verlag, 2004.
[63] B. Ewing and P. Green. Base-calling of automated sequencer traces using phred. II.
Error probabilities. Genome Research, 8(3):186–94, 1998.
[64] B. Ewing, L. Hillier, M. C. Wendl, and P. Green. Base-calling of automated sequencer
traces using phred. I. Accuracy assessment. Genome Research, 8(3):175–85, 1998.
[65] A.M. Faisst, G. Alvarez-Bolado, D. Treichel, and P. Gruss. Rotatin is a novel gene
required for axial rotation and left-right specification in mouse embryos. Mechanisms
of development, 113(1):15–28, 2002.
[66] M. Fedurco, A. Romieu, S. Williams, I. Lawrence, and G. Turcatti. BTA, a novel
reagent for DNA attachment on glass and efficient generation of solid-phase amplified
DNA colonies. Nucleic Acids Research, 34(3):e22, 2006.
[67] J.N. Fenner. Cross-cultural estimation of the human generation interval for use in
genetics-based population divergence studies. American journal of physical anthropol-
ogy, 128(2):415–423, 2005.
[68] A. Fischer, J. Pollack, O. Thalmann, B. Nickel, and S. Pa¨a¨bo. Demographic history
and genetic differentiation in apes. Current Biology, 16(11):1133–1138, 2006.
[69] P. Flicek and E. Birney. Sense from sequence reads: methods for alignment and
assembly. Nature Methods, 6(11 Suppl):S6–S12, 2009.
[70] B.A. Flusberg, D.R. Webster, J.H. Lee, K.J. Travers, E.C. Olivares, T.A. Clark, J. Ko-
rlach, and S.W. Turner. Direct detection of DNA methylation during single-molecule,
real-time sequencing. Nature methods, 7(6):461–465, 2010.
176
BIBLIOGRAPHY
[71] S. Fox, S. Filichkin, and T.C. Mockler. Applications of ultra-high-throughput sequenc-
ing. Methods in Molecular Biology, 553:79–108, 2009.
[72] N. Galtier and L. Duret. Adaptation or biased gene conversion? Extending the null
hypothesis of molecular evolution. Trends in Genetics, 23(6):273–277, 2007.
[73] R.C. Gentleman, V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis,
L. Gautier, Y. Ge, J. Gentry, et al. Bioconductor: open software development for
computational biology and bioinformatics. Genome Biology, 5(10):R80, 2004.
[74] K. S. George, X. Zhao, D. Gallahan, A. Shirkey, A. Zareh, and B. Esmaeli-Azad.
Capillary electrophoresis methodology for identification of cancer related gene expres-
sion patterns of fluorescent differential display polymerase chain reaction. Journal of
Chromatography B: Biomedical Sciences and Applications, 695(1):93–102, 1997.
[75] R.A. Gibbs, J. Rogers, M.G. Katze, R. Bumgarner, G.M. Weinstock, E.R. Mardis,
K.A. Remington, R.L. Strausberg, J.C. Venter, R.K. Wilson, et al. Evolutionary and
biomedical insights from the rhesus macaque genome. Science, 316(5822), 2007.
[76] W. Gilbert and A. Maxam. The nucleotide sequence of the lac operator. Proceedings
of the National Academy of Sciences USA, 70(12):3581–4, 1973.
[77] A. Gnirke, A. Melnikov, J. Maguire, P. Rogov, E. M. LeProust, W. Brockman, T. Fen-
nell, G. Giannoukos, S. Fisher, C. Russ, S. Gabriel, D. B. Jaffe, E. S. Lander, and
C. Nusbaum. Solution hybrid selection with ultra-long oligonucleotides for massively
parallel targeted sequencing. Nature Biotechnology, 27(2):182–9, 2009.
[78] JM Good, T. Giger, MD Dean, MW Nachman, and G.S. Barsh. Widespread Over-
Expression of the X Chromosome in Sterile F1 Hybrid Mice. PLoS Genetics, 6(9),
2010.
[79] M. Gralle and S. Pa¨a¨bo. A Comprehensive Functional Analysis of Ancestral Human
Signal Peptides. Molecular Biology and Evolution, 2010.
[80] R. Grantham. Amino acid difference formula to help explain protein evolution. Science,
185:862–864, 1974.
[81] R. E. Green, J. Krause, A. W. Briggs, T. Maricic, U. Stenzel, M. Kircher, N. Patterson,
H. Li, W. Zhai, M. H. Fritz, N. F. Hansen, E. Y. Durand, A. S. Malaspinas, J. D.
Jensen, T. Marques-Bonet, C. Alkan, et al. A draft sequence of the Neandertal genome.
Science, 328(5979):710–22, 2010.
[82] R. E. Green, J. Krause, S. E. Ptak, A. W. Briggs, M. T. Ronan, J. F. Simons, L. Du,
M. Egholm, J. M. Rothberg, M. Paunovic, and S. Pa¨a¨bo. Analysis of one million base
pairs of Neanderthal DNA. Nature, 444(7117):330–6, 2006.
[83] R. E. Green, A. S. Malaspinas, J. Krause, A. W. Briggs, P. L. Johnson, C. Uhler,
M. Meyer, J. M. Good, T. Maricic, U. Stenzel, K. Pru¨fer, M. Siebauer, H. A. Burbano,
M. Ronan, J. M. Rothberg, M. Egholm, P. Rudan, D. Brajkovic, Z. Kucan, I. Gusic,
M. Wikstrom, L. Laakkonen, J. Kelso, M. Slatkin, and S. Pa¨a¨bo. A complete Neander-
tal mitochondrial genome sequence determined by high-throughput sequencing. Cell,
134(3):416–26, 2008.
[84] R.E. Green, A.W. Briggs, J. Krause, K. Pru¨fer, H.A. Burbano, M. Siebauer, M. Lach-
mann, and S. Pa¨a¨bo. The Neandertal genome and ancient DNA authenticity. The
EMBO Journal, 28(17):2494–2502, 2009.
177
BIBLIOGRAPHY
[85] S. Griffiths-Jones, R.J. Grocock, S. Van Dongen, A. Bateman, and A.J. Enright. miR-
Base: microRNA sequences, targets and gene nomenclature. Nucleic Acids Research,
34(suppl 1):D140, 2006.
[86] A.R. Gruber, R. Lorenz, S.H. Bernhart, R. Neubock, and I.L. Hofacker. The Vienna
RNA websuite. Nucleic Acids Research, 36(Web Server issue):W70, 2008.
[87] K.D. Hansen, S.E. Brenner, and S. Dudoit. Biases in Illumina transcriptome sequencing
caused by random hexamer priming. Nucleic Acids Research, 38(12):e131, 2010.
[88] O. Harismendy, P. C. Ng, R. L. Strausberg, X. Wang, T. B. Stockwell, K. Y. Beeson,
N. J. Schork, S. S. Murray, E. J. Topol, S. Levy, and K. A. Frazer. Evaluation of next
generation sequencing platforms for population targeted sequencing studies. Genome
Biology, 10(3):R32, 2009.
[89] T. D. Harris, P. R. Buzby, H. Babcock, E. Beer, J. Bowers, I. Braslavsky, M. Causey,
J. Colonell, J. Dimeo, J. W. Efcavitch, E. Giladi, J. Gill, J. Healy, M. Jarosz, D. Lapen,
K. Moulton, S. R. Quake, K. Steinmann, E. Thayer, A. Tyurina, R. Ward, H. Weiss,
and Z. Xie. Single-molecule DNA sequencing of a viral genome. Science, 320(5872):106–
9, 2008.
[90] T. Hastie, R. Tibshirani, J. Friedman, and J. Franklin. The elements of statisti-
cal learning: data mining, inference and prediction. The Mathematical Intelligencer,
27(2):83–85, 2005.
[91] D. Haussler, S.J. O’Brien, O.A. Ryder, F.K. Barker, M. Clamp, A.J. Crawford, R. Han-
ner, O. Hanotte, W.E. Johnson, J.A. McGuire, et al. Genome 10K: A proposal to obtain
whole-genome sequence for 10 000 vertebrate species. Journal of Heredity, 100(6):659–
674, 2009.
[92] D. G. Hert, C. P. Fredlake, and A. E. Barron. Advantages and limitations of
next-generation sequencing technologies: a comparison of electrophoresis and non-
electrophoresis methods. Electrophoresis, 29(23):4618–26, 2008.
[93] P. Heyn, U. Stenzel, A.W. Briggs, M. Kircher, M. Hofreiter, and M. Meyer. Road
blocks on paleogenomes–polymerase extension profiling reveals the frequency of block-
ing lesions in ancient DNA. Nucleic Acids Research, 2010.
[94] E. Hodges, M. Rooks, Z. Xuan, A. Bhattacharjee, D. Benjamin Gordon, L. Brizuela,
W. Richard McCombie, and G. J. Hannon. Hybrid selection of discrete genomic inter-
vals on custom-designed microarrays for massively parallel sequencing. Nature Proto-
cols, 4(6):960–74, 2009.
[95] S. Hoffmann, C. Otto, S. Kurtz, C.M. Sharma, P. Khaitovich, J. Vogel, P.F. Stadler,
and J. Hackermuller. Fast mapping of short sequences with mismatches, insertions and
deletions using index structures. PLoS Computational Biology, 5(9):e1000502, 2009.
[96] Vyvayn Holland. The Complete Works of Oscar Wilde. Collins, London, UK, 1992.
[97] X. C. Huang, M. A. Quesada, and R. A. Mathies. DNA sequencing using capillary
array electrophoresis. Analytical Chemistry, 64(18):2149–54, 1992.
[98] M. Huber, G. Siegenthaler, N. Mirancea, I. Marenholz, D. Nizetic, D. Breitkreutz,
D. Mischke, and D. Hohl. Isolation and characterization of human repetin, a member of
the fused gene family of the epidermal differentiation complex. Journal of Investigative
Dermatology, 124(5):998–1007, 2005.
178
BIBLIOGRAPHY
[99] JW Ijdo, A. Baldini, DC Ward, ST Reeders, and RA Wells. Origin of human chromo-
some 2: an ancestral telomere-telomere fusion. Proceedings of the National Academy
of Sciences USA, 88(20):9051, 1991.
[100] International Human Genome Sequencing Consortium. Finishing the euchromatic se-
quence of the human genome. Nature, 431(7011):931–945, 2004.
[101] R.R. Iyer, A. Pluciennik, V. Burdett, and P.L. Modrich. DNA mismatch repair: func-
tions and mechanisms. Chem. Rev, 106(2):302–323, 2006.
[102] W.R. Jeck, J.A. Reinhardt, D.A. Baltrus, M.T. Hickenbotham, V. Magrini, E.R.
Mardis, J.L. Dangl, and C.D. Jones. Extending assembly of short DNA sequences
to handle error. Bioinformatics, 23(21):2942, 2007.
[103] Z. Jing, Y. Liu, M. Dong, S. Hu, S. Huang, et al. Identification of the DNA binding
element of the human ZNF333 protein. Journal of biochemistry and molecular biology,
37(6):663–670, 2004.
[104] B. John, A.J. Enright, A. Aravin, T. Tuschl, C. Sander, D.S. Marks, et al. Human
microRNA targets. PLoS Biology, 2(11):e363, 2004.
[105] H. Kambara and S. Takahashi. Multiple-sheathflow capillary array DNA analyser.
Nature, 361(6412):565–6, 1993.
[106] W. C. Kao, K. Stevens, and Y. S. Song. BayesCall: A model-based base-calling algo-
rithm for high-throughput short-read sequencing. Genome Research, 2009.
[107] W.C. Kao and Y. Song. naiveBayesCall: An efficient model-based base-calling al-
gorithm for high-throughput sequencing. In Research in Computational Molecular
Biology, pages 233–247. Springer, 2010.
[108] S. Katayama, Y. Tomaru, T. Kasukawa, K. Waki, M. Nakanishi, M. Nakamura,
H. Nishida, CC Yap, M. Suzuki, J. Kawai, et al. Antisense transcription in the mam-
malian transcriptome. Science, 309(5740):1564–1566, 2005.
[109] W.J. Kent. BLAT – the BLAST-like alignment tool. Genome research, 12(4):656,
2002.
[110] P. Khaitovich, W. Enard, M. Lachmann, and S. Pa¨a¨bo. Evolution of primate gene
expression. Nature Reviews Genetics, 7(9):693–702, 2006.
[111] P. Khaitovich, I. Hellmann, W. Enard, K. Nowick, M. Leinweber, H. Franz, G. Weiss,
M. Lachmann, and S. Pa¨a¨bo. Parallel patterns of evolution in the genomes and tran-
scriptomes of humans and chimpanzees. Science, 309(5742):1850, 2005.
[112] P. Khaitovich, K. Tang, H. Franz, J. Kelso, I. Hellmann, W. Enard, M. Lachmann, and
S. Pa¨a¨bo. Positive selection on gene expression in the human brain. Current Biology,
16(10):356–358, 2006.
[113] J. I. Kim, Y. S. Ju, H. Park, S. Kim, S. Lee, J. H. Yi, J. Mudge, N. A. Miller, D. Hong,
C. J. Bell, H. S. Kim, I. S. Chung, W. C. Lee, J. S. Lee, S. H. Seo, J. Y. Yun, H. N.
Woo, et al. A highly annotated whole-genome sequence of a Korean individual. Nature,
460(7258):1011–5, 2009.
[114] S. Kim, H. J. Yoo, and J. H. Hahn. Postelectrophoresis capillary scanning method for
DNA sequencing. Analytical Chemistry, 68(5):936–9, 1996.
179
BIBLIOGRAPHY
[115] M. Kircher and J. Kelso. High-throughput DNA sequencing-concepts and limitations.
BioEssays, 32(6):524–536, 2010.
[116] M. Kircher, U. Stenzel, and J. Kelso. Improved base calling for the Illumina Genome
Analyzer using machine learning strategies. Genome Biology, 10(8):R83, 2009.
[117] G. Koller, U. Schlomann, P. Golfi, T. Ferdous, S. Naus, and J.W. Bartsch. ADAM8 /
MS2 / CD156, an emerging drug target in the treatment of inflammatory and invasive
pathologies. Current pharmaceutical design, 15(20):2272–2281, 2009.
[118] J. Korlach, P. J. Marks, R. L. Cicero, J. J. Gray, D. L. Murphy, D. B. Roitman, T. T.
Pham, G. A. Otto, M. Foquet, and S. W. Turner. Selective aluminum passivation for
targeted immobilization of single DNA polymerase molecules in zero-mode waveguide
nanostructures. Proceedings of the National Academy of Sciences USA, 105(4):1176–81,
2008.
[119] J. Krause, A. W. Briggs, M. Kircher, T. Maricic, N. Zwyns, A. Derevianko, and
S. Pa¨a¨bo. A Complete mtDNA Genome of an Early Modern Human from Kostenki,
Russia. Current Biology, 2009.
[120] J. Krause, P.H. Dear, J.L. Pollack, M. Slatkin, H. Spriggs, I. Barnes, A.M. Lister,
I. Ebersberger, S. Pa¨a¨bo, and M. Hofreiter. Multiplex amplification of the mammoth
mitochondrial genome and the evolution of Elephantidae. Nature, 439(7077):724–727,
2005.
[121] J. Krause, Q. Fu, J.M. Good, B. Viola, M.V. Shunkov, A.P. Derevianko, and S. Pa¨a¨bo.
The complete mitochondrial DNA genome of an unknown hominin from southern
Siberia. Nature, 464(7290):894–897, 2010.
[122] J. Krause, L. Orlando, D. Serre, B. Viola, K. Pru¨fer, M.P. Richards, J.J. Hublin,
C. Ha¨nni, A.P. Derevianko, and S. Pa¨a¨bo. Neanderthals in central Asia and Siberia.
Nature, 449(7164):902–904, 2007.
[123] H.R. Ku¨nsch. The jackknife and the bootstrap for general stationary observations.
The Annals of Statistics, 17(3):1217–1241, 1989.
[124] D.J.G. Lahr and L.A. Katz. Reducing the impact of PCR-mediated recombination
in molecular evolution and environmental studies using a new-generation high-fidelity
DNA polymerase. BioTechniques, 47(4):857, 2009.
[125] E.S. Lander, L.M. Linton, B. Birren, C. Nusbaum, M.C. Zody, J. Baldwin, K. Devon,
K. Dewar, M. Doyle, W. FitzHugh, et al. Initial sequencing and analysis of the human
genome. Nature, 409(6822):860–921, 2001.
[126] B. Langmead, C. Trapnell, M. Pop, and S.L. Salzberg. Ultrafast and memory-efficient
alignment of short DNA sequences to the human genome. Genome Biology, 10(3):R25,
2009.
[127] M. Lapidot and Y. Pilpel. Genome-wide natural antisense transcription: coupling its
regulation to its different regulatory mechanisms. EMBO reports, 7(12):1216–1222,
2006.
[128] T. Lassmann, Y. Hayashizaki, and C. O. Daub. Tagdust–a program to eliminate
artifacts from next generation sequencing data. Bioinformatics, 25(21):2839–40, 2009.
180
BIBLIOGRAPHY
[129] C. Ledergerber and C. Dessimoz. Base-calling for next-generation sequencing plat-
forms. Briefings in Bioinformatics, 2011.
[130] B.P. Lewis, C.B. Burge, and D.P. Bartel. Conserved seed pairing, often flanked by
adenosines, indicates that thousands of human genes are microRNA targets. Cell,
120(1):15–20, 2005.
[131] H. Li and R. Durbin. Fast and accurate short read alignment with burrows-wheeler
transform. Bioinformatics, 25(14):1754–60, 2009.
[132] H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abeca-
sis, and R. Durbin. The sequence alignment/map format and samtools. Bioinformatics,
25(16):2078–9, 2009.
[133] H. Li, J. Ruan, and R. Durbin. Mapping short DNA sequencing reads and calling
variants using mapping quality scores. Genome research, 18(11):1851, 2008.
[134] R. Li, Y. Li, X. Fang, H. Yang, J. Wang, K. Kristiansen, and J. Wang. SNP detection
for massively parallel whole-genome resequencing. Genome Research, 19(6):1124, 2009.
[135] R. Li, Y. Li, K. Kristiansen, and J. Wang. SOAP: short oligonucleotide alignment
program. Bioinformatics, 24(5):713–4, 2008.
[136] R. Li, C. Yu, Y. Li, T.W. Lam, S.M. Yiu, K. Kristiansen, and J. Wang. SOAP2: an
improved ultrafast tool for short read alignment. Bioinformatics, 25(15):1966, 2009.
[137] W. Li and A. Godzik. Cd-hit: a fast program for clustering and comparing large sets
of protein or nucleotide sequences. Bioinformatics, 22(13):1658, 2006.
[138] W.H. Li, C.I. Wu, and C.C. Luo. A new method for estimating synonymous and
nonsynonymous rates of nucleotide substitution considering the relative likelihood of
nucleotide and codon changes. Molecular Biology and Evolution, 2(2):150, 1985.
[139] S. E. Linsen, E. de Wit, G. Janssens, S. Heater, L. Chapman, R. K. Parkin, B. Fritz,
S. K. Wyman, E. de Bruijn, E. E. Voest, S. Kuersten, M. Tewari, and E. Cuppen.
Limitations and possibilities of small RNA digital gene expression profiling. Nature
Methods, 6(7):474–6, 2009.
[140] S.E. Linsen, E. de Wit, G. Janssens, S. Heater, L. Chapman, R.K. Parkin, B. Fritz,
S.K. Wyman, E. de Bruijn, E.E. Voest, et al. Limitations and possibilities of small
RNA digital gene expression profiling. Nature methods, 6(7):474, 2009.
[141] L. Mamanova, A. J. Coffey, C. E. Scott, I. Kozarewa, E. H. Turner, A. Kumar,
E. Howard, J. Shendure, and D. J. Turner. Target-enrichment strategies for next-
generation sequencing. Nature Methods, 7(2):111–8, 2010.
[142] M. Margulies, M. Egholm, W. E. Altman, S. Attiya, J. S. Bader, L. A. Bemben,
J. Berka, M. S. Braverman, Y. J. Chen, Z. Chen, S. B. Dewell, L. Du, J. M. Fierro,
X. V. Gomes, B. C. Godwin, W. He, S. Helgesen, C. H. Ho, et al. Genome sequencing
in microfabricated high-density picolitre reactors. Nature, 437(7057):376–80, 2005.
[143] T. Maricic and S. Pa¨a¨bo. Optimization of 454 sequencing library preparation from
small amounts of DNA permits sequence determination of both DNA strands. Biotech-
niques, 46(1):51–2, 54–7, 2009.
181
BIBLIOGRAPHY
[144] Jr. Mariella, R. Sample preparation: the weak link in microfluidics-based biodetection.
Biomedical Microdevices, 10(6):777–84, 2008.
[145] J.C. Marioni, C.E. Mason, S.M. Mane, M. Stephens, and Y. Gilad. RNA-seq: an
assessment of technical reproducibility and comparison with gene expression arrays.
Genome Research, 18(9):1509, 2008.
[146] E. Martinez-Perez and M.P. Colaia´covo. Distribution of meiotic recombination events:
talking to your neighbors. Current opinion in genetics & development, 19(2):105–112,
2009.
[147] A. McKenna, M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis, A. Kernytsky,
K. Garimella, D. Altshuler, S. Gabriel, M. Daly, et al. The Genome Analysis Toolkit: A
MapReduce framework for analyzing next-generation DNA sequencing data. Genome
Research, 20(9):1297, 2010.
[148] P. Medvedev, M. Stanciu, and M. Brudno. Computational methods for discov-
ering structural variation with next-generation sequencing. Nature Methods, 6(11
Suppl):S13–20, 2009.
[149] M. L. Metzker. Sequencing technologies — the next generation. Nature Review Ge-
netics, 11(1):31–46, 2010.
[150] M. Meyer and M. Kircher. Illumina sequencing library preparation for highly multi-
plexed target capture and sequencing. Cold Spring Harbor protocols, 2010(6), 2010.
[151] M. Meyer, U. Stenzel, and M. Hofreiter. Parallel tagged sequencing on the 454 platform.
Nature Protocols, 3(2):267–78, 2008.
[152] A. Meyerhans, J.P. Vartanian, and S. Wain-Hobson. DNA recombination during PCR.
Nucleic Acids Research, 18(7):1687, 1990.
[153] J. R. Miller, A. L. Delcher, S. Koren, E. Venter, B. P. Walenz, A. Brownley, J. Johnson,
K. Li, C. Mobarry, and G. Sutton. Aggressive assembly of pyrosequencing reads with
mates. Bioinformatics, 24(24):2818–24, 2008.
[154] W. Miller, D.I. Drautz, A. Ratan, B. Pusey, J. Qi, A.M. Lesk, L.P. Tomsho, M.D.
Packard, F. Zhao, A. Sher, et al. Sequencing the nuclear genome of the extinct woolly
mammoth. Nature, 456(7220):387–390, 2008.
[155] A. Morgulis, G. Coulouris, Y. Raytselis, T.L. Madden, R. Agarwala, and A.A. Scha¨ffer.
Database indexing for production MegaBLAST searches. Bioinformatics, 24(16):1757,
2008.
[156] E. Mulugeta Achame, W.M. Baarends, J. Gribnau, J.A. Grootegoed, and J.G. Umen.
Evaluating the Relationship between Spermatogenic Silencing of the X Chromosome
and Evolution of the Y Chromosome in Chimpanzee and Human. PloS one, 5(12):424–
434, 2010.
[157] U. Nagalakshmi, Z. Wang, K. Waern, C. Shou, D. Raha, M. Gerstein, and M. Snyder.
The transcriptional landscape of the yeast genome defined by RNA sequencing. Science,
320(5881):1344, 2008.
[158] J.M. Nascimento, L.Z. Shi, S. Meyers, P. Gagneux, N.M. Loskutoff, E.L. Botvinick,
and M.W. Berns. The use of optical tweezers to study sperm competition and motility
in primates. Journal of The Royal Society Interface, 5(20):297, 2008.
182
BIBLIOGRAPHY
[159] R.G. Newcombe. Two-sided confidence intervals for the single proportion: comparison
of seven methods. Statistics in medicine, 17(8):857–872, 1998.
[160] J.P. Noonan. Regulatory DNAs and the evolution of human development. Current
opinion in genetics & development, 19(6):557–564, 2009.
[161] K. Nowick, T. Gernat, E. Almaas, and L. Stubbs. Differences in human and chimpanzee
gene expression patterns define an evolving network of transcription factors in brain.
Proceedings of the National Academy of Sciences, 106(52):22358, 2009.
[162] E. Oancea, J. Vriens, S. Brauchi, J. Jun, I. Splawski, and D.E. Clapham. TRPM1
forms ion channels associated with melanin content in melanocytes. Science Signaling,
2(70), 2009.
[163] S.J. Odelberg, R.B. Weiss, A. Hata, and R. White. Template-switching during
DNA synthesis by Thermus aquaticus DNA polymerase I. Nucleic Acids Research,
23(11):2049, 1995.
[164] K.E. Orii, T. Aoyama, K. Wakui, Y. Fukushima, H. Miyajima, S. Yamaguchi, T. Orii,
N. Kondo, and T. Hashimoto. Genomic and mutational analysis of the mitochondrial
trifunctional protein β-subunit (HADHB) gene in patients with trifunctional protein
deficiency. Human molecular genetics, 6(8):1215, 1997.
[165] S. Pa¨a¨bo. Human evolution. Trends in Cell Biology, 9(12):M13–M16, 1999.
[166] S. Pa¨a¨bo, D.M. Irwin, and A.C. Wilson. DNA damage promotes jumping between tem-
plates during enzymatic amplification. Journal of Biological Chemistry, 265(8):4718,
1990.
[167] L.E. Palmer, M. Dejori, R. Bolanos, and D. Fasulo. Improving de novo sequence
assembly using machine learning and comparative genomics for overlap correction.
BMC Bioinformatics, 11(1):33, 2010.
[168] J.A. Park and K.C. Kim. Expression patterns of PRDM10 during mouse embryonic
development. Development, 43(1):29–33, 2010.
[169] P. J. Park. ChIP-seq: advantages and challenges of a maturing technology. Nature
Review Genetics, 10(10):669–80, 2009.
[170] B. Paten, J. Herrero, K. Beal, and E. Birney. Sequence progressive alignment, a
framework for practical large-scale probabilistic consistency alignment. Bioinformatics,
25(3):295–301, 2009.
[171] B. Paten, J. Herrero, K. Beal, S. Fitzgerald, and E. Birney. Enredo and Pecan: genome-
wide mammalian consistency-based multiple alignment with paralogs. Genome Re-
search, 18(11):1814–28, 2008.
[172] S. Pepke, B. Wold, and A. Mortazavi. Computation for ChIP-seq and RNA-seq studies.
Nature Methods, 6(11 Suppl):S22–32, 2009.
[173] H.N. Poinar, C. Schwarz, J. Qi, B. Shapiro, R.D.E. MacPhee, B. Buigues, A. Tikhonov,
D.H. Huson, L.P. Tomsho, A. Auch, et al. Metagenomics to paleogenomics: large-scale
sequencing of mammoth DNA. Science, 311(5759):392, 2006.
183
BIBLIOGRAPHY
[174] K.S. Pollard, S.R. Salama, B. King, A.D. Kern, T. Dreszer, S. Katzman, A. Siepel, J.S.
Pedersen, G. Bejerano, R. Baertsch, et al. Forces shaping the fastest evolving regions
in the human genome. PloS Genetics, 2(10):e168, 2006.
[175] K.S. Pollard, S.R. Salama, N. Lambert, M.A. Lambot, S. Coppens, J.S. Pedersen,
S. Katzman, B. King, C. Onodera, A. Siepel, et al. An RNA gene expressed during
cortical development evolved rapidly in humans. Nature, 443(7108):167–172, 2006.
[176] M. Pop and S. L. Salzberg. Bioinformatics challenges of new sequencing technology.
Trends in Genetics, 24(3):142–9, 2008.
[177] G. J. Porreca, K. Zhang, J. B. Li, B. Xie, D. Austin, S. L. Vassallo, E. M. LeProust,
B. J. Peck, C. J. Emig, F. Dahl, Y. Gao, G. M. Church, and J. Shendure. Multiplex
amplification of large sets of human exons. Nature Methods, 4(11):931–6, 2007.
[178] S. Prabhakar, J.P. Noonan, S. Pa¨a¨bo, and E.M. Rubin. Accelerated evolution of
conserved noncoding sequences in humans. Science, 314(5800):786, 2006.
[179] S. Prabhakar, A. Visel, J.A. Akiyama, M. Shoukry, K.D. Lewis, A. Holt, I. Plajzer-
Frick, H. Morrison, D.R. FitzPatrick, V. Afzal, et al. Human-specific gain of function
in a developmental enhancer. Science, 321(5894):1346, 2008.
[180] K. Pru¨fer, U. Stenzel, M. Dannemann, R.E. Green, M. Lachmann, and J. Kelso.
PatMaN: rapid alignment of short sequences to large databases. Bioinformatics,
24(13):1530, 2008.
[181] K. Pru¨fer, U. Stenzel, M. Hofreiter, S. Pa¨a¨bo, J. Kelso, and R.E. Green. Computational
challenges in the analysis of ancient DNA. Genome Biology, 11(5):R47, 2010.
[182] D. Pushkarev, N. F. Neff, and S. R. Quake. Single-molecule sequencing of an individual
human genome. Nature Biotechnology, 27(9):847–52, 2009.
[183] M. A. Quail, I. Kozarewa, F. Smith, A. Scally, P. J. Stephens, R. Durbin, H. Swerdlow,
and D. J. Turner. A large genome center’s improvements to the Illumina sequencing
system. Nature Methods, 5(12):1005–10, 2008.
[184] A. R. Quinlan, D. A. Stewart, M. P. Stromberg, and G. T. Marth. Pyrobayes: an
improved base caller for SNP discovery in pyrosequences. Nature Methods, 5(2):179–
81, 2008.
[185] M. Rasmussen, Y. Li, S. Lindgreen, J.S. Pedersen, A. Albrechtsen, I. Moltke,
M. Metspalu, E. Metspalu, T. Kivisild, R. Gupta, et al. Ancient human genome
sequence of an extinct Palaeo-Eskimo. Nature, 463(7282):757–762, 2010.
[186] D. Reich, R.E. Green, M. Kircher, J. Krause, N. Patterson, E.Y. Durand, B. Viola,
A.W. Briggs, U. Stenzel, P.L.F. Johnson, et al. Genetic history of an archaic hominin
group from Denisova Cave in Siberia. Nature, 468(7327):1053–1060, 2010.
[187] D. Reich, K. Thangaraj, N. Patterson, A.L. Price, and L. Singh. Reconstructing Indian
population history. Nature, 461(7263):489–494, 2009.
[188] J. A. Reinhardt, D. A. Baltrus, M. T. Nishimura, W. R. Jeck, C. D. Jones, and J. L.
Dangl. De novo assembly using low-coverage short read sequence data from the rice
pathogen Pseudomonas syringae pv. oryzae. Genome Research, 19(2):294–305, 2009.
184
BIBLIOGRAPHY
[189] IBM Research. IBM Research Aims to Build Nanoscale DNA Sequencer to Help Drive
Down Cost of Personalized Genetic Analysis, 2009.
[190] B. Rhead, D. Karolchik, R.M. Kuhn, A.S. Hinrichs, A.S. Zweig, P.A. Fujita,
M. Diekhans, K.E. Smith, K.R. Rosenbloom, B.J. Raney, et al. The UCSC genome
browser database: update 2010. Nucleic Acids Research, 2009.
[191] B. G. Richter and D. P. Sexton. Managing and analyzing next-generation sequence
data. PLoS Computational Biology, 5(6):e1000369, 2009.
[192] M.D. Robinson, D.J. McCarthy, and G.K. Smyth. edgeR: a Bioconductor package
for differential expression analysis of digital gene expression data. Bioinformatics,
26(1):139, 2010.
[193] M.D. Robinson and G.K. Smyth. Moderated statistical tests for assessing differences
in tag abundance. Bioinformatics, 23(21):2881, 2007.
[194] M.D. Robinson and G.K. Smyth. Small-sample estimation of negative binomial dis-
persion, with applications to SAGE data. Biostatistics, 9(2):321, 2008.
[195] N. Rohland and M. Hofreiter. Comparison and optimization of ancient DNA extraction.
Biotechniques, 42(3):343–52, 2007.
[196] M. Ronaghi, S. Karamohamed, B. Pettersson, M. Uhlen, and P. Nyren. Real-time
DNA sequencing using detection of pyrophosphate release. Analytical Biochemistry,
242(1):84–9, 1996.
[197] M. G. Roper, C. J. Easley, L. A. Legendre, J. A. Humphrey, and J. P. Landers. Infrared
temperature control system for a completely noncontact polymerase chain reaction in
microfluidic chips. Analytical Chemistry, 79(4):1294–300, 2007.
[198] J. Rougemont, A. Amzallag, C. Iseli, L. Farinelli, I. Xenarios, and F. Naef. Probabilistic
base calling of Solexa sequencing data. BMC Bioinformatics, 9:431, 2008.
[199] JP Royston. An extension of Shapiro and Wilk’s W test for normality to large samples.
Applied Statistics, 31(2):115–124, 1982.
[200] M. Safran, I. Dalah, J. Alexander, N. Rosen, T. Iny Stein, M. Shmoish, N. Nativ,
I. Bahir, T. Doniger, H. Krug, et al. GeneCards Version 3: the human gene integrator.
Database, 2010(0), 2010.
[201] A.H. Salem, D.A. Ray, J. Xing, P.A. Callinan, J.S. Myers, D.J. Hedges, R.K. Garber,
D.J. Witherspoon, L.B. Jorde, and M.A. Batzer. Alu elements and hominid phylo-
genetics. Proceedings of the National Academy of Sciences of the United States of
America, 100(22):12787, 2003.
[202] F. Sanger, G. M. Air, B. G. Barrell, N. L. Brown, A. R. Coulson, C. A. Fiddes, C. A.
Hutchison, P. M. Slocombe, and M. Smith. Nucleotide sequence of bacteriophage phi
X174 DNA. Nature, 265(5596):687–95, 1977.
[203] F. Sanger and A. R. Coulson. A rapid method for determining sequences in DNA by
primed synthesis with DNA polymerase. Journal of Molecular Biology, 94(3):441–8,
1975.
[204] F. Sanger, S. Nicklen, and A. R. Coulson. DNA sequencing with chain-terminating
inhibitors. Proceedings of the National Academy of Sciences USA, 74(12):5463–7, 1977.
185
BIBLIOGRAPHY
[205] M. Schena, D. Shalon, RW Davis, and PO Brown. Quantitative monitoring of gene
expression patterns with a complementary DNA microarray. Science, 270(5235):467,
1995.
[206] S. C. Schuster. Next-generation sequencing transforms today’s biology. Nature Meth-
ods, 5(1):16–8, 2008.
[207] N. Servant, E. Gravier, P. Gestraud, C. Laurent, C. Paccard, A. Biton, I. Brito, J. Man-
del, B. Asselain, E. Barillot, et al. EMA- A R package for Easy Microarray data
analysis. BMC Research Notes, 3(1):277, 2010.
[208] S.S. Shapiro and M.B. Wilk. An analysis of variance test for normality (complete
samples). Biometrika, 52(3-4):591, 1965.
[209] J. Shendure and H. Ji. Next-generation DNA sequencing. Nature Biotechnology,
26(10):1135–45, 2008.
[210] J. Shendure, G. J. Porreca, N. B. Reppas, X. Lin, J. P. McCutcheon, A. M. Rosenbaum,
M. D. Wang, K. Zhang, R. D. Mitra, and G. M. Church. Accurate multiplex polony
sequencing of an evolved bacterial genome. Science, 309(5741):1728–32, 2005.
[211] J. A. Shendure, G. J. Porreca, and G. M. Church. Overview of DNA sequencing
strategies. Current Protocols in Molecular Biology, Chapter 7:Unit 7 1, 2008.
[212] ST Sherry, M.H. Ward, M. Kholodov, J. Baker, L. Phan, EM Smigielski, and
K. Sirotkin. dbSNP: the NCBI database of genetic variation. Nucleic Acids Research,
29(1):308, 2001.
[213] K. Shibata, M. Itoh, K. Aizawa, S. Nagaoka, N. Sasaki, P. Carninci, H. Konno,
J. Akiyama, K. Nishi, T. Kitsunai, H. Tashiro, N. Sumi, Y. Ishii, S. Nakamura,
M. Hazama, T. Nishine, A. Harada, R. Yamamoto, H. Matsumoto, S. Sakaguchi,
T. Ikegami, K. Kashiwagi, S. Fujiwake, K. Inoue, and Y. Togawa. RIKEN integrated
sequence analysis (RISA) system–384-format sequencing pipeline with 384 multicapil-
lary sequencer. Genome Research, 10(11):1757–71, 2000.
[214] F. Shu, S. Ramineni, and J.R. Hepler. RGS14 is a multifunctional scaffold that in-
tegrates G protein and Ras/Raf MAPkinase signalling pathways. Cellular signalling,
22(3):366–376, 2010.
[215] D.A. Siegel, M.K. Huang, and S.F. Becker. Ectopic dendrite initiation: CNS patho-
genesis as a model of CNS development* 1. International Journal of Developmental
Neuroscience, 20(3-5):373–389, 2002.
[216] L. M. Smith, J. Z. Sanders, R. J. Kaiser, P. Hughes, C. Dodd, C. R. Connell, C. Heiner,
S. B. Kent, and L. E. Hood. Fluorescence detection in automated DNA sequence
analysis. Nature, 321(6071):674–9, 1986.
[217] B.A. Sokhansanj, G.R. Rodrigue, J.P. Fitch, and M.W. David III. A quantitative model
of human DNA base excision repair. I. Mechanistic insights. Nucleic acids research,
30(8):1817, 2002.
[218] M. Somel, H. Franz, Z. Yan, A. Lorenc, S. Guo, T. Giger, J. Kelso, B. Nickel, M. Dan-
nemann, S. Bahn, et al. Transcriptional neoteny in the human brain. Proceedings of
the National Academy of Sciences USA, 106(14):5743, 2009.
186
BIBLIOGRAPHY
[219] A. Stark, J. Brennecke, N. Bushati, R.B. Russell, and S.M. Cohen. Animal MicroRNAs
confer robustness to gene expression and have a significant impact on 3’UTR evolution.
Cell, 123(6):1133–1146, 2005.
[220] M.E. Steiper and N.M. Young. Primate molecular divergence dates. Molecular phylo-
genetics and evolution, 41(2):384–394, 2006.
[221] M. Stiller, M. Knapp, U. Stenzel, M. Hofreiter, and M. Meyer. Direct multiplex se-
quencing (DMPS) – a novel method for targeted high-throughput sequencing of ancient
and highly degraded DNA. Genome Research, 19(10):1843, 2009.
[222] M.R. Stratton, P.J. Campbell, and P.A. Futreal. The cancer genome. Nature,
458(7239):719–724, 2009.
[223] H. Swerdlow and R. Gesteland. Capillary gel electrophoresis for rapid, high resolution
DNA sequencing. Nucleic Acids Research, 18(6):1415–9, 1990.
[224] R Development Core Team. R: A Language and Environment for Statistical Comput-
ing. R Foundation for Statistical Computing, Vienna, Austria, 2008.
[225] A. Tenesa, P. Navarro, B.J. Hayes, D.L. Duffy, G.M. Clarke, M.E. Goddard, and P.M.
Visscher. Recent human effective population size estimated from linkage disequilibrium.
Genome Research, 17(4):520, 2007.
[226] The ENCODE Project Consortium. Identification and analysis of functional elements
in 1% of the human genome by the ENCODE pilot project. Nature, 447(7146):799–816,
2007.
[227] J.D. Thompson, D.G. Higgins, and T.J. Gibson. CLUSTAL W: improving the sensitiv-
ity of progressive multiple sequence alignment through sequence weighting, position-
specific gap penalties and weight matrix choice. Nucleic Acids Research, 22(22):4673,
1994.
[228] C. Trapnell, L. Pachter, and S.L. Salzberg. TopHat: discovering splice junctions with
RNA-Seq. Bioinformatics, 25(9):1105, 2009.
[229] C. Trapnell, B.A. Williams, G. Pertea, A. Mortazavi, G. Kwan, M.J. Van Baren, S.L.
Salzberg, B.J. Wold, and L. Pachter. Transcript assembly and quantification by RNA-
Seq reveals unannotated transcripts and isoform switching during cell differentiation.
Nature biotechnology, 28(5):511–515, 2010.
[230] I. Tsochantaridis, T. Joachims, T. Hofmann, and Y. Altun. Large margin methods
for structured and interdependent output variables. Journal of Machine Learning
Research, 6(2):1453, 2006.
[231] G. Turcatti, A. Romieu, M. Fedurco, and A. P. Tairi. A new class of cleavable flu-
orescent nucleotides: synthesis and optimization as reversible terminators for DNA
sequencing by synthesis. Nucleic Acids Research, 36(4):e25, 2008.
[232] E. H. Turner, C. Lee, S. B. Ng, D. A. Nickerson, and J. Shendure. Massively par-
allel exon capture and library-free resequencing across 16 genomes. Nature Methods,
6(5):315–6, 2009.
[233] K. Ueno and E. S. Yeung. Simultaneous monitoring of DNA fragments separated
by electrophoresis in a multiplexed array of 100 capillaries. Analytical Chemistry,
66(9):1424–1431, 1994.
187
BIBLIOGRAPHY
[234] V.E. Velculescu, L. Zhang, B. Vogelstein, and K.W. Kinzler. Serial analysis of gene
expression. Science, 270(5235):484, 1995.
[235] J.C. Venter, M.D. Adams, E.W. Myers, P.W. Li, R.J. Mural, G.G. Sutton, H.O. Smith,
M. Yandell, C.A. Evans, R.A. Holt, et al. The sequence of the human genome. Science,
291(5507):1304, 2001.
[236] J.D. Wall and M.F. Hammer. Archaic admixture in the human genome. Current
opinion in genetics & development, 16(6):606–610, 2006.
[237] P. K. Wall, J. Leebens-Mack, A. S. Chanderbali, A. Barakat, E. Wolcott, H. Liang,
L. Landherr, L. P. Tomsho, Y. Hu, J. E. Carlson, H. Ma, S. C. Schuster, D. E. Soltis,
P. S. Soltis, N. Altman, and C. W. dePamphilis. Comparison of next generation
sequencing technologies for transcriptome characterization. BMC Genomics, 10:347,
2009.
[238] L. Wang, Z. Feng, X. Wang, X. Wang, and X. Zhang. DEGseq: an R package for iden-
tifying differentially expressed genes from RNA-seq data. Bioinformatics, 26(1):136,
2010.
[239] D. Weigel and R. Mott. The 1001 genomes project for Arabidopsis thaliana. Genome
Biology, 10(5):107, 2009.
[240] A. Wetterbom, A. Ameur, L. Feuk, U. Gyllensten, and L. Cavelier. Identification of
novel exons and transcribed regions by chimpanzee transcriptome sequencing. Genome
Biology, 11(7):R78, 2010.
[241] D. A. Wheeler, M. Srinivasan, M. Egholm, Y. Shen, L. Chen, A. McGuire, W. He, Y. J.
Chen, V. Makhijani, G. T. Roth, X. Gomes, K. Tartaro, F. Niazi, C. L. Turcotte, G. P.
Irzyk, J. R. Lupski, C. Chinault, X. Z. Song, Y. Liu, Y. Yuan, L. Nazareth, X. Qin,
D. M. Muzny, M. Margulies, G. M. Weinstock, R. A. Gibbs, and J. M. Rothberg.
The complete genome of an individual by massively parallel DNA sequencing. Nature,
452(7189):872–6, 2008.
[242] N. Whiteford, T. Skelly, C. Curtis, M.E. Ritchie, A. Lo¨hr, A.W. Zaranek, I. Abni-
zova, and C. Brown. Swift: primary data analysis for the Illumina Solexa sequencing
platform. Bioinformatics, 25(17):2194, 2009.
[243] T. Wicker, E. Schlagenhauf, A. Graner, T. J. Close, B. Keller, and N. Stein. 454
sequencing put to the test using the complex genome of barley. BMC Genomics,
7:275, 2006.
[244] E.B. Wilson. Probable inference, the law of succession, and statistical inference. Jour-
nal of the American Statistical Association, 22(158):209–212, 1927.
[245] R. Wu and A. D. Kaiser. Structure and base sequence in the cohesive ends of bacte-
riophage lambda DNA. Journal of Molecular Biology, 35(3):523–37, 1968.
[246] Z. Wu, R.A. Irizarry, R. Gentleman, F. Martinez-Murillo, and F. Spencer. A model-
based background adjustment for oligonucleotide expression arrays. Journal of the
American Statistical Association, 99(468):909–917, 2004.
[247] R. Yelin, D. Dahary, R. Sorek, E.Y. Levanon, O. Goldstein, A. Shoshan, A. Diber,
S. Biton, Y. Tamir, R. Khosravi, et al. Widespread occurrence of antisense transcrip-
tion in the human genome. Nature Biotechnology, 21(4):379–386, 2003.
188
BIBLIOGRAPHY
[248] J.J. Yunis and OM Prakash. The origin of man: a chromosomal pictorial legacy.
Science, 215(4539):1525, 1982.
[249] R. J. Zagursky and R. M. McCormick. DNA sequencing separations in capillary gels on
a modified commercial DNA sequencing instrument. Biotechniques, 9(1):74–9, 1990.
[250] D.R. Zerbino and E. Birney. Velvet: algorithms for de novo short read assembly using
de Bruijn graphs. Genome Research, 18(5):821, 2008.
[251] Z. Zhang, S. Schwartz, L. Wagner, and W. Miller. A greedy algorithm for aligning
DNA sequences. Journal of Computational Biology, 7(1-2):203–214, 2000.
[252] X. Zhou, Z. Su, R. D. Sammons, Y. Peng, P. J. Tranel, Jr. Stewart, C. N., and J. S.
Yuan. Novel software package for cross-platform transcriptome analysis (CPTRA).
BMC Bioinformatics, 10 Suppl 11:S16, 2009.
[253] Z. Zhu and A. S. Waggoner. Molecular mechanism controlling the incorporation of
fluorescent nucleotides into DNA by PCR. Cytometry, 28(3):206–11, 1997.
[254] A. V. Zimin, A. L. Delcher, L. Florea, D. R. Kelley, M. C. Schatz, D. Puiu, F. Hanra-
han, G. Pertea, C. P. Van Tassell, T. S. Sonstegard, G. Marcais, M. Roberts, P. Sub-
ramanian, J. A. Yorke, and S. L. Salzberg. A whole-genome assembly of the domestic
cow, Bos taurus. Genome Biology, 10(4):R42, 2009.
189
Appendix
Tables
Table 1: Results of the simulation of 10,000 clusters, each with a thousand identical se-
quences. Random sequences were created using the GC content of φX 174 (44.7%) as a
reference. I used a model with pre-phasing (0.4% per cycle), phasing (0.4% per cycle) and
T accumulation (3.8% per cycle) and simulated the fluorophores attached for 150 sequencing
cycles. For each cycle, the number of fluorophores attached to the sequences of the cluster
was determined and the fraction of fluorophores representing the current cycle, the previous
and the next cycles as well as representing cycles more than one ahead and more than one
behind calculated. Further, the fraction of fluorophores attached due to T accumulation was
determined. The results were averaged over all 1,000 sequences. T accumulation is given as
a fraction of the starting fluorophores in a cluster.
Cycle Back>1 Back=1 InPhase Ahead=1 Ahead>1 T accumulation
1 0.000 0.004 0.992 0.004 0.000 0.000
2 0.000 0.008 0.984 0.008 0.000 0.010
3 0.000 0.012 0.976 0.012 0.000 0.021
4 0.000 0.016 0.969 0.016 0.000 0.032
5 0.000 0.019 0.961 0.019 0.000 0.042
6 0.000 0.023 0.954 0.023 0.000 0.053
7 0.000 0.027 0.946 0.027 0.000 0.063
8 0.000 0.030 0.939 0.030 0.000 0.073
9 0.001 0.034 0.931 0.034 0.001 0.083
10 0.001 0.037 0.924 0.037 0.001 0.094
11 0.001 0.041 0.917 0.040 0.001 0.105
12 0.001 0.044 0.910 0.044 0.001 0.115
13 0.001 0.047 0.903 0.047 0.001 0.126
14 0.001 0.050 0.897 0.050 0.001 0.136
15 0.002 0.054 0.890 0.053 0.002 0.147
16 0.002 0.057 0.883 0.057 0.002 0.157
17 0.002 0.060 0.877 0.060 0.002 0.168
18 0.002 0.063 0.870 0.063 0.002 0.178
19 0.002 0.066 0.864 0.066 0.002 0.188
20 0.003 0.069 0.857 0.069 0.003 0.199
21 0.003 0.072 0.851 0.071 0.003 0.210
22 0.003 0.075 0.845 0.074 0.003 0.220
23 0.004 0.077 0.839 0.077 0.003 0.231
24 0.004 0.080 0.833 0.080 0.004 0.241
25 0.004 0.083 0.827 0.082 0.004 0.252
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Cycle Back>1 Back=1 InPhase Ahead=1 Ahead>1 T accumulation
26 0.004 0.085 0.821 0.085 0.004 0.262
27 0.005 0.088 0.815 0.088 0.005 0.273
28 0.005 0.091 0.809 0.090 0.005 0.283
29 0.005 0.093 0.803 0.093 0.005 0.294
30 0.006 0.096 0.798 0.095 0.006 0.304
31 0.006 0.098 0.792 0.098 0.006 0.315
32 0.007 0.100 0.786 0.100 0.006 0.325
33 0.007 0.103 0.781 0.102 0.007 0.336
34 0.007 0.105 0.776 0.105 0.007 0.346
35 0.008 0.107 0.770 0.107 0.008 0.357
36 0.008 0.110 0.765 0.109 0.008 0.367
37 0.008 0.112 0.760 0.111 0.008 0.378
38 0.009 0.114 0.755 0.114 0.009 0.388
39 0.009 0.116 0.750 0.116 0.009 0.399
40 0.010 0.118 0.744 0.118 0.010 0.409
41 0.010 0.120 0.739 0.120 0.010 0.420
42 0.011 0.122 0.734 0.122 0.011 0.430
43 0.011 0.124 0.730 0.124 0.011 0.441
44 0.012 0.126 0.725 0.126 0.011 0.451
45 0.012 0.128 0.720 0.128 0.012 0.462
46 0.012 0.130 0.715 0.130 0.012 0.472
47 0.013 0.132 0.711 0.132 0.013 0.482
48 0.013 0.134 0.706 0.133 0.013 0.493
49 0.014 0.136 0.701 0.135 0.014 0.503
50 0.014 0.137 0.697 0.137 0.014 0.514
51 0.015 0.139 0.692 0.139 0.015 0.524
52 0.015 0.141 0.688 0.140 0.015 0.535
53 0.016 0.143 0.684 0.142 0.016 0.545
54 0.016 0.144 0.679 0.144 0.016 0.556
55 0.017 0.146 0.675 0.145 0.017 0.566
56 0.017 0.147 0.671 0.147 0.017 0.577
57 0.018 0.149 0.667 0.149 0.018 0.588
58 0.019 0.151 0.662 0.150 0.018 0.598
59 0.019 0.152 0.658 0.152 0.019 0.609
60 0.020 0.154 0.654 0.153 0.019 0.619
61 0.020 0.155 0.650 0.155 0.020 0.629
62 0.021 0.157 0.646 0.156 0.020 0.640
63 0.021 0.158 0.642 0.157 0.021 0.650
64 0.022 0.159 0.639 0.159 0.022 0.661
65 0.022 0.161 0.635 0.160 0.022 0.671
66 0.023 0.162 0.631 0.162 0.023 0.682
67 0.023 0.163 0.627 0.163 0.023 0.692
68 0.024 0.165 0.624 0.164 0.024 0.702
69 0.025 0.166 0.620 0.165 0.024 0.713
70 0.025 0.167 0.616 0.167 0.025 0.723
71 0.026 0.168 0.613 0.168 0.026 0.734
72 0.026 0.169 0.609 0.169 0.026 0.745
73 0.027 0.171 0.606 0.170 0.027 0.755
74 0.027 0.172 0.602 0.171 0.027 0.766
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Cycle Back>1 Back=1 InPhase Ahead=1 Ahead>1 T accumulation
75 0.028 0.173 0.599 0.172 0.028 0.776
76 0.029 0.174 0.595 0.174 0.028 0.787
77 0.029 0.175 0.592 0.175 0.029 0.797
78 0.030 0.176 0.589 0.176 0.030 0.807
79 0.030 0.177 0.585 0.177 0.030 0.818
80 0.031 0.178 0.582 0.178 0.031 0.828
81 0.032 0.179 0.579 0.179 0.031 0.839
82 0.032 0.180 0.576 0.180 0.032 0.849
83 0.033 0.181 0.572 0.181 0.033 0.860
84 0.033 0.182 0.569 0.182 0.033 0.870
85 0.034 0.183 0.566 0.183 0.034 0.881
86 0.035 0.184 0.563 0.183 0.034 0.891
87 0.035 0.185 0.560 0.184 0.035 0.902
88 0.036 0.186 0.557 0.185 0.036 0.912
89 0.037 0.187 0.554 0.186 0.036 0.923
90 0.037 0.188 0.551 0.187 0.037 0.934
91 0.038 0.188 0.548 0.188 0.038 0.944
92 0.038 0.189 0.545 0.189 0.038 0.955
93 0.039 0.190 0.543 0.189 0.039 0.965
94 0.040 0.191 0.540 0.190 0.039 0.976
95 0.040 0.192 0.537 0.191 0.040 0.986
96 0.041 0.192 0.534 0.192 0.041 0.997
97 0.042 0.193 0.532 0.192 0.041 1.008
98 0.042 0.194 0.529 0.193 0.042 1.018
99 0.043 0.195 0.526 0.194 0.042 1.029
100 0.043 0.195 0.524 0.195 0.043 1.039
101 0.044 0.196 0.521 0.195 0.044 1.050
102 0.045 0.197 0.518 0.196 0.044 1.061
103 0.045 0.197 0.516 0.197 0.045 1.071
104 0.046 0.198 0.513 0.197 0.046 1.082
105 0.047 0.199 0.511 0.198 0.046 1.092
106 0.047 0.199 0.508 0.199 0.047 1.103
107 0.048 0.200 0.506 0.199 0.047 1.113
108 0.048 0.201 0.503 0.200 0.048 1.123
109 0.049 0.201 0.501 0.200 0.049 1.134
110 0.050 0.202 0.498 0.201 0.049 1.145
111 0.050 0.202 0.496 0.201 0.050 1.155
112 0.051 0.203 0.494 0.202 0.051 1.166
113 0.052 0.203 0.491 0.202 0.051 1.176
114 0.052 0.204 0.489 0.203 0.052 1.186
115 0.053 0.204 0.487 0.203 0.053 1.197
116 0.054 0.205 0.485 0.204 0.053 1.207
117 0.054 0.205 0.482 0.204 0.054 1.217
118 0.055 0.206 0.480 0.205 0.054 1.228
119 0.055 0.206 0.478 0.205 0.055 1.238
120 0.056 0.207 0.476 0.206 0.056 1.249
121 0.057 0.207 0.474 0.206 0.056 1.259
122 0.057 0.207 0.472 0.207 0.057 1.270
123 0.058 0.208 0.469 0.207 0.057 1.281
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Cycle Back>1 Back=1 InPhase Ahead=1 Ahead>1 T accumulation
124 0.059 0.208 0.467 0.208 0.058 1.291
125 0.059 0.209 0.465 0.208 0.059 1.302
126 0.060 0.209 0.463 0.208 0.059 1.312
127 0.060 0.210 0.461 0.209 0.060 1.322
128 0.061 0.210 0.459 0.209 0.061 1.333
129 0.062 0.210 0.457 0.209 0.061 1.343
130 0.062 0.211 0.455 0.210 0.062 1.354
131 0.063 0.211 0.453 0.210 0.063 1.365
132 0.064 0.211 0.451 0.211 0.063 1.375
133 0.064 0.212 0.449 0.211 0.064 1.385
134 0.065 0.212 0.447 0.211 0.064 1.396
135 0.066 0.212 0.446 0.212 0.065 1.406
136 0.066 0.213 0.444 0.212 0.066 1.417
137 0.067 0.213 0.442 0.212 0.066 1.428
138 0.067 0.213 0.440 0.212 0.067 1.438
139 0.068 0.214 0.438 0.213 0.068 1.448
140 0.069 0.214 0.436 0.213 0.068 1.459
141 0.069 0.214 0.435 0.213 0.069 1.469
142 0.070 0.214 0.433 0.213 0.069 1.480
143 0.071 0.214 0.431 0.214 0.070 1.491
144 0.071 0.215 0.429 0.214 0.071 1.501
145 0.072 0.215 0.428 0.214 0.071 1.512
146 0.072 0.215 0.426 0.214 0.072 1.522
147 0.073 0.215 0.424 0.215 0.072 1.533
148 0.074 0.216 0.423 0.215 0.073 1.543
149 0.074 0.216 0.421 0.215 0.074 1.553
150 0.075 0.216 0.419 0.215 0.074 1.560
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Abbreviations
A/C/G/T Deoxyadenosine, deoxycytosine, deoxyguanosine, deoxythymidine
AIC Akaike information criterion
ATP Adenosine triphosphate
dATP Deoxyadenosine triphosphate
dATPαS Deoxy-adenosine-5’-(alpha-thio)-triphosphate
bp base pair(s)
CAE Capillary Array Electrophoresis
CAS Chinese Academy of Sciences
cDNA complementary DNA synthesized from a mRNA template
CEPH Centre d’Etude du Polymorphisme Humain
CCD Charge-Coupled Device (semi-conductor device used in digital cameras)
ChIP-Seq Chromatin Immuno-Precipitation sequencing
CNV Copy Number Variation
DGE Digital Gene Expression
DNA DeoxyriboNucleic acid
dNTPs/NTPs deoxy-nucleotides
ddNTPs dideoxy-nucleotides (modified nucleotides missing a hydroxyl group at
the third carbon atom of the sugar)
EndoVIII Escherichia coli endonuclease VIII
FDR False Discovery Rate
FRET Fluorescence Resonance Energy Transfer
GA Short for Illumina Genome Analyzer
GC Frequency of Guanine and Cytosine nucleobases
HAR Human Accelerated Region
HGDP Human Genome Diversity Panel
InDel Insertion/Deletion
IPAR Integrated Primary Analysis and Reporting (Illumina software)
IUPAC International Union of Pure and Applied Chemistry
kb/Mb/Gb kilo base (103 nt) / mega base (106 nt) / giga base (109 nt)
MeDIP-Seq Methylation-Dependent Immuno-Precipitation sequencing
miRNA microRNA
MPG Max Planck Society (German: Max-Planck-Gesellschaft)
MPI Max Planck Institute
mRNA messenger RNA/transcripts
mtDNA mitochondrial DNA
nt nucleotide(s)
OLB Off-Line Basecaller (Illumina software)
PCA Principal Component Analysis
PEC Primer Extension Capture
PCR Polymerase Chain Reaction
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qPCR quantitative Polymerase Chain Reaction
QC Quality control
RMSD Root Mean Square Deviation
RNA RiboNucleic acid
RNAseq Sequencing of mRNAs/transcripts
RTA Real Time Analysis (Illumina software)
SAGE Serial Analysis of Gene Expression
SCS Sequencing Control Software (Illumina software)
SMRT Single Molecule Real Time
SNP Single Nucleotide Polymorphism
SNC Single Nucleotide Change (on the human lineage)
SVM Support Vector Machine
TCEP tris-(2-carboxyethyl)-phosphine)
UDG Uracil-DNA Glycosylase
UTR Untranslated region of mRNA
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φX174, 18, 59, 66, 89, 130, 131
3’ UTRs, see Untranslated region
454 Life Sciences, 20
454 sequencing, 20, 32, 33, 129, 163
5’ UTRs, see Untranslated region
ABI, see Applied Biosystems
ABI Prism, 18
Admixture, 152, 161
Amplification bias, 60
ancient DNA, 126
Applied Biosystems, 18, 26
Artifact, 22, 40, 57
Asynchronous sequencing, 29
Background error rate, see Error rate
Barcode, 35, 40, 49
BASE, 32
Base calling, 39, 65
Beads, 21, 28
Mixed, 22
Block Jackknife, 158
Bridge amplification, 24, 37
Burrows-Wheeler transformed alignment, see
BWA
BWA, 41, 133, 136
Capillary Array Electrophoresis (CAE), see
Sanger sequencing
Catalog of changes, 136
cBot, see Cluster station
CCDS, 139
Centre d’Etude du Polymorphisme Humain,
134
CEPH, see Centre d’Etude du Polymorphis-
me Humain
Chastity filter, 58
CIF, see Cluster Intensity Format
Cluster, see Sequence cluster
Cluster Intensity Format, 66, 131
Cluster station, 54
Color-space encoding, 26
Complete Genomics, 26
Cross-talk matrix, 66
ddNTP, 19
Denisovans, 127, 131, 151, 161
DGE, see Digital Gene Expression
Digital Gene Expression, 41, 93, 167
DNA sequencing, see Sequencing
dNTP, 19
ELAND, 41, 97
Electrophoresis, 19
Emulsion PCR, 21
Endoplasmic reticulum, 139
Ensemble, 22, 30
Error rate
Background, 22
Sequencing, 20, 22, 24, 28, 30, 47, 58
Firecrest, 54, 65
Flatness, 52
Flow cell, 23, 29, 32, 38, 40, 52
Flow cell tilt, 52
Flow cycle, 22
Fluorescence Resonance Energy Transfer, 33
Footprint, 52, 54
Forked adapters, 23
FRET, see Fluorescence Resonance Energy
Transfer
GATK, see Genome Analysis Tool Kit
GE MegaBACE, 18
General Electrics (GE) Healthcare, 18
Genome Analysis Tool Kit, 60, 90
Genome Analyzer, 23, 33, 37, 64, 93, 130,
163, 166, 167
Ghost well, 22
GS FLX, see 454 sequencing
GS Junior, 32
HAR, see Human accelerated region
Helicos, 28
HeliScope, 28, 33
HGDP, see Human Genome Diversity Panel
HiSeq2000, 32
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Homopolymer, 20
Human accelerated region, 144, 149, 150
Human Genome Diversity Panel, 134
Ibis, 65, 166
IBM, 32
Illumina, see Genome Analyzer
Image analysis, 39, 65
In vitro amplification, 20, 24
In vivo amplification, 20
InDels, 22, 137
Index, see Barcode
Integrated Primary Analysis and Reporting,
55, 65
Intensities, 39
Intensity files, 66
Ion Torrent, 32
IPAR, see Integrated Primary Analysis and
Reporting
Life Technologies, 26, 32
Machine learning, 70
Mate pair sequencing, 34, 164
Messenger RNA, 93, 146
microRNA, 146
miRNA, see microRNA
Mitochondria, 126, 143
mitochondrial DNA, 127, 162
Mixed beads, 22
mRNA, see Messenger RNA
mtDNA, see mitochondrial DNA
MySeq, 32
Nanopores
BASE, 32
Silicon-based, 32
Neandertals, 127, 129, 151, 161
Non-reversible termination, 19
Nucleotide modification, 32
Off-Line Basecaller, 54, 65
OLB, see Off-Line Basecaller
Oxford Nanopore, 32
Pacific Biosciences, 30, 33
Paired End Module, 24
Paired end sequencing, 24, 32, 34, 164
Pass Filter flag, 58
PCA, see Principal component analysis
PCR duplicates, 60
PEC, see Primer Extension Capture
Personal Genome Maschine, 32
PF, see Pass Filter
PGM, see Personal Genome Machine
Phasing, 22, 24, 28, 40, 49, 66, 70, 166
bi-directional, 24
unidirectional, 24
phiX 174, see φX174
Picotiter plate, 21
Polonator, 26
Pre-phasing, see Phasing
Primer Extension Capture, 129
Principal component analysis, 104
Pyrosequencing, 20
qPCR, 55
Real Time Analysis, 54, 65, 131
Restriction enzyme enrichment, 130
Reversible terminator chemistry, 23
RNAseq, 93, 118, 171
Roche Diagnostics, 21
Roche sequencing, see 454 sequencing
RTA, see Real Time Analysis
SAGE, see Serial Analysis of Gene Expres-
sion
Sanger sequencing, 19, 33, 163
Sequence cluster, 24, 37, 54, 57
Sequencing, 18, 37, 94, 129
Sequencing by synthesis, 20
Sequencing error rate, see Error rate
Sequencing library, 21, 23, 38, 40, 129
Sequencing-by-ligation, 26
Serial Analysis of Gene Expression, 93, 167
Signal peptide, 139
Simple repeat, 20
Single Molecule Real Time, 30, 33
Single nucleotide polymorphism, 34, 164
Single-molecule sequencing, 28, 32, 33
SMRT, see Single Molecule Real Time
SMS, see Single-molecule sequencing
SNC, 136
SNP, see Single nucleotide polymorphism
Solexa sequencing, see Genome Analyzer
SOLiD sequencing, 26, 32, 33, 163
Stage tilt, 54
Statistical learner, 70
T accumulation, 67, 70, 130
Tilt, 52, 54
Titanium, see 454 sequencing
214
Untranslated region, 98, 100, 144, 145
UTR, see Untranslated region
Virtual-terminator chemistry, 29
Well (picotiter plate), 22
Zero-mode waveguides, 30
ZMW, see Zero-mode waveguides
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